data_1dny_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dny _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.539 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.576 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 2.1 t -65.76 -46.74 88.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.445 ' HG3' ' HB3' ' A' ' 78' ' ' ALA . 7.5 mt-10 -70.98 -25.05 62.53 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.539 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 28.2 m -59.11 -48.93 79.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -68.37 -57.29 6.12 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.397 -0.814 . . . . 0.0 109.034 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.721 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -54.55 -19.26 5.56 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.276 -0.97 . . . . 0.0 108.956 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -74.79 -51.4 14.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 2.9 mt-10 -58.24 -63.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.721 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -43.55 -54.73 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.149 -0.969 . . . . 0.0 108.88 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.727 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 1.8 m95 -42.68 -57.54 2.68 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.58 -0.7 . . . . 0.0 110.924 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 6.8 pt-20 -65.83 -30.86 71.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.943 -1.098 . . . . 0.0 111.167 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.427 ' N ' ' HG3' ' A' ' 24' ' ' GLU . 17.8 ttm180 -75.15 -71.38 0.36 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.846 -1.159 . . . . 0.0 109.865 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.593 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 69.0 t -55.09 -34.5 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.536 -0.727 . . . . 0.0 110.555 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 39.2 mt -86.08 -17.63 34.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.894 -1.129 . . . . 0.0 109.883 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.94 27.61 60.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.481 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -102.96 -176.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -1.216 . . . . 0.0 108.886 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 t -142.3 83.24 1.82 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.131 -0.98 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 130.41 -74.87 0.43 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.528 HG23 ' N ' ' A' ' 33' ' ' GLY . 3.8 mt 58.35 152.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -1.174 . . . . 0.0 109.781 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.528 ' N ' HG23 ' A' ' 32' ' ' ILE . . . -96.61 -133.19 7.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 9.9 mt -120.42 -67.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.863 -1.375 . . . . 0.0 110.159 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 2.4 tt -85.12 35.64 0.59 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.74 -1.225 . . . . 0.0 109.657 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -59.07 -166.47 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 109.588 178.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.1 m-20 -134.17 115.81 14.64 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.727 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 72.1 m-85 . . . . . 0 N--CA 1.506 2.374 0 O-C-N 121.12 -0.988 . . . . 0.0 110.904 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.309 0.576 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.61 -23.92 12.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 109.498 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 27' ' ' LEU . 1.7 mptt -71.33 -68.32 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.587 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -46.9 -44.69 19.94 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.965 -1.085 . . . . 0.0 108.362 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.548 ' SD ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.24 -53.88 31.09 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.399 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.533 ' CB ' ' CG1' ' A' ' 26' ' ' VAL . . . -43.65 -42.31 5.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.516 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 17.1 t -59.56 -48.31 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.449 ' HA ' HG22 ' A' ' 55' ' ' VAL . . . -58.08 -31.9 67.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.029 -1.045 . . . . 0.0 108.43 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.04 70.89 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.552 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 6.8 tp-100 -63.07 -31.21 72.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.534 ' CG1' HG12 ' A' ' 81' ' ' VAL . 2.6 t -75.9 -28.8 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' TYR . 6.1 t60 -77.72 -33.63 52.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.204 -0.935 . . . . 0.0 110.047 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -80.92 -46.5 15.1 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.489 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -62.97 -36.33 83.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.603 ' CD2' HG12 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -141.71 156.6 45.61 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.586 0.708 . . . . 0.0 109.434 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -95.29 43.94 1.09 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.55 HG12 ' CG1' ' A' ' 81' ' ' VAL . 4.8 p -91.91 149.12 4.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.422 0.63 . . . . 0.0 110.014 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 61' ' ' VAL . 9.5 tt0 -80.73 97.32 7.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 110.384 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.535 HD23 ' CD1' ' A' ' 77' ' ' LEU . 1.1 tp -126.7 86.22 59.02 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.528 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 35.6 Cg_endo -77.47 175.67 11.0 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.696 2.264 . . . . 0.0 110.983 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.548 ' CD2' ' SD ' ' A' ' 49' ' ' MET . 2.5 mm? -67.56 -41.87 83.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.435 -0.79 . . . . 0.0 109.299 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.44 -29.14 65.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.07 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.528 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 3.7 t -76.84 -34.05 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.587 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -69.88 -21.2 63.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -87.4 -34.63 18.7 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -72.85 -28.31 62.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.993 0.902 . . . . 0.0 108.735 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.545 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -146.13 65.66 10.87 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.157 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.572 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.7 Cg_endo -77.38 60.74 7.15 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.903 2.402 . . . . 0.0 112.674 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.562 ' HA ' ' CZ2' ' A' ' 23' ' ' TRP . 6.3 t -154.03 176.04 12.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.512 -1.368 . . . . 0.0 111.164 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.592 HG12 ' CE2' ' A' ' 23' ' ' TRP . 9.6 mt -74.28 -42.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.268 -0.895 . . . . 0.0 111.606 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -70.39 -45.24 66.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.583 -1.323 . . . . 0.0 108.666 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.524 ' HB1' ' CG2' ' A' ' 73' ' ' THR . . . -66.27 -35.01 79.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.647 -0.658 . . . . 0.0 109.945 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -73.04 -62.03 1.61 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.9 -1.125 . . . . 0.0 108.589 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 82' ' ' ALA . . . -51.15 -28.04 10.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 2.0 tp60 -81.15 -34.47 32.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.8 -1.187 . . . . 0.0 108.564 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.503 ' CD2' HD13 ' A' ' 63' ' ' LEU . 11.5 t80 -61.89 -33.16 73.7 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.603 HG12 ' CD2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.94 -73.65 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 122.44 1.114 . . . . 0.0 108.198 178.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.576 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -39.0 -27.05 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.156 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 81' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.059 -1.025 . . . . 0.0 109.523 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.579 ' HA ' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 121.153 0.502 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.591 ' CG2' ' CB ' ' A' ' 82' ' ' ALA . 28.1 t -54.55 -49.62 65.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 20' ' ' ALA . 3.9 tt0 -69.68 -26.84 64.57 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.579 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 32.7 t -53.66 -52.29 60.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.947 -1.096 . . . . 0.0 108.796 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 1.3 tppm? -65.68 -53.07 46.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 109.251 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.715 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 3.5 mp -57.67 -31.62 66.51 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.653 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 16' ' ' GLU . . . -59.84 -51.67 68.73 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -59.52 -64.74 0.84 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.715 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -44.49 -53.6 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.721 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 3.6 m95 -43.52 -61.93 1.23 Allowed 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.469 0.652 . . . . 0.0 110.523 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.553 ' N ' HD12 ' A' ' 32' ' ' ILE . 3.5 pt-20 -64.01 -36.42 83.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.363 -0.836 . . . . 0.0 110.664 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -68.66 -63.34 1.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.314 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.585 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 61.3 t -68.52 -34.49 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 111.12 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.509 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 40.7 mt -83.84 4.75 27.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.867 -1.146 . . . . 0.0 109.939 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.21 51.77 48.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.509 ' CG2' ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -129.09 171.76 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -1.161 . . . . 0.0 109.249 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.1 t -139.51 70.63 1.37 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.103 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.6 68.94 0.31 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.553 HD12 ' N ' ' A' ' 24' ' ' GLU . 2.9 mp -85.87 146.17 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -1.093 . . . . 0.0 109.615 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' A' ' 74' ' ' ILE . . . -66.88 -135.16 0.04 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.536 ' CG1' ' HB2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -123.73 -54.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.013 -1.286 . . . . 0.0 109.973 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.528 ' C ' ' OG1' ' A' ' 73' ' ' THR . 0.2 OUTLIER -96.6 44.46 1.06 Allowed 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.275 -1.516 . . . . 0.0 108.17 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.81 114.9 12.62 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.485 ' O ' ' C ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -62.75 113.51 3.07 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.385 -1.447 . . . . 0.0 108.649 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.721 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 90.7 m-85 . . . . . 0 N--CA 1.511 2.622 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.119 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.317 0.579 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.5 tp -52.08 -38.88 58.69 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.262 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 1.3 mttp -50.78 -62.79 1.39 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.113 -0.992 . . . . 0.0 108.615 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.502 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -50.29 -44.57 54.03 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.599 ' CG ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.89 -45.7 64.25 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 47' ' ' LYS . . . -49.09 -42.97 40.66 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.55 ' HA ' HD12 ' A' ' 22' ' ' ILE . 4.6 t -64.07 -64.34 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -45.35 -40.33 7.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -63.32 -47.01 84.03 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.491 ' HG3' ' OE2' ' A' ' 58' ' ' GLU . 2.2 tp60 -50.32 -28.16 7.41 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.513 HG11 HG12 ' A' ' 81' ' ' VAL . 3.8 t -75.49 -62.43 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 59' ' ' TYR . 20.9 t-80 -54.05 -37.91 64.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.03 -1.044 . . . . 0.0 108.773 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 53' ' ' ALA . 4.0 mtt180 -69.37 -38.12 77.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.529 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -75.11 -56.99 4.18 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.341 -0.85 . . . . 0.0 108.903 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CD1' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -119.05 176.88 5.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 108.825 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.66 43.68 1.17 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.483 HG23 HG11 ' A' ' 81' ' ' VAL . 10.5 t -93.79 158.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.402 ' O ' ' CE2' ' A' ' 80' ' ' TYR . 3.0 tt0 -70.8 99.83 1.8 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 109.416 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.485 ' HG ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -134.45 68.44 72.76 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 0.0 109.276 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.523 ' CG ' HG22 ' A' ' 67' ' ' VAL . 36.9 Cg_endo -82.05 -168.02 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.959 2.439 . . . . 0.0 109.964 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.599 HD23 ' CG ' ' A' ' 49' ' ' MET . 0.4 OUTLIER -89.26 -37.14 15.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.136 -0.977 . . . . 0.0 109.311 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 67' ' ' VAL . 5.7 pttt -56.66 -37.64 71.09 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.538 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 58.5 t -69.72 -47.24 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.572 ' O ' ' CA ' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -54.82 -35.98 64.51 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.45 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 5.8 m-85 -74.45 -39.27 62.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 108.769 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.99 84.16 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.885 0.85 . . . . 0.0 108.863 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.493 ' NE2' ' CG1' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -135.09 70.87 69.41 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.146 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.58 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 30.4 Cg_endo -75.0 59.85 5.29 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.787 2.325 . . . . 0.0 112.224 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.529 ' CG2' ' HB3' ' A' ' 76' ' ' ALA . 1.9 t -153.18 167.53 28.99 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 117.337 -1.745 . . . . 0.0 112.453 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.637 HG12 ' CZ2' ' A' ' 23' ' ' TRP . 2.4 mt -63.07 -72.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.592 -0.693 . . . . 0.0 111.195 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB2' ' CG1' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -40.08 -57.86 1.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.554 -0.716 . . . . 0.0 109.468 -178.428 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.529 ' HB3' ' CG2' ' A' ' 73' ' ' THR . . . -57.55 -52.33 65.83 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.379 -0.825 . . . . 0.0 109.527 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.549 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -55.1 -65.37 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.706 -1.246 . . . . 0.0 108.708 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.542 ' O ' ' CB ' ' A' ' 82' ' ' ALA . . . -44.78 -30.89 1.04 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -77.94 -43.9 28.49 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 108.633 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.553 ' N ' ' HG2' ' A' ' 79' ' ' GLN . 2.3 t80 -58.8 -32.6 69.49 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.996 -1.065 . . . . 0.0 108.244 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.513 HG12 HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -88.6 -67.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 122.46 1.124 . . . . 0.0 109.16 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.591 ' CB ' ' CG2' ' A' ' 15' ' ' VAL . . . -54.13 -48.65 70.58 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.802 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 79' ' ' GLN . 5.6 t . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.871 -1.143 . . . . 0.0 109.765 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.564 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.587 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 2.4 t -49.12 -44.45 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.548 ' HG3' ' CB ' ' A' ' 78' ' ' ALA . 4.2 mt-10 -72.65 -35.59 67.8 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.564 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 53.9 p -55.56 -48.77 74.23 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.416 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.529 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 8.6 tptm -68.69 -55.92 9.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.95 -1.094 . . . . 0.0 109.415 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.727 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -54.71 -31.06 57.54 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.062 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.06 -50.16 67.27 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -59.79 -54.54 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.727 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -51.43 -54.24 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.729 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 1.7 m95 -41.19 -60.14 1.32 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.463 0.649 . . . . 0.0 110.334 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.553 ' CB ' HD11 ' A' ' 32' ' ' ILE . 5.1 pt-20 -64.52 -30.86 71.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.95 . . . . 0.0 109.606 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 tpp85 -70.06 -66.19 0.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.507 -0.746 . . . . 0.0 110.039 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.559 HG11 ' CB ' ' A' ' 50' ' ' ALA . 53.6 t -68.41 -34.45 65.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.366 -0.834 . . . . 0.0 111.102 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 24.9 mt -84.18 -8.65 59.01 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.869 -1.144 . . . . 0.0 110.155 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.8 51.7 44.27 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.778 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.482 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -122.71 -166.21 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.016 -1.285 . . . . 0.0 108.965 178.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 p -143.62 64.38 1.33 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.156 -1.018 . . . . 0.0 109.863 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 136.89 -72.86 0.45 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.286 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.553 HD11 ' CB ' ' A' ' 24' ' ' GLU . 1.8 mp 59.53 147.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -1.154 . . . . 0.0 109.309 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.55 ' O ' ' CD1' ' A' ' 74' ' ' ILE . . . -78.34 -153.41 6.66 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.503 ' O ' ' N ' ' A' ' 75' ' ' LYS . 30.0 mm -113.56 15.67 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.035 -1.273 . . . . 0.0 109.626 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.477 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 7.3 tt -167.65 66.67 0.08 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.452 ' N ' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -101.55 169.74 8.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.584 0.707 . . . . 0.0 110.103 -179.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' O ' ' C ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -96.03 104.36 16.3 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.729 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 63.8 m-85 . . . . . 0 N--CA 1.519 3.002 0 O-C-N 121.78 -0.575 . . . . 0.0 112.293 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 46' ' ' LEU . 1.4 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.512 ' N ' ' OG ' ' A' ' 45' ' ' SER . 14.2 tp -53.59 -44.39 69.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.107 -0.995 . . . . 0.0 108.835 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.486 ' CD ' ' O ' ' A' ' 26' ' ' VAL . 6.8 mttm -48.25 -60.3 2.76 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.549 ' CB ' HD13 ' A' ' 68' ' ' LEU . . . -46.99 -48.9 21.57 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.553 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.86 -50.17 27.23 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.559 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -49.24 -43.41 42.75 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.547 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 12.0 t -58.93 -64.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.457 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -45.58 -39.99 8.27 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -63.83 -45.34 90.0 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.538 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -48.28 -34.4 10.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.533 ' CG1' HG12 ' A' ' 81' ' ' VAL . 2.5 t -71.24 -31.68 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ALA . 9.3 t60 -81.62 -35.04 30.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.415 -0.803 . . . . 0.0 109.12 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -75.73 -35.32 60.27 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 1.2 mp0 -78.87 -50.98 10.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.476 ' O ' ' O ' ' A' ' 56' ' ' HIS . 2.4 m-85 -113.83 -178.54 3.4 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.895 0.855 . . . . 0.0 109.71 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -112.51 38.4 2.76 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.552 ' CG1' HG13 ' A' ' 81' ' ' VAL . 5.0 p -93.17 149.28 4.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.378 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.442 ' N ' HG22 ' A' ' 61' ' ' VAL . 45.9 tt0 -90.15 97.11 11.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.194 -0.941 . . . . 0.0 110.549 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.595 ' CD2' ' CG1' ' A' ' 67' ' ' VAL . 4.9 mt -113.47 98.95 48.31 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.6 Cg_endo -78.99 164.13 25.21 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.866 2.378 . . . . 0.0 111.238 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.553 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 3.9 mm? -63.7 -34.85 78.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.538 ' HD3' ' N ' ' A' ' 66' ' ' LYS . 1.1 mmtt -56.08 -60.61 3.24 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.595 ' CG1' ' CD2' ' A' ' 63' ' ' LEU . 2.7 t -48.32 -52.81 7.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.549 HD13 ' CB ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -47.1 -33.21 4.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 66' ' ' LYS . 1.7 m-85 -88.28 -36.34 16.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.524 -0.735 . . . . 0.0 109.969 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . -65.13 -32.32 73.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HG2' ' HB1' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -140.53 71.85 31.19 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.1 Cg_endo -76.82 60.64 6.8 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.772 2.315 . . . . 0.0 112.052 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 13.5 t -154.66 170.86 20.54 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.569 -1.252 . . . . 0.0 110.816 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.667 HG12 ' CE2' ' A' ' 23' ' ' TRP . 3.5 mt -65.71 -74.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.255 -0.903 . . . . 0.0 111.214 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -42.6 -58.86 2.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.286 -178.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.505 ' CB ' ' CG2' ' A' ' 73' ' ' THR . . . -47.61 -61.92 1.69 Allowed 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.173 -0.955 . . . . 0.0 110.04 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.57 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -53.53 -66.94 0.3 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.127 -0.983 . . . . 0.0 109.496 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.548 ' CB ' ' HG3' ' A' ' 16' ' ' GLU . . . -47.01 -35.94 7.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.183 -0.948 . . . . 0.0 108.837 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 78.0 mm-40 -70.19 -40.15 74.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.568 ' CE2' HG21 ' A' ' 67' ' ' VAL . 1.5 t80 -55.28 -35.46 65.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.552 HG13 ' CG1' ' A' ' 61' ' ' VAL . 0.1 OUTLIER -87.69 -68.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.411 1.101 . . . . 0.0 108.301 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.587 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -43.93 -50.65 8.05 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.45 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 79' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.534 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.605 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.582 ' CG2' ' HB2' ' A' ' 82' ' ' ALA . 40.5 t -46.4 -54.49 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.53 ' OE2' ' CG2' ' A' ' 34' ' ' ILE . 12.8 mt-10 -68.12 -37.74 81.44 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.605 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.7 m -48.95 -54.0 17.39 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.17 -1.012 . . . . 0.0 108.562 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.559 ' O ' HG22 ' A' ' 22' ' ' ILE . 1.2 tptt -60.05 -69.28 0.22 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.335 -0.853 . . . . 0.0 108.837 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.533 ' CA ' HG22 ' A' ' 22' ' ' ILE . 8.3 mt -38.76 -48.25 1.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.604 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -51.52 -52.4 47.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.766 -1.209 . . . . 0.0 108.216 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.08 -60.31 4.03 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -44.27 -47.42 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.723 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 3.7 m95 -49.43 -63.05 1.22 Allowed 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.797 -0.564 . . . . 0.0 109.912 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.58 ' N ' ' CD1' ' A' ' 32' ' ' ILE . 1.6 tt0 -61.49 -42.37 98.69 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.377 -0.827 . . . . 0.0 110.046 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -65.13 0.73 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 110.779 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.477 ' CG1' ' HB1' ' A' ' 50' ' ' ALA . 2.8 t -69.82 -32.62 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.393 -0.817 . . . . 0.0 111.717 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 33.8 mt -87.36 -33.46 19.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.681 -1.262 . . . . 0.0 110.249 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.58 58.4 1.74 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.339 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -130.4 177.1 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.207 -1.173 . . . . 0.0 108.582 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.81 38.22 3.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.027 -1.045 . . . . 0.0 109.764 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -150.24 -96.75 0.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 10.3 mt 52.7 103.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.923 -1.339 . . . . 0.0 109.877 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.407 ' C ' HG13 ' A' ' 34' ' ' ILE . . . -107.86 -77.69 1.05 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.63 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 1.1 pp -166.03 101.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -1.195 . . . . 0.0 109.931 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.63 ' CB ' ' O ' ' A' ' 34' ' ' ILE . 22.4 tp 103.44 35.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.722 0.772 . . . . 0.0 109.237 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -83.0 177.87 8.42 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.7 t30 -109.52 116.94 32.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.723 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 52.4 m-85 . . . . . 0 N--CA 1.502 2.138 0 O-C-N 121.273 -0.892 . . . . 0.0 110.315 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 46' ' ' LEU . 4.1 mm? -53.35 -36.34 61.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.107 -0.995 . . . . 0.0 109.013 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 26' ' ' VAL . 0.5 OUTLIER -66.5 -60.5 2.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -0.912 . . . . 0.0 109.042 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.548 ' HA ' HG22 ' A' ' 51' ' ' VAL . . . -52.37 -49.71 63.85 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.132 -0.98 . . . . 0.0 108.636 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.599 ' CG ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.29 -45.61 45.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' HB1' ' CG1' ' A' ' 26' ' ' VAL . . . -49.23 -44.59 43.64 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.72 ' HA ' HD13 ' A' ' 22' ' ' ILE . 18.3 t -60.14 -58.46 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.429 ' HA ' HG22 ' A' ' 55' ' ' VAL . . . -48.58 -26.96 2.48 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 50' ' ' ALA . . . -73.24 -43.54 60.99 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.528 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -54.65 -28.49 47.5 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.557 HG13 ' CG2' ' A' ' 81' ' ' VAL . 2.6 t -73.77 -53.88 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 1.3 t-80 -56.3 -43.04 78.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.123 -0.986 . . . . 0.0 109.103 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -46.3 83.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 109.014 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -66.07 -50.15 65.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 108.855 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.555 ' CD1' HG12 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -129.63 154.58 46.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.451 -0.781 . . . . 0.0 109.009 179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -94.53 40.04 1.09 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.506 HG12 ' CG1' ' A' ' 81' ' ' VAL . 7.0 p -93.09 162.75 2.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.272 0.558 . . . . 0.0 109.7 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -69.39 117.85 11.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.865 . . . . 0.0 110.138 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.511 HD22 ' CG2' ' A' ' 81' ' ' VAL . 0.2 OUTLIER -142.73 69.46 19.78 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.4 Cg_endo -80.23 154.66 22.01 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.866 2.378 . . . . 0.0 110.632 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.599 HD23 ' CG ' ' A' ' 49' ' ' MET . 4.4 mt -57.19 -40.68 77.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.782 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -49.91 -44.94 50.44 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.499 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 6.7 t -64.86 -41.98 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.501 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -62.58 -26.39 68.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.462 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 m-85 -87.86 -36.0 17.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . -67.43 -32.0 72.57 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.959 0.885 . . . . 0.0 108.614 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.414 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -147.34 70.06 11.68 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.0 Cg_endo -75.11 60.26 5.47 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.812 2.342 . . . . 0.0 111.305 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.518 ' OG1' ' HA ' ' A' ' 35' ' ' LEU . 5.8 t -153.07 165.62 35.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.712 -1.195 . . . . 0.0 110.828 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.619 HG13 ' CZ2' ' A' ' 23' ' ' TRP . 2.9 mt -66.47 -64.87 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.602 -0.686 . . . . 0.0 110.501 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.506 ' HB3' HD13 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -49.75 -60.58 2.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.867 -1.145 . . . . 0.0 109.859 -179.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.468 ' CB ' ' CG2' ' A' ' 73' ' ' THR . . . -56.74 -67.84 0.27 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.958 -1.089 . . . . 0.0 110.372 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.442 ' CD1' HD11 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -49.42 -58.45 5.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.808 -1.182 . . . . 0.0 108.763 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' ILE . . . -44.94 -55.98 5.0 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 34.6 mm-40 -50.49 -49.83 54.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 108.844 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.493 ' CD2' HG12 ' A' ' 67' ' ' VAL . 7.2 t80 -48.3 -45.67 35.21 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.669 0.747 . . . . 0.0 109.302 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.557 ' CG2' HG13 ' A' ' 55' ' ' VAL . 3.5 t -81.73 -59.43 2.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 122.432 1.11 . . . . 0.0 109.313 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.582 ' HB2' ' CG2' ' A' ' 15' ' ' VAL . . . -53.73 -68.09 0.21 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.238 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.414 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.549 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.61 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 3.6 t -48.35 -43.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -72.08 -43.79 64.28 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 53.5 p -47.12 -50.1 20.83 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.391 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HE2' ' OE1' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -61.03 -70.35 0.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 108.706 179.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.839 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 4.3 mp -40.79 -35.12 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.371 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 16' ' ' GLU . . . -61.89 -51.82 66.61 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.995 -1.066 . . . . 0.0 108.399 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -61.25 -56.06 24.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.298 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.839 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -52.67 -50.47 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.889 -1.132 . . . . 0.0 108.862 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.632 ' CH2' ' CG1' ' A' ' 74' ' ' ILE . 5.2 m95 -46.15 -59.82 2.66 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.413 0.625 . . . . 0.0 110.227 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.532 ' CB ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -61.77 -37.06 82.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.227 -0.921 . . . . 0.0 110.021 -178.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -60.89 -49.42 77.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.289 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.584 ' CG1' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -87.79 -48.9 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.241 -0.912 . . . . 0.0 110.778 -179.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.428 ' HA ' ' HG2' ' A' ' 47' ' ' LYS . 45.7 mt -63.76 -9.97 17.32 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.363 -0.836 . . . . 0.0 109.87 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.07 58.63 11.89 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.32 167.48 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -1.196 . . . . 0.0 109.45 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 t -126.78 81.43 2.01 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.249 -0.907 . . . . 0.0 109.185 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.453 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . 139.4 -73.55 0.4 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.564 ' CG2' HD13 ' A' ' 74' ' ' ILE . 14.7 mt 60.89 143.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -1.105 . . . . 0.0 109.628 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.46 -119.45 1.14 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.518 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.5 tt -149.28 -64.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.812 -1.405 . . . . 0.0 109.831 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.755 ' HA ' ' CG2' ' A' ' 73' ' ' THR . 0.6 OUTLIER -88.38 32.1 0.79 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.365 -1.46 . . . . 0.0 109.66 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 73' ' ' THR . 15.5 m-20 -59.73 167.12 2.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.343 -0.848 . . . . 0.0 110.753 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 11.8 t-20 -110.53 40.37 2.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.652 ' CE1' ' C ' ' A' ' 72' ' ' PRO . 8.7 m-30 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.769 -0.582 . . . . 0.0 111.008 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.342 0.591 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -57.84 -39.63 78.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.856 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.462 ' CG ' ' O ' ' A' ' 26' ' ' VAL . 1.9 tptt -64.84 -64.14 0.94 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.583 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -47.9 -47.5 32.01 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.085 -1.009 . . . . 0.0 108.32 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.545 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.25 -49.93 31.5 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.584 ' CB ' ' CG1' ' A' ' 26' ' ' VAL . . . -46.81 -46.67 20.87 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 54' ' ' GLN . 15.0 t -56.92 -54.16 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 51' ' ' VAL . . . -48.42 -38.77 20.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.58 -44.05 97.73 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.535 ' CB ' HG12 ' A' ' 22' ' ' ILE . 3.0 tp-100 -48.7 -36.14 15.54 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.483 HG11 HG12 ' A' ' 81' ' ' VAL . 6.8 t -68.03 -45.71 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 59' ' ' TYR . 5.7 t-160 -69.94 -33.64 72.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.077 -1.015 . . . . 0.0 109.098 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -41.4 39.49 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 12.8 mm-40 -71.91 -46.06 59.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.599 ' CE1' HG12 ' A' ' 81' ' ' VAL . 0.7 OUTLIER -124.87 168.85 12.7 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.608 0.718 . . . . 0.0 109.41 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -99.18 31.84 2.92 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.484 HG12 ' HB2' ' A' ' 59' ' ' TYR . 6.5 p -93.59 123.13 45.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.414 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 4.6 tt0 -69.21 97.76 0.96 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 110.856 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -103.05 106.65 51.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.133 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 35.8 Cg_endo -79.88 166.6 21.11 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.445 2.096 . . . . 0.0 111.292 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.553 ' N ' HD21 ' A' ' 65' ' ' LEU . 3.4 mm? -69.02 -40.87 78.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -51.19 -51.7 51.29 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.457 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 3.0 t -55.93 -41.21 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.583 HD21 ' CB ' ' A' ' 48' ' ' ALA . 1.2 tp -62.43 -24.15 67.26 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.512 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 m-85 -87.62 -36.67 17.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.405 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.22 -32.55 74.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.459 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.08 71.74 18.42 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.652 ' C ' ' CE1' ' A' ' 38' ' ' PHE . 30.5 Cg_endo -77.82 64.82 8.24 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.259 1.973 . . . . 0.0 108.209 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.755 ' CG2' ' HA ' ' A' ' 35' ' ' LEU . 81.4 m -152.68 165.11 36.29 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 117.961 -1.496 . . . . 0.0 111.939 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.632 ' CG1' ' CH2' ' A' ' 23' ' ' TRP . 7.3 mt -71.93 -72.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.14 -0.975 . . . . 0.0 109.286 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.529 ' HB3' ' HG ' ' A' ' 35' ' ' LEU . 3.2 ttmm -45.21 -44.68 11.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.617 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -61.66 -55.02 35.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 108.955 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.543 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -59.11 -63.23 1.38 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.128 -0.983 . . . . 0.0 108.758 179.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.589 ' N ' ' CD2' ' A' ' 19' ' ' LEU . . . -44.87 -38.96 4.98 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 1.1 tp60 -68.89 -44.41 73.3 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.51 ' O ' ' CG2' ' A' ' 83' ' ' THR . 28.4 t80 -52.22 -35.56 49.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.14 -0.975 . . . . 0.0 108.386 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.599 HG12 ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.15 -70.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 122.375 1.084 . . . . 0.0 108.43 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.61 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -40.11 -27.77 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.06 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 80' ' ' TYR . 9.8 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.458 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.698 ' HA ' ' HB3' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.568 ' CG2' ' CB ' ' A' ' 82' ' ' ALA . 20.6 t -53.42 -47.66 58.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 119.939 -1.726 . . . . 0.0 106.674 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.531 ' HG3' ' CG2' ' A' ' 74' ' ' ILE . 3.6 tm-20 -69.16 -29.19 67.15 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.698 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 35.2 p -54.13 -49.36 69.37 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.302 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.454 ' HE2' ' HG3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -60.95 -51.38 69.53 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.777 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 6.7 mt -58.71 -40.7 84.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.174 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.82 -46.45 67.73 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.859 -1.15 . . . . 0.0 108.122 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 22' ' ' ILE . 23.0 mt-10 -65.21 -66.43 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.489 -0.757 . . . . 0.0 109.214 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.777 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -45.34 -46.51 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.966 . . . . 0.0 108.851 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.74 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 5.4 m95 -50.72 -64.49 0.79 Allowed 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.437 0.636 . . . . 0.0 110.867 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.531 ' CB ' HD11 ' A' ' 32' ' ' ILE . 2.6 pt-20 -59.53 -38.09 80.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.17 -61.59 2.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 110.413 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' CG2' HD12 ' A' ' 22' ' ' ILE . 4.8 t -75.2 -33.23 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.135 -0.978 . . . . 0.0 111.337 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 41.9 mt -81.9 -8.07 59.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.706 -1.246 . . . . 0.0 109.829 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.19 53.29 45.91 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -137.38 -172.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.265 . . . . 0.0 109.03 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 t -153.29 121.0 5.99 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.467 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.24 20.81 54.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.531 HD11 ' CB ' ' A' ' 24' ' ' GLU . 3.2 mt -42.08 150.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -1.199 . . . . 0.0 109.298 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.518 ' N ' HG23 ' A' ' 32' ' ' ILE . . . -73.74 -170.43 21.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -106.33 12.3 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -1.047 . . . . 0.0 109.743 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.568 ' HA ' ' CG2' ' A' ' 73' ' ' THR . 10.4 tp -169.24 62.24 0.05 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.084 -1.01 . . . . 0.0 109.39 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.525 ' N ' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -89.59 -161.96 0.83 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.249 -0.907 . . . . 0.0 109.916 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.448 ' ND2' ' HG2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -129.66 29.76 4.99 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.226 -0.921 . . . . 0.0 110.132 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.74 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 1.9 m-85 . . . . . 0 N--CA 1.5 2.041 0 O-C-N 121.961 -0.462 . . . . 0.0 111.144 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.9 tp -47.64 -41.11 21.41 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.167 -0.958 . . . . 0.0 108.982 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 26' ' ' VAL . 8.0 mttt -50.29 -61.18 2.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.101 -1.0 . . . . 0.0 108.567 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HB1' ' CD2' ' A' ' 68' ' ' LEU . . . -48.42 -46.32 37.32 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.702 ' HA ' HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.59 -52.39 30.58 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.448 ' HB1' HG13 ' A' ' 26' ' ' VAL . . . -46.87 -42.75 17.93 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.558 ' HA ' ' CG1' ' A' ' 22' ' ' ILE . 7.6 t -58.79 -61.2 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HB3' ' CD1' ' A' ' 68' ' ' LEU . . . -45.9 -48.78 16.1 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -51.95 -47.4 64.78 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.52 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -46.29 -37.05 6.83 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.045 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 52' ' ' ALA . 2.2 t -73.04 -32.96 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.687 -0.633 . . . . 0.0 109.565 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 59' ' ' TYR . 2.5 t-80 -78.1 -44.18 26.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.784 -1.198 . . . . 0.0 108.38 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -34.01 73.86 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -78.31 -48.35 15.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -128.87 170.09 13.81 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.45 51.59 0.74 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 177.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 59' ' ' TYR . 96.5 t -91.24 161.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-O 121.845 0.831 . . . . 0.0 110.798 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.581 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 12.6 pt-20 -75.26 49.05 0.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.797 -0.565 . . . . 0.0 110.16 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -111.01 86.82 6.37 Favored Pre-proline 0 C--N 1.295 -1.796 0 O-C-N 121.108 -0.995 . . . . 0.0 110.986 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 37.3 Cg_endo -83.05 -152.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.745 2.297 . . . . 0.0 107.985 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.702 HD12 ' HA ' ' A' ' 49' ' ' MET . 7.9 tp -90.87 -41.55 11.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.457 -1.402 . . . . 0.0 109.611 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.545 ' HG3' ' N ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -50.29 -39.59 45.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.91 -1.119 . . . . 0.0 108.426 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.553 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 4.3 t -63.12 -34.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.533 ' CD2' ' HB1' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -65.6 -27.65 68.56 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.459 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 27.6 m-85 -86.92 -35.48 18.9 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.37 -35.34 80.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.432 ' O ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.72 71.93 19.91 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.641 ' C ' ' CE1' ' A' ' 38' ' ' PHE . 32.9 Cg_endo -77.59 64.65 8.1 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.52 2.147 . . . . 0.0 107.955 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 35' ' ' LEU . 94.5 m -152.87 158.75 42.62 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.243 -1.383 . . . . 0.0 111.716 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.645 ' CD1' ' CE2' ' A' ' 23' ' ' TRP . 5.3 mm -64.1 -77.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.438 -0.789 . . . . 0.0 110.314 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.531 ' HB3' HD11 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -42.24 -49.4 4.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.65 -0.656 . . . . 0.0 110.002 -178.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -58.88 -69.15 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 109.13 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.481 ' HG ' HD11 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -47.57 -49.47 26.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.718 -1.239 . . . . 0.0 108.817 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 82' ' ' ALA . . . -55.64 -27.57 50.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 1.5 pt20 -78.84 -32.56 46.17 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.528 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -67.79 -34.5 76.9 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.43 HG13 ' CG1' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -88.14 -63.12 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.317 1.056 . . . . 0.0 108.484 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.568 ' CB ' ' CG2' ' A' ' 15' ' ' VAL . . . -59.2 -31.24 68.85 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.425 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 13.4 m . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.517 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.63 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.573 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 1.1 m -50.55 -56.56 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -26.67 65.41 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 73.5 m -57.03 -51.11 70.57 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HD3' ' CG ' ' A' ' 58' ' ' GLU . 1.3 tptm -61.43 -66.18 0.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.683 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 4.3 mm? -41.04 -47.44 3.1 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.84 -48.27 64.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.864 -1.148 . . . . 0.0 108.502 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 4.3 mt-10 -64.82 -64.55 0.84 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.307 -0.871 . . . . 0.0 108.709 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.683 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -43.39 -47.08 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.705 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 3.7 m95 -50.25 -70.82 0.08 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.427 0.632 . . . . 0.0 110.741 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -55.27 -29.95 59.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.336 -0.852 . . . . 0.0 110.549 -178.199 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -76.23 -67.77 0.65 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 109.907 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.588 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 94.8 t -62.29 -31.55 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 110.11 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.463 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 19.4 mt -93.41 -4.68 50.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 110.121 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.52 56.27 25.41 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -136.97 -179.0 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 108.965 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.9 t -153.1 137.03 16.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.361 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.64 6.46 87.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.571 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.4 mt -42.83 131.05 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -1.094 . . . . 0.0 109.301 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' A' ' 74' ' ' ILE . . . -71.29 -135.37 0.14 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -119.1 -55.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.961 -1.317 . . . . 0.0 110.185 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.472 HD11 ' HE2' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -92.09 39.97 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.184 -1.573 . . . . 0.0 108.878 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.476 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 1.3 m-20 -58.67 -172.06 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.612 0.72 . . . . 0.0 109.908 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 38' ' ' PHE . 54.7 m-20 -126.29 115.39 19.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.705 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 25.4 m-85 . . . . . 0 N--CA 1.499 1.996 0 O-C-N 121.11 -0.994 . . . . 0.0 110.342 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.277 0.561 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.27 -44.49 53.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.633 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.521 ' HG3' ' CG1' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -58.88 -71.37 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 109.23 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.602 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -46.98 -44.61 20.28 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.552 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.53 -51.03 29.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB1' HG11 ' A' ' 26' ' ' VAL . . . -47.36 -44.23 23.87 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.607 ' HA ' HD12 ' A' ' 22' ' ' ILE . 15.2 t -58.62 -58.03 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.541 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . . . -48.46 -40.13 25.24 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.4 -46.41 88.77 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.511 ' HG2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -51.87 -31.17 26.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.469 HG21 ' HA ' ' A' ' 52' ' ' ALA . 3.3 t -74.21 -48.36 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.638 -0.664 . . . . 0.0 109.38 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 59' ' ' TYR . 4.6 t-80 -67.91 -34.59 76.92 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.155 -0.966 . . . . 0.0 109.189 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -76.02 -31.7 59.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 0.0 108.712 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.554 ' CG ' ' HD3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -82.67 -44.45 15.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.453 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.55 ' CD1' HG12 ' A' ' 81' ' ' VAL . 10.4 m-85 -120.51 -173.8 2.66 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.873 0.844 . . . . 0.0 109.639 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -117.95 39.96 3.25 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 59' ' ' TYR . 1.3 t -93.09 137.91 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.33 0.586 . . . . 0.0 109.626 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 48.4 tt0 -69.37 95.46 0.8 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.327 -0.858 . . . . 0.0 109.292 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.541 ' CD2' ' HB3' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -116.4 91.57 33.78 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 35.6 Cg_endo -79.28 159.98 26.21 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.548 2.166 . . . . 0.0 110.215 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.552 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 2.3 mm? -57.83 -39.75 78.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.127 -0.983 . . . . 0.0 108.711 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -53.37 -52.22 59.97 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.509 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 2.6 t -51.07 -39.9 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.602 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -64.28 -26.83 68.67 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.493 ' N ' ' O ' ' A' ' 66' ' ' LYS . 4.3 m-30 -84.2 -36.38 22.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.464 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.44 -30.41 68.33 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.464 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -145.36 66.88 12.68 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.564 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.7 Cg_endo -76.46 53.15 3.85 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.86 2.374 . . . . 0.0 112.15 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 4.3 t -151.63 175.39 12.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.72 -1.237 . . . . 0.0 110.873 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.62 HG12 ' CE2' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -72.57 -67.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.687 -0.633 . . . . 0.0 110.794 -179.021 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.472 ' HE2' HD11 ' A' ' 35' ' ' LEU . 4.0 tttt -39.91 -56.87 1.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.575 -0.703 . . . . 0.0 109.303 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -59.44 -54.49 46.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 108.886 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -49.99 -64.49 0.79 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.731 -1.231 . . . . 0.0 108.585 179.032 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.545 ' O ' ' CB ' ' A' ' 82' ' ' ALA . . . -46.15 -33.78 3.8 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.459 -0.776 . . . . 0.0 109.022 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -77.57 -40.26 42.98 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.947 -1.095 . . . . 0.0 109.142 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CE1' ' NE2' ' A' ' 71' ' ' GLN . 3.1 t80 -60.16 -34.27 73.34 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.933 -1.104 . . . . 0.0 108.127 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.55 HG12 ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -89.12 -66.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.386 1.088 . . . . 0.0 108.977 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.573 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -57.52 -28.17 63.24 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.81 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 79' ' ' GLN . 4.3 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 109.371 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.658 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 121.005 0.431 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.561 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 2.2 t -47.07 -65.68 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.533 ' N ' HG13 ' A' ' 15' ' ' VAL . 4.0 pt-20 -70.76 -23.72 62.47 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.658 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 6.6 m -60.86 -44.85 96.47 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.394 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' O ' HG22 ' A' ' 22' ' ' ILE . 3.4 tptm -69.93 -61.57 1.73 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.964 -1.094 . . . . 0.0 108.351 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.551 ' CD1' ' HA ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -48.34 -37.32 16.35 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.069 -1.052 . . . . 0.0 108.414 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 16' ' ' GLU . . . -58.19 -47.81 82.26 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.486 ' OE1' ' NH1' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -65.38 -51.99 56.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.378 -0.826 . . . . 0.0 108.785 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.638 ' CD1' ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -54.37 -44.13 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.744 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.8 m95 -54.25 -68.57 0.17 Allowed 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.962 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 29' ' ' VAL . 9.2 pt-20 -59.32 -33.21 70.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.486 ' NH1' ' OE1' ' A' ' 21' ' ' GLU . 24.1 ttm180 -71.17 -71.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 109.448 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.554 HG11 ' CB ' ' A' ' 50' ' ' ALA . 60.8 t -54.71 -33.78 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.556 -0.715 . . . . 0.0 110.232 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.466 ' CG ' ' O ' ' A' ' 23' ' ' TRP . 13.1 mt -91.43 -9.05 46.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 0.0 110.197 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.67 52.81 48.37 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.123 -0.986 . . . . 0.0 110.977 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -129.84 -173.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.249 . . . . 0.0 108.469 178.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.0 t -154.47 120.18 5.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.073 -1.017 . . . . 0.0 109.947 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.45 20.89 50.45 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.578 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.481 ' CD1' ' HB3' ' A' ' 24' ' ' GLU . 2.8 mp -50.8 161.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.117 -1.225 . . . . 0.0 109.74 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.537 ' O ' ' CD1' ' A' ' 74' ' ' ILE . . . -81.05 -153.01 9.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.474 ' O ' ' CG2' ' A' ' 34' ' ' ILE . 48.8 mm -121.37 19.85 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.78 -1.423 . . . . 0.0 109.762 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.496 ' C ' ' OG1' ' A' ' 73' ' ' THR . 1.7 tt -165.62 53.72 0.11 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.902 -1.124 . . . . 0.0 110.523 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.536 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 1.4 m-20 -84.76 160.08 20.34 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.42 45.91 1.33 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.833 -1.167 . . . . 0.0 108.787 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.744 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 13.4 m-85 . . . . . 0 N--CA 1.511 2.621 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.307 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.314 0.578 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.59 -52.6 54.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.409 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 16.4 mttp -53.37 -51.45 62.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -53.62 -44.69 69.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.404 -1.435 . . . . 0.0 108.02 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.545 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.71 -48.98 49.53 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.554 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -48.88 -52.37 24.74 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.638 ' CG1' ' CD1' ' A' ' 22' ' ' ILE . 41.8 t -46.25 -59.5 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 55' ' ' VAL . . . -52.52 -52.95 52.12 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 52' ' ' ALA . . . -47.34 -49.09 25.02 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.573 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 6.3 tp-100 -50.9 -37.66 45.23 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.606 ' CG1' ' CG1' ' A' ' 81' ' ' VAL . 21.0 t -63.52 -60.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -54.86 -46.85 74.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.209 -0.932 . . . . 0.0 110.504 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.505 ' HG3' ' N ' ' A' ' 58' ' ' GLU . 0.8 OUTLIER -61.43 -36.69 81.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.659 -1.276 . . . . 0.0 109.01 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -75.69 -53.67 8.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 108.934 179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CE1' HG12 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -120.99 157.49 29.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.6 41.0 1.09 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.54 ' CG1' HG13 ' A' ' 81' ' ' VAL . 5.8 p -92.5 159.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.441 0.638 . . . . 0.0 109.672 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.44 ' N ' HG22 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -69.22 105.98 2.7 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.455 -0.778 . . . . 0.0 110.213 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.492 HD22 HG22 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -132.93 69.59 78.98 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 34.9 Cg_endo -77.92 156.96 30.95 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.683 2.255 . . . . 0.0 110.856 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.545 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 3.5 mm? -57.88 -39.67 78.38 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -55.37 -53.16 59.69 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 2.9 t -50.84 -48.45 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.574 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -55.03 -23.62 20.68 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 66' ' ' LYS . 6.2 m-85 -87.58 -39.67 14.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.05 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.406 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.17 -33.6 76.13 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.406 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -143.15 71.27 18.33 Favored Pre-proline 0 C--N 1.296 -1.749 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.3 Cg_endo -77.24 56.05 5.31 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.881 2.388 . . . . 0.0 112.236 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 15.3 t -154.11 174.91 14.08 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 117.34 -1.744 . . . . 0.0 112.725 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.627 HG12 ' CZ2' ' A' ' 23' ' ' TRP . 1.0 OUTLIER -66.12 -72.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.207 -0.933 . . . . 0.0 111.516 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.45 ' HB3' HD11 ' A' ' 35' ' ' LEU . 32.2 ttmt -45.73 -49.33 14.88 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.133 -0.979 . . . . 0.0 109.766 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.432 ' CB ' ' CG2' ' A' ' 73' ' ' THR . . . -66.38 -71.64 0.19 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.453 -0.78 . . . . 0.0 110.081 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -42.14 -55.85 3.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.309 -0.87 . . . . 0.0 108.952 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.551 ' HA ' ' CD1' ' A' ' 19' ' ' LEU . . . -50.28 -56.24 12.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 108.502 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.46 ' OE1' ' OG1' ' A' ' 83' ' ' THR . 4.0 tp60 -50.35 -45.27 54.98 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.584 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 5.7 t80 -54.46 -35.82 63.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.166 -0.959 . . . . 0.0 108.613 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.606 ' CG1' ' CG1' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -79.78 -62.17 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 122.563 1.173 . . . . 0.0 108.976 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.561 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -53.01 -63.55 1.11 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.566 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.46 ' OG1' ' OE1' ' A' ' 79' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.049 -1.032 . . . . 0.0 109.712 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.594 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.107 0.479 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.591 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 53.0 t -61.03 -48.66 88.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -71.84 -23.6 61.56 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.594 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 20.9 m -56.09 -50.08 72.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.508 ' HE2' ' CG ' ' A' ' 58' ' ' GLU . 5.6 tptm -68.36 -52.44 33.12 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.753 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 2.3 mt -54.25 -37.35 64.56 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.696 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 16' ' ' GLU . . . -61.61 -45.83 92.42 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 22' ' ' ILE . 2.7 tt0 -61.82 -60.25 3.94 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.753 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -48.08 -57.57 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.609 ' CE3' ' CG2' ' A' ' 32' ' ' ILE . 1.9 m95 -38.24 -66.83 0.23 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.916 0.865 . . . . 0.0 110.308 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.494 ' HB2' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -58.32 -43.43 88.19 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.443 0.64 . . . . 0.0 109.578 -178.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 26' ' ' VAL . 4.2 tpp180 -63.07 -71.93 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.517 -0.74 . . . . 0.0 110.511 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.577 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 91.1 t -63.17 -31.6 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 0.0 111.27 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 13.9 mt -93.05 -12.16 31.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.682 -1.261 . . . . 0.0 110.584 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 69.42 66.72 2.15 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.283 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -133.22 -168.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -1.09 . . . . 0.0 109.327 179.421 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -153.42 69.26 0.81 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.428 -0.795 . . . . 0.0 109.04 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 142.16 -76.87 0.3 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.609 ' CG2' ' CE3' ' A' ' 23' ' ' TRP . 9.8 mt 60.07 128.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.397 -1.061 . . . . 0.0 110.768 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.519 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -75.19 -143.45 1.02 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.511 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -113.55 -62.93 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.122 -1.223 . . . . 0.0 109.763 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.559 ' C ' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -89.68 39.89 0.97 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.561 -1.337 . . . . 0.0 108.861 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.6 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 2.6 m-20 -60.05 -165.15 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.64 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -129.22 122.82 30.5 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CE1' ' N ' ' A' ' 73' ' ' THR . 7.9 m-30 . . . . . 0 N--CA 1.5 2.049 0 O-C-N 121.098 -1.001 . . . . 0.0 109.07 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.146 0.498 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -48.44 69.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.704 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 26' ' ' VAL . 4.9 mttt -56.81 -59.64 4.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.847 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.602 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -47.69 -51.87 20.33 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.975 -1.078 . . . . 0.0 109.141 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.548 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.72 -50.02 26.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.459 ' HB1' HG11 ' A' ' 26' ' ' VAL . . . -47.69 -41.86 23.55 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.546 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 17.9 t -61.12 -57.26 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.531 ' CB ' HD12 ' A' ' 68' ' ' LEU . . . -49.15 -46.16 44.79 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -57.58 -40.69 79.56 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.524 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 2.7 tp-100 -54.75 -33.76 61.66 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.533 ' CG1' HD12 ' A' ' 63' ' ' LEU . 3.5 t -68.95 -51.79 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' TYR . 4.3 t-160 -65.7 -37.46 86.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 109.252 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 53' ' ' ALA . 5.4 mtt180 -70.42 -32.33 69.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 108.727 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.508 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -81.47 -54.81 5.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.81 . . . . 0.0 108.864 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.585 ' CD1' HG12 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -118.38 -179.6 3.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.371 -0.831 . . . . 0.0 109.174 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.69 44.57 1.03 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.473 HG23 ' CG1' ' A' ' 81' ' ' VAL . 13.4 t -93.39 129.91 43.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.503 0.668 . . . . 0.0 109.734 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.76 104.05 2.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.729 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.595 HD21 ' CE1' ' A' ' 80' ' ' TYR . 6.5 mt -124.23 100.99 35.26 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 108.981 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 36.6 Cg_endo -80.18 157.4 23.15 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.548 2.166 . . . . 0.0 110.451 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.548 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 1.9 mm? -57.03 -44.22 82.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.079 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.485 ' HG3' ' HB2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -50.86 -51.24 53.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.0 -1.063 . . . . 0.0 108.337 179.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.543 HG12 ' CD2' ' A' ' 63' ' ' LEU . 2.7 t -50.76 -45.34 27.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.602 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -57.56 -25.02 59.33 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 66' ' ' LYS . 19.0 m-85 -86.72 -37.23 18.12 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.446 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.16 -30.68 68.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.78 . . . . 0.0 109.305 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.457 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -144.82 66.11 12.86 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.596 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 34.3 Cg_endo -77.52 54.37 4.71 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.895 2.397 . . . . 0.0 110.588 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.622 ' N ' ' CE1' ' A' ' 38' ' ' PHE . 9.7 t -151.93 159.35 43.82 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.215 -0.928 . . . . 0.0 110.024 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.59 HG12 ' NE1' ' A' ' 23' ' ' TRP . 2.4 mt -64.49 -60.0 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.163 -0.961 . . . . 0.0 112.005 -178.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 9.2 tttm -40.29 -53.85 2.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.318 -0.864 . . . . 0.0 108.912 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB3' ' CG2' ' A' ' 73' ' ' THR . . . -69.71 -60.93 2.0 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.666 -0.646 . . . . 0.0 110.051 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.584 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.3 OUTLIER -45.15 -59.17 2.76 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.707 -1.245 . . . . 0.0 108.623 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.462 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -50.22 -40.58 47.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.524 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -70.56 -34.91 72.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.05 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.595 ' CE1' HD21 ' A' ' 63' ' ' LEU . 7.7 t80 -63.14 -37.42 87.17 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.15 -0.969 . . . . 0.0 108.634 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.585 HG12 ' CD1' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -86.39 -62.19 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.367 1.08 . . . . 0.0 108.566 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.591 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -60.68 -54.24 47.63 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.031 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.334 179.855 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.598 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.186 0.517 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.572 ' CB ' ' HB1' ' A' ' 82' ' ' ALA . 3.7 t -53.33 -51.84 36.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.504 ' HG3' ' CG2' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -68.79 -33.87 74.59 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.598 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.8 m -49.8 -52.2 33.9 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.407 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.481 ' O ' HG23 ' A' ' 22' ' ' ILE . 27.6 tptt -59.23 -49.46 77.75 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.293 -0.879 . . . . 0.0 108.728 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.777 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 9.9 mt -61.9 -41.76 98.28 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.512 ' O ' ' CG ' ' A' ' 24' ' ' GLU . . . -52.72 -45.38 66.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.792 -1.192 . . . . 0.0 108.036 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -64.56 -66.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 108.898 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.777 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -44.94 -48.12 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.72 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 3.3 m95 -46.69 -66.98 0.32 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.428 0.633 . . . . 0.0 110.504 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -63.73 -30.0 71.15 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.339 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -71.05 -64.18 0.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.037 -1.039 . . . . 0.0 110.223 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.563 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 99.3 t -71.37 -34.42 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 111.086 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 47.3 mt -79.33 4.78 14.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.669 -1.269 . . . . 0.0 110.052 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.34 49.12 61.47 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -134.1 -179.97 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.074 -1.251 . . . . 0.0 109.167 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.91 115.46 10.03 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.289 -0.882 . . . . 0.0 109.367 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 119.67 -69.64 0.36 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.506 HG21 ' CB ' ' A' ' 23' ' ' TRP . 10.2 mm 57.05 113.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -1.071 . . . . 0.0 109.656 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.45 -145.48 1.78 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.64 ' O ' ' N ' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -108.75 -50.81 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -1.22 . . . . 0.0 110.2 -179.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.501 ' C ' ' OG1' ' A' ' 73' ' ' THR . 0.5 OUTLIER -109.81 45.21 1.11 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 119.775 -1.828 . . . . 0.0 109.174 179.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.483 ' O ' ' HB ' ' A' ' 73' ' ' THR . 2.5 m-20 -61.2 -164.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -135.27 118.8 16.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.72 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 70.5 m-85 . . . . . 0 N--CA 1.504 2.257 0 O-C-N 120.924 -1.11 . . . . 0.0 109.31 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 49' ' ' MET . 16.6 tp -64.35 -55.79 18.8 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.091 -1.006 . . . . 0.0 109.568 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.486 ' HD2' ' O ' ' A' ' 26' ' ' VAL . 1.9 mmtm -43.3 -58.35 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -51.62 -43.33 62.53 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.564 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.44 -50.63 51.66 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 178.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 47' ' ' LYS . . . -47.37 -43.12 22.99 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.543 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 11.2 t -61.18 -60.76 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.45 ' HA ' HG21 ' A' ' 55' ' ' VAL . . . -47.74 -42.98 26.63 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 57' ' ' ARG . . . -58.23 -41.17 83.51 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.556 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -55.47 -29.99 59.74 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.498 HG11 HG12 ' A' ' 81' ' ' VAL . 6.6 t -75.19 -59.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 59' ' ' TYR . 64.8 t-80 -57.33 -31.68 65.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 0.0 109.246 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -78.76 -38.58 38.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.122 -0.986 . . . . 0.0 108.737 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.483 ' OE2' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -71.94 -48.61 44.03 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.566 ' CE1' HG12 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -127.47 -178.82 4.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.481 -0.762 . . . . 0.0 109.17 178.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -110.72 44.97 1.19 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 59' ' ' TYR . 13.9 t -93.14 153.9 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.799 -0.563 . . . . 0.0 109.723 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' O ' ' CE2' ' A' ' 80' ' ' TYR . 11.3 tt0 -70.78 94.85 1.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.457 HD12 HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -125.35 74.14 68.0 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.467 ' HG2' ' CG2' ' A' ' 67' ' ' VAL . 35.4 Cg_endo -77.2 -176.92 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.771 2.314 . . . . 0.0 110.885 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.564 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 3.9 mm? -81.27 -41.88 21.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.352 -0.843 . . . . 0.0 109.134 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -59.88 -37.66 79.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.263 -0.898 . . . . 0.0 108.701 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.467 ' CG2' ' HG2' ' A' ' 64' ' ' PRO . 8.9 t -65.11 -47.08 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.574 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -52.74 -25.84 12.34 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.486 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.7 m-85 -79.17 -42.2 26.68 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.477 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -70.28 -26.18 63.68 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.841 0.829 . . . . 0.0 108.783 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.477 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -147.02 65.76 9.9 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.2 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.567 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 34.4 Cg_endo -78.81 55.73 5.67 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 123.074 2.516 . . . . 0.0 112.722 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.535 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 4.7 t -153.18 172.65 16.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.259 -1.526 . . . . 0.0 111.996 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.626 HG12 ' CE2' ' A' ' 23' ' ' TRP . 0.9 OUTLIER -64.36 -54.83 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.616 -0.677 . . . . 0.0 110.78 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.64 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -55.49 -65.2 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.019 -1.051 . . . . 0.0 109.497 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.535 ' HB1' ' CG2' ' A' ' 73' ' ' THR . . . -48.04 -53.93 14.73 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.585 -0.697 . . . . 0.0 110.206 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.3 OUTLIER -57.64 -65.11 0.69 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.714 -1.241 . . . . 0.0 109.155 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 82' ' ' ALA . . . -44.05 -34.92 1.91 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 80' ' ' TYR . 0.6 OUTLIER -71.71 -44.45 64.15 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 108.657 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.488 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 2.3 t80 -57.58 -34.91 69.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.105 -0.997 . . . . 0.0 109.015 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.566 HG12 ' CE1' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -87.65 -63.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.289 1.042 . . . . 0.0 108.219 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.572 ' HB1' ' CB ' ' A' ' 15' ' ' VAL . . . -51.69 -59.57 4.14 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.024 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.55 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.604 ' CG1' ' CB ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -54.08 -36.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.461 ' HG2' ' CB ' ' A' ' 78' ' ' ALA . 2.9 mt-10 -77.98 -36.16 49.33 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.55 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.8 m -56.3 -49.09 75.27 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG3' ' OE2' ' A' ' 58' ' ' GLU . 10.0 tptt -67.64 -59.47 3.31 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.776 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -54.24 -27.37 34.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 109.38 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.12 -52.23 37.17 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -55.28 36.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.769 -0.772 . . . . 0.0 108.925 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.776 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -53.52 -53.51 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 108.758 179.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.737 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 1.7 m95 -40.49 -57.74 1.74 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.449 0.642 . . . . 0.0 109.72 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.518 ' CA ' HD12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -61.49 -49.97 74.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.492 -0.755 . . . . 0.0 109.69 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -52.26 -47.69 65.65 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.48 -0.762 . . . . 0.0 110.683 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.557 HG21 ' CD1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -85.92 -50.38 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.093 -1.004 . . . . 0.0 110.371 -178.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 23' ' ' TRP . 42.7 mt -68.86 -6.66 28.39 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.598 -0.689 . . . . 0.0 109.977 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.83 60.02 9.17 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -129.9 -178.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -1.162 . . . . 0.0 109.167 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 30' ' ' SER . 1.3 p -148.91 40.0 0.87 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.59 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.37 59.86 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.583 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.2 mt -85.18 136.49 22.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.445 -1.032 . . . . 0.0 109.416 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.98 -120.92 0.04 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -138.59 -61.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.815 -1.403 . . . . 0.0 109.773 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.493 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -90.02 37.82 0.9 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.676 -1.265 . . . . 0.0 108.544 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -58.99 -167.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.785 0.802 . . . . 0.0 109.484 178.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -131.72 110.96 11.25 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.737 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 53.6 m-85 . . . . . 0 N--CA 1.507 2.401 0 O-C-N 121.562 -0.711 . . . . 0.0 110.197 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 46' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 45' ' ' SER . 0.5 OUTLIER -45.15 -47.2 12.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.151 -0.968 . . . . 0.0 109.294 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 7.0 tptt -47.83 -62.51 1.42 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 109.202 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.532 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -49.77 -48.79 50.21 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.045 -1.034 . . . . 0.0 108.594 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.603 ' CG ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.4 -47.81 47.51 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.538 ' HB2' ' CG1' ' A' ' 26' ' ' VAL . . . -48.36 -42.12 30.69 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.559 ' HA ' HG12 ' A' ' 22' ' ' ILE . 14.8 t -62.67 -52.99 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 55' ' ' VAL . . . -48.4 -45.5 36.01 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.28 77.4 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.562 ' CG ' ' OE2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -51.91 -31.88 30.38 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.028 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 52' ' ' ALA . 21.2 t -68.37 -42.03 83.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 59' ' ' TYR . 12.5 t-80 -71.16 -40.77 71.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.368 -0.832 . . . . 0.0 109.033 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -41.66 68.46 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.562 ' OE2' ' CG ' ' A' ' 54' ' ' GLN . 71.2 mt-10 -63.91 -49.4 72.81 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.518 ' CD1' ' CG1' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -139.96 172.63 12.49 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.74 45.87 0.94 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.97 145.66 7.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.437 0.637 . . . . 0.0 109.837 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.85 111.43 5.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 109.461 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.462 HD21 HD13 ' A' ' 77' ' ' LEU . 1.3 tt -147.01 85.37 6.99 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.299 -0.876 . . . . 0.0 109.436 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.1 Cg_endo -79.56 172.18 14.75 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.793 2.329 . . . . 0.0 109.589 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.603 HD23 ' CG ' ' A' ' 49' ' ' MET . 2.1 mt -68.17 -43.23 78.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.716 -1.24 . . . . 0.0 109.116 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.416 ' CG ' ' N ' ' A' ' 67' ' ' VAL . 12.5 ptmm? -47.05 -37.9 10.19 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.512 HG12 ' CE2' ' A' ' 80' ' ' TYR . 2.1 t -70.91 -42.21 77.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.532 HD21 ' CB ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -61.28 -22.38 64.8 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.472 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 46.1 m-85 -83.55 -40.46 19.09 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.438 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -68.39 -29.61 68.34 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.994 0.902 . . . . 0.0 108.797 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.438 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -140.58 68.42 31.03 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.573 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.9 Cg_endo -76.9 55.23 4.86 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.989 2.459 . . . . 0.0 113.069 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.567 ' HA ' ' CZ2' ' A' ' 23' ' ' TRP . 10.2 t -153.39 174.44 14.35 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.736 -1.227 . . . . 0.0 110.887 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.591 HG12 ' CD2' ' A' ' 23' ' ' TRP . 21.0 mt -72.71 -65.07 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.311 -0.868 . . . . 0.0 109.883 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -39.76 -54.43 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.645 -0.659 . . . . 0.0 109.577 -179.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -62.76 -59.84 4.33 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.358 -0.839 . . . . 0.0 109.068 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.3 OUTLIER -44.54 -62.6 1.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.021 -1.049 . . . . 0.0 108.739 179.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.517 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -48.7 -39.83 26.05 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.79 -40.82 79.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.913 . . . . 0.0 108.868 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.512 ' CE2' HG12 ' A' ' 67' ' ' VAL . 4.3 t80 -56.12 -35.12 66.73 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.518 ' CG1' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.21 -69.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 122.334 1.064 . . . . 0.0 109.135 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.604 ' CB ' ' CG1' ' A' ' 15' ' ' VAL . . . -48.44 -25.99 1.9 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.341 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.06 . . . . 0.0 109.6 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.594 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 C--O 1.209 -1.049 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.559 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 2.2 t -52.0 -49.44 38.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.596 ' CG ' ' CB ' ' A' ' 78' ' ' ALA . 2.3 mt-10 -73.08 -38.25 66.47 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.594 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 16.6 m -53.27 -48.63 68.12 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.31 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' HG2' ' HG3' ' A' ' 58' ' ' GLU . 6.9 tptt -63.28 -56.66 14.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -0.985 . . . . 0.0 108.861 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.794 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 1.3 tp -52.9 -37.54 60.78 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.432 -0.792 . . . . 0.0 109.15 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.68 84.13 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -61.89 -65.27 0.72 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.534 -0.729 . . . . 0.0 109.056 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.794 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -45.81 -45.91 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.951 -1.093 . . . . 0.0 108.895 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.738 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.5 m95 -47.37 -65.12 0.62 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.66 0.743 . . . . 0.0 109.938 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.534 ' N ' HD12 ' A' ' 32' ' ' ILE . 8.0 pt-20 -60.22 -32.62 71.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 110.65 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -65.47 -61.66 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.128 -0.982 . . . . 0.0 110.664 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' CG2' HD12 ' A' ' 22' ' ' ILE . 22.0 t -77.44 -31.83 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.1 -1.0 . . . . 0.0 110.762 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 38.0 mt -78.83 -3.6 45.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.984 -1.073 . . . . 0.0 110.008 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.89 54.67 36.04 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.58 -172.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.186 -1.185 . . . . 0.0 109.374 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 t -143.29 38.22 1.4 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.386 -0.821 . . . . 0.0 109.073 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.57 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . -157.14 -94.84 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.57 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER 19.76 86.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 117.746 0.773 . . . . 0.0 110.922 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.437 ' CA ' HD11 ' A' ' 74' ' ' ILE . . . -135.62 20.23 3.7 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 118.624 -1.751 . . . . 0.0 112.139 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.531 ' O ' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -174.69 114.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 120.222 -1.752 . . . . 0.0 110.979 178.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.554 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 1.9 tp 37.81 42.47 0.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.348 0.594 . . . . 0.0 110.639 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.529 ' CB ' HG21 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -76.7 -178.42 4.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.827 . . . . 0.0 109.043 178.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 38' ' ' PHE . 7.2 m120 -114.03 112.42 23.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.727 -1.233 . . . . 0.0 109.062 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.738 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 55.1 m-85 . . . . . 0 N--CA 1.505 2.314 0 O-C-N 121.165 -0.959 . . . . 0.0 109.452 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.144 0.497 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -50.95 -62.81 1.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 109.519 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 50' ' ' ALA . 18.2 mttp -46.52 -54.86 8.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.082 -1.011 . . . . 0.0 108.782 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.521 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -48.92 -44.33 40.28 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.62 ' CG ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.63 -46.14 58.04 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.301 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HB1' ' CG1' ' A' ' 26' ' ' VAL . . . -48.64 -47.58 40.22 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.8 t -56.63 -56.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.503 ' HA ' HG21 ' A' ' 55' ' ' VAL . . . -48.89 -35.64 15.28 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.93 89.45 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -54.78 -29.53 54.48 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 63' ' ' LEU . 5.0 t -73.97 -61.66 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 59' ' ' TYR . 71.3 t60 -52.4 -36.32 53.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.904 -1.123 . . . . 0.0 109.435 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.479 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -75.13 -44.8 44.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.044 . . . . 0.0 109.158 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 35.4 mm-40 -69.74 -33.47 72.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.408 -0.808 . . . . 0.0 109.217 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.548 ' CD1' HG12 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -143.91 162.34 36.38 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.539 -0.725 . . . . 0.0 109.436 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -96.57 39.94 1.15 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.505 ' CG1' HG13 ' A' ' 81' ' ' VAL . 7.1 p -92.96 153.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -82.78 111.27 18.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.56 HD13 ' CD1' ' A' ' 80' ' ' TYR . 4.9 tp -145.24 78.28 12.37 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.512 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 35.1 Cg_endo -79.0 -172.04 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.883 2.389 . . . . 0.0 110.284 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.62 HD23 ' CG ' ' A' ' 49' ' ' MET . 2.4 mt -78.67 -37.63 41.34 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.033 -1.042 . . . . 0.0 109.278 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -53.08 -36.67 60.94 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.533 ' CG1' HD11 ' A' ' 63' ' ' LEU . 2.6 t -72.75 -45.2 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.538 HD11 ' CD1' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -62.26 -24.16 67.11 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.4 m-85 -87.52 -35.98 17.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 108.896 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.455 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -70.74 -30.31 66.79 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.478 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.94 66.82 15.13 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -178.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.3 Cg_endo -75.88 59.37 5.75 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.915 2.41 . . . . 0.0 112.235 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 35' ' ' LEU . 4.1 t -153.8 174.37 14.65 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 117.559 -1.656 . . . . 0.0 112.584 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.582 HG12 ' CE2' ' A' ' 23' ' ' TRP . 29.0 mt -67.72 -56.94 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.47 ' HB3' HD13 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -61.85 -57.51 11.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.672 -1.268 . . . . 0.0 108.84 -178.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.51 -55.09 11.96 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.572 -0.705 . . . . 0.0 109.144 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.577 ' CB ' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -55.17 -65.42 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.0 -1.062 . . . . 0.0 109.076 179.354 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.596 ' CB ' ' CG ' ' A' ' 16' ' ' GLU . . . -43.59 -46.13 7.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.489 ' O ' HG23 ' A' ' 83' ' ' THR . 47.5 mm-40 -61.78 -53.14 60.03 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.56 ' CD1' HD13 ' A' ' 63' ' ' LEU . 2.5 t80 -43.18 -39.2 2.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.327 -0.858 . . . . 0.0 109.252 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.548 HG12 ' CD1' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -87.93 -67.31 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.433 1.111 . . . . 0.0 109.041 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.559 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -40.03 -25.94 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.868 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 79' ' ' GLN . 2.1 t . . . . . 0 N--CA 1.492 1.666 0 O-C-N 120.858 -1.151 . . . . 0.0 109.572 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.566 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.557 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 43.5 t -49.92 -48.93 22.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.472 ' CG ' ' CB ' ' A' ' 78' ' ' ALA . 31.6 mt-10 -71.17 -29.36 65.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.566 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 35.4 m -53.04 -51.12 62.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.038 -1.039 . . . . 0.0 108.679 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.553 ' HG2' ' HG2' ' A' ' 58' ' ' GLU . 1.0 OUTLIER -68.93 -54.61 14.45 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.02 -1.072 . . . . 0.0 108.818 179.6 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.707 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -48.35 -38.43 19.2 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.78 -1.168 . . . . 0.0 108.063 179.128 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.03 -50.57 73.6 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.66 -62.94 1.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.707 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -45.78 -52.23 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.626 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 2.2 m95 -41.51 -62.41 0.88 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.425 0.631 . . . . 0.0 109.727 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.527 ' CA ' HD12 ' A' ' 32' ' ' ILE . 4.8 pt-20 -66.25 -33.41 75.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.437 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -62.38 -63.9 1.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.349 -179.001 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.524 ' O ' ' CD ' ' A' ' 47' ' ' LYS . 11.8 t -79.23 -35.01 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.918 . . . . 0.0 111.606 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 38.4 mt -75.64 -2.79 31.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.884 -1.135 . . . . 0.0 109.955 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.88 59.06 10.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -131.45 -174.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -1.154 . . . . 0.0 109.083 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t -150.79 49.94 0.86 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.256 -0.902 . . . . 0.0 109.208 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 168.18 -73.05 0.14 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.528 HG23 ' CD1' ' A' ' 74' ' ' ILE . 5.1 mt 59.43 143.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.433 -1.04 . . . . 0.0 109.776 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' A' ' 74' ' ' ILE . . . -83.73 -143.53 5.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.52 ' CA ' HD11 ' A' ' 74' ' ' ILE . 5.3 tt -127.64 25.2 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -1.231 . . . . 0.0 109.388 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.601 ' HA ' ' CG2' ' A' ' 73' ' ' THR . 6.2 tp -179.52 61.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.155 -0.965 . . . . 0.0 109.516 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.55 ' O ' ' CG2' ' A' ' 73' ' ' THR . 0.6 OUTLIER -91.57 -160.48 0.73 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.488 -0.757 . . . . 0.0 109.32 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -126.84 29.85 5.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.878 -1.139 . . . . 0.0 109.953 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 63.0 m-85 . . . . . 0 N--CA 1.507 2.395 0 O-C-N 122.139 -0.351 . . . . 0.0 110.216 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.237 0.542 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.09 -43.31 82.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.961 . . . . 0.0 109.335 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 26' ' ' VAL . 0.5 OUTLIER -61.13 -65.29 0.72 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -0.969 . . . . 0.0 109.625 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 51' ' ' VAL . . . -49.68 -47.96 49.94 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.888 -1.132 . . . . 0.0 108.227 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.546 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.41 -37.93 18.28 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.012 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 47' ' ' LYS . . . -57.22 -49.75 75.01 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.544 ' HA ' HD12 ' A' ' 22' ' ' ILE . 9.4 t -57.13 -57.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.469 ' HA ' HG22 ' A' ' 55' ' ' VAL . . . -48.67 -35.08 13.08 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -67.58 -45.19 76.27 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.598 ' O ' ' CB ' ' A' ' 58' ' ' GLU . 4.4 tp-100 -49.18 -31.8 9.13 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.597 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 3.4 t -68.75 -30.77 48.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.593 -0.692 . . . . 0.0 109.314 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 53' ' ' ALA . 2.8 t60 -81.57 -43.36 18.78 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.183 -0.948 . . . . 0.0 109.509 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HG2' ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -77.4 -34.05 54.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.956 -1.09 . . . . 0.0 108.611 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.598 ' CB ' ' O ' ' A' ' 54' ' ' GLN . 42.3 tp10 -77.1 -37.66 53.87 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.604 ' CD2' HG12 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -137.64 157.71 45.93 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 4.3 tt0 -93.78 32.02 1.5 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.53 HG12 ' CG1' ' A' ' 81' ' ' VAL . 6.7 p -93.64 144.33 9.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 3.1 pt-20 -69.75 136.24 50.7 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.05 -1.031 . . . . 0.0 109.456 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.537 ' CD2' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -143.22 92.24 6.79 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.507 ' HG2' ' CG2' ' A' ' 67' ' ' VAL . 36.2 Cg_endo -78.79 162.19 26.99 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.554 2.169 . . . . 0.0 110.762 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.546 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 4.1 mm? -70.3 -29.62 66.42 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -63.67 -55.07 26.33 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.625 ' CG2' ' CZ ' ' A' ' 80' ' ' TYR . 3.9 t -49.97 -42.03 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.53 ' O ' ' CA ' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -61.78 -32.14 72.39 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 66' ' ' LYS . 23.4 m-85 -80.43 -37.7 31.53 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.449 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.4 -35.07 79.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.449 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -144.98 69.56 14.47 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -178.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.581 ' C ' ' CE2' ' A' ' 38' ' ' PHE . 30.4 Cg_endo -77.67 66.84 8.02 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.712 2.275 . . . . 0.0 109.115 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.601 ' CG2' ' HA ' ' A' ' 35' ' ' LEU . 22.2 m -153.31 161.98 41.78 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 117.088 -1.845 . . . . 0.0 113.108 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.528 ' CD1' HG23 ' A' ' 32' ' ' ILE . 87.2 mt -57.8 -70.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 110.007 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 21.8 ttpp -57.67 -49.39 76.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.259 -0.901 . . . . 0.0 109.305 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 77' ' ' LEU . . . -58.65 -71.35 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.854 -1.154 . . . . 0.0 109.369 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.523 ' CB ' ' O ' ' A' ' 73' ' ' THR . 1.0 OUTLIER -42.76 -58.21 2.44 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 81' ' ' VAL . . . -49.67 -60.65 2.68 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 12.5 mm100 -45.37 -42.09 9.74 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.227 -0.92 . . . . 0.0 108.865 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.625 ' CZ ' ' CG2' ' A' ' 67' ' ' VAL . 7.8 t80 -54.39 -39.01 66.82 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.604 HG12 ' CD2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -87.46 -66.78 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.386 1.089 . . . . 0.0 108.659 179.227 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.557 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -45.01 -40.96 6.97 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.089 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.397 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.566 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.573 ' CB ' ' HB1' ' A' ' 82' ' ' ALA . 16.0 m -49.5 -37.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.525 ' N ' HG22 ' A' ' 15' ' ' VAL . 1.1 mt-10 -82.99 -38.45 22.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.566 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 24.8 p -53.47 -38.99 64.14 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.536 ' HE2' ' CG ' ' A' ' 58' ' ' GLU . 0.4 OUTLIER -71.49 -57.89 4.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.587 -0.695 . . . . 0.0 109.23 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.749 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 3.9 mm? -54.2 -42.4 69.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.941 -1.099 . . . . 0.0 108.422 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 24' ' ' GLU . . . -56.0 -46.75 78.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -60.48 -63.64 1.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.749 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -46.98 -51.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.65 ' CE3' ' CG2' ' A' ' 32' ' ' ILE . 2.1 m95 -39.38 -66.73 0.27 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.607 0.718 . . . . 0.0 109.929 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.495 ' HA ' HG23 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -63.68 -25.63 68.3 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.972 -178.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.472 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . 4.5 tpp180 -74.06 -67.12 0.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.115 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.594 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 72.4 t -71.36 -31.63 44.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 111.0 -178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 21.6 mt -85.58 -7.95 58.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.992 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.58 56.44 9.78 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.484 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.9 179.3 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.886 -1.361 . . . . 0.0 108.724 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -140.98 74.09 1.45 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.157 -0.964 . . . . 0.0 108.984 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 146.32 -80.35 0.22 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.65 ' CG2' ' CE3' ' A' ' 23' ' ' TRP . 9.8 mt 59.58 150.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.223 -1.163 . . . . 0.0 109.64 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.541 ' N ' HG23 ' A' ' 32' ' ' ILE . . . -82.53 -122.52 0.72 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.565 ' HA ' ' CD1' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -147.11 -52.51 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.717 -1.46 . . . . 0.0 111.079 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.674 ' HA ' ' CG2' ' A' ' 73' ' ' THR . 5.5 mt -95.5 31.14 2.07 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.049 -1.657 . . . . 0.0 110.976 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.516 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 2.9 m-20 -59.15 -166.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.113 -0.992 . . . . 0.0 109.616 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.509 ' CG ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -133.98 30.62 3.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.086 -1.009 . . . . 0.0 109.245 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.599 ' CD1' ' CZ2' ' A' ' 23' ' ' TRP . 6.5 m-30 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.362 -0.836 . . . . 0.0 109.64 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 46' ' ' LEU . 4.2 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.981 0.419 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 49' ' ' MET . 0.4 OUTLIER -43.97 -51.02 8.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.014 -1.054 . . . . 0.0 109.246 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -44.91 -47.44 11.24 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.599 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -57.2 -45.41 83.82 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.543 ' HG2' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -46.68 -51.77 15.28 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.556 ' CB ' HG13 ' A' ' 26' ' ' VAL . . . -48.3 -50.0 31.76 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.542 ' HA ' HG12 ' A' ' 22' ' ' ILE . 21.2 t -51.22 -55.49 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.494 ' HA ' HG21 ' A' ' 55' ' ' VAL . . . -50.18 -46.2 54.09 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.05 -38.35 56.75 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.574 ' HG2' ' HB ' ' A' ' 22' ' ' ILE . 3.4 tp-100 -58.63 -41.04 85.03 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.579 ' CG1' ' CG1' ' A' ' 81' ' ' VAL . 14.7 t -61.5 -40.54 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 59' ' ' TYR . 11.9 t60 -69.15 -53.27 20.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.056 -1.027 . . . . 0.0 109.149 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -38.57 84.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.037 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.536 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 13.3 mm-40 -71.82 -56.64 5.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.305 -0.872 . . . . 0.0 108.651 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.628 ' CD1' ' CG1' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -127.03 165.04 20.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.767 0.794 . . . . 0.0 109.532 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -95.78 46.18 1.09 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.6 t -91.44 138.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.514 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.63 103.16 1.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 109.765 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.547 ' CD2' HD13 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -138.94 82.58 19.81 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.055 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 34.5 Cg_endo -77.81 -178.84 4.91 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.78 2.32 . . . . 0.0 110.418 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.543 HD23 ' HG2' ' A' ' 49' ' ' MET . 2.5 mm? -65.22 -37.93 88.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 109.089 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -56.26 -60.99 2.71 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.591 HG13 ' NE2' ' A' ' 71' ' ' GLN . 15.2 t -47.04 -43.07 6.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.599 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -61.81 -48.68 79.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -65.51 -19.84 66.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . -76.31 -52.11 10.62 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.271 1.034 . . . . 0.0 108.838 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.591 ' NE2' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -132.58 72.35 77.91 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.034 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.579 ' C ' ' CE1' ' A' ' 38' ' ' PHE . 31.2 Cg_endo -76.4 67.43 7.06 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.397 2.064 . . . . 0.0 108.207 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.674 ' CG2' ' HA ' ' A' ' 35' ' ' LEU . 22.2 m -151.4 165.77 33.11 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.227 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.634 ' CG1' ' CE2' ' A' ' 23' ' ' TRP . 6.1 mt -76.79 -69.58 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.331 -0.856 . . . . 0.0 109.798 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -45.84 -47.54 15.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.182 -0.948 . . . . 0.0 108.867 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -59.5 -55.48 34.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.387 -0.821 . . . . 0.0 109.147 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.547 HD13 ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -56.23 -65.6 0.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.102 -0.999 . . . . 0.0 108.876 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.516 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -43.35 -37.42 2.26 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.46 -0.775 . . . . 0.0 109.054 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.447 ' O ' ' O ' ' A' ' 83' ' ' THR . 10.1 tp60 -69.95 -43.85 70.74 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.002 -1.061 . . . . 0.0 108.548 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.464 ' CD2' HD13 ' A' ' 63' ' ' LEU . 10.4 t80 -59.84 -33.4 71.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.33 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.628 ' CG1' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -86.93 -60.74 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 122.48 1.133 . . . . 0.0 108.196 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.573 ' HB1' ' CB ' ' A' ' 15' ' ' VAL . . . -54.35 -65.32 0.6 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.418 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.585 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.607 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.539 ' CG2' ' HB2' ' A' ' 82' ' ' ALA . 2.7 t -49.37 -49.62 17.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -29.51 48.54 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.607 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 7.3 m -60.84 -42.31 97.53 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.664 -1.215 . . . . 0.0 108.684 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.46 ' HG2' ' HG3' ' A' ' 58' ' ' GLU . 0.7 OUTLIER -69.1 -51.31 39.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.579 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -61.11 -46.7 89.53 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.733 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.36 -45.43 55.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 22' ' ' ILE . 1.7 mm-40 -62.76 -69.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.537 -0.727 . . . . 0.0 109.541 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.632 ' CD1' ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -47.06 -40.58 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.872 -1.143 . . . . 0.0 108.919 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.727 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.6 m95 -49.25 -67.44 0.26 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.369 -0.832 . . . . 0.0 109.507 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.505 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . 4.0 pt-20 -58.85 -39.29 80.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.439 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -69.51 -70.85 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.795 -1.191 . . . . 0.0 109.744 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG13 ' HB1' ' A' ' 50' ' ' ALA . 55.3 t -55.92 -31.41 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 110.85 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.504 ' CG ' ' O ' ' A' ' 23' ' ' TRP . 14.2 mt -96.53 15.0 22.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.115 -0.991 . . . . 0.0 110.8 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.42 44.77 45.65 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 121.208 -0.932 . . . . 0.0 110.978 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.526 ' HB ' ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -117.82 -170.3 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.093 -1.239 . . . . 0.0 108.885 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 30' ' ' SER . 5.7 p -145.99 49.4 1.2 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.184 -0.948 . . . . 0.0 109.48 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 143.37 -66.8 0.46 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.526 ' CD1' ' HB ' ' A' ' 29' ' ' VAL . 1.7 mp 57.61 156.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -1.171 . . . . 0.0 109.776 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' CD1' ' A' ' 74' ' ' ILE . . . -80.31 -157.73 15.65 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.534 HG12 ' CG ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -102.7 -49.08 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.272 . . . . 0.0 110.346 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.567 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 0.2 OUTLIER -93.06 34.95 1.08 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.801 -1.187 . . . . 0.0 109.294 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -64.77 155.19 34.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.689 -0.632 . . . . 0.0 109.902 179.034 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.8 m-20 -97.84 122.12 40.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.1 -1.0 . . . . 0.0 108.626 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.727 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 79.0 m-85 . . . . . 0 N--CA 1.504 2.233 0 O-C-N 121.109 -0.995 . . . . 0.0 109.319 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.92 -34.65 60.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.509 ' HG2' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -56.46 -51.98 66.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.114 -0.991 . . . . 0.0 108.39 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.509 ' N ' ' HG2' ' A' ' 47' ' ' LYS . . . -58.73 -46.15 88.03 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.576 ' CG ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -52.99 -32.91 48.99 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.257 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.467 ' HB1' HG13 ' A' ' 26' ' ' VAL . . . -60.94 -44.57 97.06 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.632 ' CG1' ' CD1' ' A' ' 22' ' ' ILE . 4.3 t -62.13 -69.97 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' A' ' 55' ' ' VAL . . . -44.81 -50.14 10.39 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.264 -0.897 . . . . 0.0 108.679 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 49' ' ' MET . . . -55.89 -46.04 78.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.566 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 8.1 tp-100 -48.21 -33.54 8.73 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.492 HG11 ' CE1' ' A' ' 59' ' ' TYR . 3.5 t -67.26 -67.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 59' ' ' TYR . 3.0 t-160 -46.86 -36.25 7.27 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.792 -1.192 . . . . 0.0 109.593 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -72.1 -42.66 65.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.792 -1.193 . . . . 0.0 108.717 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.46 ' HG3' ' HG2' ' A' ' 18' ' ' LYS . 52.8 mm-40 -71.58 -50.76 27.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.575 ' CD1' HG12 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -116.91 160.14 21.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -93.67 36.95 1.07 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' A' ' 59' ' ' TYR . 6.3 p -94.11 145.56 7.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -82.78 112.61 19.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.5 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.598 ' CD2' ' CD1' ' A' ' 77' ' ' LEU . 15.9 tp -133.14 94.7 19.79 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.8 Cg_endo -80.91 163.66 20.53 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.784 2.323 . . . . 0.0 110.771 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.576 HD23 ' CG ' ' A' ' 49' ' ' MET . 4.5 mt -65.15 -39.1 92.51 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.385 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -48.45 -53.33 18.28 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.589 ' CG1' ' CD1' ' A' ' 63' ' ' LEU . 1.2 t -56.01 -46.13 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.536 ' O ' ' CA ' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -58.13 -22.32 50.5 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.477 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.3 m-85 -86.03 -37.66 18.68 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.438 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.7 -31.57 69.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.438 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -142.15 67.4 21.55 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.559 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 33.0 Cg_endo -77.13 61.58 7.28 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.912 2.408 . . . . 0.0 111.933 -178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.567 ' OG1' ' HA ' ' A' ' 35' ' ' LEU . 4.4 t -152.95 176.06 12.26 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.198 -1.401 . . . . 0.0 112.053 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.629 HG12 ' CE2' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -73.64 -69.22 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.904 -0.498 . . . . 0.0 110.411 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.534 ' CG ' HG12 ' A' ' 34' ' ' ILE . 11.6 tmtt? -39.91 -56.53 1.79 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.52 ' HB1' ' CG2' ' A' ' 73' ' ' THR . . . -58.05 -64.33 0.95 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.514 -0.742 . . . . 0.0 109.884 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.598 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -46.27 -62.98 1.11 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.781 -1.2 . . . . 0.0 108.974 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.497 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -44.78 -48.82 10.91 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 51.2 mm-40 -61.55 -44.5 96.93 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.44 ' CD2' HD12 ' A' ' 63' ' ' LEU . 1.1 t80 -53.29 -37.11 61.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.891 -1.13 . . . . 0.0 108.927 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.575 HG12 ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.24 -65.43 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.431 1.11 . . . . 0.0 108.535 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.539 ' HB2' ' CG2' ' A' ' 15' ' ' VAL . . . -49.09 -20.7 0.6 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.355 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.451 ' OG1' ' OE1' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.531 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.605 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 82' ' ' ALA . 35.3 t -48.07 -58.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.42 ' HG3' ' HB2' ' A' ' 78' ' ' ALA . 1.2 mp0 -66.01 -36.67 83.9 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.605 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 70.7 m -48.55 -55.92 9.77 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.302 177.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' CE ' ' HB2' ' A' ' 58' ' ' GLU . 20.1 tttm -52.44 -67.43 0.25 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.551 ' CD2' ' HB3' ' A' ' 77' ' ' LEU . 0.8 OUTLIER -43.0 -46.48 5.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.336 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -49.82 -57.98 6.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.78 -1.2 . . . . 0.0 109.08 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -51.08 71.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 109.4 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.624 ' CD1' ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -54.69 -44.06 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.726 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 3.3 m95 -52.22 -66.2 0.42 Allowed 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.619 0.723 . . . . 0.0 109.721 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -58.9 -53.73 55.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.463 -0.773 . . . . 0.0 110.046 -178.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -54.15 -66.08 0.46 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 109.982 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.503 ' CG1' ' CB ' ' A' ' 50' ' ' ALA . 21.6 t -58.56 -43.73 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.797 . . . . 0.0 110.719 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 42.3 mt -78.69 -12.38 60.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.996 -1.065 . . . . 0.0 110.347 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 72.73 53.27 8.45 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.409 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.36 -178.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.125 -1.221 . . . . 0.0 109.127 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.08 39.71 1.34 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.209 -0.932 . . . . 0.0 109.472 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -156.17 -91.2 0.08 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.486 ' CG2' ' CE3' ' A' ' 23' ' ' TRP . 14.7 mt 58.63 149.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -1.164 . . . . 0.0 109.721 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 32' ' ' ILE . . . -107.38 -154.96 19.41 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 75' ' ' LYS . 9.1 pt -98.84 2.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.139 -1.212 . . . . 0.0 110.024 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 75' ' ' LYS . 1.3 tt -162.41 69.1 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.979 -1.076 . . . . 0.0 108.986 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.412 ' N ' ' OG1' ' A' ' 73' ' ' THR . 1.8 m-20 -98.49 160.68 14.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.679 -0.638 . . . . 0.0 109.562 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.5 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.2 t-20 -89.49 106.83 18.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.726 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 43.4 m-85 . . . . . 0 N--CA 1.511 2.595 0 O-C-N 121.789 -0.569 . . . . 0.0 111.111 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.2 0.524 . . . . 0.0 109.821 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.15 -58.86 3.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.08 -1.012 . . . . 0.0 109.51 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 2.0 tptt -47.0 -59.35 3.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 109.854 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.549 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -58.06 -45.26 87.38 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.032 -1.042 . . . . 0.0 109.137 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.58 ' HG2' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.77 -49.6 37.87 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.331 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.503 ' CB ' ' CG1' ' A' ' 26' ' ' VAL . . . -50.38 -55.63 14.86 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.624 ' CG1' ' CD1' ' A' ' 22' ' ' ILE . 21.6 t -43.13 -60.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.474 ' HB3' HD21 ' A' ' 63' ' ' LEU . . . -49.95 -54.89 16.96 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.501 ' CB ' ' HE3' ' A' ' 49' ' ' MET . . . -47.36 -50.63 21.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.532 ' HG2' ' HB ' ' A' ' 22' ' ' ILE . 7.3 tp-100 -46.91 -38.6 10.76 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 52' ' ' ALA . 17.0 t -60.23 -62.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 59' ' ' TYR . 17.3 t60 -58.34 -32.82 68.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.419 -0.801 . . . . 0.0 110.046 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -74.29 -39.33 62.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.046 -1.034 . . . . 0.0 109.548 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.528 ' HB2' ' CE ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -78.29 -44.59 24.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 109.295 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.549 ' CD2' HG12 ' A' ' 81' ' ' VAL . 5.4 m-85 -110.96 -174.43 2.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 54.5 tp60 -113.54 29.15 8.22 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' A' ' 59' ' ' TYR . 3.4 p -93.85 134.3 31.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.654 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -74.34 103.61 4.78 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.465 -0.772 . . . . 0.0 110.097 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -116.81 95.79 47.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.118 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.514 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 37.4 Cg_endo -82.88 169.17 13.43 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.721 2.281 . . . . 0.0 110.157 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.58 HD23 ' HG2' ' A' ' 49' ' ' MET . 1.9 mt -66.52 -37.73 85.65 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.076 -1.015 . . . . 0.0 109.045 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -40.69 64.84 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.583 HG12 ' CD2' ' A' ' 80' ' ' TYR . 4.6 t -65.53 -43.6 94.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.549 HD21 ' CB ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -58.06 -26.14 62.12 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.115 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.492 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 10.2 m-85 -86.29 -34.73 20.27 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.72 -25.39 64.73 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.915 0.864 . . . . 0.0 108.736 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.44 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -154.58 66.76 5.28 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -177.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.568 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.7 Cg_endo -75.1 53.99 3.55 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.767 2.311 . . . . 0.0 112.338 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.483 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 14.6 t -153.23 170.03 21.58 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.591 -1.318 . . . . 0.0 111.238 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.579 HD12 ' CG ' ' A' ' 23' ' ' TRP . 9.4 mm -60.25 -71.69 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.869 -0.519 . . . . 0.0 111.776 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -50.22 -54.04 23.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.057 -1.027 . . . . 0.0 110.362 -178.049 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.483 ' HB1' ' CG2' ' A' ' 73' ' ' THR . . . -53.45 -67.93 0.22 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.551 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -53.27 -59.32 4.72 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.479 -0.889 . . . . 0.0 109.323 -179.276 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.49 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -45.78 -44.68 14.17 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.51 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -61.71 -42.42 98.92 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.056 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.583 ' CD2' HG12 ' A' ' 67' ' ' VAL . 2.8 t80 -56.04 -33.82 65.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 108.856 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.549 HG12 ' CD2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -86.98 -60.98 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.481 1.134 . . . . 0.0 108.898 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.526 ' HB2' ' CG2' ' A' ' 15' ' ' VAL . . . -53.61 -41.24 66.46 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.688 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.469 ' HB ' ' OE1' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 120.927 -1.108 . . . . 0.0 109.598 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.583 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.963 0.411 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.608 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 57.5 t -51.62 -51.68 25.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.501 ' OE1' ' CD1' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -70.45 -27.92 64.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.583 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 49.5 m -53.4 -51.68 61.81 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.799 -1.161 . . . . 0.0 108.166 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.557 ' O ' HG22 ' A' ' 22' ' ' ILE . 5.7 tptm -66.53 -62.74 1.3 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.361 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.534 ' HA ' HG22 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -39.93 -49.72 2.46 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 16' ' ' GLU . . . -51.23 -51.48 53.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' LYS . 4.0 mt-10 -58.64 -62.79 1.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.653 ' CD1' ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -42.89 -46.36 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.068 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.631 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 4.1 m95 -54.93 -70.77 0.09 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 121.702 0.763 . . . . 0.0 110.194 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -57.83 -47.33 82.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 110.272 -178.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.436 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 14.2 ttm180 -62.41 -65.18 0.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.015 -1.053 . . . . 0.0 110.302 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.537 ' CG1' ' HB2' ' A' ' 50' ' ' ALA . 29.5 t -61.76 -36.13 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.372 -0.83 . . . . 0.0 111.007 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 42.2 mt -84.54 -35.78 22.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.974 -1.079 . . . . 0.0 110.01 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 92.59 56.55 1.53 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.208 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.465 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.53 172.49 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -1.203 . . . . 0.0 109.159 179.507 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.2 t -131.8 39.23 3.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.198 -0.939 . . . . 0.0 109.174 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -157.36 -89.0 0.07 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.601 ' CG2' ' CE3' ' A' ' 23' ' ' TRP . 10.8 mt 59.07 141.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -1.158 . . . . 0.0 109.804 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.489 ' O ' HD11 ' A' ' 74' ' ' ILE . . . -101.77 -147.26 19.71 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.501 ' CD1' ' OE1' ' A' ' 16' ' ' GLU . 20.2 tt -113.1 9.58 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.116 -1.226 . . . . 0.0 110.285 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.533 ' C ' ' OG1' ' A' ' 73' ' ' THR . 0.2 OUTLIER -163.01 60.28 0.19 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.778 -1.202 . . . . 0.0 110.029 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 4.1 m-20 -92.76 148.86 21.69 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -83.4 52.27 2.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.687 -1.258 . . . . 0.0 109.272 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.631 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 22.6 m-85 . . . . . 0 N--CA 1.502 2.138 0 O-C-N 121.63 -0.669 . . . . 0.0 110.322 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.24 -54.75 22.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.761 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -55.44 -60.35 3.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 109.826 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 51' ' ' VAL . . . -52.49 -44.57 65.72 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.797 -1.189 . . . . 0.0 108.73 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.583 ' HA ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.38 -45.72 55.55 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.537 ' HB2' ' CG1' ' A' ' 26' ' ' VAL . . . -51.83 -56.04 16.36 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.653 ' CG1' ' CD1' ' A' ' 22' ' ' ILE . 34.2 t -43.82 -66.19 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.478 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -48.23 -44.27 32.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 108.721 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -58.96 -47.3 85.58 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.568 ' HG2' ' HB ' ' A' ' 22' ' ' ILE . 1.6 tp-100 -47.56 -33.24 6.24 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.523 HG11 HG12 ' A' ' 81' ' ' VAL . 15.0 t -67.53 -37.52 78.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 53' ' ' ALA . 36.5 t60 -77.48 -42.14 36.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.163 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -39.19 78.92 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.588 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 8.2 tp10 -74.53 -48.79 24.93 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.605 ' CD2' HG12 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -125.13 159.01 32.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 179.041 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -94.55 37.54 1.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.537 HG12 ' CG1' ' A' ' 81' ' ' VAL . 7.3 p -94.51 159.31 2.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.305 0.574 . . . . 0.0 109.834 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.34 119.09 18.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 0.0 109.662 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.489 ' HG ' HG21 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -143.21 74.11 17.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.93 . . . . 0.0 108.8 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.2 Cg_endo -79.82 165.47 22.19 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.778 2.318 . . . . 0.0 110.267 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 49' ' ' MET . 7.5 mt -65.18 -39.3 92.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.055 -1.028 . . . . 0.0 109.115 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -51.61 -45.34 63.19 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.484 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 2.7 t -61.59 -45.46 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.575 ' HG ' ' CE2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -57.49 -28.9 63.83 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.321 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.437 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 49.4 m-85 -79.19 -42.91 24.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.013 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.435 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.64 -34.9 79.29 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.907 0.86 . . . . 0.0 109.153 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.435 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -144.02 71.46 16.66 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.585 ' CA ' ' CD2' ' A' ' 38' ' ' PHE . 33.7 Cg_endo -77.09 56.01 5.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.829 2.353 . . . . 0.0 111.959 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 36' ' ' ASP . 4.8 t -152.26 178.82 9.1 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 117.664 -1.614 . . . . 0.0 113.094 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.612 HG12 ' CE2' ' A' ' 23' ' ' TRP . 1.4 mt -69.97 -78.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.514 -178.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.522 ' CB ' HD11 ' A' ' 35' ' ' LEU . 5.2 tttm -41.05 -54.86 2.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.503 -0.748 . . . . 0.0 109.388 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -52.65 -63.05 1.27 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.612 -0.835 . . . . 0.0 108.826 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.533 ' O ' ' CG2' ' A' ' 81' ' ' VAL . 0.2 OUTLIER -48.81 -63.64 1.03 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.448 -1.407 . . . . 0.0 108.245 178.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.567 ' CA ' HG13 ' A' ' 15' ' ' VAL . . . -43.18 -31.66 0.62 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.6 OUTLIER -79.18 -46.46 17.87 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -55.4 -33.14 63.25 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.605 HG12 ' CD2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -89.02 -68.3 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 122.269 1.033 . . . . 0.0 109.014 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.608 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -55.94 -55.3 34.28 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.648 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' GLN . 76.1 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.41 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.616 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.655 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 48.4 t -44.72 -54.78 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.491 ' HG2' ' CB ' ' A' ' 78' ' ' ALA . 2.4 mt-10 -70.88 -30.1 66.38 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.616 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 69.8 m -55.94 -49.61 73.05 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.062 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -70.67 -56.28 6.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.4 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.724 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 3.4 mm? -50.14 -43.23 51.91 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -56.54 -49.05 75.93 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -60.67 -62.35 1.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.724 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -45.91 -52.26 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.655 ' CE3' ' CG2' ' A' ' 32' ' ' ILE . 1.9 m95 -40.53 -67.26 0.25 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.946 0.879 . . . . 0.0 110.417 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HA ' HG23 ' A' ' 29' ' ' VAL . 14.6 pt-20 -63.02 -28.05 69.84 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.494 0.664 . . . . 0.0 109.903 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -73.05 -65.29 0.82 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.543 -0.723 . . . . 0.0 110.501 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.587 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 76.8 t -69.68 -30.98 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 110.356 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 21.9 mt -86.88 -20.66 27.12 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.118 -0.989 . . . . 0.0 110.019 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.04 62.4 2.35 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.126 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.512 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -138.39 -167.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.284 . . . . 0.0 108.906 179.038 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.01 70.09 1.26 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.186 -0.946 . . . . 0.0 109.301 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 132.0 -73.15 0.47 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.655 ' CG2' ' CE3' ' A' ' 23' ' ' TRP . 6.1 mt 61.49 133.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.24 -1.153 . . . . 0.0 109.29 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.57 ' O ' ' CD1' ' A' ' 74' ' ' ILE . . . -52.35 -171.64 0.03 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.451 ' C ' ' HB ' ' A' ' 74' ' ' ILE . 6.4 tt -106.2 8.49 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.102 -1.234 . . . . 0.0 109.188 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.667 ' HA ' ' CG2' ' A' ' 73' ' ' THR . 22.2 tp -157.52 48.98 0.42 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.081 -1.012 . . . . 0.0 109.872 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.605 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 5.9 m-20 -74.04 -166.38 0.39 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.117 -0.989 . . . . 0.0 110.29 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -132.48 33.35 3.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.453 -0.78 . . . . 0.0 109.122 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.612 ' CE1' ' C ' ' A' ' 72' ' ' PRO . 5.8 m-30 . . . . . 0 N--CA 1.5 2.053 0 O-C-N 121.875 -0.516 . . . . 0.0 111.245 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -43.09 -59.11 2.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.368 -0.833 . . . . 0.0 109.463 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.53 ' HB2' ' CG1' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -54.56 -42.82 71.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.053 -1.029 . . . . 0.0 109.115 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 51' ' ' VAL . . . -52.43 -52.88 51.7 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.552 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.95 -41.79 25.85 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.506 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -50.47 -48.52 56.63 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 22' ' ' ILE . 10.0 t -54.51 -55.57 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HA ' HG21 ' A' ' 55' ' ' VAL . . . -49.27 -47.92 46.29 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.63 -42.63 67.96 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 8.3 tp-100 -56.47 -30.38 62.86 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.532 HG12 ' CG1' ' A' ' 61' ' ' VAL . 21.2 t -70.63 -43.43 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -0.825 . . . . 0.0 109.208 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 59' ' ' TYR . 3.1 t60 -77.28 -32.74 55.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.019 . . . . 0.0 109.293 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -39.22 28.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 108.956 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -74.65 -44.78 48.72 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.575 ' CE1' HG12 ' A' ' 81' ' ' VAL . 1.1 m-85 -122.27 -176.8 3.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.918 . . . . 0.0 109.233 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -114.28 35.2 4.28 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.532 ' CG1' HG12 ' A' ' 55' ' ' VAL . 3.2 p -93.7 158.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.572 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -96.65 102.36 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.923 . . . . 0.0 110.453 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.498 ' CD2' HG21 ' A' ' 55' ' ' VAL . 3.2 tp -115.83 99.89 53.0 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 33.7 Cg_endo -77.15 152.82 31.51 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.378 2.052 . . . . 0.0 111.035 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.552 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 1.9 mm? -52.74 -41.7 64.24 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' PHE . 1.5 ttmt -53.44 -57.1 11.84 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.503 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 4.0 t -50.08 -38.69 15.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.469 ' HG ' ' HE2' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -63.87 -31.11 72.18 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 66' ' ' LYS . 2.0 m-85 -84.25 -35.07 23.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.59 89.46 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.538 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.2 69.14 27.69 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.612 ' C ' ' CE1' ' A' ' 38' ' ' PHE . 31.9 Cg_endo -78.95 69.28 7.97 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.361 2.041 . . . . 0.0 108.001 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.667 ' CG2' ' HA ' ' A' ' 35' ' ' LEU . 98.5 m -151.83 167.2 29.04 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.013 -1.475 . . . . 0.0 111.633 -177.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.636 HG12 ' CE2' ' A' ' 23' ' ' TRP . 5.5 mt -67.41 -77.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.352 -0.842 . . . . 0.0 110.99 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 16.7 ttpp -45.91 -46.6 16.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.333 -0.854 . . . . 0.0 109.517 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -58.73 -68.54 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.96 . . . . 0.0 109.75 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -44.55 -59.21 2.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.772 -1.205 . . . . 0.0 108.522 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.537 ' CA ' HG13 ' A' ' 15' ' ' VAL . . . -47.26 -32.91 5.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -77.84 -44.17 28.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 0.0 109.042 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.424 ' CD1' HG12 ' A' ' 67' ' ' VAL . 3.3 t80 -64.83 -29.29 70.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.312 -0.868 . . . . 0.0 108.974 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.575 HG12 ' CE1' ' A' ' 59' ' ' TYR . 21.3 t -86.68 -59.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.332 1.063 . . . . 0.0 109.309 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.655 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -58.28 -26.67 63.26 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.458 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.056 -1.028 . . . . 0.0 109.661 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.61 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.71 0.29 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.65 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 40.2 t -65.29 -55.97 17.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.431 ' CG ' ' HB3' ' A' ' 78' ' ' ALA . 42.1 mt-10 -77.59 -32.01 53.35 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.61 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -63.02 -42.89 99.92 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.837 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.514 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -66.32 -63.71 1.02 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.552 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.529 ' HA ' HG22 ' A' ' 22' ' ' ILE . 5.5 mp -45.76 -45.07 14.36 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -47.54 -51.78 19.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.791 -1.193 . . . . 0.0 108.347 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.458 ' OE1' ' NH1' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -61.43 -62.08 2.08 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.651 ' CD1' ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -43.46 -43.44 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-O 122.27 1.033 . . . . 0.0 108.331 178.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.729 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 3.7 m95 -53.19 -67.88 0.22 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.987 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.551 ' HB3' HD11 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -64.31 -35.14 79.89 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.378 -0.826 . . . . 0.0 110.288 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' NH1' ' OE1' ' A' ' 21' ' ' GLU . 27.1 ttm180 -68.83 -58.64 3.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.489 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.474 ' O ' ' CE ' ' A' ' 47' ' ' LYS . 65.7 t -74.19 -37.24 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 0.0 110.823 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 36.9 mt -77.22 -51.99 9.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.902 -1.124 . . . . 0.0 109.946 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.2 53.22 0.28 Allowed Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.184 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -137.42 -171.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -1.185 . . . . 0.0 108.716 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.81 39.87 0.96 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.3 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -161.06 -80.58 0.04 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.609 HG21 ' CE3' ' A' ' 23' ' ' TRP . 6.9 mt 40.83 94.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.52 -0.988 . . . . 0.0 109.932 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.494 ' C ' ' CD1' ' A' ' 34' ' ' ILE . . . -59.22 -88.49 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.546 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 5.0 mp -151.1 -58.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.994 -1.298 . . . . 0.0 110.599 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.499 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 0.7 OUTLIER -87.25 34.93 0.69 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.16 -1.588 . . . . 0.0 109.501 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -63.34 166.97 5.74 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.438 0.637 . . . . 0.0 109.634 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.6 m120 -106.52 116.79 32.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.213 -0.93 . . . . 0.0 108.525 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.729 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 46.6 m-85 . . . . . 0 N--CA 1.501 2.105 0 O-C-N 121.284 -0.885 . . . . 0.0 109.793 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 46' ' ' LEU . 2.9 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.443 ' CD1' ' C ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -42.52 -51.07 5.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.653 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' CE ' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -51.99 -61.96 1.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 109.77 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.56 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -49.34 -51.26 35.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.082 -1.011 . . . . 0.0 109.414 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.551 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -46.45 -47.05 19.19 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 53' ' ' ALA . . . -50.86 -54.57 22.7 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.651 ' CG1' ' CD1' ' A' ' 22' ' ' ILE . 38.2 t -44.65 -59.13 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.473 ' HA ' HG22 ' A' ' 55' ' ' VAL . . . -51.76 -46.62 64.17 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -53.44 -49.62 66.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.562 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 4.9 tp-100 -45.6 -39.9 8.21 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.521 ' CG1' HG13 ' A' ' 81' ' ' VAL . 2.6 t -66.36 -34.45 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.55 0.69 . . . . 0.0 109.471 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 53' ' ' ALA . 13.4 t-160 -82.13 -32.68 29.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.879 -1.138 . . . . 0.0 109.825 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -76.68 -37.01 56.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.982 -1.074 . . . . 0.0 108.566 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -76.65 -51.23 11.92 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.32 -0.863 . . . . 0.0 108.859 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.521 ' HB2' HG12 ' A' ' 61' ' ' VAL . 2.0 m-85 -112.33 179.02 4.11 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.762 0.791 . . . . 0.0 109.439 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -109.85 40.51 1.89 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.557 HG12 ' CG1' ' A' ' 81' ' ' VAL . 4.3 p -92.9 127.06 45.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.763 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -71.19 97.09 1.47 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.722 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.521 HD21 ' CG1' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -112.36 102.12 53.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.508 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.471 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 36.4 Cg_endo -79.64 160.47 25.05 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.428 2.085 . . . . 0.0 110.688 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.551 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 3.2 mm? -61.69 -45.45 93.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.274 -0.891 . . . . 0.0 108.943 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HG2' ' HB2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -52.02 -44.21 64.07 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.097 -1.002 . . . . 0.0 108.827 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.521 ' CG1' HD21 ' A' ' 63' ' ' LEU . 2.0 t -56.09 -42.99 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.56 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -60.29 -24.9 65.32 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.481 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 14.1 m-85 -87.31 -38.87 15.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.359 -0.838 . . . . 0.0 108.904 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.452 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.85 -31.74 72.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.452 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -144.59 70.34 15.42 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.758 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.576 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 33.2 Cg_endo -76.91 53.06 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.791 2.327 . . . . 0.0 111.887 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.617 ' HA ' ' CZ2' ' A' ' 23' ' ' TRP . 6.2 t -152.24 167.62 28.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.699 -1.251 . . . . 0.0 110.769 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.587 HG12 ' CE2' ' A' ' 23' ' ' TRP . 14.0 mt -68.68 -60.58 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.961 -1.087 . . . . 0.0 110.014 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.542 ' CB ' HG23 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -42.13 -58.03 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.517 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HB1' ' CG2' ' A' ' 73' ' ' THR . . . -64.88 -66.81 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 110.245 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.3 OUTLIER -47.77 -64.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.017 . . . . 0.0 109.309 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.481 ' HA ' HG21 ' A' ' 81' ' ' VAL . . . -43.69 -45.28 6.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.472 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 3.4 tp60 -62.17 -39.67 93.44 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.487 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -57.56 -34.19 68.92 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.557 ' CG1' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -84.47 -69.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.65 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -43.46 -36.04 1.84 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.256 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.459 ' HB ' ' NE2' ' A' ' 79' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.025 -1.047 . . . . 0.0 109.686 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.629 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.545 ' CG2' ' HB2' ' A' ' 82' ' ' ALA . 30.9 t -51.58 -54.02 14.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -70.85 -27.34 63.77 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.629 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 68.3 m -58.21 -50.39 73.71 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.916 -1.114 . . . . 0.0 108.514 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.473 ' HG2' ' HG3' ' A' ' 58' ' ' GLU . 4.0 tptt -64.26 -51.36 63.96 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.647 -0.658 . . . . 0.0 109.654 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.595 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -60.89 -49.06 79.01 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.571 -1.252 . . . . 0.0 108.344 179.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -47.31 -42.41 21.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.339 -1.476 . . . . 0.0 107.498 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.48 -63.01 1.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.595 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -48.94 -38.94 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.881 -1.137 . . . . 0.0 108.243 179.354 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.722 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 3.0 m95 -49.15 -66.96 0.31 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.884 0.849 . . . . 0.0 109.129 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -53.86 -47.25 71.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.827 -0.545 . . . . 0.0 110.459 -178.743 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -60.06 -68.53 0.28 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.039 -1.038 . . . . 0.0 110.629 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.531 ' CG2' HD11 ' A' ' 22' ' ' ILE . 47.5 t -61.93 -34.67 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 110.979 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' CD1' ' CE3' ' A' ' 23' ' ' TRP . 64.7 mt -83.14 -43.67 15.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.802 -1.186 . . . . 0.0 109.991 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 106.45 49.63 0.91 Allowed Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.789 -1.196 . . . . 0.0 110.685 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.478 ' O ' ' CG ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.59 176.57 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.983 -1.304 . . . . 0.0 109.22 179.378 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 t -132.68 35.48 3.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 108.549 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -149.83 -98.39 0.19 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.559 HG22 ' CE3' ' A' ' 23' ' ' TRP . 1.3 mt 53.6 104.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.054 -1.262 . . . . 0.0 108.434 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.2 -88.12 1.95 Allowed Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.571 -1.3 . . . . 0.0 111.535 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.575 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 1.7 mt -142.36 111.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.053 -1.263 . . . . 0.0 109.531 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.575 ' CB ' ' O ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER 88.62 46.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.734 0.778 . . . . 0.0 109.737 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.657 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -83.97 -148.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -128.26 114.3 16.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.542 -1.349 . . . . 0.0 110.8 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.722 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 66.6 m-85 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 120.973 -1.079 . . . . 0.0 108.436 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.39 -31.29 33.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.038 -1.038 . . . . 0.0 109.07 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.1 tptt -64.91 -71.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.557 ' CB ' ' HB3' ' A' ' 38' ' ' PHE . . . -46.99 -48.47 21.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.897 -1.127 . . . . 0.0 108.245 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.566 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.55 -45.23 37.36 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.425 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.503 ' HB1' HG13 ' A' ' 26' ' ' VAL . . . -49.67 -47.99 49.77 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.56 ' CG1' HG21 ' A' ' 22' ' ' ILE . 7.1 t -58.34 -55.81 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 55' ' ' VAL . . . -48.65 -53.38 18.82 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.99 -43.72 50.59 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.574 ' CG ' HG13 ' A' ' 22' ' ' ILE . 8.0 tp-100 -52.51 -34.96 51.97 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.534 ' CG1' HG12 ' A' ' 81' ' ' VAL . 18.9 t -65.66 -49.27 78.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.567 -0.708 . . . . 0.0 109.759 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' TYR . 18.7 t60 -68.42 -33.61 74.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.969 -1.082 . . . . 0.0 109.589 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.12 -37.08 34.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.964 -1.085 . . . . 0.0 108.441 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 58.6 mm-40 -70.48 -44.38 67.81 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CD1' HG12 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -136.04 175.93 9.15 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.46 40.95 1.18 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.479 HG23 ' CG1' ' A' ' 81' ' ' VAL . 7.9 t -93.03 125.93 45.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 19.9 tt0 -68.89 92.04 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 0.0 109.292 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.478 HD23 HD12 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -112.31 95.64 31.87 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 35.4 Cg_endo -78.57 169.73 19.38 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.354 2.036 . . . . 0.0 110.553 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.568 ' N ' HD21 ' A' ' 65' ' ' LEU . 3.5 mm? -66.91 -37.17 83.86 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.437 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -56.13 -55.82 28.36 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.519 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 4.4 t -48.45 -46.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.536 ' O ' ' CA ' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -58.49 -38.08 76.9 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.482 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 8.1 m-85 -74.84 -36.56 62.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 109.291 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.88 -38.77 86.93 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.324 -0.86 . . . . 0.0 109.217 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.484 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -139.23 66.06 36.83 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -178.547 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.536 ' CA ' ' O ' ' A' ' 68' ' ' LEU . 33.3 Cg_endo -77.19 61.31 7.23 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.973 2.448 . . . . 0.0 112.462 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.564 ' CG2' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -152.13 150.09 29.51 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.881 -1.137 . . . . 0.0 110.657 178.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.527 HG12 ' CE2' ' A' ' 23' ' ' TRP . 9.4 mt -53.73 -54.04 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.854 -1.154 . . . . 0.0 109.669 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.524 ' CG ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -51.26 -65.68 0.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.97 -1.081 . . . . 0.0 109.17 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.71 -63.45 1.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 0.0 109.661 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 73' ' ' THR . 0.3 OUTLIER -45.54 -67.04 0.32 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.541 -0.724 . . . . 0.0 109.128 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 74' ' ' ILE . . . -45.69 -49.84 14.16 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -56.7 -40.02 74.88 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.222 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.517 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 3.8 t80 -56.31 -37.75 70.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 108.573 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.534 HG12 ' CG1' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -86.73 -63.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.619 1.199 . . . . 0.0 108.981 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.545 ' HB2' ' CG2' ' A' ' 15' ' ' VAL . . . -49.7 -20.77 0.88 Allowed 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.209 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.47 ' CB ' ' OE1' ' A' ' 79' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.449 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.596 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.952 0.406 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.571 ' CG2' ' HB2' ' A' ' 82' ' ' ALA . 56.8 t -49.74 -52.48 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 178.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -72.72 -22.48 60.88 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.079 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.596 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 60.5 m -58.64 -48.21 81.78 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.226 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.535 ' HE2' ' CG ' ' A' ' 58' ' ' GLU . 7.8 tptt -68.85 -51.89 35.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.304 -0.872 . . . . 0.0 108.723 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.771 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 3.4 mm? -54.99 -36.86 65.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 16' ' ' GLU . . . -56.79 -48.3 78.23 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 23.7 mt-10 -64.25 -63.09 1.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.174 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.771 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -47.86 -45.94 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.836 -1.165 . . . . 0.0 108.405 179.58 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.706 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.9 m95 -49.34 -68.44 0.18 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.449 0.642 . . . . 0.0 110.228 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.481 ' HA ' HG23 ' A' ' 29' ' ' VAL . 8.8 pt-20 -61.04 -31.5 71.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 110.218 -178.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -68.56 -68.32 0.4 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 110.333 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.598 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 77.6 t -67.99 -33.38 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 -178.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 37.2 mt -82.13 0.08 42.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.951 -1.093 . . . . 0.0 110.033 -179.182 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.79 56.9 22.61 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.481 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -136.84 -174.47 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -1.189 . . . . 0.0 109.161 179.518 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 t -153.02 60.35 0.78 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.272 -0.893 . . . . 0.0 109.322 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 165.43 -76.65 0.14 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.141 -1.983 . . . . 0.0 108.141 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.55 HG21 ' CE3' ' A' ' 23' ' ' TRP . 6.8 mt 58.37 151.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.426 -1.044 . . . . 0.0 109.952 178.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.512 ' N ' HG23 ' A' ' 32' ' ' ILE . . . -92.97 -164.26 37.66 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -100.94 -2.02 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.381 -1.07 . . . . 0.0 110.326 -179.727 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.506 ' C ' ' OG1' ' A' ' 73' ' ' THR . 1.6 tp -156.19 53.28 0.56 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.826 -1.171 . . . . 0.0 109.94 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.569 ' N ' ' OG1' ' A' ' 73' ' ' THR . 0.5 OUTLIER -71.45 -154.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.776 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -138.14 35.06 2.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.03 -1.044 . . . . 0.0 108.601 178.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.706 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 12.5 m-85 . . . . . 0 N--CA 1.509 2.497 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.3 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 46' ' ' LEU . 81.0 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.516 ' N ' HD21 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -48.24 -36.7 14.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 109.387 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.505 ' CG ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -60.5 -63.58 1.25 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.883 . . . . 0.0 109.515 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.573 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -49.82 -47.02 51.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.89 -1.131 . . . . 0.0 108.214 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.562 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.43 -42.28 42.33 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.323 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.457 ' HB1' ' CG1' ' A' ' 26' ' ' VAL . . . -51.04 -49.0 61.37 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 48' ' ' ALA . 15.6 t -56.23 -54.33 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.554 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HA ' HG22 ' A' ' 55' ' ' VAL . . . -48.17 -44.27 32.33 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -56.81 -44.84 82.36 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 9.0 tp-100 -47.71 -39.96 18.95 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.022 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.549 HG12 ' CG1' ' A' ' 61' ' ' VAL . 3.1 t -64.79 -32.2 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.328 0.585 . . . . 0.0 109.661 179.253 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 53' ' ' ALA . 7.6 t60 -82.16 -33.23 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.928 -1.108 . . . . 0.0 109.02 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -39.86 35.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.055 -1.028 . . . . 0.0 108.581 179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.555 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 1.1 mm-40 -75.92 -42.76 47.92 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -126.33 169.27 13.1 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.782 0.801 . . . . 0.0 109.771 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -103.23 33.21 3.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.698 -1.594 . . . . 0.0 106.698 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.549 ' CG1' HG12 ' A' ' 55' ' ' VAL . 6.2 p -93.35 121.5 44.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -68.82 99.26 1.01 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 110.297 -178.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.581 HD11 ' CD1' ' A' ' 80' ' ' TYR . 9.1 tp -100.9 110.17 60.17 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.547 ' HG2' ' CG2' ' A' ' 67' ' ' VAL . 35.1 Cg_endo -78.78 154.77 26.75 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.29 1.993 . . . . 0.0 110.719 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.562 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 2.4 mm? -63.67 -42.03 98.1 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -32.56 65.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.288 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.547 ' CG2' ' HG2' ' A' ' 64' ' ' PRO . 2.2 t -71.42 -36.2 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.573 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -66.85 -25.23 66.32 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.271 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.456 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 m-85 -87.54 -35.9 17.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 108.989 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB1' ' HG2' ' A' ' 71' ' ' GLN . . . -67.98 -37.36 81.41 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.07 0.938 . . . . 0.0 108.543 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.464 ' HG2' ' HB1' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -138.09 68.45 48.85 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -178.989 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.563 ' CA ' ' CD2' ' A' ' 38' ' ' PHE . 34.5 Cg_endo -78.24 52.93 4.29 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 123.306 2.671 . . . . 0.0 113.105 -177.249 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 36' ' ' ASP . 15.2 t -154.65 169.37 24.05 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 116.729 -1.988 . . . . 0.0 114.042 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.602 HD13 ' CD1' ' A' ' 23' ' ' TRP . 9.3 mm -51.14 -64.63 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.033 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.549 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -55.08 -72.98 0.06 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.099 -1.001 . . . . 0.0 109.742 -178.451 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 73' ' ' THR . . . -48.16 -62.37 1.51 Allowed 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.268 -0.895 . . . . 0.0 110.648 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.569 ' CB ' ' O ' ' A' ' 73' ' ' THR . 0.5 OUTLIER -52.29 -64.8 0.7 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.963 -1.086 . . . . 0.0 109.553 -179.442 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 74' ' ' ILE . . . -46.14 -43.11 14.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.064 -1.022 . . . . 0.0 109.16 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 25.2 mm-40 -65.99 -52.16 51.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.315 -0.865 . . . . 0.0 108.842 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.581 ' CD1' HD11 ' A' ' 63' ' ' LEU . 18.8 t80 -43.07 -41.83 3.71 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.526 HG22 ' CG1' ' A' ' 55' ' ' VAL . 18.4 t -74.59 -59.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.316 1.055 . . . . 0.0 108.991 179.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.571 ' HB2' ' CG2' ' A' ' 15' ' ' VAL . . . -58.77 -73.27 0.08 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.282 -179.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.468 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.584 ' HB2' ' HA2' ' A' ' 33' ' ' GLY . 53.2 t80 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.052 0.453 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.487 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 29.3 m -103.67 6.53 10.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.023 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 9' ' ' VAL . . . 165.67 148.85 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.905 0 O-C-N 121.581 -0.699 . . . . 0.0 109.892 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 35.8 Cg_endo -81.23 -171.68 1.3 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.596 2.197 . . . . 0.0 109.117 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.457 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -115.45 -12.11 11.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.895 -1.128 . . . . 0.0 109.789 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 12' ' ' THR . 8.7 m120 -156.19 151.12 26.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.539 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -62.26 -15.19 45.65 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.353 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.576 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 2.1 t -65.76 -46.74 88.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' HG3' ' HB3' ' A' ' 78' ' ' ALA . 7.5 mt-10 -70.98 -25.05 62.53 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.539 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 28.2 m -59.11 -48.93 79.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -68.37 -57.29 6.12 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.397 -0.814 . . . . 0.0 109.034 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.721 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -54.55 -19.26 5.56 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.276 -0.97 . . . . 0.0 108.956 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -74.79 -51.4 14.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 2.9 mt-10 -58.24 -63.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.721 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -43.55 -54.73 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.149 -0.969 . . . . 0.0 108.88 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.727 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 1.8 m95 -42.68 -57.54 2.68 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.58 -0.7 . . . . 0.0 110.924 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 6.8 pt-20 -65.83 -30.86 71.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.943 -1.098 . . . . 0.0 111.167 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.427 ' N ' ' HG3' ' A' ' 24' ' ' GLU . 17.8 ttm180 -75.15 -71.38 0.36 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.846 -1.159 . . . . 0.0 109.865 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.593 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 69.0 t -55.09 -34.5 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.536 -0.727 . . . . 0.0 110.555 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 39.2 mt -86.08 -17.63 34.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.894 -1.129 . . . . 0.0 109.883 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.94 27.61 60.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.481 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -102.96 -176.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -1.216 . . . . 0.0 108.886 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 t -142.3 83.24 1.82 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.131 -0.98 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 130.41 -74.87 0.43 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.528 HG23 ' N ' ' A' ' 33' ' ' GLY . 3.8 mt 58.35 152.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -1.174 . . . . 0.0 109.781 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.584 ' HA2' ' HB2' ' A' ' 8' ' ' TYR . . . -96.61 -133.19 7.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 9.9 mt -120.42 -67.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.863 -1.375 . . . . 0.0 110.159 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 2.4 tt -85.12 35.64 0.59 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.74 -1.225 . . . . 0.0 109.657 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -59.07 -166.47 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 109.588 178.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.522 ' CB ' ' HG2' ' A' ' 40' ' ' GLN . 1.1 m-20 -134.17 115.81 14.64 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.727 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 72.1 m-85 -41.54 -23.1 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.12 -0.988 . . . . 0.0 110.904 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.482 ' N ' ' O ' ' A' ' 37' ' ' ASN . 5.0 t80 -108.33 44.0 1.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.551 -1.343 . . . . 0.0 109.061 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.522 ' HG2' ' CB ' ' A' ' 37' ' ' ASN . 13.1 mm-40 -86.62 -14.29 43.16 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.5 tt 168.89 64.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.13 -120.08 1.83 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 44' ' ' HIS . . . 176.7 133.99 1.9 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 10.7 m170 61.56 -178.18 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -1.228 . . . . 0.0 109.026 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.99 -8.37 11.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.125 -0.985 . . . . 0.0 109.482 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.61 -23.92 12.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 109.498 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 27' ' ' LEU . 1.7 mptt -71.33 -68.32 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.587 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -46.9 -44.69 19.94 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.965 -1.085 . . . . 0.0 108.362 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.548 ' SD ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.24 -53.88 31.09 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.399 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.533 ' CB ' ' CG1' ' A' ' 26' ' ' VAL . . . -43.65 -42.31 5.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.516 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 17.1 t -59.56 -48.31 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.449 ' HA ' HG22 ' A' ' 55' ' ' VAL . . . -58.08 -31.9 67.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.029 -1.045 . . . . 0.0 108.43 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.04 70.89 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.552 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 6.8 tp-100 -63.07 -31.21 72.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.534 ' CG1' HG12 ' A' ' 81' ' ' VAL . 2.6 t -75.9 -28.8 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' TYR . 6.1 t60 -77.72 -33.63 52.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.204 -0.935 . . . . 0.0 110.047 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -80.92 -46.5 15.1 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.489 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -62.97 -36.33 83.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.603 ' CD2' HG12 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -141.71 156.6 45.61 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.586 0.708 . . . . 0.0 109.434 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -95.29 43.94 1.09 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.55 HG12 ' CG1' ' A' ' 81' ' ' VAL . 4.8 p -91.91 149.12 4.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.422 0.63 . . . . 0.0 110.014 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 61' ' ' VAL . 9.5 tt0 -80.73 97.32 7.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 110.384 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.535 HD23 ' CD1' ' A' ' 77' ' ' LEU . 1.1 tp -126.7 86.22 59.02 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.528 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 35.6 Cg_endo -77.47 175.67 11.0 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.696 2.264 . . . . 0.0 110.983 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.548 ' CD2' ' SD ' ' A' ' 49' ' ' MET . 2.5 mm? -67.56 -41.87 83.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.435 -0.79 . . . . 0.0 109.299 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.44 -29.14 65.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.07 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.528 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 3.7 t -76.84 -34.05 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.587 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -69.88 -21.2 63.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -87.4 -34.63 18.7 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -72.85 -28.31 62.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.993 0.902 . . . . 0.0 108.735 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.545 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -146.13 65.66 10.87 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.157 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.572 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.7 Cg_endo -77.38 60.74 7.15 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.903 2.402 . . . . 0.0 112.674 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.562 ' HA ' ' CZ2' ' A' ' 23' ' ' TRP . 6.3 t -154.03 176.04 12.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.512 -1.368 . . . . 0.0 111.164 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.592 HG12 ' CE2' ' A' ' 23' ' ' TRP . 9.6 mt -74.28 -42.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.268 -0.895 . . . . 0.0 111.606 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -70.39 -45.24 66.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.583 -1.323 . . . . 0.0 108.666 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.524 ' HB1' ' CG2' ' A' ' 73' ' ' THR . . . -66.27 -35.01 79.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.647 -0.658 . . . . 0.0 109.945 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -73.04 -62.03 1.61 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.9 -1.125 . . . . 0.0 108.589 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 82' ' ' ALA . . . -51.15 -28.04 10.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 2.0 tp60 -81.15 -34.47 32.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.8 -1.187 . . . . 0.0 108.564 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.503 ' CD2' HD13 ' A' ' 63' ' ' LEU . 11.5 t80 -61.89 -33.16 73.7 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.603 HG12 ' CD2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.94 -73.65 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 122.44 1.114 . . . . 0.0 108.198 178.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.576 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -39.0 -27.05 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.156 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 81' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.059 -1.025 . . . . 0.0 109.523 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 76.6 t80 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.5 m -119.94 51.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.173 -0.954 . . . . 0.0 110.015 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -179.09 141.53 0.37 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.136 -0.978 . . . . 0.0 109.895 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 36.3 Cg_endo -82.92 -158.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.862 2.375 . . . . 0.0 110.345 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.479 ' OG1' ' OE1' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -129.88 -43.81 1.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.139 -0.976 . . . . 0.0 109.867 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -133.84 169.21 17.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.9 -1.125 . . . . 0.0 108.382 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.579 ' HA ' ' HB2' ' A' ' 17' ' ' SER . . . -73.21 -33.6 65.46 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.699 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.591 ' CG2' ' CB ' ' A' ' 82' ' ' ALA . 28.1 t -54.55 -49.62 65.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 20' ' ' ALA . 3.9 tt0 -69.68 -26.84 64.57 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.579 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 32.7 t -53.66 -52.29 60.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.947 -1.096 . . . . 0.0 108.796 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 1.3 tppm? -65.68 -53.07 46.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 109.251 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.715 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 3.5 mp -57.67 -31.62 66.51 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.653 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 16' ' ' GLU . . . -59.84 -51.67 68.73 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -59.52 -64.74 0.84 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.715 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -44.49 -53.6 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.721 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 3.6 m95 -43.52 -61.93 1.23 Allowed 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.469 0.652 . . . . 0.0 110.523 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.553 ' N ' HD12 ' A' ' 32' ' ' ILE . 3.5 pt-20 -64.01 -36.42 83.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.363 -0.836 . . . . 0.0 110.664 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -68.66 -63.34 1.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.314 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.585 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 61.3 t -68.52 -34.49 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 111.12 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.509 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 40.7 mt -83.84 4.75 27.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.867 -1.146 . . . . 0.0 109.939 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.21 51.77 48.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.509 ' CG2' ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -129.09 171.76 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -1.161 . . . . 0.0 109.249 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.1 t -139.51 70.63 1.37 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.103 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.6 68.94 0.31 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.553 HD12 ' N ' ' A' ' 24' ' ' GLU . 2.9 mp -85.87 146.17 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -1.093 . . . . 0.0 109.615 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' A' ' 74' ' ' ILE . . . -66.88 -135.16 0.04 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.536 ' CG1' ' HB2' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -123.73 -54.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.013 -1.286 . . . . 0.0 109.973 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.528 ' C ' ' OG1' ' A' ' 73' ' ' THR . 0.2 OUTLIER -96.6 44.46 1.06 Allowed 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.275 -1.516 . . . . 0.0 108.17 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.81 114.9 12.62 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -62.75 113.51 3.07 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.385 -1.447 . . . . 0.0 108.649 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.721 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 90.7 m-85 -38.94 -38.1 0.41 Allowed 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.119 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -90.23 33.97 0.88 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.44 -0.787 . . . . 0.0 109.833 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 37' ' ' ASN . 7.2 mt-30 -80.89 63.21 5.19 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.508 ' CB ' ' O ' ' A' ' 40' ' ' GLN . 2.2 mt 80.54 43.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.72 -131.59 1.08 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.87 -38.81 0.02 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -135.88 174.49 10.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.324 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.03 -34.61 7.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.11 -0.993 . . . . 0.0 109.444 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.5 tp -52.08 -38.88 58.69 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.262 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 1.3 mttp -50.78 -62.79 1.39 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.113 -0.992 . . . . 0.0 108.615 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.502 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -50.29 -44.57 54.03 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.599 ' CG ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.89 -45.7 64.25 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 47' ' ' LYS . . . -49.09 -42.97 40.66 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.55 ' HA ' HD12 ' A' ' 22' ' ' ILE . 4.6 t -64.07 -64.34 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -45.35 -40.33 7.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -63.32 -47.01 84.03 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.491 ' HG3' ' OE2' ' A' ' 58' ' ' GLU . 2.2 tp60 -50.32 -28.16 7.41 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.513 HG11 HG12 ' A' ' 81' ' ' VAL . 3.8 t -75.49 -62.43 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 59' ' ' TYR . 20.9 t-80 -54.05 -37.91 64.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.03 -1.044 . . . . 0.0 108.773 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 53' ' ' ALA . 4.0 mtt180 -69.37 -38.12 77.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.529 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -75.11 -56.99 4.18 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.341 -0.85 . . . . 0.0 108.903 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CD1' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -119.05 176.88 5.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 108.825 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.66 43.68 1.17 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.483 HG23 HG11 ' A' ' 81' ' ' VAL . 10.5 t -93.79 158.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' O ' ' CE2' ' A' ' 80' ' ' TYR . 3.0 tt0 -70.8 99.83 1.8 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 109.416 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.485 ' HG ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -134.45 68.44 72.76 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 0.0 109.276 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.523 ' CG ' HG22 ' A' ' 67' ' ' VAL . 36.9 Cg_endo -82.05 -168.02 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.959 2.439 . . . . 0.0 109.964 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.599 HD23 ' CG ' ' A' ' 49' ' ' MET . 0.4 OUTLIER -89.26 -37.14 15.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.136 -0.977 . . . . 0.0 109.311 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 67' ' ' VAL . 5.7 pttt -56.66 -37.64 71.09 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.538 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 58.5 t -69.72 -47.24 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.572 ' O ' ' CA ' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -54.82 -35.98 64.51 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.45 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 5.8 m-85 -74.45 -39.27 62.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 108.769 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.99 84.16 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.885 0.85 . . . . 0.0 108.863 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.493 ' NE2' ' CG1' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -135.09 70.87 69.41 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.146 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.58 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 30.4 Cg_endo -75.0 59.85 5.29 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.787 2.325 . . . . 0.0 112.224 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.529 ' CG2' ' HB3' ' A' ' 76' ' ' ALA . 1.9 t -153.18 167.53 28.99 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 117.337 -1.745 . . . . 0.0 112.453 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.637 HG12 ' CZ2' ' A' ' 23' ' ' TRP . 2.4 mt -63.07 -72.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.592 -0.693 . . . . 0.0 111.195 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB2' ' CG1' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -40.08 -57.86 1.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.554 -0.716 . . . . 0.0 109.468 -178.428 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.529 ' HB3' ' CG2' ' A' ' 73' ' ' THR . . . -57.55 -52.33 65.83 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.379 -0.825 . . . . 0.0 109.527 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.549 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -55.1 -65.37 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.706 -1.246 . . . . 0.0 108.708 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.542 ' O ' ' CB ' ' A' ' 82' ' ' ALA . . . -44.78 -30.89 1.04 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -77.94 -43.9 28.49 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 108.633 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.553 ' N ' ' HG2' ' A' ' 79' ' ' GLN . 2.3 t80 -58.8 -32.6 69.49 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.996 -1.065 . . . . 0.0 108.244 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.513 HG12 HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -88.6 -67.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 122.46 1.124 . . . . 0.0 109.16 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.591 ' CB ' ' CG2' ' A' ' 15' ' ' VAL . . . -54.13 -48.65 70.58 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.802 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 79' ' ' GLN . 5.6 t . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.871 -1.143 . . . . 0.0 109.765 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.0 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 34' ' ' ILE . 8.0 m -104.36 127.14 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.39 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 34' ' ' ILE . . . -50.52 169.97 0.19 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.835 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.538 ' HB3' ' CD1' ' A' ' 34' ' ' ILE . 34.4 Cg_endo -76.86 159.07 34.78 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.843 2.362 . . . . 0.0 110.581 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.45 -0.89 10.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 110.053 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -156.51 152.65 27.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.978 -1.076 . . . . 0.0 108.303 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.564 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -62.46 -32.01 72.82 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.847 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.587 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 2.4 t -49.12 -44.45 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.548 ' HG3' ' CB ' ' A' ' 78' ' ' ALA . 4.2 mt-10 -72.65 -35.59 67.8 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.564 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 53.9 p -55.56 -48.77 74.23 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.416 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.529 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 8.6 tptm -68.69 -55.92 9.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.95 -1.094 . . . . 0.0 109.415 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.727 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -54.71 -31.06 57.54 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.062 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.06 -50.16 67.27 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -59.79 -54.54 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.727 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -51.43 -54.24 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.729 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 1.7 m95 -41.19 -60.14 1.32 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.463 0.649 . . . . 0.0 110.334 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.553 ' CB ' HD11 ' A' ' 32' ' ' ILE . 5.1 pt-20 -64.52 -30.86 71.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.95 . . . . 0.0 109.606 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 tpp85 -70.06 -66.19 0.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.507 -0.746 . . . . 0.0 110.039 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.559 HG11 ' CB ' ' A' ' 50' ' ' ALA . 53.6 t -68.41 -34.45 65.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.366 -0.834 . . . . 0.0 111.102 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 24.9 mt -84.18 -8.65 59.01 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.869 -1.144 . . . . 0.0 110.155 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.8 51.7 44.27 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.778 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.482 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -122.71 -166.21 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.016 -1.285 . . . . 0.0 108.965 178.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 p -143.62 64.38 1.33 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.156 -1.018 . . . . 0.0 109.863 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 136.89 -72.86 0.45 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.286 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.553 HD11 ' CB ' ' A' ' 24' ' ' GLU . 1.8 mp 59.53 147.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -1.154 . . . . 0.0 109.309 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.55 ' O ' ' CD1' ' A' ' 74' ' ' ILE . . . -78.34 -153.41 6.66 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.538 ' CD1' ' HB3' ' A' ' 11' ' ' PRO . 30.0 mm -113.56 15.67 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.035 -1.273 . . . . 0.0 109.626 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.477 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 7.3 tt -167.65 66.67 0.08 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' N ' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -101.55 169.74 8.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.584 0.707 . . . . 0.0 110.103 -179.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.572 ' O ' ' N ' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -96.03 104.36 16.3 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.729 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 63.8 m-85 -26.83 -38.22 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.002 0 O-C-N 121.78 -0.575 . . . . 0.0 112.293 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.571 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 52.6 t80 -88.18 28.57 1.05 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.303 -1.498 . . . . 0.0 110.128 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 37' ' ' ASN . 18.0 mm100 -84.13 78.62 9.73 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 108.504 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 40' ' ' GLN . 1.3 mt 71.62 54.46 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . 129.24 168.74 12.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' SER . . . 103.56 -49.57 0.93 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 26.2 m170 55.53 -86.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -1.137 . . . . 0.0 109.369 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 43' ' ' GLY . 1.4 p -166.55 -61.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 109.34 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.512 ' N ' ' OG ' ' A' ' 45' ' ' SER . 14.2 tp -53.59 -44.39 69.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.107 -0.995 . . . . 0.0 108.835 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' CD ' ' O ' ' A' ' 26' ' ' VAL . 6.8 mttm -48.25 -60.3 2.76 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.549 ' CB ' HD13 ' A' ' 68' ' ' LEU . . . -46.99 -48.9 21.57 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.553 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.86 -50.17 27.23 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.559 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -49.24 -43.41 42.75 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.547 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 12.0 t -58.93 -64.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.457 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -45.58 -39.99 8.27 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -63.83 -45.34 90.0 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.538 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -48.28 -34.4 10.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.533 ' CG1' HG12 ' A' ' 81' ' ' VAL . 2.5 t -71.24 -31.68 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ALA . 9.3 t60 -81.62 -35.04 30.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.415 -0.803 . . . . 0.0 109.12 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -75.73 -35.32 60.27 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 1.2 mp0 -78.87 -50.98 10.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.476 ' O ' ' O ' ' A' ' 56' ' ' HIS . 2.4 m-85 -113.83 -178.54 3.4 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.895 0.855 . . . . 0.0 109.71 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -112.51 38.4 2.76 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.552 ' CG1' HG13 ' A' ' 81' ' ' VAL . 5.0 p -93.17 149.28 4.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.378 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.442 ' N ' HG22 ' A' ' 61' ' ' VAL . 45.9 tt0 -90.15 97.11 11.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.194 -0.941 . . . . 0.0 110.549 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.595 ' CD2' ' CG1' ' A' ' 67' ' ' VAL . 4.9 mt -113.47 98.95 48.31 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.6 Cg_endo -78.99 164.13 25.21 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.866 2.378 . . . . 0.0 111.238 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.553 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 3.9 mm? -63.7 -34.85 78.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.538 ' HD3' ' N ' ' A' ' 66' ' ' LYS . 1.1 mmtt -56.08 -60.61 3.24 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.595 ' CG1' ' CD2' ' A' ' 63' ' ' LEU . 2.7 t -48.32 -52.81 7.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.549 HD13 ' CB ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -47.1 -33.21 4.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 66' ' ' LYS . 1.7 m-85 -88.28 -36.34 16.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.524 -0.735 . . . . 0.0 109.969 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . -65.13 -32.32 73.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HG2' ' HB1' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -140.53 71.85 31.19 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.1 Cg_endo -76.82 60.64 6.8 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.772 2.315 . . . . 0.0 112.052 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 13.5 t -154.66 170.86 20.54 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.569 -1.252 . . . . 0.0 110.816 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.667 HG12 ' CE2' ' A' ' 23' ' ' TRP . 3.5 mt -65.71 -74.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.255 -0.903 . . . . 0.0 111.214 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -42.6 -58.86 2.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.286 -178.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.505 ' CB ' ' CG2' ' A' ' 73' ' ' THR . . . -47.61 -61.92 1.69 Allowed 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.173 -0.955 . . . . 0.0 110.04 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.57 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -53.53 -66.94 0.3 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.127 -0.983 . . . . 0.0 109.496 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.548 ' CB ' ' HG3' ' A' ' 16' ' ' GLU . . . -47.01 -35.94 7.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.183 -0.948 . . . . 0.0 108.837 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 78.0 mm-40 -70.19 -40.15 74.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.568 ' CE2' HG21 ' A' ' 67' ' ' VAL . 1.5 t80 -55.28 -35.46 65.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.552 HG13 ' CG1' ' A' ' 61' ' ' VAL . 0.1 OUTLIER -87.69 -68.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.411 1.101 . . . . 0.0 108.301 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.587 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -43.93 -50.65 8.05 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.45 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 79' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.534 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.258 0.552 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.8 m -105.25 140.03 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 108.991 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.89 152.14 95.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.089 -1.007 . . . . 0.0 109.552 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.536 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 34.9 Cg_endo -78.12 -177.32 3.79 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.627 2.218 . . . . 0.0 110.763 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.18 -3.25 8.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.866 . . . . 0.0 109.692 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -131.83 129.18 40.11 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.904 -1.123 . . . . 0.0 108.021 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.605 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -50.99 -31.7 18.83 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.54 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.582 ' CG2' ' HB2' ' A' ' 82' ' ' ALA . 40.5 t -46.4 -54.49 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.53 ' OE2' ' CG2' ' A' ' 34' ' ' ILE . 12.8 mt-10 -68.12 -37.74 81.44 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.605 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.7 m -48.95 -54.0 17.39 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.17 -1.012 . . . . 0.0 108.562 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.559 ' O ' HG22 ' A' ' 22' ' ' ILE . 1.2 tptt -60.05 -69.28 0.22 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.335 -0.853 . . . . 0.0 108.837 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.533 ' CA ' HG22 ' A' ' 22' ' ' ILE . 8.3 mt -38.76 -48.25 1.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.604 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -51.52 -52.4 47.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.766 -1.209 . . . . 0.0 108.216 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.08 -60.31 4.03 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -44.27 -47.42 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.723 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 3.7 m95 -49.43 -63.05 1.22 Allowed 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.797 -0.564 . . . . 0.0 109.912 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.58 ' N ' ' CD1' ' A' ' 32' ' ' ILE . 1.6 tt0 -61.49 -42.37 98.69 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.377 -0.827 . . . . 0.0 110.046 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -65.13 0.73 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 110.779 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.477 ' CG1' ' HB1' ' A' ' 50' ' ' ALA . 2.8 t -69.82 -32.62 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.393 -0.817 . . . . 0.0 111.717 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 33.8 mt -87.36 -33.46 19.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.681 -1.262 . . . . 0.0 110.249 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.58 58.4 1.74 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.339 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -130.4 177.1 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.207 -1.173 . . . . 0.0 108.582 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.81 38.22 3.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.027 -1.045 . . . . 0.0 109.764 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -150.24 -96.75 0.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 10.3 mt 52.7 103.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.923 -1.339 . . . . 0.0 109.877 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.407 ' C ' HG13 ' A' ' 34' ' ' ILE . . . -107.86 -77.69 1.05 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.63 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 1.1 pp -166.03 101.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -1.195 . . . . 0.0 109.931 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.63 ' CB ' ' O ' ' A' ' 34' ' ' ILE . 22.4 tp 103.44 35.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.722 0.772 . . . . 0.0 109.237 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -83.0 177.87 8.42 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.547 ' CB ' ' HG2' ' A' ' 40' ' ' GLN . 1.7 t30 -109.52 116.94 32.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.723 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 52.4 m-85 -41.54 -24.6 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.273 -0.892 . . . . 0.0 110.315 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 37' ' ' ASN . 19.0 t80 -98.25 27.15 4.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.489 -1.382 . . . . 0.0 109.778 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.547 ' HG2' ' CB ' ' A' ' 37' ' ' ASN . 10.8 mm100 -82.62 76.88 9.45 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 5.2 mp 64.12 65.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.137 -0.977 . . . . 0.0 108.518 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . 129.48 156.67 8.9 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.95 135.63 7.37 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.98 -76.76 0.21 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -1.096 . . . . 0.0 109.403 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.09 -71.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.937 . . . . 0.0 109.402 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 46' ' ' LEU . 4.1 mm? -53.35 -36.34 61.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.107 -0.995 . . . . 0.0 109.013 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 26' ' ' VAL . 0.5 OUTLIER -66.5 -60.5 2.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -0.912 . . . . 0.0 109.042 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.548 ' HA ' HG22 ' A' ' 51' ' ' VAL . . . -52.37 -49.71 63.85 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.132 -0.98 . . . . 0.0 108.636 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.599 ' CG ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.29 -45.61 45.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' HB1' ' CG1' ' A' ' 26' ' ' VAL . . . -49.23 -44.59 43.64 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.72 ' HA ' HD13 ' A' ' 22' ' ' ILE . 18.3 t -60.14 -58.46 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' HA ' HG22 ' A' ' 55' ' ' VAL . . . -48.58 -26.96 2.48 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 50' ' ' ALA . . . -73.24 -43.54 60.99 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.528 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -54.65 -28.49 47.5 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.557 HG13 ' CG2' ' A' ' 81' ' ' VAL . 2.6 t -73.77 -53.88 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 1.3 t-80 -56.3 -43.04 78.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.123 -0.986 . . . . 0.0 109.103 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -46.3 83.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 109.014 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -66.07 -50.15 65.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 108.855 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.555 ' CD1' HG12 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -129.63 154.58 46.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.451 -0.781 . . . . 0.0 109.009 179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -94.53 40.04 1.09 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.506 HG12 ' CG1' ' A' ' 81' ' ' VAL . 7.0 p -93.09 162.75 2.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.272 0.558 . . . . 0.0 109.7 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -69.39 117.85 11.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.865 . . . . 0.0 110.138 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.511 HD22 ' CG2' ' A' ' 81' ' ' VAL . 0.2 OUTLIER -142.73 69.46 19.78 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.4 Cg_endo -80.23 154.66 22.01 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.866 2.378 . . . . 0.0 110.632 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.599 HD23 ' CG ' ' A' ' 49' ' ' MET . 4.4 mt -57.19 -40.68 77.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.782 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -49.91 -44.94 50.44 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.499 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 6.7 t -64.86 -41.98 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.501 ' CD2' ' HB2' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -62.58 -26.39 68.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.462 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 m-85 -87.86 -36.0 17.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . -67.43 -32.0 72.57 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.959 0.885 . . . . 0.0 108.614 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.414 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -147.34 70.06 11.68 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.0 Cg_endo -75.11 60.26 5.47 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.812 2.342 . . . . 0.0 111.305 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.518 ' OG1' ' HA ' ' A' ' 35' ' ' LEU . 5.8 t -153.07 165.62 35.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.712 -1.195 . . . . 0.0 110.828 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.619 HG13 ' CZ2' ' A' ' 23' ' ' TRP . 2.9 mt -66.47 -64.87 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.602 -0.686 . . . . 0.0 110.501 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.506 ' HB3' HD13 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -49.75 -60.58 2.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.867 -1.145 . . . . 0.0 109.859 -179.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.468 ' CB ' ' CG2' ' A' ' 73' ' ' THR . . . -56.74 -67.84 0.27 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.958 -1.089 . . . . 0.0 110.372 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.442 ' CD1' HD11 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -49.42 -58.45 5.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.808 -1.182 . . . . 0.0 108.763 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' ILE . . . -44.94 -55.98 5.0 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 34.6 mm-40 -50.49 -49.83 54.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 108.844 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.493 ' CD2' HG12 ' A' ' 67' ' ' VAL . 7.2 t80 -48.3 -45.67 35.21 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.669 0.747 . . . . 0.0 109.302 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.557 ' CG2' HG13 ' A' ' 55' ' ' VAL . 3.5 t -81.73 -59.43 2.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 122.432 1.11 . . . . 0.0 109.313 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.582 ' HB2' ' CG2' ' A' ' 15' ' ' VAL . . . -53.73 -68.09 0.21 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.238 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.414 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.504 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 6.0 t80 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.3 0.571 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.95 129.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.22 155.19 1.24 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.929 . . . . 0.0 109.639 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.01 150.77 34.36 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.65 2.234 . . . . 0.0 110.692 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.523 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 91.9 m -116.0 7.21 14.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 0.0 109.757 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 12' ' ' THR . 0.6 OUTLIER -148.47 133.47 18.16 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.549 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -54.65 -29.99 54.02 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.996 -1.065 . . . . 0.0 109.459 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.61 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 3.6 t -48.35 -43.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -72.08 -43.79 64.28 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 53.5 p -47.12 -50.1 20.83 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.391 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HE2' ' OE1' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -61.03 -70.35 0.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 108.706 179.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.839 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 4.3 mp -40.79 -35.12 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.371 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 16' ' ' GLU . . . -61.89 -51.82 66.61 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.995 -1.066 . . . . 0.0 108.399 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -61.25 -56.06 24.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.298 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.839 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -52.67 -50.47 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.889 -1.132 . . . . 0.0 108.862 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.632 ' CH2' ' CG1' ' A' ' 74' ' ' ILE . 5.2 m95 -46.15 -59.82 2.66 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.413 0.625 . . . . 0.0 110.227 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.532 ' CB ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -61.77 -37.06 82.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.227 -0.921 . . . . 0.0 110.021 -178.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -60.89 -49.42 77.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.289 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.584 ' CG1' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -87.79 -48.9 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.241 -0.912 . . . . 0.0 110.778 -179.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.428 ' HA ' ' HG2' ' A' ' 47' ' ' LYS . 45.7 mt -63.76 -9.97 17.32 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.363 -0.836 . . . . 0.0 109.87 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.07 58.63 11.89 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.32 167.48 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -1.196 . . . . 0.0 109.45 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 t -126.78 81.43 2.01 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.249 -0.907 . . . . 0.0 109.185 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.453 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . 139.4 -73.55 0.4 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.564 ' CG2' HD13 ' A' ' 74' ' ' ILE . 14.7 mt 60.89 143.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -1.105 . . . . 0.0 109.628 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' HA2' ' CD1' ' A' ' 8' ' ' TYR . . . -86.46 -119.45 1.14 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.518 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.5 tt -149.28 -64.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.812 -1.405 . . . . 0.0 109.831 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.755 ' HA ' ' CG2' ' A' ' 73' ' ' THR . 0.6 OUTLIER -88.38 32.1 0.79 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.365 -1.46 . . . . 0.0 109.66 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 73' ' ' THR . 15.5 m-20 -59.73 167.12 2.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.343 -0.848 . . . . 0.0 110.753 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 39' ' ' PHE . 11.8 t-20 -110.53 40.37 2.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.652 ' CE1' ' C ' ' A' ' 72' ' ' PRO . 8.7 m-30 62.76 -56.3 0.15 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.769 -0.582 . . . . 0.0 111.008 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.489 ' N ' ' O ' ' A' ' 37' ' ' ASN . 2.8 t80 -86.47 22.14 1.94 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.443 -1.411 . . . . 0.0 110.238 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 9.9 mm-40 -81.4 -1.84 47.16 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.502 ' CG2' ' O ' ' A' ' 41' ' ' ILE . 9.9 tp 174.8 57.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.49 116.77 0.51 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 44' ' ' HIS . . . -150.12 -74.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.498 ' CB ' ' O ' ' A' ' 43' ' ' GLY . 0.5 OUTLIER 77.36 -156.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -1.089 . . . . 0.0 109.514 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -121.53 -51.62 2.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.925 . . . . 0.0 109.553 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -57.84 -39.63 78.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.856 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.462 ' CG ' ' O ' ' A' ' 26' ' ' VAL . 1.9 tptt -64.84 -64.14 0.94 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.583 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -47.9 -47.5 32.01 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.085 -1.009 . . . . 0.0 108.32 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.545 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.25 -49.93 31.5 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.584 ' CB ' ' CG1' ' A' ' 26' ' ' VAL . . . -46.81 -46.67 20.87 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 54' ' ' GLN . 15.0 t -56.92 -54.16 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 51' ' ' VAL . . . -48.42 -38.77 20.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.58 -44.05 97.73 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.535 ' CB ' HG12 ' A' ' 22' ' ' ILE . 3.0 tp-100 -48.7 -36.14 15.54 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.483 HG11 HG12 ' A' ' 81' ' ' VAL . 6.8 t -68.03 -45.71 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 59' ' ' TYR . 5.7 t-160 -69.94 -33.64 72.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.077 -1.015 . . . . 0.0 109.098 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -41.4 39.49 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 12.8 mm-40 -71.91 -46.06 59.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.599 ' CE1' HG12 ' A' ' 81' ' ' VAL . 0.7 OUTLIER -124.87 168.85 12.7 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.608 0.718 . . . . 0.0 109.41 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -99.18 31.84 2.92 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.484 HG12 ' HB2' ' A' ' 59' ' ' TYR . 6.5 p -93.59 123.13 45.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.414 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 4.6 tt0 -69.21 97.76 0.96 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 110.856 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -103.05 106.65 51.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.133 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 35.8 Cg_endo -79.88 166.6 21.11 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.445 2.096 . . . . 0.0 111.292 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.553 ' N ' HD21 ' A' ' 65' ' ' LEU . 3.4 mm? -69.02 -40.87 78.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -51.19 -51.7 51.29 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.457 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 3.0 t -55.93 -41.21 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.583 HD21 ' CB ' ' A' ' 48' ' ' ALA . 1.2 tp -62.43 -24.15 67.26 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.512 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 m-85 -87.62 -36.67 17.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.405 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.22 -32.55 74.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.459 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.08 71.74 18.42 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.652 ' C ' ' CE1' ' A' ' 38' ' ' PHE . 30.5 Cg_endo -77.82 64.82 8.24 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.259 1.973 . . . . 0.0 108.209 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.755 ' CG2' ' HA ' ' A' ' 35' ' ' LEU . 81.4 m -152.68 165.11 36.29 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 117.961 -1.496 . . . . 0.0 111.939 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.632 ' CG1' ' CH2' ' A' ' 23' ' ' TRP . 7.3 mt -71.93 -72.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.14 -0.975 . . . . 0.0 109.286 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.529 ' HB3' ' HG ' ' A' ' 35' ' ' LEU . 3.2 ttmm -45.21 -44.68 11.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.617 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -61.66 -55.02 35.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 108.955 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.543 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -59.11 -63.23 1.38 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.128 -0.983 . . . . 0.0 108.758 179.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.589 ' N ' ' CD2' ' A' ' 19' ' ' LEU . . . -44.87 -38.96 4.98 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 1.1 tp60 -68.89 -44.41 73.3 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.51 ' O ' ' CG2' ' A' ' 83' ' ' THR . 28.4 t80 -52.22 -35.56 49.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.14 -0.975 . . . . 0.0 108.386 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.599 HG12 ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.15 -70.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 122.375 1.084 . . . . 0.0 108.43 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.61 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -40.11 -27.77 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.06 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 80' ' ' TYR . 9.8 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.458 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.537 ' CZ ' ' O ' ' A' ' 10' ' ' ALA . 52.5 t80 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.426 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 15.3 m -121.34 54.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 109.966 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.537 ' O ' ' CZ ' ' A' ' 8' ' ' TYR . . . 171.02 146.3 0.13 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 110.131 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 36.3 Cg_endo -81.37 -154.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.937 2.425 . . . . 0.0 110.413 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.47 HG23 HG22 ' A' ' 34' ' ' ILE . 1.8 t -126.63 -57.26 1.36 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.911 -1.118 . . . . 0.0 110.1 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 16' ' ' GLU . 45.8 p30 -131.56 175.93 8.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.831 -1.168 . . . . 0.0 108.209 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.698 ' HA ' ' HB3' ' A' ' 17' ' ' SER . . . -74.92 -36.53 62.16 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.626 -1.296 . . . . 0.0 110.068 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.568 ' CG2' ' CB ' ' A' ' 82' ' ' ALA . 20.6 t -53.42 -47.66 58.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 119.939 -1.726 . . . . 0.0 106.674 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.531 ' HG3' ' CG2' ' A' ' 74' ' ' ILE . 3.6 tm-20 -69.16 -29.19 67.15 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.698 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 35.2 p -54.13 -49.36 69.37 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.302 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.454 ' HE2' ' HG3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -60.95 -51.38 69.53 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.777 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 6.7 mt -58.71 -40.7 84.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.174 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.82 -46.45 67.73 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.859 -1.15 . . . . 0.0 108.122 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 22' ' ' ILE . 23.0 mt-10 -65.21 -66.43 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.489 -0.757 . . . . 0.0 109.214 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.777 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -45.34 -46.51 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.966 . . . . 0.0 108.851 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.74 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 5.4 m95 -50.72 -64.49 0.79 Allowed 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.437 0.636 . . . . 0.0 110.867 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.531 ' CB ' HD11 ' A' ' 32' ' ' ILE . 2.6 pt-20 -59.53 -38.09 80.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.17 -61.59 2.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 110.413 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' CG2' HD12 ' A' ' 22' ' ' ILE . 4.8 t -75.2 -33.23 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.135 -0.978 . . . . 0.0 111.337 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 41.9 mt -81.9 -8.07 59.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.706 -1.246 . . . . 0.0 109.829 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.19 53.29 45.91 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -137.38 -172.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.265 . . . . 0.0 109.03 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 t -153.29 121.0 5.99 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.467 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.24 20.81 54.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.531 HD11 ' CB ' ' A' ' 24' ' ' GLU . 3.2 mt -42.08 150.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -1.199 . . . . 0.0 109.298 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.518 ' N ' HG23 ' A' ' 32' ' ' ILE . . . -73.74 -170.43 21.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -106.33 12.3 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -1.047 . . . . 0.0 109.743 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.568 ' HA ' ' CG2' ' A' ' 73' ' ' THR . 10.4 tp -169.24 62.24 0.05 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.084 -1.01 . . . . 0.0 109.39 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.525 ' N ' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -89.59 -161.96 0.83 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.249 -0.907 . . . . 0.0 109.916 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -129.66 29.76 4.99 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.226 -0.921 . . . . 0.0 110.132 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.74 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 1.9 m-85 57.64 -65.01 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.961 -0.462 . . . . 0.0 111.144 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 37' ' ' ASN . 13.4 t80 -86.46 29.94 0.74 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.685 -1.259 . . . . 0.0 110.251 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.499 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 13.8 mt-30 -80.99 -4.55 55.5 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 0.3 OUTLIER 165.64 66.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.89 -130.48 2.45 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.48 -118.86 0.46 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -49.72 157.33 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -1.101 . . . . 0.0 109.618 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.8 p -94.0 -24.03 17.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.327 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.9 tp -47.64 -41.11 21.41 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.167 -0.958 . . . . 0.0 108.982 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 26' ' ' VAL . 8.0 mttt -50.29 -61.18 2.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.101 -1.0 . . . . 0.0 108.567 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HB1' ' CD2' ' A' ' 68' ' ' LEU . . . -48.42 -46.32 37.32 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.702 ' HA ' HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.59 -52.39 30.58 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.448 ' HB1' HG13 ' A' ' 26' ' ' VAL . . . -46.87 -42.75 17.93 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.558 ' HA ' ' CG1' ' A' ' 22' ' ' ILE . 7.6 t -58.79 -61.2 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HB3' ' CD1' ' A' ' 68' ' ' LEU . . . -45.9 -48.78 16.1 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -51.95 -47.4 64.78 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.52 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -46.29 -37.05 6.83 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.045 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.483 HG22 ' HA ' ' A' ' 52' ' ' ALA . 2.2 t -73.04 -32.96 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.687 -0.633 . . . . 0.0 109.565 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 59' ' ' TYR . 2.5 t-80 -78.1 -44.18 26.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.784 -1.198 . . . . 0.0 108.38 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -34.01 73.86 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -78.31 -48.35 15.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -128.87 170.09 13.81 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.45 51.59 0.74 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 177.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 59' ' ' TYR . 96.5 t -91.24 161.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-O 121.845 0.831 . . . . 0.0 110.798 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.581 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 12.6 pt-20 -75.26 49.05 0.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.797 -0.565 . . . . 0.0 110.16 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -111.01 86.82 6.37 Favored Pre-proline 0 C--N 1.295 -1.796 0 O-C-N 121.108 -0.995 . . . . 0.0 110.986 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 37.3 Cg_endo -83.05 -152.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.745 2.297 . . . . 0.0 107.985 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.702 HD12 ' HA ' ' A' ' 49' ' ' MET . 7.9 tp -90.87 -41.55 11.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.457 -1.402 . . . . 0.0 109.611 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.545 ' HG3' ' N ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -50.29 -39.59 45.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.91 -1.119 . . . . 0.0 108.426 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.553 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 4.3 t -63.12 -34.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.533 ' CD2' ' HB1' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -65.6 -27.65 68.56 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.459 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 27.6 m-85 -86.92 -35.48 18.9 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.37 -35.34 80.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.432 ' O ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.72 71.93 19.91 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.641 ' C ' ' CE1' ' A' ' 38' ' ' PHE . 32.9 Cg_endo -77.59 64.65 8.1 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.52 2.147 . . . . 0.0 107.955 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 35' ' ' LEU . 94.5 m -152.87 158.75 42.62 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.243 -1.383 . . . . 0.0 111.716 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.645 ' CD1' ' CE2' ' A' ' 23' ' ' TRP . 5.3 mm -64.1 -77.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.438 -0.789 . . . . 0.0 110.314 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.531 ' HB3' HD11 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -42.24 -49.4 4.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.65 -0.656 . . . . 0.0 110.002 -178.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -58.88 -69.15 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 109.13 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.481 ' HG ' HD11 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -47.57 -49.47 26.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.718 -1.239 . . . . 0.0 108.817 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 82' ' ' ALA . . . -55.64 -27.57 50.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 1.5 pt20 -78.84 -32.56 46.17 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.528 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -67.79 -34.5 76.9 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.43 HG13 ' CG1' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -88.14 -63.12 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.317 1.056 . . . . 0.0 108.484 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.568 ' CB ' ' CG2' ' A' ' 15' ' ' VAL . . . -59.2 -31.24 68.85 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.425 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 13.4 m . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.517 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' A' ' 10' ' ' ALA . 37.0 t80 . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 9.9 m -114.93 40.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.886 . . . . 0.0 109.535 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.575 ' O ' ' CE1' ' A' ' 8' ' ' TYR . . . 169.81 145.85 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.317 -0.865 . . . . 0.0 109.676 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 36.3 Cg_endo -80.62 -161.39 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.708 2.272 . . . . 0.0 110.45 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.55 -55.76 1.41 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.099 -1.001 . . . . 0.0 110.094 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 14' ' ' ALA . 22.4 t-20 -119.36 169.84 9.65 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.63 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -73.26 -35.61 66.24 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.336 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.573 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 1.1 m -50.55 -56.56 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.467 ' OE1' ' HB3' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -68.68 -26.67 65.41 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 73.5 m -57.03 -51.11 70.57 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HD3' ' CG ' ' A' ' 58' ' ' GLU . 1.3 tptm -61.43 -66.18 0.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.683 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 4.3 mm? -41.04 -47.44 3.1 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.84 -48.27 64.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.864 -1.148 . . . . 0.0 108.502 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 4.3 mt-10 -64.82 -64.55 0.84 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.307 -0.871 . . . . 0.0 108.709 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.683 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -43.39 -47.08 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.705 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 3.7 m95 -50.25 -70.82 0.08 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.427 0.632 . . . . 0.0 110.741 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -55.27 -29.95 59.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.336 -0.852 . . . . 0.0 110.549 -178.199 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -76.23 -67.77 0.65 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 109.907 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.588 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 94.8 t -62.29 -31.55 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 110.11 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.463 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 19.4 mt -93.41 -4.68 50.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 110.121 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.52 56.27 25.41 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -136.97 -179.0 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 108.965 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.9 t -153.1 137.03 16.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.361 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.64 6.46 87.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.571 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.4 mt -42.83 131.05 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -1.094 . . . . 0.0 109.301 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' A' ' 74' ' ' ILE . . . -71.29 -135.37 0.14 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -119.1 -55.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.961 -1.317 . . . . 0.0 110.185 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.472 HD11 ' HE2' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -92.09 39.97 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.184 -1.573 . . . . 0.0 108.878 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.476 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 1.3 m-20 -58.67 -172.06 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.612 0.72 . . . . 0.0 109.908 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 54.7 m-20 -126.29 115.39 19.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.705 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 25.4 m-85 -41.52 -24.9 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.11 -0.994 . . . . 0.0 110.342 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -99.65 37.42 1.6 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.501 -1.375 . . . . 0.0 109.585 179.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.52 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 17.4 mm100 -81.33 -10.65 59.52 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 0.3 OUTLIER 165.71 60.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.68 74.78 0.31 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 45' ' ' SER . . . -124.45 -81.73 0.5 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' A' ' 43' ' ' GLY . 46.5 t-80 63.26 -75.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -1.115 . . . . 0.0 109.457 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER 174.26 -61.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 109.515 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.27 -44.49 53.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.633 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.521 ' HG3' ' CG1' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -58.88 -71.37 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 109.23 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.602 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -46.98 -44.61 20.28 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.552 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.53 -51.03 29.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB1' HG11 ' A' ' 26' ' ' VAL . . . -47.36 -44.23 23.87 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.607 ' HA ' HD12 ' A' ' 22' ' ' ILE . 15.2 t -58.62 -58.03 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.541 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . . . -48.46 -40.13 25.24 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.4 -46.41 88.77 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.511 ' HG2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -51.87 -31.17 26.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.469 HG21 ' HA ' ' A' ' 52' ' ' ALA . 3.3 t -74.21 -48.36 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.638 -0.664 . . . . 0.0 109.38 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 59' ' ' TYR . 4.6 t-80 -67.91 -34.59 76.92 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.155 -0.966 . . . . 0.0 109.189 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -76.02 -31.7 59.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 0.0 108.712 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.554 ' CG ' ' HD3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -82.67 -44.45 15.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.453 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.55 ' CD1' HG12 ' A' ' 81' ' ' VAL . 10.4 m-85 -120.51 -173.8 2.66 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.873 0.844 . . . . 0.0 109.639 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -117.95 39.96 3.25 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 59' ' ' TYR . 1.3 t -93.09 137.91 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.33 0.586 . . . . 0.0 109.626 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 48.4 tt0 -69.37 95.46 0.8 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.327 -0.858 . . . . 0.0 109.292 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.541 ' CD2' ' HB3' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -116.4 91.57 33.78 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.509 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 35.6 Cg_endo -79.28 159.98 26.21 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.548 2.166 . . . . 0.0 110.215 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.552 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 2.3 mm? -57.83 -39.75 78.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.127 -0.983 . . . . 0.0 108.711 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -53.37 -52.22 59.97 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.509 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 2.6 t -51.07 -39.9 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.602 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -64.28 -26.83 68.67 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.493 ' N ' ' O ' ' A' ' 66' ' ' LYS . 4.3 m-30 -84.2 -36.38 22.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.464 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.44 -30.41 68.33 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.464 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -145.36 66.88 12.68 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.564 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.7 Cg_endo -76.46 53.15 3.85 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.86 2.374 . . . . 0.0 112.15 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 4.3 t -151.63 175.39 12.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.72 -1.237 . . . . 0.0 110.873 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.62 HG12 ' CE2' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -72.57 -67.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.687 -0.633 . . . . 0.0 110.794 -179.021 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.472 ' HE2' HD11 ' A' ' 35' ' ' LEU . 4.0 tttt -39.91 -56.87 1.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.575 -0.703 . . . . 0.0 109.303 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -59.44 -54.49 46.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 108.886 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -49.99 -64.49 0.79 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.731 -1.231 . . . . 0.0 108.585 179.032 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.545 ' O ' ' CB ' ' A' ' 82' ' ' ALA . . . -46.15 -33.78 3.8 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.459 -0.776 . . . . 0.0 109.022 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -77.57 -40.26 42.98 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.947 -1.095 . . . . 0.0 109.142 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CE1' ' NE2' ' A' ' 71' ' ' GLN . 3.1 t80 -60.16 -34.27 73.34 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.933 -1.104 . . . . 0.0 108.127 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.55 HG12 ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -89.12 -66.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.386 1.088 . . . . 0.0 108.977 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.573 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -57.52 -28.17 63.24 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.81 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 79' ' ' GLN . 4.3 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 109.371 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.515 ' CE2' ' HA2' ' A' ' 33' ' ' GLY . 34.8 t80 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -108.92 118.03 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.442 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.2 163.67 0.52 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.071 -1.018 . . . . 0.0 109.301 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.49 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 36.2 Cg_endo -78.85 157.12 27.47 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.576 2.184 . . . . 0.0 110.776 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -130.67 1.11 4.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 110.709 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.555 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 2.3 p-10 -145.43 150.42 36.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.702 -1.248 . . . . 0.0 108.779 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.658 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -57.57 -25.42 59.95 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.019 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.561 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 2.2 t -47.07 -65.68 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.533 ' N ' HG13 ' A' ' 15' ' ' VAL . 4.0 pt-20 -70.76 -23.72 62.47 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.658 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 6.6 m -60.86 -44.85 96.47 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.394 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' O ' HG22 ' A' ' 22' ' ' ILE . 3.4 tptm -69.93 -61.57 1.73 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.964 -1.094 . . . . 0.0 108.351 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.551 ' CD1' ' HA ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -48.34 -37.32 16.35 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.069 -1.052 . . . . 0.0 108.414 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 16' ' ' GLU . . . -58.19 -47.81 82.26 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.486 ' OE1' ' NH1' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -65.38 -51.99 56.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.378 -0.826 . . . . 0.0 108.785 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.638 ' CD1' ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -54.37 -44.13 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.744 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.8 m95 -54.25 -68.57 0.17 Allowed 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.962 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 29' ' ' VAL . 9.2 pt-20 -59.32 -33.21 70.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.486 ' NH1' ' OE1' ' A' ' 21' ' ' GLU . 24.1 ttm180 -71.17 -71.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 109.448 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.554 HG11 ' CB ' ' A' ' 50' ' ' ALA . 60.8 t -54.71 -33.78 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.556 -0.715 . . . . 0.0 110.232 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.466 ' CG ' ' O ' ' A' ' 23' ' ' TRP . 13.1 mt -91.43 -9.05 46.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 0.0 110.197 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.67 52.81 48.37 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.123 -0.986 . . . . 0.0 110.977 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -129.84 -173.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.249 . . . . 0.0 108.469 178.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.0 t -154.47 120.18 5.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.073 -1.017 . . . . 0.0 109.947 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.45 20.89 50.45 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.578 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.481 ' CD1' ' HB3' ' A' ' 24' ' ' GLU . 2.8 mp -50.8 161.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.117 -1.225 . . . . 0.0 109.74 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.537 ' O ' ' CD1' ' A' ' 74' ' ' ILE . . . -81.05 -153.01 9.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 9' ' ' VAL . 48.8 mm -121.37 19.85 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.78 -1.423 . . . . 0.0 109.762 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.496 ' C ' ' OG1' ' A' ' 73' ' ' THR . 1.7 tt -165.62 53.72 0.11 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.902 -1.124 . . . . 0.0 110.523 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.536 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 1.4 m-20 -84.76 160.08 20.34 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.653 ' O ' ' N ' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -88.42 45.91 1.33 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.833 -1.167 . . . . 0.0 108.787 179.06 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.744 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 13.4 m-85 51.01 -65.73 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.307 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.653 ' N ' ' O ' ' A' ' 37' ' ' ASN . 4.2 t80 -86.43 37.24 0.73 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.622 -1.299 . . . . 0.0 108.83 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 1.1 mm-40 -80.42 -7.76 59.26 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.2 tt 166.09 74.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.437 -0.789 . . . . 0.0 109.012 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.24 -118.95 0.95 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.972 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.522 ' CA ' ' HD3' ' A' ' 47' ' ' LYS . . . -58.11 162.33 9.91 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -116.27 -59.5 1.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 109.224 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.57 -59.57 0.67 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.91 . . . . 0.0 109.444 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.59 -52.6 54.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.409 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.522 ' HD3' ' CA ' ' A' ' 43' ' ' GLY . 16.4 mttp -53.37 -51.45 62.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -53.62 -44.69 69.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.404 -1.435 . . . . 0.0 108.02 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.545 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.71 -48.98 49.53 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.554 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -48.88 -52.37 24.74 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.638 ' CG1' ' CD1' ' A' ' 22' ' ' ILE . 41.8 t -46.25 -59.5 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 55' ' ' VAL . . . -52.52 -52.95 52.12 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 52' ' ' ALA . . . -47.34 -49.09 25.02 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.573 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 6.3 tp-100 -50.9 -37.66 45.23 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.606 ' CG1' ' CG1' ' A' ' 81' ' ' VAL . 21.0 t -63.52 -60.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -54.86 -46.85 74.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.209 -0.932 . . . . 0.0 110.504 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.505 ' HG3' ' N ' ' A' ' 58' ' ' GLU . 0.8 OUTLIER -61.43 -36.69 81.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.659 -1.276 . . . . 0.0 109.01 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.505 ' N ' ' HG3' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -75.69 -53.67 8.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 108.934 179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CE1' HG12 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -120.99 157.49 29.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.6 41.0 1.09 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.54 ' CG1' HG13 ' A' ' 81' ' ' VAL . 5.8 p -92.5 159.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.441 0.638 . . . . 0.0 109.672 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.44 ' N ' HG22 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -69.22 105.98 2.7 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.455 -0.778 . . . . 0.0 110.213 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.492 HD22 HG22 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -132.93 69.59 78.98 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 34.9 Cg_endo -77.92 156.96 30.95 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.683 2.255 . . . . 0.0 110.856 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.545 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 3.5 mm? -57.88 -39.67 78.38 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -55.37 -53.16 59.69 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 2.9 t -50.84 -48.45 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.574 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -55.03 -23.62 20.68 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 66' ' ' LYS . 6.2 m-85 -87.58 -39.67 14.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.05 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.406 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.17 -33.6 76.13 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.406 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -143.15 71.27 18.33 Favored Pre-proline 0 C--N 1.296 -1.749 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.3 Cg_endo -77.24 56.05 5.31 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.881 2.388 . . . . 0.0 112.236 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 15.3 t -154.11 174.91 14.08 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 117.34 -1.744 . . . . 0.0 112.725 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.627 HG12 ' CZ2' ' A' ' 23' ' ' TRP . 1.0 OUTLIER -66.12 -72.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.207 -0.933 . . . . 0.0 111.516 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.45 ' HB3' HD11 ' A' ' 35' ' ' LEU . 32.2 ttmt -45.73 -49.33 14.88 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.133 -0.979 . . . . 0.0 109.766 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.432 ' CB ' ' CG2' ' A' ' 73' ' ' THR . . . -66.38 -71.64 0.19 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.453 -0.78 . . . . 0.0 110.081 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -42.14 -55.85 3.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.309 -0.87 . . . . 0.0 108.952 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.551 ' HA ' ' CD1' ' A' ' 19' ' ' LEU . . . -50.28 -56.24 12.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 108.502 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.46 ' OE1' ' OG1' ' A' ' 83' ' ' THR . 4.0 tp60 -50.35 -45.27 54.98 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.584 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 5.7 t80 -54.46 -35.82 63.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.166 -0.959 . . . . 0.0 108.613 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.606 ' CG1' ' CG1' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -79.78 -62.17 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 122.563 1.173 . . . . 0.0 108.976 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.561 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -53.01 -63.55 1.11 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.566 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.46 ' OG1' ' OE1' ' A' ' 79' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.049 -1.032 . . . . 0.0 109.712 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.658 ' CE2' ' HA2' ' A' ' 33' ' ' GLY . 7.9 t80 . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.292 0.568 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -115.82 51.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.607 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.588 ' O ' ' CE1' ' A' ' 8' ' ' TYR . . . -168.73 174.52 2.09 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 10' ' ' ALA . 36.5 Cg_endo -81.45 174.13 10.86 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.597 2.198 . . . . 0.0 110.888 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.403 ' H ' ' CG ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -118.15 -52.52 2.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.469 ' O ' ' OG ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -110.71 176.83 4.88 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.594 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -79.81 -33.13 40.66 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.917 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.591 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 53.0 t -61.03 -48.66 88.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -71.84 -23.6 61.56 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.594 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 20.9 m -56.09 -50.08 72.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.508 ' HE2' ' CG ' ' A' ' 58' ' ' GLU . 5.6 tptm -68.36 -52.44 33.12 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.753 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 2.3 mt -54.25 -37.35 64.56 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.696 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 16' ' ' GLU . . . -61.61 -45.83 92.42 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 22' ' ' ILE . 2.7 tt0 -61.82 -60.25 3.94 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.753 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -48.08 -57.57 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.609 ' CE3' ' CG2' ' A' ' 32' ' ' ILE . 1.9 m95 -38.24 -66.83 0.23 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.916 0.865 . . . . 0.0 110.308 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.494 ' HB2' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -58.32 -43.43 88.19 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.443 0.64 . . . . 0.0 109.578 -178.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 26' ' ' VAL . 4.2 tpp180 -63.07 -71.93 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.517 -0.74 . . . . 0.0 110.511 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.577 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 91.1 t -63.17 -31.6 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 0.0 111.27 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 13.9 mt -93.05 -12.16 31.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.682 -1.261 . . . . 0.0 110.584 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 69.42 66.72 2.15 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.283 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -133.22 -168.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -1.09 . . . . 0.0 109.327 179.421 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -153.42 69.26 0.81 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.428 -0.795 . . . . 0.0 109.04 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 142.16 -76.87 0.3 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.609 ' CG2' ' CE3' ' A' ' 23' ' ' TRP . 9.8 mt 60.07 128.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.397 -1.061 . . . . 0.0 110.768 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.658 ' HA2' ' CE2' ' A' ' 8' ' ' TYR . . . -75.19 -143.45 1.02 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.511 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -113.55 -62.93 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.122 -1.223 . . . . 0.0 109.763 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.559 ' C ' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -89.68 39.89 0.97 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.561 -1.337 . . . . 0.0 108.861 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.6 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 2.6 m-20 -60.05 -165.15 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.64 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -129.22 122.82 30.5 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CE1' ' N ' ' A' ' 73' ' ' THR . 7.9 m-30 -49.97 -21.37 1.19 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.098 -1.001 . . . . 0.0 109.07 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -97.71 39.86 1.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.025 -1.047 . . . . 0.0 108.323 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.546 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 4.4 mm-40 -80.73 83.03 6.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 40' ' ' GLN . 21.8 pt 46.2 62.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.655 0.74 . . . . 0.0 109.885 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.66 -103.23 1.8 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.33 -137.57 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -165.46 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -1.095 . . . . 0.0 109.407 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.0 m -86.46 -10.57 53.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 109.66 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -48.44 69.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.704 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 26' ' ' VAL . 4.9 mttt -56.81 -59.64 4.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.847 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.602 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -47.69 -51.87 20.33 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.975 -1.078 . . . . 0.0 109.141 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.548 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.72 -50.02 26.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' HB1' HG11 ' A' ' 26' ' ' VAL . . . -47.69 -41.86 23.55 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.546 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 17.9 t -61.12 -57.26 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.531 ' CB ' HD12 ' A' ' 68' ' ' LEU . . . -49.15 -46.16 44.79 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -57.58 -40.69 79.56 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.524 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 2.7 tp-100 -54.75 -33.76 61.66 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.533 ' CG1' HD12 ' A' ' 63' ' ' LEU . 3.5 t -68.95 -51.79 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' TYR . 4.3 t-160 -65.7 -37.46 86.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 109.252 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 53' ' ' ALA . 5.4 mtt180 -70.42 -32.33 69.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 108.727 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.508 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -81.47 -54.81 5.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.81 . . . . 0.0 108.864 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.585 ' CD1' HG12 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -118.38 -179.6 3.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.371 -0.831 . . . . 0.0 109.174 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.69 44.57 1.03 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.473 HG23 ' CG1' ' A' ' 81' ' ' VAL . 13.4 t -93.39 129.91 43.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.503 0.668 . . . . 0.0 109.734 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.76 104.05 2.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.729 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.595 HD21 ' CE1' ' A' ' 80' ' ' TYR . 6.5 mt -124.23 100.99 35.26 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 108.981 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 36.6 Cg_endo -80.18 157.4 23.15 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.548 2.166 . . . . 0.0 110.451 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.548 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 1.9 mm? -57.03 -44.22 82.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.079 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.485 ' HG3' ' HB2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -50.86 -51.24 53.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.0 -1.063 . . . . 0.0 108.337 179.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.543 HG12 ' CD2' ' A' ' 63' ' ' LEU . 2.7 t -50.76 -45.34 27.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.602 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -57.56 -25.02 59.33 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 66' ' ' LYS . 19.0 m-85 -86.72 -37.23 18.12 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.446 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.16 -30.68 68.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.78 . . . . 0.0 109.305 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.457 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -144.82 66.11 12.86 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.596 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 34.3 Cg_endo -77.52 54.37 4.71 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.895 2.397 . . . . 0.0 110.588 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.622 ' N ' ' CE1' ' A' ' 38' ' ' PHE . 9.7 t -151.93 159.35 43.82 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.215 -0.928 . . . . 0.0 110.024 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.59 HG12 ' NE1' ' A' ' 23' ' ' TRP . 2.4 mt -64.49 -60.0 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.163 -0.961 . . . . 0.0 112.005 -178.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 9.2 tttm -40.29 -53.85 2.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.318 -0.864 . . . . 0.0 108.912 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB3' ' CG2' ' A' ' 73' ' ' THR . . . -69.71 -60.93 2.0 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.666 -0.646 . . . . 0.0 110.051 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.584 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.3 OUTLIER -45.15 -59.17 2.76 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.707 -1.245 . . . . 0.0 108.623 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.462 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -50.22 -40.58 47.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.524 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -70.56 -34.91 72.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.05 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.595 ' CE1' HD21 ' A' ' 63' ' ' LEU . 7.7 t80 -63.14 -37.42 87.17 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.15 -0.969 . . . . 0.0 108.634 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.585 HG12 ' CD1' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -86.39 -62.19 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.367 1.08 . . . . 0.0 108.566 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.591 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -60.68 -54.24 47.63 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.031 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.334 179.855 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.466 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 34.5 t80 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 11.4 m -121.71 39.43 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.16 -0.962 . . . . 0.0 109.781 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 9' ' ' VAL . . . 169.35 145.36 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.88 . . . . 0.0 109.949 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' CB ' ' OE2' ' A' ' 16' ' ' GLU . 36.8 Cg_endo -82.16 -167.69 0.51 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.743 2.295 . . . . 0.0 110.267 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.12 -45.69 2.11 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.094 -1.004 . . . . 0.0 109.769 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -122.89 153.63 39.39 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.598 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -67.81 -30.51 69.95 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.678 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.572 ' CB ' ' HB1' ' A' ' 82' ' ' ALA . 3.7 t -53.33 -51.84 36.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.516 ' OE2' ' CB ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -68.79 -33.87 74.59 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.598 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.8 m -49.8 -52.2 33.9 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.407 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.481 ' O ' HG23 ' A' ' 22' ' ' ILE . 27.6 tptt -59.23 -49.46 77.75 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.293 -0.879 . . . . 0.0 108.728 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.777 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 9.9 mt -61.9 -41.76 98.28 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.512 ' O ' ' CG ' ' A' ' 24' ' ' GLU . . . -52.72 -45.38 66.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.792 -1.192 . . . . 0.0 108.036 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -64.56 -66.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 108.898 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.777 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -44.94 -48.12 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.72 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 3.3 m95 -46.69 -66.98 0.32 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.428 0.633 . . . . 0.0 110.504 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -63.73 -30.0 71.15 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.339 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -71.05 -64.18 0.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.037 -1.039 . . . . 0.0 110.223 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.563 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 99.3 t -71.37 -34.42 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 111.086 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 47.3 mt -79.33 4.78 14.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.669 -1.269 . . . . 0.0 110.052 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.34 49.12 61.47 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -134.1 -179.97 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.074 -1.251 . . . . 0.0 109.167 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.91 115.46 10.03 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.289 -0.882 . . . . 0.0 109.367 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 119.67 -69.64 0.36 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.506 HG21 ' CB ' ' A' ' 23' ' ' TRP . 10.2 mm 57.05 113.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -1.071 . . . . 0.0 109.656 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.45 -145.48 1.78 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.64 ' O ' ' N ' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -108.75 -50.81 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -1.22 . . . . 0.0 110.2 -179.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.501 ' C ' ' OG1' ' A' ' 73' ' ' THR . 0.5 OUTLIER -109.81 45.21 1.11 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 119.775 -1.828 . . . . 0.0 109.174 179.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.483 ' O ' ' HB ' ' A' ' 73' ' ' THR . 2.5 m-20 -61.2 -164.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 1.6 m-20 -135.27 118.8 16.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.72 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 70.5 m-85 -48.69 -22.3 0.76 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.924 -1.11 . . . . 0.0 109.31 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.444 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 55.4 t80 -98.25 38.4 1.33 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.93 -1.106 . . . . 0.0 108.989 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.553 ' O ' HG23 ' A' ' 41' ' ' ILE . 10.9 mm-40 -81.07 77.03 8.01 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 40' ' ' GLN . 2.5 tt 60.75 39.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.549 0.69 . . . . 0.0 109.531 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.43 -113.18 1.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.36 -57.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.68 -169.06 2.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -1.137 . . . . 0.0 109.353 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.8 t -94.07 -5.59 47.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.307 -0.87 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 49' ' ' MET . 16.6 tp -64.35 -55.79 18.8 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.091 -1.006 . . . . 0.0 109.568 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' HD2' ' O ' ' A' ' 26' ' ' VAL . 1.9 mmtm -43.3 -58.35 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -51.62 -43.33 62.53 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.564 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.44 -50.63 51.66 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 178.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 47' ' ' LYS . . . -47.37 -43.12 22.99 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.543 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 11.2 t -61.18 -60.76 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.45 ' HA ' HG21 ' A' ' 55' ' ' VAL . . . -47.74 -42.98 26.63 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 57' ' ' ARG . . . -58.23 -41.17 83.51 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.556 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -55.47 -29.99 59.74 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.498 HG11 HG12 ' A' ' 81' ' ' VAL . 6.6 t -75.19 -59.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 59' ' ' TYR . 64.8 t-80 -57.33 -31.68 65.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 0.0 109.246 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -78.76 -38.58 38.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.122 -0.986 . . . . 0.0 108.737 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.483 ' OE2' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -71.94 -48.61 44.03 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.566 ' CE1' HG12 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -127.47 -178.82 4.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.481 -0.762 . . . . 0.0 109.17 178.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -110.72 44.97 1.19 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 59' ' ' TYR . 13.9 t -93.14 153.9 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.799 -0.563 . . . . 0.0 109.723 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' O ' ' CE2' ' A' ' 80' ' ' TYR . 11.3 tt0 -70.78 94.85 1.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.457 HD12 HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -125.35 74.14 68.0 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.467 ' HG2' ' CG2' ' A' ' 67' ' ' VAL . 35.4 Cg_endo -77.2 -176.92 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.771 2.314 . . . . 0.0 110.885 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.564 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 3.9 mm? -81.27 -41.88 21.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.352 -0.843 . . . . 0.0 109.134 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -59.88 -37.66 79.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.263 -0.898 . . . . 0.0 108.701 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.467 ' CG2' ' HG2' ' A' ' 64' ' ' PRO . 8.9 t -65.11 -47.08 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.574 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -52.74 -25.84 12.34 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.486 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.7 m-85 -79.17 -42.2 26.68 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.477 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -70.28 -26.18 63.68 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.841 0.829 . . . . 0.0 108.783 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.477 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -147.02 65.76 9.9 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.2 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.567 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 34.4 Cg_endo -78.81 55.73 5.67 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 123.074 2.516 . . . . 0.0 112.722 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.535 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 4.7 t -153.18 172.65 16.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.259 -1.526 . . . . 0.0 111.996 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.626 HG12 ' CE2' ' A' ' 23' ' ' TRP . 0.9 OUTLIER -64.36 -54.83 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.616 -0.677 . . . . 0.0 110.78 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.64 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -55.49 -65.2 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.019 -1.051 . . . . 0.0 109.497 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.535 ' HB1' ' CG2' ' A' ' 73' ' ' THR . . . -48.04 -53.93 14.73 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.585 -0.697 . . . . 0.0 110.206 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.3 OUTLIER -57.64 -65.11 0.69 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.714 -1.241 . . . . 0.0 109.155 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.529 ' O ' ' CB ' ' A' ' 82' ' ' ALA . . . -44.05 -34.92 1.91 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 80' ' ' TYR . 0.6 OUTLIER -71.71 -44.45 64.15 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 108.657 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.488 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 2.3 t80 -57.58 -34.91 69.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.105 -0.997 . . . . 0.0 109.015 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.566 HG12 ' CE1' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -87.65 -63.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.289 1.042 . . . . 0.0 108.219 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.572 ' HB1' ' CB ' ' A' ' 15' ' ' VAL . . . -51.69 -59.57 4.14 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.024 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.32 0.581 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.469 ' HB ' ' CG1' ' A' ' 34' ' ' ILE . 1.6 t -103.11 106.71 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.15 156.56 1.8 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.447 -0.783 . . . . 0.0 110.147 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.56 ' HA ' ' CG2' ' A' ' 34' ' ' ILE . 36.4 Cg_endo -79.78 162.72 23.97 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.905 2.403 . . . . 0.0 110.52 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -124.26 -0.19 8.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.803 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -147.84 162.32 39.48 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.55 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -73.92 -29.98 62.33 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.534 -1.267 . . . . 0.0 109.328 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.604 ' CG1' ' CB ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -54.08 -36.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.461 ' HG2' ' CB ' ' A' ' 78' ' ' ALA . 2.9 mt-10 -77.98 -36.16 49.33 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.55 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.8 m -56.3 -49.09 75.27 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG3' ' OE2' ' A' ' 58' ' ' GLU . 10.0 tptt -67.64 -59.47 3.31 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.776 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -54.24 -27.37 34.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 109.38 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.12 -52.23 37.17 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -55.28 36.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.769 -0.772 . . . . 0.0 108.925 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.776 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -53.52 -53.51 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 108.758 179.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.737 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 1.7 m95 -40.49 -57.74 1.74 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.449 0.642 . . . . 0.0 109.72 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.518 ' CA ' HD12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -61.49 -49.97 74.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.492 -0.755 . . . . 0.0 109.69 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -52.26 -47.69 65.65 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.48 -0.762 . . . . 0.0 110.683 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.557 HG21 ' CD1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -85.92 -50.38 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.093 -1.004 . . . . 0.0 110.371 -178.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 23' ' ' TRP . 42.7 mt -68.86 -6.66 28.39 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.598 -0.689 . . . . 0.0 109.977 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.83 60.02 9.17 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -129.9 -178.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -1.162 . . . . 0.0 109.167 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 30' ' ' SER . 1.3 p -148.91 40.0 0.87 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.59 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.37 59.86 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.583 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.2 mt -85.18 136.49 22.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.445 -1.032 . . . . 0.0 109.416 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.98 -120.92 0.04 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.56 ' CG2' ' HA ' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -138.59 -61.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.815 -1.403 . . . . 0.0 109.773 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.493 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -90.02 37.82 0.9 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.676 -1.265 . . . . 0.0 108.544 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -58.99 -167.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.785 0.802 . . . . 0.0 109.484 178.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -131.72 110.96 11.25 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.737 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 53.6 m-85 -37.3 -28.87 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.562 -0.711 . . . . 0.0 110.197 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 37' ' ' ASN . 19.9 t80 -91.57 34.42 0.97 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.765 -1.209 . . . . 0.0 109.052 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 37' ' ' ASN . 6.7 mm-40 -81.78 -12.39 58.58 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 10.0 tt 170.36 79.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.445 -0.784 . . . . 0.0 108.918 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.92 -127.62 1.18 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.614 -1.279 . . . . 0.0 109.95 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.34 -48.43 0.19 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -107.59 117.26 33.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.422 -1.046 . . . . 0.0 109.223 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -53.16 -19.6 3.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.855 . . . . 0.0 109.639 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 45' ' ' SER . 0.5 OUTLIER -45.15 -47.2 12.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.151 -0.968 . . . . 0.0 109.294 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 7.0 tptt -47.83 -62.51 1.42 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 109.202 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.532 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -49.77 -48.79 50.21 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.045 -1.034 . . . . 0.0 108.594 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.603 ' CG ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.4 -47.81 47.51 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.538 ' HB2' ' CG1' ' A' ' 26' ' ' VAL . . . -48.36 -42.12 30.69 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.559 ' HA ' HG12 ' A' ' 22' ' ' ILE . 14.8 t -62.67 -52.99 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 55' ' ' VAL . . . -48.4 -45.5 36.01 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.28 77.4 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.562 ' CG ' ' OE2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -51.91 -31.88 30.38 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.028 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 52' ' ' ALA . 21.2 t -68.37 -42.03 83.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 59' ' ' TYR . 12.5 t-80 -71.16 -40.77 71.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.368 -0.832 . . . . 0.0 109.033 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -41.66 68.46 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.562 ' OE2' ' CG ' ' A' ' 54' ' ' GLN . 71.2 mt-10 -63.91 -49.4 72.81 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.518 ' CD1' ' CG1' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -139.96 172.63 12.49 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.74 45.87 0.94 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.97 145.66 7.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.437 0.637 . . . . 0.0 109.837 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.85 111.43 5.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 109.461 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.462 HD21 HD13 ' A' ' 77' ' ' LEU . 1.3 tt -147.01 85.37 6.99 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.299 -0.876 . . . . 0.0 109.436 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.1 Cg_endo -79.56 172.18 14.75 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.793 2.329 . . . . 0.0 109.589 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.603 HD23 ' CG ' ' A' ' 49' ' ' MET . 2.1 mt -68.17 -43.23 78.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.716 -1.24 . . . . 0.0 109.116 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.416 ' CG ' ' N ' ' A' ' 67' ' ' VAL . 12.5 ptmm? -47.05 -37.9 10.19 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.512 HG12 ' CE2' ' A' ' 80' ' ' TYR . 2.1 t -70.91 -42.21 77.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.532 HD21 ' CB ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -61.28 -22.38 64.8 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.472 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 46.1 m-85 -83.55 -40.46 19.09 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.438 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -68.39 -29.61 68.34 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.994 0.902 . . . . 0.0 108.797 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.438 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -140.58 68.42 31.03 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.573 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.9 Cg_endo -76.9 55.23 4.86 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.989 2.459 . . . . 0.0 113.069 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.567 ' HA ' ' CZ2' ' A' ' 23' ' ' TRP . 10.2 t -153.39 174.44 14.35 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.736 -1.227 . . . . 0.0 110.887 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.591 HG12 ' CD2' ' A' ' 23' ' ' TRP . 21.0 mt -72.71 -65.07 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.311 -0.868 . . . . 0.0 109.883 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -39.76 -54.43 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.645 -0.659 . . . . 0.0 109.577 -179.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -62.76 -59.84 4.33 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.358 -0.839 . . . . 0.0 109.068 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.3 OUTLIER -44.54 -62.6 1.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.021 -1.049 . . . . 0.0 108.739 179.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.517 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -48.7 -39.83 26.05 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.79 -40.82 79.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.913 . . . . 0.0 108.868 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.512 ' CE2' HG12 ' A' ' 67' ' ' VAL . 4.3 t80 -56.12 -35.12 66.73 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.518 ' CG1' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.21 -69.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 122.334 1.064 . . . . 0.0 109.135 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.604 ' CB ' ' CG1' ' A' ' 15' ' ' VAL . . . -48.44 -25.99 1.9 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.341 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.06 . . . . 0.0 109.6 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.489 ' CE1' ' HA3' ' A' ' 33' ' ' GLY . 2.5 t80 . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.06 129.76 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . -49.1 157.25 0.84 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.182 -0.949 . . . . 0.0 109.753 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.454 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 35.1 Cg_endo -76.2 -170.05 0.8 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.699 2.266 . . . . 0.0 110.717 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.05 -3.5 11.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 0.0 109.848 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.65 165.97 27.17 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.975 -1.078 . . . . 0.0 108.637 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.594 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -77.38 -22.36 51.81 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.02 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.559 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 2.2 t -52.0 -49.44 38.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.596 ' CG ' ' CB ' ' A' ' 78' ' ' ALA . 2.3 mt-10 -73.08 -38.25 66.47 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.594 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 16.6 m -53.27 -48.63 68.12 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.31 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' HG2' ' HG3' ' A' ' 58' ' ' GLU . 6.9 tptt -63.28 -56.66 14.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -0.985 . . . . 0.0 108.861 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.794 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 1.3 tp -52.9 -37.54 60.78 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.432 -0.792 . . . . 0.0 109.15 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.68 84.13 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -61.89 -65.27 0.72 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.534 -0.729 . . . . 0.0 109.056 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.794 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -45.81 -45.91 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.951 -1.093 . . . . 0.0 108.895 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.738 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.5 m95 -47.37 -65.12 0.62 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.66 0.743 . . . . 0.0 109.938 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.534 ' N ' HD12 ' A' ' 32' ' ' ILE . 8.0 pt-20 -60.22 -32.62 71.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 110.65 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -65.47 -61.66 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.128 -0.982 . . . . 0.0 110.664 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' CG2' HD12 ' A' ' 22' ' ' ILE . 22.0 t -77.44 -31.83 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.1 -1.0 . . . . 0.0 110.762 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 38.0 mt -78.83 -3.6 45.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.984 -1.073 . . . . 0.0 110.008 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.89 54.67 36.04 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.58 -172.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.186 -1.185 . . . . 0.0 109.374 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 t -143.29 38.22 1.4 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.386 -0.821 . . . . 0.0 109.073 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.57 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . -157.14 -94.84 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.57 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER 19.76 86.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 117.746 0.773 . . . . 0.0 110.922 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.489 ' HA3' ' CE1' ' A' ' 8' ' ' TYR . . . -135.62 20.23 3.7 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 118.624 -1.751 . . . . 0.0 112.139 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.531 ' O ' ' CG2' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -174.69 114.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 120.222 -1.752 . . . . 0.0 110.979 178.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.554 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 1.9 tp 37.81 42.47 0.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.348 0.594 . . . . 0.0 110.639 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.529 ' CB ' HG21 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -76.7 -178.42 4.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.827 . . . . 0.0 109.043 178.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.528 ' HB2' ' HG2' ' A' ' 40' ' ' GLN . 7.2 m120 -114.03 112.42 23.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.727 -1.233 . . . . 0.0 109.062 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.738 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 55.1 m-85 -42.31 -26.52 0.11 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.165 -0.959 . . . . 0.0 109.452 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 37' ' ' ASN . 16.8 t80 -92.3 36.24 0.99 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.943 -1.098 . . . . 0.0 108.697 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.528 ' HG2' ' HB2' ' A' ' 37' ' ' ASN . 9.2 mm100 -80.66 -12.31 59.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.3 tt 168.94 64.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.47 -170.58 12.11 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.5 -53.44 1.06 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -141.84 -118.51 0.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -1.182 . . . . 0.0 109.426 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.14 -5.47 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.791 -1.193 . . . . 0.0 109.795 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -50.95 -62.81 1.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 109.519 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 50' ' ' ALA . 18.2 mttp -46.52 -54.86 8.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.082 -1.011 . . . . 0.0 108.782 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.521 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -48.92 -44.33 40.28 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.62 ' CG ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.63 -46.14 58.04 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.301 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HB1' ' CG1' ' A' ' 26' ' ' VAL . . . -48.64 -47.58 40.22 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.8 t -56.63 -56.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.503 ' HA ' HG21 ' A' ' 55' ' ' VAL . . . -48.89 -35.64 15.28 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.93 89.45 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -54.78 -29.53 54.48 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 63' ' ' LEU . 5.0 t -73.97 -61.66 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 59' ' ' TYR . 71.3 t60 -52.4 -36.32 53.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.904 -1.123 . . . . 0.0 109.435 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.479 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -75.13 -44.8 44.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.044 . . . . 0.0 109.158 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 35.4 mm-40 -69.74 -33.47 72.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.408 -0.808 . . . . 0.0 109.217 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.548 ' CD1' HG12 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -143.91 162.34 36.38 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.539 -0.725 . . . . 0.0 109.436 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -96.57 39.94 1.15 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.505 ' CG1' HG13 ' A' ' 81' ' ' VAL . 7.1 p -92.96 153.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -82.78 111.27 18.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.56 HD13 ' CD1' ' A' ' 80' ' ' TYR . 4.9 tp -145.24 78.28 12.37 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.512 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 35.1 Cg_endo -79.0 -172.04 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.883 2.389 . . . . 0.0 110.284 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.62 HD23 ' CG ' ' A' ' 49' ' ' MET . 2.4 mt -78.67 -37.63 41.34 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.033 -1.042 . . . . 0.0 109.278 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -53.08 -36.67 60.94 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.533 ' CG1' HD11 ' A' ' 63' ' ' LEU . 2.6 t -72.75 -45.2 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.538 HD11 ' CD1' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -62.26 -24.16 67.11 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.4 m-85 -87.52 -35.98 17.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 108.896 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.455 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -70.74 -30.31 66.79 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.478 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.94 66.82 15.13 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -178.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.3 Cg_endo -75.88 59.37 5.75 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.915 2.41 . . . . 0.0 112.235 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 35' ' ' LEU . 4.1 t -153.8 174.37 14.65 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 117.559 -1.656 . . . . 0.0 112.584 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.582 HG12 ' CE2' ' A' ' 23' ' ' TRP . 29.0 mt -67.72 -56.94 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.47 ' HB3' HD13 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -61.85 -57.51 11.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.672 -1.268 . . . . 0.0 108.84 -178.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.51 -55.09 11.96 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.572 -0.705 . . . . 0.0 109.144 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.577 ' CB ' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -55.17 -65.42 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.0 -1.062 . . . . 0.0 109.076 179.354 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.596 ' CB ' ' CG ' ' A' ' 16' ' ' GLU . . . -43.59 -46.13 7.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.489 ' O ' HG23 ' A' ' 83' ' ' THR . 47.5 mm-40 -61.78 -53.14 60.03 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.56 ' CD1' HD13 ' A' ' 63' ' ' LEU . 2.5 t80 -43.18 -39.2 2.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.327 -0.858 . . . . 0.0 109.252 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.548 HG12 ' CD1' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -87.93 -67.31 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.433 1.111 . . . . 0.0 109.041 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.559 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -40.03 -25.94 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.868 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 79' ' ' GLN . 2.1 t . . . . . 0 N--CA 1.492 1.666 0 O-C-N 120.858 -1.151 . . . . 0.0 109.572 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.559 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 33.0 t80 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 19.8 m -109.61 28.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.965 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 9' ' ' VAL . . . 168.39 147.22 0.08 OUTLIER Pre-proline 0 C--N 1.296 -1.72 0 O-C-N 121.363 -0.836 . . . . 0.0 109.867 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -81.24 -172.23 1.45 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.665 2.244 . . . . 0.0 110.357 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.467 HG23 ' OE2' ' A' ' 16' ' ' GLU . 5.6 t -115.78 -28.72 6.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.557 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.492 ' OD1' ' HB2' ' A' ' 16' ' ' GLU . 10.1 p30 -141.14 156.31 45.97 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.566 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -62.35 -34.76 77.29 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.838 -1.164 . . . . 0.0 109.758 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.557 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 43.5 t -49.92 -48.93 22.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.492 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 31.6 mt-10 -71.17 -29.36 65.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.566 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 35.4 m -53.04 -51.12 62.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.038 -1.039 . . . . 0.0 108.679 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.553 ' HG2' ' HG2' ' A' ' 58' ' ' GLU . 1.0 OUTLIER -68.93 -54.61 14.45 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.02 -1.072 . . . . 0.0 108.818 179.6 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.707 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -48.35 -38.43 19.2 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.78 -1.168 . . . . 0.0 108.063 179.128 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.03 -50.57 73.6 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.66 -62.94 1.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.707 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -45.78 -52.23 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.626 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 2.2 m95 -41.51 -62.41 0.88 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.425 0.631 . . . . 0.0 109.727 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.527 ' CA ' HD12 ' A' ' 32' ' ' ILE . 4.8 pt-20 -66.25 -33.41 75.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.437 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -62.38 -63.9 1.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.349 -179.001 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.524 ' O ' ' CD ' ' A' ' 47' ' ' LYS . 11.8 t -79.23 -35.01 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.918 . . . . 0.0 111.606 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 38.4 mt -75.64 -2.79 31.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.884 -1.135 . . . . 0.0 109.955 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.88 59.06 10.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -131.45 -174.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -1.154 . . . . 0.0 109.083 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t -150.79 49.94 0.86 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.256 -0.902 . . . . 0.0 109.208 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 168.18 -73.05 0.14 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.528 HG23 ' CD1' ' A' ' 74' ' ' ILE . 5.1 mt 59.43 143.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.433 -1.04 . . . . 0.0 109.776 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' A' ' 74' ' ' ILE . . . -83.73 -143.53 5.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.52 ' CA ' HD11 ' A' ' 74' ' ' ILE . 5.3 tt -127.64 25.2 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -1.231 . . . . 0.0 109.388 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.601 ' HA ' ' CG2' ' A' ' 73' ' ' THR . 6.2 tp -179.52 61.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.155 -0.965 . . . . 0.0 109.516 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.55 ' O ' ' CG2' ' A' ' 73' ' ' THR . 0.6 OUTLIER -91.57 -160.48 0.73 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.488 -0.757 . . . . 0.0 109.32 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.605 ' O ' ' N ' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -126.84 29.85 5.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.878 -1.139 . . . . 0.0 109.953 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 63.0 m-85 58.24 -56.17 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 O-C-N 122.139 -0.351 . . . . 0.0 110.216 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.605 ' N ' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -84.91 26.17 0.87 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.631 -1.293 . . . . 0.0 109.809 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.502 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 7.7 mm100 -80.59 76.69 7.44 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.504 ' CG2' ' O ' ' A' ' 41' ' ' ILE . 9.2 mt 66.93 74.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.83 96.71 2.46 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 39' ' ' PHE . . . -167.93 -59.73 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.7 m170 53.25 -161.16 0.12 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.121 -1.223 . . . . 0.0 109.489 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -109.92 -50.01 3.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.09 -43.31 82.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.961 . . . . 0.0 109.335 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 26' ' ' VAL . 0.5 OUTLIER -61.13 -65.29 0.72 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -0.969 . . . . 0.0 109.625 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 51' ' ' VAL . . . -49.68 -47.96 49.94 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.888 -1.132 . . . . 0.0 108.227 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.546 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.41 -37.93 18.28 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.012 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 47' ' ' LYS . . . -57.22 -49.75 75.01 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.544 ' HA ' HD12 ' A' ' 22' ' ' ILE . 9.4 t -57.13 -57.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.469 ' HA ' HG22 ' A' ' 55' ' ' VAL . . . -48.67 -35.08 13.08 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -67.58 -45.19 76.27 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.598 ' O ' ' CB ' ' A' ' 58' ' ' GLU . 4.4 tp-100 -49.18 -31.8 9.13 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.597 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 3.4 t -68.75 -30.77 48.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.593 -0.692 . . . . 0.0 109.314 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 53' ' ' ALA . 2.8 t60 -81.57 -43.36 18.78 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.183 -0.948 . . . . 0.0 109.509 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HG2' ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -77.4 -34.05 54.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.956 -1.09 . . . . 0.0 108.611 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.598 ' CB ' ' O ' ' A' ' 54' ' ' GLN . 42.3 tp10 -77.1 -37.66 53.87 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.604 ' CD2' HG12 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -137.64 157.71 45.93 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 4.3 tt0 -93.78 32.02 1.5 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.53 HG12 ' CG1' ' A' ' 81' ' ' VAL . 6.7 p -93.64 144.33 9.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 3.1 pt-20 -69.75 136.24 50.7 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.05 -1.031 . . . . 0.0 109.456 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.537 ' CD2' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -143.22 92.24 6.79 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.507 ' HG2' ' CG2' ' A' ' 67' ' ' VAL . 36.2 Cg_endo -78.79 162.19 26.99 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.554 2.169 . . . . 0.0 110.762 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.546 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 4.1 mm? -70.3 -29.62 66.42 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -63.67 -55.07 26.33 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.625 ' CG2' ' CZ ' ' A' ' 80' ' ' TYR . 3.9 t -49.97 -42.03 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.53 ' O ' ' CA ' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -61.78 -32.14 72.39 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 66' ' ' LYS . 23.4 m-85 -80.43 -37.7 31.53 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.449 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.4 -35.07 79.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.449 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -144.98 69.56 14.47 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -178.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.581 ' C ' ' CE2' ' A' ' 38' ' ' PHE . 30.4 Cg_endo -77.67 66.84 8.02 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.712 2.275 . . . . 0.0 109.115 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.601 ' CG2' ' HA ' ' A' ' 35' ' ' LEU . 22.2 m -153.31 161.98 41.78 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 117.088 -1.845 . . . . 0.0 113.108 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.528 ' CD1' HG23 ' A' ' 32' ' ' ILE . 87.2 mt -57.8 -70.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 110.007 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 21.8 ttpp -57.67 -49.39 76.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.259 -0.901 . . . . 0.0 109.305 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 77' ' ' LEU . . . -58.65 -71.35 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.854 -1.154 . . . . 0.0 109.369 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.523 ' CB ' ' O ' ' A' ' 73' ' ' THR . 1.0 OUTLIER -42.76 -58.21 2.44 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 81' ' ' VAL . . . -49.67 -60.65 2.68 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 12.5 mm100 -45.37 -42.09 9.74 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.227 -0.92 . . . . 0.0 108.865 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.625 ' CZ ' ' CG2' ' A' ' 67' ' ' VAL . 7.8 t80 -54.39 -39.01 66.82 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.604 HG12 ' CD2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -87.46 -66.78 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.386 1.089 . . . . 0.0 108.659 179.227 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.557 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -45.01 -40.96 6.97 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.089 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.397 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.409 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 21.6 t80 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.03 118.04 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.762 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.462 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . . . -56.0 172.71 0.31 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.872 . . . . 0.0 109.536 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.538 ' HA ' ' CD1' ' A' ' 34' ' ' ILE . 36.3 Cg_endo -77.9 156.05 30.64 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.876 2.384 . . . . 0.0 110.96 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.444 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 26.3 m -109.98 3.66 20.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 109.608 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.467 ' HB3' HG23 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -169.53 173.11 6.61 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.566 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -73.48 -28.08 61.74 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.658 -1.217 . . . . 0.0 109.746 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.573 ' CB ' ' HB1' ' A' ' 82' ' ' ALA . 16.0 m -49.5 -37.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.525 ' N ' HG22 ' A' ' 15' ' ' VAL . 1.1 mt-10 -82.99 -38.45 22.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.566 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 24.8 p -53.47 -38.99 64.14 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.536 ' HE2' ' CG ' ' A' ' 58' ' ' GLU . 0.4 OUTLIER -71.49 -57.89 4.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.587 -0.695 . . . . 0.0 109.23 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.749 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 3.9 mm? -54.2 -42.4 69.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.941 -1.099 . . . . 0.0 108.422 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 24' ' ' GLU . . . -56.0 -46.75 78.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -60.48 -63.64 1.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.749 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -46.98 -51.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.65 ' CE3' ' CG2' ' A' ' 32' ' ' ILE . 2.1 m95 -39.38 -66.73 0.27 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.607 0.718 . . . . 0.0 109.929 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.495 ' HA ' HG23 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -63.68 -25.63 68.3 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.972 -178.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.472 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . 4.5 tpp180 -74.06 -67.12 0.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.115 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.594 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 72.4 t -71.36 -31.63 44.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 111.0 -178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 21.6 mt -85.58 -7.95 58.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.992 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.58 56.44 9.78 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.484 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.9 179.3 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.886 -1.361 . . . . 0.0 108.724 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -140.98 74.09 1.45 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.157 -0.964 . . . . 0.0 108.984 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 146.32 -80.35 0.22 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.65 ' CG2' ' CE3' ' A' ' 23' ' ' TRP . 9.8 mt 59.58 150.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.223 -1.163 . . . . 0.0 109.64 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.541 ' N ' HG23 ' A' ' 32' ' ' ILE . . . -82.53 -122.52 0.72 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.565 ' HA ' ' CD1' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -147.11 -52.51 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.717 -1.46 . . . . 0.0 111.079 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.674 ' HA ' ' CG2' ' A' ' 73' ' ' THR . 5.5 mt -95.5 31.14 2.07 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.049 -1.657 . . . . 0.0 110.976 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.516 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 2.9 m-20 -59.15 -166.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.113 -0.992 . . . . 0.0 109.616 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -133.98 30.62 3.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.086 -1.009 . . . . 0.0 109.245 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.599 ' CD1' ' CZ2' ' A' ' 23' ' ' TRP . 6.5 m-30 63.91 -61.88 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.362 -0.836 . . . . 0.0 109.64 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 37' ' ' ASN . 51.5 t80 -83.43 21.37 1.18 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.903 -1.123 . . . . 0.0 110.737 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.517 ' O ' ' CG2' ' A' ' 41' ' ' ILE . 8.1 mm-40 -79.13 0.75 26.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.772 -1.205 . . . . 0.0 108.342 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 40' ' ' GLN . 0.1 OUTLIER 170.66 59.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.35 -132.43 1.9 Allowed Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.116 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -170.55 124.55 1.14 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.78 -176.41 0.2 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.429 -1.042 . . . . 0.0 109.752 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 46' ' ' LEU . 4.2 t -124.25 -21.56 4.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.14 -0.975 . . . . 0.0 110.351 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 49' ' ' MET . 0.4 OUTLIER -43.97 -51.02 8.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.014 -1.054 . . . . 0.0 109.246 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -44.91 -47.44 11.24 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.599 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -57.2 -45.41 83.82 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.543 ' HG2' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -46.68 -51.77 15.28 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.556 ' CB ' HG13 ' A' ' 26' ' ' VAL . . . -48.3 -50.0 31.76 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.542 ' HA ' HG12 ' A' ' 22' ' ' ILE . 21.2 t -51.22 -55.49 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.494 ' HA ' HG21 ' A' ' 55' ' ' VAL . . . -50.18 -46.2 54.09 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.05 -38.35 56.75 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.574 ' HG2' ' HB ' ' A' ' 22' ' ' ILE . 3.4 tp-100 -58.63 -41.04 85.03 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.579 ' CG1' ' CG1' ' A' ' 81' ' ' VAL . 14.7 t -61.5 -40.54 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 59' ' ' TYR . 11.9 t60 -69.15 -53.27 20.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.056 -1.027 . . . . 0.0 109.149 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -38.57 84.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.037 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.536 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 13.3 mm-40 -71.82 -56.64 5.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.305 -0.872 . . . . 0.0 108.651 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.628 ' CD1' ' CG1' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -127.03 165.04 20.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.767 0.794 . . . . 0.0 109.532 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -95.78 46.18 1.09 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.6 t -91.44 138.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.514 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.63 103.16 1.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 109.765 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.547 ' CD2' HD13 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -138.94 82.58 19.81 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.055 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 34.5 Cg_endo -77.81 -178.84 4.91 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.78 2.32 . . . . 0.0 110.418 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.543 HD23 ' HG2' ' A' ' 49' ' ' MET . 2.5 mm? -65.22 -37.93 88.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 109.089 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -56.26 -60.99 2.71 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.591 HG13 ' NE2' ' A' ' 71' ' ' GLN . 15.2 t -47.04 -43.07 6.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.599 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -61.81 -48.68 79.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -65.51 -19.84 66.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . -76.31 -52.11 10.62 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.271 1.034 . . . . 0.0 108.838 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.591 ' NE2' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -132.58 72.35 77.91 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.034 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.579 ' C ' ' CE1' ' A' ' 38' ' ' PHE . 31.2 Cg_endo -76.4 67.43 7.06 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.397 2.064 . . . . 0.0 108.207 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.674 ' CG2' ' HA ' ' A' ' 35' ' ' LEU . 22.2 m -151.4 165.77 33.11 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.227 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.634 ' CG1' ' CE2' ' A' ' 23' ' ' TRP . 6.1 mt -76.79 -69.58 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.331 -0.856 . . . . 0.0 109.798 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -45.84 -47.54 15.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.182 -0.948 . . . . 0.0 108.867 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -59.5 -55.48 34.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.387 -0.821 . . . . 0.0 109.147 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.547 HD13 ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -56.23 -65.6 0.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.102 -0.999 . . . . 0.0 108.876 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.516 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -43.35 -37.42 2.26 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.46 -0.775 . . . . 0.0 109.054 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.447 ' O ' ' O ' ' A' ' 83' ' ' THR . 10.1 tp60 -69.95 -43.85 70.74 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.002 -1.061 . . . . 0.0 108.548 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.464 ' CD2' HD13 ' A' ' 63' ' ' LEU . 10.4 t80 -59.84 -33.4 71.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.33 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.628 ' CG1' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -86.93 -60.74 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 122.48 1.133 . . . . 0.0 108.196 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.573 ' HB1' ' CB ' ' A' ' 15' ' ' VAL . . . -54.35 -65.32 0.6 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.418 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.585 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.485 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 2.1 t80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.36 0.6 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' A' ' 10' ' ' ALA . 13.5 m -103.66 125.03 58.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.54 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . . . -48.58 176.2 0.04 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.461 -0.774 . . . . 0.0 109.578 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 10' ' ' ALA . 34.8 Cg_endo -76.63 136.52 17.28 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.612 2.208 . . . . 0.0 110.792 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.05 -9.01 13.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.35 -0.844 . . . . 0.0 109.323 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.418 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 15.6 m120 -141.36 153.88 45.34 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.607 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -64.98 -27.68 69.0 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.452 -1.299 . . . . 0.0 110.081 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.539 ' CG2' ' HB2' ' A' ' 82' ' ' ALA . 2.7 t -49.37 -49.62 17.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -78.18 -29.51 48.54 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.607 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 7.3 m -60.84 -42.31 97.53 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.664 -1.215 . . . . 0.0 108.684 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.46 ' HG2' ' HG3' ' A' ' 58' ' ' GLU . 0.7 OUTLIER -69.1 -51.31 39.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.579 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -61.11 -46.7 89.53 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.733 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.36 -45.43 55.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 22' ' ' ILE . 1.7 mm-40 -62.76 -69.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.537 -0.727 . . . . 0.0 109.541 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.632 ' CD1' ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -47.06 -40.58 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.872 -1.143 . . . . 0.0 108.919 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.727 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.6 m95 -49.25 -67.44 0.26 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.369 -0.832 . . . . 0.0 109.507 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.505 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . 4.0 pt-20 -58.85 -39.29 80.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.439 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -69.51 -70.85 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.795 -1.191 . . . . 0.0 109.744 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG13 ' HB1' ' A' ' 50' ' ' ALA . 55.3 t -55.92 -31.41 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 110.85 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.504 ' CG ' ' O ' ' A' ' 23' ' ' TRP . 14.2 mt -96.53 15.0 22.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.115 -0.991 . . . . 0.0 110.8 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.42 44.77 45.65 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 121.208 -0.932 . . . . 0.0 110.978 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.526 ' HB ' ' CD1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -117.82 -170.3 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.093 -1.239 . . . . 0.0 108.885 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 30' ' ' SER . 5.7 p -145.99 49.4 1.2 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.184 -0.948 . . . . 0.0 109.48 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 143.37 -66.8 0.46 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.526 ' CD1' ' HB ' ' A' ' 29' ' ' VAL . 1.7 mp 57.61 156.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -1.171 . . . . 0.0 109.776 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' CD1' ' A' ' 74' ' ' ILE . . . -80.31 -157.73 15.65 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.534 HG12 ' CG ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -102.7 -49.08 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.272 . . . . 0.0 110.346 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.567 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 0.2 OUTLIER -93.06 34.95 1.08 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.801 -1.187 . . . . 0.0 109.294 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -64.77 155.19 34.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.689 -0.632 . . . . 0.0 109.902 179.034 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 40' ' ' GLN . 1.8 m-20 -97.84 122.12 40.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.1 -1.0 . . . . 0.0 108.626 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.727 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 79.0 m-85 -44.5 -25.55 0.27 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.109 -0.995 . . . . 0.0 109.319 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 37' ' ' ASN . 11.9 t80 -102.05 41.26 1.23 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 108.846 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.507 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 16.5 mm-40 -79.88 -22.63 42.62 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 8.4 tt 171.0 66.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.23 -104.94 2.04 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.18 49.15 0.05 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 173.38 -167.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -1.153 . . . . 0.0 109.377 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -141.01 -38.99 0.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 109.192 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.92 -34.65 60.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.509 ' HG2' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -56.46 -51.98 66.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.114 -0.991 . . . . 0.0 108.39 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.509 ' N ' ' HG2' ' A' ' 47' ' ' LYS . . . -58.73 -46.15 88.03 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.576 ' CG ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -52.99 -32.91 48.99 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.257 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.467 ' HB1' HG13 ' A' ' 26' ' ' VAL . . . -60.94 -44.57 97.06 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.632 ' CG1' ' CD1' ' A' ' 22' ' ' ILE . 4.3 t -62.13 -69.97 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' A' ' 55' ' ' VAL . . . -44.81 -50.14 10.39 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.264 -0.897 . . . . 0.0 108.679 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 49' ' ' MET . . . -55.89 -46.04 78.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.566 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 8.1 tp-100 -48.21 -33.54 8.73 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.492 HG11 ' CE1' ' A' ' 59' ' ' TYR . 3.5 t -67.26 -67.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 59' ' ' TYR . 3.0 t-160 -46.86 -36.25 7.27 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.792 -1.192 . . . . 0.0 109.593 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -72.1 -42.66 65.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.792 -1.193 . . . . 0.0 108.717 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.46 ' HG3' ' HG2' ' A' ' 18' ' ' LYS . 52.8 mm-40 -71.58 -50.76 27.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.575 ' CD1' HG12 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -116.91 160.14 21.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -93.67 36.95 1.07 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' A' ' 59' ' ' TYR . 6.3 p -94.11 145.56 7.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -82.78 112.61 19.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.5 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.598 ' CD2' ' CD1' ' A' ' 77' ' ' LEU . 15.9 tp -133.14 94.7 19.79 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.8 Cg_endo -80.91 163.66 20.53 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.784 2.323 . . . . 0.0 110.771 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.576 HD23 ' CG ' ' A' ' 49' ' ' MET . 4.5 mt -65.15 -39.1 92.51 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.385 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -48.45 -53.33 18.28 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.589 ' CG1' ' CD1' ' A' ' 63' ' ' LEU . 1.2 t -56.01 -46.13 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.536 ' O ' ' CA ' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -58.13 -22.32 50.5 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.477 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.3 m-85 -86.03 -37.66 18.68 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.438 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.7 -31.57 69.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.438 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -142.15 67.4 21.55 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.559 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 33.0 Cg_endo -77.13 61.58 7.28 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.912 2.408 . . . . 0.0 111.933 -178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.567 ' OG1' ' HA ' ' A' ' 35' ' ' LEU . 4.4 t -152.95 176.06 12.26 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.198 -1.401 . . . . 0.0 112.053 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.629 HG12 ' CE2' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -73.64 -69.22 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.904 -0.498 . . . . 0.0 110.411 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.534 ' CG ' HG12 ' A' ' 34' ' ' ILE . 11.6 tmtt? -39.91 -56.53 1.79 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.52 ' HB1' ' CG2' ' A' ' 73' ' ' THR . . . -58.05 -64.33 0.95 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.514 -0.742 . . . . 0.0 109.884 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.598 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -46.27 -62.98 1.11 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.781 -1.2 . . . . 0.0 108.974 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.497 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -44.78 -48.82 10.91 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 51.2 mm-40 -61.55 -44.5 96.93 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.44 ' CD2' HD12 ' A' ' 63' ' ' LEU . 1.1 t80 -53.29 -37.11 61.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.891 -1.13 . . . . 0.0 108.927 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.575 HG12 ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.24 -65.43 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.431 1.11 . . . . 0.0 108.535 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.539 ' HB2' ' CG2' ' A' ' 15' ' ' VAL . . . -49.09 -20.7 0.6 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.355 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.451 ' OG1' ' OE1' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.531 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.541 ' CD1' ' O ' ' A' ' 32' ' ' ILE . 10.8 t80 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.433 0.635 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.41 130.47 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.94 160.63 0.47 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.118 -0.988 . . . . 0.0 110.02 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.504 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 33.3 Cg_endo -74.56 -159.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.855 2.37 . . . . 0.0 110.837 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.508 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 1.8 m -116.42 -7.3 11.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 12' ' ' THR . 13.5 m120 -140.66 149.45 42.27 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.878 -1.139 . . . . 0.0 108.267 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.605 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -61.61 -26.52 68.04 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.444 -1.302 . . . . 0.0 109.409 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 82' ' ' ALA . 35.3 t -48.07 -58.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.504 ' HB2' ' CB ' ' A' ' 11' ' ' PRO . 1.2 mp0 -66.01 -36.67 83.9 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.605 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 70.7 m -48.55 -55.92 9.77 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.302 177.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' CE ' ' HB2' ' A' ' 58' ' ' GLU . 20.1 tttm -52.44 -67.43 0.25 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.551 ' CD2' ' HB3' ' A' ' 77' ' ' LEU . 0.8 OUTLIER -43.0 -46.48 5.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.336 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -49.82 -57.98 6.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.78 -1.2 . . . . 0.0 109.08 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -51.08 71.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 109.4 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.624 ' CD1' ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -54.69 -44.06 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.726 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 3.3 m95 -52.22 -66.2 0.42 Allowed 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.619 0.723 . . . . 0.0 109.721 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -58.9 -53.73 55.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.463 -0.773 . . . . 0.0 110.046 -178.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -54.15 -66.08 0.46 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 109.982 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.503 ' CG1' ' CB ' ' A' ' 50' ' ' ALA . 21.6 t -58.56 -43.73 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.797 . . . . 0.0 110.719 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 42.3 mt -78.69 -12.38 60.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.996 -1.065 . . . . 0.0 110.347 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 72.73 53.27 8.45 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.409 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.36 -178.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.125 -1.221 . . . . 0.0 109.127 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.08 39.71 1.34 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.209 -0.932 . . . . 0.0 109.472 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -156.17 -91.2 0.08 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.541 ' O ' ' CD1' ' A' ' 8' ' ' TYR . 14.7 mt 58.63 149.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -1.164 . . . . 0.0 109.721 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 32' ' ' ILE . . . -107.38 -154.96 19.41 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 75' ' ' LYS . 9.1 pt -98.84 2.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.139 -1.212 . . . . 0.0 110.024 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 75' ' ' LYS . 1.3 tt -162.41 69.1 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.979 -1.076 . . . . 0.0 108.986 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.412 ' N ' ' OG1' ' A' ' 73' ' ' THR . 1.8 m-20 -98.49 160.68 14.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.679 -0.638 . . . . 0.0 109.562 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 40' ' ' GLN . 1.2 t-20 -89.49 106.83 18.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.726 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 43.4 m-85 -31.73 -34.02 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.595 0 O-C-N 121.789 -0.569 . . . . 0.0 111.111 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 37' ' ' ASN . 12.6 t80 -99.59 38.28 1.46 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.734 -1.229 . . . . 0.0 109.784 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 37' ' ' ASN . 5.3 mm-40 -81.27 -22.0 38.99 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -172.67 52.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.427 -0.795 . . . . 0.0 109.082 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.04 -138.24 3.8 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.56 132.13 2.0 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 69.12 162.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -1.162 . . . . 0.0 109.263 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.81 -10.3 31.85 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 109.821 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.15 -58.86 3.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.08 -1.012 . . . . 0.0 109.51 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 2.0 tptt -47.0 -59.35 3.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 109.854 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.549 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -58.06 -45.26 87.38 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.032 -1.042 . . . . 0.0 109.137 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.58 ' HG2' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.77 -49.6 37.87 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.331 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.503 ' CB ' ' CG1' ' A' ' 26' ' ' VAL . . . -50.38 -55.63 14.86 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.624 ' CG1' ' CD1' ' A' ' 22' ' ' ILE . 21.6 t -43.13 -60.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.474 ' HB3' HD21 ' A' ' 63' ' ' LEU . . . -49.95 -54.89 16.96 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.501 ' CB ' ' HE3' ' A' ' 49' ' ' MET . . . -47.36 -50.63 21.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.532 ' HG2' ' HB ' ' A' ' 22' ' ' ILE . 7.3 tp-100 -46.91 -38.6 10.76 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 52' ' ' ALA . 17.0 t -60.23 -62.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 59' ' ' TYR . 17.3 t60 -58.34 -32.82 68.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.419 -0.801 . . . . 0.0 110.046 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -74.29 -39.33 62.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.046 -1.034 . . . . 0.0 109.548 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.528 ' HB2' ' CE ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -78.29 -44.59 24.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 109.295 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.549 ' CD2' HG12 ' A' ' 81' ' ' VAL . 5.4 m-85 -110.96 -174.43 2.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 60' ' ' GLN . 54.5 tp60 -113.54 29.15 8.22 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' A' ' 59' ' ' TYR . 3.4 p -93.85 134.3 31.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.654 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -74.34 103.61 4.78 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.465 -0.772 . . . . 0.0 110.097 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -116.81 95.79 47.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.118 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.514 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 37.4 Cg_endo -82.88 169.17 13.43 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.721 2.281 . . . . 0.0 110.157 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.58 HD23 ' HG2' ' A' ' 49' ' ' MET . 1.9 mt -66.52 -37.73 85.65 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.076 -1.015 . . . . 0.0 109.045 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -40.69 64.84 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.583 HG12 ' CD2' ' A' ' 80' ' ' TYR . 4.6 t -65.53 -43.6 94.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.549 HD21 ' CB ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -58.06 -26.14 62.12 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.115 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.492 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 10.2 m-85 -86.29 -34.73 20.27 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.72 -25.39 64.73 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.915 0.864 . . . . 0.0 108.736 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.44 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -154.58 66.76 5.28 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -177.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.568 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.7 Cg_endo -75.1 53.99 3.55 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.767 2.311 . . . . 0.0 112.338 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.483 ' CG2' ' HB1' ' A' ' 76' ' ' ALA . 14.6 t -153.23 170.03 21.58 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.591 -1.318 . . . . 0.0 111.238 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.579 HD12 ' CG ' ' A' ' 23' ' ' TRP . 9.4 mm -60.25 -71.69 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.869 -0.519 . . . . 0.0 111.776 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -50.22 -54.04 23.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.057 -1.027 . . . . 0.0 110.362 -178.049 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.483 ' HB1' ' CG2' ' A' ' 73' ' ' THR . . . -53.45 -67.93 0.22 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.551 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -53.27 -59.32 4.72 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.479 -0.889 . . . . 0.0 109.323 -179.276 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.49 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -45.78 -44.68 14.17 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.51 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -61.71 -42.42 98.92 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.056 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.583 ' CD2' HG12 ' A' ' 67' ' ' VAL . 2.8 t80 -56.04 -33.82 65.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 108.856 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.549 HG12 ' CD2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -86.98 -60.98 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.481 1.134 . . . . 0.0 108.898 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.526 ' HB2' ' CG2' ' A' ' 15' ' ' VAL . . . -53.61 -41.24 66.46 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.688 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.469 ' HB ' ' OE1' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 120.927 -1.108 . . . . 0.0 109.598 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' A' ' 32' ' ' ILE . 47.8 t80 . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 46.3 t -108.69 36.39 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.967 . . . . 0.0 110.38 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' ' CE1' ' A' ' 8' ' ' TYR . . . 169.27 142.73 0.07 OUTLIER Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.195 -0.941 . . . . 0.0 110.354 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.64 -158.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.94 2.427 . . . . 0.0 110.442 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.457 ' OG1' ' OE1' ' A' ' 16' ' ' GLU . 0.6 OUTLIER -128.71 -41.93 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.429 -0.794 . . . . 0.0 109.105 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -131.8 171.73 13.17 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.583 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -73.1 -33.87 65.84 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.681 -1.262 . . . . 0.0 110.165 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.608 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 57.5 t -51.62 -51.68 25.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.501 ' OE1' ' CD1' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -70.45 -27.92 64.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.583 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 49.5 m -53.4 -51.68 61.81 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.799 -1.161 . . . . 0.0 108.166 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.557 ' O ' HG22 ' A' ' 22' ' ' ILE . 5.7 tptm -66.53 -62.74 1.3 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.361 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.534 ' HA ' HG22 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -39.93 -49.72 2.46 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 16' ' ' GLU . . . -51.23 -51.48 53.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' LYS . 4.0 mt-10 -58.64 -62.79 1.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.653 ' CD1' ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -42.89 -46.36 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.068 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.631 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 4.1 m95 -54.93 -70.77 0.09 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 121.702 0.763 . . . . 0.0 110.194 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -57.83 -47.33 82.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 110.272 -178.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.436 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 14.2 ttm180 -62.41 -65.18 0.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.015 -1.053 . . . . 0.0 110.302 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.537 ' CG1' ' HB2' ' A' ' 50' ' ' ALA . 29.5 t -61.76 -36.13 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.372 -0.83 . . . . 0.0 111.007 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 42.2 mt -84.54 -35.78 22.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.974 -1.079 . . . . 0.0 110.01 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 92.59 56.55 1.53 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.208 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.465 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.53 172.49 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -1.203 . . . . 0.0 109.159 179.507 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.2 t -131.8 39.23 3.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.198 -0.939 . . . . 0.0 109.174 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -157.36 -89.0 0.07 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.601 ' CG2' ' CE3' ' A' ' 23' ' ' TRP . 10.8 mt 59.07 141.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -1.158 . . . . 0.0 109.804 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.489 ' O ' HD11 ' A' ' 74' ' ' ILE . . . -101.77 -147.26 19.71 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.501 ' CD1' ' OE1' ' A' ' 16' ' ' GLU . 20.2 tt -113.1 9.58 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.116 -1.226 . . . . 0.0 110.285 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.533 ' C ' ' OG1' ' A' ' 73' ' ' THR . 0.2 OUTLIER -163.01 60.28 0.19 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.778 -1.202 . . . . 0.0 110.029 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 4.1 m-20 -92.76 148.86 21.69 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -83.4 52.27 2.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.687 -1.258 . . . . 0.0 109.272 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.631 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 22.6 m-85 37.84 26.26 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.63 -0.669 . . . . 0.0 110.322 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 37' ' ' ASN . 17.3 t80 -162.52 27.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.864 -1.147 . . . . 0.0 110.57 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.478 ' HG3' ' OD1' ' A' ' 36' ' ' ASP . 62.2 mm-40 -80.53 -7.7 59.31 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.536 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 0.2 OUTLIER 178.04 56.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.8 134.76 4.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 44' ' ' HIS . . . -160.17 -98.89 0.14 Allowed Glycine 0 N--CA 1.489 2.21 0 O-C-N 120.949 -1.324 . . . . 0.0 109.891 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 43' ' ' GLY . 2.6 t-160 77.64 132.44 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -1.066 . . . . 0.0 109.146 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 t -58.53 -53.93 52.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.61 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.24 -54.75 22.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.761 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -55.44 -60.35 3.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 109.826 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 51' ' ' VAL . . . -52.49 -44.57 65.72 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.797 -1.189 . . . . 0.0 108.73 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.583 ' HA ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.38 -45.72 55.55 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.537 ' HB2' ' CG1' ' A' ' 26' ' ' VAL . . . -51.83 -56.04 16.36 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.653 ' CG1' ' CD1' ' A' ' 22' ' ' ILE . 34.2 t -43.82 -66.19 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.478 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -48.23 -44.27 32.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 108.721 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -58.96 -47.3 85.58 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.568 ' HG2' ' HB ' ' A' ' 22' ' ' ILE . 1.6 tp-100 -47.56 -33.24 6.24 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.523 HG11 HG12 ' A' ' 81' ' ' VAL . 15.0 t -67.53 -37.52 78.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 53' ' ' ALA . 36.5 t60 -77.48 -42.14 36.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.163 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -39.19 78.92 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.588 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 8.2 tp10 -74.53 -48.79 24.93 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.605 ' CD2' HG12 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -125.13 159.01 32.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 179.041 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -94.55 37.54 1.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.537 HG12 ' CG1' ' A' ' 81' ' ' VAL . 7.3 p -94.51 159.31 2.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.305 0.574 . . . . 0.0 109.834 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.34 119.09 18.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 0.0 109.662 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.489 ' HG ' HG21 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -143.21 74.11 17.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.93 . . . . 0.0 108.8 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.2 Cg_endo -79.82 165.47 22.19 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.778 2.318 . . . . 0.0 110.267 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 49' ' ' MET . 7.5 mt -65.18 -39.3 92.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.055 -1.028 . . . . 0.0 109.115 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -51.61 -45.34 63.19 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.484 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 2.7 t -61.59 -45.46 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.575 ' HG ' ' CE2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -57.49 -28.9 63.83 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.321 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.437 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 49.4 m-85 -79.19 -42.91 24.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.013 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.435 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.64 -34.9 79.29 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.907 0.86 . . . . 0.0 109.153 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.435 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -144.02 71.46 16.66 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.585 ' CA ' ' CD2' ' A' ' 38' ' ' PHE . 33.7 Cg_endo -77.09 56.01 5.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.829 2.353 . . . . 0.0 111.959 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 36' ' ' ASP . 4.8 t -152.26 178.82 9.1 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 117.664 -1.614 . . . . 0.0 113.094 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.612 HG12 ' CE2' ' A' ' 23' ' ' TRP . 1.4 mt -69.97 -78.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.514 -178.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.522 ' CB ' HD11 ' A' ' 35' ' ' LEU . 5.2 tttm -41.05 -54.86 2.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.503 -0.748 . . . . 0.0 109.388 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -52.65 -63.05 1.27 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.612 -0.835 . . . . 0.0 108.826 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.533 ' O ' ' CG2' ' A' ' 81' ' ' VAL . 0.2 OUTLIER -48.81 -63.64 1.03 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.448 -1.407 . . . . 0.0 108.245 178.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.567 ' CA ' HG13 ' A' ' 15' ' ' VAL . . . -43.18 -31.66 0.62 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.6 OUTLIER -79.18 -46.46 17.87 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -55.4 -33.14 63.25 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.605 HG12 ' CD2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -89.02 -68.3 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 122.269 1.033 . . . . 0.0 109.014 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.608 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -55.94 -55.3 34.28 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.648 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' GLN . 76.1 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.41 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.496 ' CD2' ' HA2' ' A' ' 33' ' ' GLY . 59.8 t80 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.305 0.574 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 t -104.12 123.74 58.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 108.719 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . . . -49.22 170.15 0.15 Allowed Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.175 -0.953 . . . . 0.0 109.358 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.421 ' HD2' ' CB ' ' A' ' 10' ' ' ALA . 34.4 Cg_endo -77.27 139.09 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.654 2.236 . . . . 0.0 110.742 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.9 0.51 17.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.5 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' ALA . 1.1 m-80 -136.22 130.6 33.37 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.616 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -48.82 -34.87 13.26 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.552 -1.259 . . . . 0.0 109.711 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.655 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 48.4 t -44.72 -54.78 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.491 ' HG2' ' CB ' ' A' ' 78' ' ' ALA . 2.4 mt-10 -70.88 -30.1 66.38 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.616 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 69.8 m -55.94 -49.61 73.05 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.062 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -70.67 -56.28 6.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.4 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.724 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 3.4 mm? -50.14 -43.23 51.91 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -56.54 -49.05 75.93 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -60.67 -62.35 1.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.724 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -45.91 -52.26 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.655 ' CE3' ' CG2' ' A' ' 32' ' ' ILE . 1.9 m95 -40.53 -67.26 0.25 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.946 0.879 . . . . 0.0 110.417 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HA ' HG23 ' A' ' 29' ' ' VAL . 14.6 pt-20 -63.02 -28.05 69.84 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.494 0.664 . . . . 0.0 109.903 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -73.05 -65.29 0.82 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.543 -0.723 . . . . 0.0 110.501 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.587 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 76.8 t -69.68 -30.98 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 110.356 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 21.9 mt -86.88 -20.66 27.12 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.118 -0.989 . . . . 0.0 110.019 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.04 62.4 2.35 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.126 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.512 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -138.39 -167.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.284 . . . . 0.0 108.906 179.038 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.01 70.09 1.26 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.186 -0.946 . . . . 0.0 109.301 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 132.0 -73.15 0.47 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.655 ' CG2' ' CE3' ' A' ' 23' ' ' TRP . 6.1 mt 61.49 133.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.24 -1.153 . . . . 0.0 109.29 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.57 ' O ' ' CD1' ' A' ' 74' ' ' ILE . . . -52.35 -171.64 0.03 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.451 ' C ' ' HB ' ' A' ' 74' ' ' ILE . 6.4 tt -106.2 8.49 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.102 -1.234 . . . . 0.0 109.188 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.667 ' HA ' ' CG2' ' A' ' 73' ' ' THR . 22.2 tp -157.52 48.98 0.42 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.081 -1.012 . . . . 0.0 109.872 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.605 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 5.9 m-20 -74.04 -166.38 0.39 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.117 -0.989 . . . . 0.0 110.29 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -132.48 33.35 3.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.453 -0.78 . . . . 0.0 109.122 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.612 ' CE1' ' C ' ' A' ' 72' ' ' PRO . 5.8 m-30 61.76 -52.07 0.13 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.875 -0.516 . . . . 0.0 111.245 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -81.27 25.64 0.48 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.684 -1.26 . . . . 0.0 110.925 -178.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.481 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 13.9 mm100 -80.74 -0.05 36.74 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 0.8 OUTLIER 167.97 63.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.16 -137.63 2.69 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.71 -67.35 0.04 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.79 169.68 9.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -1.188 . . . . 0.0 109.465 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -98.19 -13.01 21.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.38 -0.825 . . . . 0.0 109.197 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -43.09 -59.11 2.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.368 -0.833 . . . . 0.0 109.463 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.53 ' HB2' ' CG1' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -54.56 -42.82 71.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.053 -1.029 . . . . 0.0 109.115 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 51' ' ' VAL . . . -52.43 -52.88 51.7 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.552 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.95 -41.79 25.85 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.506 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -50.47 -48.52 56.63 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 22' ' ' ILE . 10.0 t -54.51 -55.57 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HA ' HG21 ' A' ' 55' ' ' VAL . . . -49.27 -47.92 46.29 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.63 -42.63 67.96 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 8.3 tp-100 -56.47 -30.38 62.86 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.532 HG12 ' CG1' ' A' ' 61' ' ' VAL . 21.2 t -70.63 -43.43 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -0.825 . . . . 0.0 109.208 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 59' ' ' TYR . 3.1 t60 -77.28 -32.74 55.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.019 . . . . 0.0 109.293 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -39.22 28.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 108.956 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -74.65 -44.78 48.72 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.575 ' CE1' HG12 ' A' ' 81' ' ' VAL . 1.1 m-85 -122.27 -176.8 3.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.918 . . . . 0.0 109.233 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -114.28 35.2 4.28 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.532 ' CG1' HG12 ' A' ' 55' ' ' VAL . 3.2 p -93.7 158.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.572 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -96.65 102.36 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.923 . . . . 0.0 110.453 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.498 ' CD2' HG21 ' A' ' 55' ' ' VAL . 3.2 tp -115.83 99.89 53.0 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 33.7 Cg_endo -77.15 152.82 31.51 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.378 2.052 . . . . 0.0 111.035 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.552 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 1.9 mm? -52.74 -41.7 64.24 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' PHE . 1.5 ttmt -53.44 -57.1 11.84 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.503 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 4.0 t -50.08 -38.69 15.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.469 ' HG ' ' HE2' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -63.87 -31.11 72.18 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 66' ' ' LYS . 2.0 m-85 -84.25 -35.07 23.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.59 89.46 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.538 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.2 69.14 27.69 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.612 ' C ' ' CE1' ' A' ' 38' ' ' PHE . 31.9 Cg_endo -78.95 69.28 7.97 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.361 2.041 . . . . 0.0 108.001 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.667 ' CG2' ' HA ' ' A' ' 35' ' ' LEU . 98.5 m -151.83 167.2 29.04 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.013 -1.475 . . . . 0.0 111.633 -177.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.636 HG12 ' CE2' ' A' ' 23' ' ' TRP . 5.5 mt -67.41 -77.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.352 -0.842 . . . . 0.0 110.99 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 16.7 ttpp -45.91 -46.6 16.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.333 -0.854 . . . . 0.0 109.517 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -58.73 -68.54 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.96 . . . . 0.0 109.75 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -44.55 -59.21 2.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.772 -1.205 . . . . 0.0 108.522 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.537 ' CA ' HG13 ' A' ' 15' ' ' VAL . . . -47.26 -32.91 5.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -77.84 -44.17 28.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 0.0 109.042 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.424 ' CD1' HG12 ' A' ' 67' ' ' VAL . 3.3 t80 -64.83 -29.29 70.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.312 -0.868 . . . . 0.0 108.974 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.575 HG12 ' CE1' ' A' ' 59' ' ' TYR . 21.3 t -86.68 -59.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.332 1.063 . . . . 0.0 109.309 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.655 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -58.28 -26.67 63.26 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.458 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.056 -1.028 . . . . 0.0 109.661 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.556 ' CE1' ' HA2' ' A' ' 33' ' ' GLY . 82.6 t80 . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 9' ' ' VAL . 6.6 m -103.23 120.63 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 0.0 109.559 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.529 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . . . -59.04 175.76 0.32 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.334 -0.854 . . . . 0.0 109.951 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 10' ' ' ALA . 34.8 Cg_endo -77.63 -158.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.861 2.374 . . . . 0.0 110.896 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 p -126.62 -34.1 2.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.111 -0.993 . . . . 0.0 110.852 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' A' ' 17' ' ' SER . 38.8 p-10 -122.29 169.04 11.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.841 -1.162 . . . . 0.0 109.131 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.61 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -74.65 -2.89 28.16 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.304 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.65 ' CG1' ' HB1' ' A' ' 82' ' ' ALA . 40.2 t -65.29 -55.97 17.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.431 ' CG ' ' HB3' ' A' ' 78' ' ' ALA . 42.1 mt-10 -77.59 -32.01 53.35 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.61 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -63.02 -42.89 99.92 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.837 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.514 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -66.32 -63.71 1.02 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.552 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.529 ' HA ' HG22 ' A' ' 22' ' ' ILE . 5.5 mp -45.76 -45.07 14.36 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -47.54 -51.78 19.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.791 -1.193 . . . . 0.0 108.347 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.458 ' OE1' ' NH1' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -61.43 -62.08 2.08 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.651 ' CD1' ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -43.46 -43.44 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-O 122.27 1.033 . . . . 0.0 108.331 178.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.729 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 3.7 m95 -53.19 -67.88 0.22 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.987 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.551 ' HB3' HD11 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -64.31 -35.14 79.89 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.378 -0.826 . . . . 0.0 110.288 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' NH1' ' OE1' ' A' ' 21' ' ' GLU . 27.1 ttm180 -68.83 -58.64 3.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.489 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.474 ' O ' ' CE ' ' A' ' 47' ' ' LYS . 65.7 t -74.19 -37.24 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 0.0 110.823 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 36.9 mt -77.22 -51.99 9.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.902 -1.124 . . . . 0.0 109.946 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.2 53.22 0.28 Allowed Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.184 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -137.42 -171.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -1.185 . . . . 0.0 108.716 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.81 39.87 0.96 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.3 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -161.06 -80.58 0.04 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.609 HG21 ' CE3' ' A' ' 23' ' ' TRP . 6.9 mt 40.83 94.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.52 -0.988 . . . . 0.0 109.932 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.556 ' HA2' ' CE1' ' A' ' 8' ' ' TYR . . . -59.22 -88.49 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.546 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 5.0 mp -151.1 -58.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.994 -1.298 . . . . 0.0 110.599 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.499 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 0.7 OUTLIER -87.25 34.93 0.69 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.16 -1.588 . . . . 0.0 109.501 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -63.34 166.97 5.74 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.438 0.637 . . . . 0.0 109.634 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 40' ' ' GLN . 1.6 m120 -106.52 116.79 32.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.213 -0.93 . . . . 0.0 108.525 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.729 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 46.6 m-85 -41.45 -27.27 0.08 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.284 -0.885 . . . . 0.0 109.793 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.454 ' N ' ' O ' ' A' ' 37' ' ' ASN . 6.5 t80 -93.02 35.96 1.05 Allowed 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.581 -1.248 . . . . 0.0 108.942 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.566 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 13.3 mm-40 -80.26 -12.96 59.57 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 0.0 OUTLIER 157.82 90.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.603 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.21 -137.83 2.79 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.18 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -139.01 -82.16 0.09 OUTLIER Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.152 -1.205 . . . . 0.0 110.215 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.75 -175.48 2.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.038 -1.272 . . . . 0.0 110.227 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 46' ' ' LEU . 2.9 p -75.18 -29.45 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -0.753 . . . . 0.0 109.601 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.443 ' CD1' ' C ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -42.52 -51.07 5.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.653 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' CE ' ' O ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -51.99 -61.96 1.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 109.77 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.56 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -49.34 -51.26 35.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.082 -1.011 . . . . 0.0 109.414 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.551 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -46.45 -47.05 19.19 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 53' ' ' ALA . . . -50.86 -54.57 22.7 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.651 ' CG1' ' CD1' ' A' ' 22' ' ' ILE . 38.2 t -44.65 -59.13 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.473 ' HA ' HG22 ' A' ' 55' ' ' VAL . . . -51.76 -46.62 64.17 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -53.44 -49.62 66.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.562 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 4.9 tp-100 -45.6 -39.9 8.21 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.521 ' CG1' HG13 ' A' ' 81' ' ' VAL . 2.6 t -66.36 -34.45 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.55 0.69 . . . . 0.0 109.471 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 53' ' ' ALA . 13.4 t-160 -82.13 -32.68 29.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.879 -1.138 . . . . 0.0 109.825 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -76.68 -37.01 56.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.982 -1.074 . . . . 0.0 108.566 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -76.65 -51.23 11.92 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.32 -0.863 . . . . 0.0 108.859 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.521 ' HB2' HG12 ' A' ' 61' ' ' VAL . 2.0 m-85 -112.33 179.02 4.11 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.762 0.791 . . . . 0.0 109.439 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -109.85 40.51 1.89 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.557 HG12 ' CG1' ' A' ' 81' ' ' VAL . 4.3 p -92.9 127.06 45.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.763 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -71.19 97.09 1.47 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.722 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.521 HD21 ' CG1' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -112.36 102.12 53.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.508 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.471 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 36.4 Cg_endo -79.64 160.47 25.05 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.428 2.085 . . . . 0.0 110.688 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.551 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 3.2 mm? -61.69 -45.45 93.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.274 -0.891 . . . . 0.0 108.943 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HG2' ' HB2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -52.02 -44.21 64.07 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.097 -1.002 . . . . 0.0 108.827 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.521 ' CG1' HD21 ' A' ' 63' ' ' LEU . 2.0 t -56.09 -42.99 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.56 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -60.29 -24.9 65.32 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.481 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 14.1 m-85 -87.31 -38.87 15.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.359 -0.838 . . . . 0.0 108.904 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.85 -31.74 72.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.452 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -144.59 70.34 15.42 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.758 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.576 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 33.2 Cg_endo -76.91 53.06 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.791 2.327 . . . . 0.0 111.887 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.617 ' HA ' ' CZ2' ' A' ' 23' ' ' TRP . 6.2 t -152.24 167.62 28.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.699 -1.251 . . . . 0.0 110.769 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.587 HG12 ' CE2' ' A' ' 23' ' ' TRP . 14.0 mt -68.68 -60.58 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.961 -1.087 . . . . 0.0 110.014 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.542 ' CB ' HG23 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -42.13 -58.03 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.517 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HB1' ' CG2' ' A' ' 73' ' ' THR . . . -64.88 -66.81 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 110.245 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.3 OUTLIER -47.77 -64.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.017 . . . . 0.0 109.309 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.481 ' HA ' HG21 ' A' ' 81' ' ' VAL . . . -43.69 -45.28 6.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.472 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 3.4 tp60 -62.17 -39.67 93.44 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.487 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -57.56 -34.19 68.92 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.557 ' CG1' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -84.47 -69.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.65 ' HB1' ' CG1' ' A' ' 15' ' ' VAL . . . -43.46 -36.04 1.84 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.256 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.459 ' HB ' ' NE2' ' A' ' 79' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.025 -1.047 . . . . 0.0 109.686 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.565 ' CZ ' ' HA2' ' A' ' 33' ' ' GLY . 55.8 t80 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.426 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 15.3 m -126.22 41.43 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.134 -0.979 . . . . 0.0 109.945 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . 169.71 144.06 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.919 . . . . 0.0 109.827 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.455 ' HA ' ' OH ' ' A' ' 8' ' ' TYR . 36.3 Cg_endo -82.55 -159.94 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.776 2.317 . . . . 0.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.45 ' N ' ' OE2' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -119.41 -44.69 2.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 109.403 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.446 ' O ' ' OG ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -126.59 168.35 14.43 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.133 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.629 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -76.47 -32.09 58.18 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.088 -1.445 . . . . 0.0 109.586 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.545 ' CG2' ' HB2' ' A' ' 82' ' ' ALA . 30.9 t -51.58 -54.02 14.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.45 ' OE2' ' N ' ' A' ' 12' ' ' THR . 3.1 pt-20 -70.85 -27.34 63.77 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.629 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 68.3 m -58.21 -50.39 73.71 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.916 -1.114 . . . . 0.0 108.514 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.473 ' HG2' ' HG3' ' A' ' 58' ' ' GLU . 4.0 tptt -64.26 -51.36 63.96 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.647 -0.658 . . . . 0.0 109.654 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.595 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -60.89 -49.06 79.01 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.571 -1.252 . . . . 0.0 108.344 179.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -47.31 -42.41 21.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.339 -1.476 . . . . 0.0 107.498 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.48 -63.01 1.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.595 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -48.94 -38.94 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.881 -1.137 . . . . 0.0 108.243 179.354 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.722 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 3.0 m95 -49.15 -66.96 0.31 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.884 0.849 . . . . 0.0 109.129 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -53.86 -47.25 71.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.827 -0.545 . . . . 0.0 110.459 -178.743 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -60.06 -68.53 0.28 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.039 -1.038 . . . . 0.0 110.629 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.531 ' CG2' HD11 ' A' ' 22' ' ' ILE . 47.5 t -61.93 -34.67 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 110.979 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' CD1' ' CE3' ' A' ' 23' ' ' TRP . 64.7 mt -83.14 -43.67 15.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.802 -1.186 . . . . 0.0 109.991 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 106.45 49.63 0.91 Allowed Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.789 -1.196 . . . . 0.0 110.685 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.478 ' O ' ' CG ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.59 176.57 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.983 -1.304 . . . . 0.0 109.22 179.378 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 t -132.68 35.48 3.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 108.549 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -149.83 -98.39 0.19 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.559 HG22 ' CE3' ' A' ' 23' ' ' TRP . 1.3 mt 53.6 104.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.054 -1.262 . . . . 0.0 108.434 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.565 ' HA2' ' CZ ' ' A' ' 8' ' ' TYR . . . -99.2 -88.12 1.95 Allowed Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.571 -1.3 . . . . 0.0 111.535 -178.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.575 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 1.7 mt -142.36 111.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.053 -1.263 . . . . 0.0 109.531 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.575 ' CB ' ' O ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER 88.62 46.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.734 0.778 . . . . 0.0 109.737 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.657 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -83.97 -148.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 40' ' ' GLN . 26.2 m-20 -128.26 114.3 16.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.542 -1.349 . . . . 0.0 110.8 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.722 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 66.6 m-85 -67.51 -67.56 0.45 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.973 -1.079 . . . . 0.0 108.436 178.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.552 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 30.1 t80 -126.23 30.25 5.65 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.589 -0.694 . . . . 0.0 110.441 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 37' ' ' ASN . 16.9 mm-40 -79.91 -8.13 59.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.471 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -175.83 52.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.19 -101.45 1.76 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 44' ' ' HIS . . . 170.99 113.09 0.29 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER 70.03 120.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -1.11 . . . . 0.0 109.94 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.8 p -66.12 -15.74 63.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.925 . . . . 0.0 109.599 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.39 -31.29 33.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.038 -1.038 . . . . 0.0 109.07 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.1 tptt -64.91 -71.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.557 ' CB ' ' HB3' ' A' ' 38' ' ' PHE . . . -46.99 -48.47 21.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.897 -1.127 . . . . 0.0 108.245 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.566 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.55 -45.23 37.36 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.425 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.503 ' HB1' HG13 ' A' ' 26' ' ' VAL . . . -49.67 -47.99 49.77 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.56 ' CG1' HG21 ' A' ' 22' ' ' ILE . 7.1 t -58.34 -55.81 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 55' ' ' VAL . . . -48.65 -53.38 18.82 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.99 -43.72 50.59 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.574 ' CG ' HG13 ' A' ' 22' ' ' ILE . 8.0 tp-100 -52.51 -34.96 51.97 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.534 ' CG1' HG12 ' A' ' 81' ' ' VAL . 18.9 t -65.66 -49.27 78.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.567 -0.708 . . . . 0.0 109.759 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' TYR . 18.7 t60 -68.42 -33.61 74.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.969 -1.082 . . . . 0.0 109.589 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.12 -37.08 34.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.964 -1.085 . . . . 0.0 108.441 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 58.6 mm-40 -70.48 -44.38 67.81 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CD1' HG12 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -136.04 175.93 9.15 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.46 40.95 1.18 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.479 HG23 ' CG1' ' A' ' 81' ' ' VAL . 7.9 t -93.03 125.93 45.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 19.9 tt0 -68.89 92.04 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 0.0 109.292 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.478 HD23 HD12 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -112.31 95.64 31.87 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 35.4 Cg_endo -78.57 169.73 19.38 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.354 2.036 . . . . 0.0 110.553 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.568 ' N ' HD21 ' A' ' 65' ' ' LEU . 3.5 mm? -66.91 -37.17 83.86 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.437 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -56.13 -55.82 28.36 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.519 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 4.4 t -48.45 -46.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.536 ' O ' ' CA ' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -58.49 -38.08 76.9 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.482 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 8.1 m-85 -74.84 -36.56 62.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 109.291 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.88 -38.77 86.93 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.324 -0.86 . . . . 0.0 109.217 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.484 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -139.23 66.06 36.83 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -178.547 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.536 ' CA ' ' O ' ' A' ' 68' ' ' LEU . 33.3 Cg_endo -77.19 61.31 7.23 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.973 2.448 . . . . 0.0 112.462 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.564 ' CG2' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -152.13 150.09 29.51 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.881 -1.137 . . . . 0.0 110.657 178.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.527 HG12 ' CE2' ' A' ' 23' ' ' TRP . 9.4 mt -53.73 -54.04 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.854 -1.154 . . . . 0.0 109.669 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.524 ' CG ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -51.26 -65.68 0.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.97 -1.081 . . . . 0.0 109.17 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.71 -63.45 1.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 0.0 109.661 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 73' ' ' THR . 0.3 OUTLIER -45.54 -67.04 0.32 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.541 -0.724 . . . . 0.0 109.128 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 74' ' ' ILE . . . -45.69 -49.84 14.16 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -56.7 -40.02 74.88 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.222 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.517 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 3.8 t80 -56.31 -37.75 70.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 108.573 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.534 HG12 ' CG1' ' A' ' 55' ' ' VAL . 0.2 OUTLIER -86.73 -63.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.619 1.199 . . . . 0.0 108.981 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.545 ' HB2' ' CG2' ' A' ' 15' ' ' VAL . . . -49.7 -20.77 0.88 Allowed 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.209 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.47 ' CB ' ' OE1' ' A' ' 79' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.449 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.0 t80 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' O ' ' CB ' ' A' ' 10' ' ' ALA . 23.0 m -121.0 30.63 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.916 . . . . 0.0 109.67 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 9' ' ' VAL . . . 169.02 157.82 0.17 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.472 -0.767 . . . . 0.0 109.767 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.74 -159.33 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.741 2.294 . . . . 0.0 110.516 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.1 m -124.55 -51.15 1.73 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.63 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -137.37 177.29 7.98 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.596 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -71.3 -37.54 71.82 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.654 -1.218 . . . . 0.0 109.937 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.571 ' CG2' ' HB2' ' A' ' 82' ' ' ALA . 56.8 t -49.74 -52.48 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 178.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -72.72 -22.48 60.88 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.079 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.596 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 60.5 m -58.64 -48.21 81.78 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.226 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.535 ' HE2' ' CG ' ' A' ' 58' ' ' GLU . 7.8 tptt -68.85 -51.89 35.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.304 -0.872 . . . . 0.0 108.723 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.771 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 3.4 mm? -54.99 -36.86 65.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 16' ' ' GLU . . . -56.79 -48.3 78.23 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 23.7 mt-10 -64.25 -63.09 1.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.174 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.771 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -47.86 -45.94 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.836 -1.165 . . . . 0.0 108.405 179.58 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.706 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.9 m95 -49.34 -68.44 0.18 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.449 0.642 . . . . 0.0 110.228 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' HA ' HG23 ' A' ' 29' ' ' VAL . 8.8 pt-20 -61.04 -31.5 71.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 110.218 -178.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -68.56 -68.32 0.4 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 110.333 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.598 ' CG2' ' CD1' ' A' ' 22' ' ' ILE . 77.6 t -67.99 -33.38 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 -178.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 37.2 mt -82.13 0.08 42.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.951 -1.093 . . . . 0.0 110.033 -179.182 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.79 56.9 22.61 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.481 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -136.84 -174.47 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -1.189 . . . . 0.0 109.161 179.518 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 t -153.02 60.35 0.78 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.272 -0.893 . . . . 0.0 109.322 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 165.43 -76.65 0.14 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.141 -1.983 . . . . 0.0 108.141 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.55 HG21 ' CE3' ' A' ' 23' ' ' TRP . 6.8 mt 58.37 151.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.426 -1.044 . . . . 0.0 109.952 178.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.512 ' N ' HG23 ' A' ' 32' ' ' ILE . . . -92.97 -164.26 37.66 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -100.94 -2.02 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.381 -1.07 . . . . 0.0 110.326 -179.727 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.506 ' C ' ' OG1' ' A' ' 73' ' ' THR . 1.6 tp -156.19 53.28 0.56 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.826 -1.171 . . . . 0.0 109.94 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.569 ' N ' ' OG1' ' A' ' 73' ' ' THR . 0.5 OUTLIER -71.45 -154.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.776 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 39' ' ' PHE . 95.2 m-20 -138.14 35.06 2.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.03 -1.044 . . . . 0.0 108.601 178.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.706 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 12.5 m-85 56.37 -52.36 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.3 -179.321 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.625 ' N ' ' O ' ' A' ' 37' ' ' ASN . 72.1 t80 -83.88 29.19 0.55 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.284 -1.51 . . . . 0.0 109.945 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.565 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 5.3 mm-40 -80.4 87.82 5.62 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.565 ' CG1' ' O ' ' A' ' 40' ' ' GLN . 33.8 pt 44.52 70.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 43' ' ' GLY . . . 167.5 -128.0 1.66 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 39' ' ' PHE . . . -42.64 161.31 0.04 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -141.82 -41.93 0.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -1.116 . . . . 0.0 109.615 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 46' ' ' LEU . 81.0 p -155.24 -86.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -0.916 . . . . 0.0 109.466 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.516 ' N ' HD21 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -48.24 -36.7 14.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 109.387 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.505 ' CG ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -60.5 -63.58 1.25 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.883 . . . . 0.0 109.515 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.573 ' CB ' ' CD2' ' A' ' 68' ' ' LEU . . . -49.82 -47.02 51.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.89 -1.131 . . . . 0.0 108.214 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.562 ' HG2' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.43 -42.28 42.33 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.323 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.457 ' HB1' ' CG1' ' A' ' 26' ' ' VAL . . . -51.04 -49.0 61.37 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 48' ' ' ALA . 15.6 t -56.23 -54.33 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.554 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.465 ' HA ' HG22 ' A' ' 55' ' ' VAL . . . -48.17 -44.27 32.33 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -56.81 -44.84 82.36 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 9.0 tp-100 -47.71 -39.96 18.95 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.022 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.549 HG12 ' CG1' ' A' ' 61' ' ' VAL . 3.1 t -64.79 -32.2 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.328 0.585 . . . . 0.0 109.661 179.253 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 53' ' ' ALA . 7.6 t60 -82.16 -33.23 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.928 -1.108 . . . . 0.0 109.02 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -39.86 35.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.055 -1.028 . . . . 0.0 108.581 179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.555 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 1.1 mm-40 -75.92 -42.76 47.92 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -126.33 169.27 13.1 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.782 0.801 . . . . 0.0 109.771 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -103.23 33.21 3.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.698 -1.594 . . . . 0.0 106.698 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.549 ' CG1' HG12 ' A' ' 55' ' ' VAL . 6.2 p -93.35 121.5 44.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -68.82 99.26 1.01 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 110.297 -178.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.581 HD11 ' CD1' ' A' ' 80' ' ' TYR . 9.1 tp -100.9 110.17 60.17 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.547 ' HG2' ' CG2' ' A' ' 67' ' ' VAL . 35.1 Cg_endo -78.78 154.77 26.75 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.29 1.993 . . . . 0.0 110.719 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.562 ' CD2' ' HG2' ' A' ' 49' ' ' MET . 2.4 mm? -63.67 -42.03 98.1 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -32.56 65.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.288 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.547 ' CG2' ' HG2' ' A' ' 64' ' ' PRO . 2.2 t -71.42 -36.2 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.573 ' CD2' ' CB ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -66.85 -25.23 66.32 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.271 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.456 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 m-85 -87.54 -35.9 17.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 108.989 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB1' ' HG2' ' A' ' 71' ' ' GLN . . . -67.98 -37.36 81.41 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.07 0.938 . . . . 0.0 108.543 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.464 ' HG2' ' HB1' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -138.09 68.45 48.85 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -178.989 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.563 ' CA ' ' CD2' ' A' ' 38' ' ' PHE . 34.5 Cg_endo -78.24 52.93 4.29 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 123.306 2.671 . . . . 0.0 113.105 -177.249 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 36' ' ' ASP . 15.2 t -154.65 169.37 24.05 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 116.729 -1.988 . . . . 0.0 114.042 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.602 HD13 ' CD1' ' A' ' 23' ' ' TRP . 9.3 mm -51.14 -64.63 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.033 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.549 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -55.08 -72.98 0.06 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.099 -1.001 . . . . 0.0 109.742 -178.451 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 73' ' ' THR . . . -48.16 -62.37 1.51 Allowed 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.268 -0.895 . . . . 0.0 110.648 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.569 ' CB ' ' O ' ' A' ' 73' ' ' THR . 0.5 OUTLIER -52.29 -64.8 0.7 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.963 -1.086 . . . . 0.0 109.553 -179.442 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 74' ' ' ILE . . . -46.14 -43.11 14.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.064 -1.022 . . . . 0.0 109.16 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 25.2 mm-40 -65.99 -52.16 51.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.315 -0.865 . . . . 0.0 108.842 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.581 ' CD1' HD11 ' A' ' 63' ' ' LEU . 18.8 t80 -43.07 -41.83 3.71 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.526 HG22 ' CG1' ' A' ' 55' ' ' VAL . 18.4 t -74.59 -59.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.316 1.055 . . . . 0.0 108.991 179.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.571 ' HB2' ' CG2' ' A' ' 15' ' ' VAL . . . -58.77 -73.27 0.08 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.282 -179.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.468 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.542 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.063 HG21 ' HB2' ' A' ' 82' ' ' ALA . 2.1 t -65.76 -46.74 88.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HG2' ' HB3' ' A' ' 78' ' ' ALA . 7.5 mt-10 -70.98 -25.05 62.53 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.542 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 28.2 m -59.11 -48.93 79.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.689 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -68.37 -57.29 6.12 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.397 -0.814 . . . . 0.0 109.034 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.708 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -54.55 -19.26 5.56 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.276 -0.97 . . . . 0.0 108.956 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -74.79 -51.4 14.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.527 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 2.9 mt-10 -58.24 -63.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.826 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -43.55 -54.73 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.149 -0.969 . . . . 0.0 108.88 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.758 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.8 m95 -42.68 -57.54 2.68 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.58 -0.7 . . . . 0.0 110.924 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.724 ' HA ' HD11 ' A' ' 32' ' ' ILE . 6.8 pt-20 -65.83 -30.86 71.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.943 -1.098 . . . . 0.0 111.167 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.447 ' N ' ' HG3' ' A' ' 24' ' ' GLU . 17.8 ttm180 -75.15 -71.38 0.36 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.846 -1.159 . . . . 0.0 109.865 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.033 HG11 ' HB3' ' A' ' 50' ' ' ALA . 69.0 t -55.09 -34.5 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.536 -0.727 . . . . 0.0 110.555 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.512 ' HB2' HG23 ' A' ' 29' ' ' VAL . 39.2 mt -86.08 -17.63 34.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.894 -1.129 . . . . 0.0 109.883 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.94 27.61 60.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -102.96 -176.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -1.216 . . . . 0.0 108.886 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 t -142.3 83.24 1.82 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.131 -0.98 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 130.41 -74.87 0.43 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.868 ' CG2' HD11 ' A' ' 74' ' ' ILE . 3.8 mt 58.35 152.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -1.174 . . . . 0.0 109.781 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.933 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -96.61 -133.19 7.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.941 HG22 ' HB2' ' A' ' 75' ' ' LYS . 9.9 mt -120.42 -67.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.863 -1.375 . . . . 0.0 110.159 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.75 HD23 ' O ' ' A' ' 35' ' ' LEU . 2.4 tt -85.12 35.64 0.59 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.74 -1.225 . . . . 0.0 109.657 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.496 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -59.07 -166.47 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 109.588 178.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.1 m-20 -134.17 115.81 14.64 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.727 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 72.1 m-85 . . . . . 0 N--CA 1.506 2.374 0 O-C-N 121.12 -0.988 . . . . 0.0 110.904 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.309 0.576 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.441 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -53.61 -23.92 12.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 109.498 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 26' ' ' VAL . 1.7 mptt -71.33 -68.32 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.038 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -46.9 -44.69 19.94 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.965 -1.085 . . . . 0.0 108.362 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.849 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.24 -53.88 31.09 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.399 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.033 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -43.65 -42.31 5.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.826 HG13 ' CG1' ' A' ' 22' ' ' ILE . 17.1 t -59.56 -48.31 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.961 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -58.08 -31.9 67.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.029 -1.045 . . . . 0.0 108.43 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.04 70.89 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.562 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 6.8 tp-100 -63.07 -31.21 72.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.61 HG21 HD22 ' A' ' 63' ' ' LEU . 2.6 t -75.9 -28.8 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' TYR . 39.4 t-80 -77.72 -33.63 52.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.204 -0.935 . . . . 0.0 110.047 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -80.92 -46.5 15.1 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.493 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -62.97 -36.33 83.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.677 ' CD2' HG11 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -141.71 156.6 45.61 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.586 0.708 . . . . 0.0 109.434 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -95.29 43.94 1.09 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.011 HG11 ' CG1' ' A' ' 81' ' ' VAL . 4.8 p -91.91 149.12 4.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.422 0.63 . . . . 0.0 110.014 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -80.73 97.32 7.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 110.384 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.78 HD21 ' CD1' ' A' ' 77' ' ' LEU . 1.1 tp -126.7 86.22 59.02 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 35.6 Cg_endo -77.47 175.67 11.0 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.696 2.264 . . . . 0.0 110.983 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.849 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.5 mm? -67.56 -41.87 83.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.435 -0.79 . . . . 0.0 109.299 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.44 -29.14 65.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.07 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.531 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 3.7 t -76.84 -34.05 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.038 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -69.88 -21.2 63.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.426 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -87.4 -34.63 18.7 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.488 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -72.85 -28.31 62.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.993 0.902 . . . . 0.0 108.735 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.595 ' CB ' ' HB1' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -146.13 65.66 10.87 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.157 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.572 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.7 Cg_endo -77.38 60.74 7.15 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.903 2.402 . . . . 0.0 112.674 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.666 HG23 ' H ' ' A' ' 76' ' ' ALA . 6.3 t -154.03 176.04 12.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.512 -1.368 . . . . 0.0 111.164 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.933 HD12 ' O ' ' A' ' 33' ' ' GLY . 9.6 mt -74.28 -42.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.268 -0.895 . . . . 0.0 111.606 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.941 ' HB2' HG22 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -70.39 -45.24 66.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.583 -1.323 . . . . 0.0 108.666 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.666 ' H ' HG23 ' A' ' 73' ' ' THR . . . -66.27 -35.01 79.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.647 -0.658 . . . . 0.0 109.945 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.78 ' CD1' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -73.04 -62.03 1.61 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.9 -1.125 . . . . 0.0 108.589 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.707 ' HB1' ' HB ' ' A' ' 15' ' ' VAL . . . -51.15 -28.04 10.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 2.0 tp60 -81.15 -34.47 32.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.8 -1.187 . . . . 0.0 108.564 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.689 ' CD2' HD12 ' A' ' 63' ' ' LEU . 11.5 t80 -61.89 -33.16 73.7 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.011 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -88.94 -73.65 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 122.44 1.114 . . . . 0.0 108.198 178.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 1.063 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -39.0 -27.05 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.156 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 81' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.059 -1.025 . . . . 0.0 109.523 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.633 ' HA ' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 121.153 0.502 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.024 HG21 ' CB ' ' A' ' 82' ' ' ALA . 28.1 t -54.55 -49.62 65.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.662 ' OE2' HD12 ' A' ' 34' ' ' ILE . 3.9 tt0 -69.68 -26.84 64.57 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.633 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 32.7 t -53.66 -52.29 60.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.947 -1.096 . . . . 0.0 108.796 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.684 ' O ' HG22 ' A' ' 22' ' ' ILE . 1.3 tppm? -65.68 -53.07 46.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 109.251 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HA ' HG23 ' A' ' 22' ' ' ILE . 3.5 mp -57.67 -31.62 66.51 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.653 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 16' ' ' GLU . . . -59.84 -51.67 68.73 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -59.52 -64.74 0.84 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.811 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -44.49 -53.6 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.774 ' HE3' HG21 ' A' ' 32' ' ' ILE . 3.6 m95 -43.52 -61.93 1.23 Allowed 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.469 0.652 . . . . 0.0 110.523 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.772 ' CA ' HD11 ' A' ' 32' ' ' ILE . 3.5 pt-20 -64.01 -36.42 83.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.363 -0.836 . . . . 0.0 110.664 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -68.66 -63.34 1.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.314 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.029 HG11 ' HB3' ' A' ' 50' ' ' ALA . 61.3 t -68.52 -34.49 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 111.12 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.526 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 40.7 mt -83.84 4.75 27.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.867 -1.146 . . . . 0.0 109.939 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.21 51.77 48.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.645 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -129.09 171.76 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -1.161 . . . . 0.0 109.249 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.1 t -139.51 70.63 1.37 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.103 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.6 68.94 0.31 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.774 HG21 ' HE3' ' A' ' 23' ' ' TRP . 2.9 mp -85.87 146.17 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -1.093 . . . . 0.0 109.615 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.822 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -66.88 -135.16 0.04 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.662 HD12 ' OE2' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -123.73 -54.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.013 -1.286 . . . . 0.0 109.973 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.913 HD23 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -96.6 44.46 1.06 Allowed 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.275 -1.516 . . . . 0.0 108.17 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.81 114.9 12.62 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.485 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.7 t30 -62.75 113.51 3.07 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.385 -1.447 . . . . 0.0 108.649 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.721 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 90.7 m-85 . . . . . 0 N--CA 1.511 2.622 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.119 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.317 0.579 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 46' ' ' LEU . 6.5 tp -52.08 -38.88 58.69 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.262 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.3 mttp -50.78 -62.79 1.39 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.113 -0.992 . . . . 0.0 108.615 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.992 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -50.29 -44.57 54.03 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.664 ' CG ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.89 -45.7 64.25 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.339 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.029 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -49.09 -42.97 40.66 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.811 HG13 ' CG1' ' A' ' 22' ' ' ILE . 4.6 t -64.07 -64.34 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.97 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -45.35 -40.33 7.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -63.32 -47.01 84.03 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.501 ' HG3' ' OE2' ' A' ' 58' ' ' GLU . 2.2 tp60 -50.32 -28.16 7.41 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.594 HG21 ' HG ' ' A' ' 63' ' ' LEU . 3.8 t -75.49 -62.43 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 59' ' ' TYR . 20.9 t-80 -54.05 -37.91 64.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.03 -1.044 . . . . 0.0 108.773 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 53' ' ' ALA . 4.0 mtt180 -69.37 -38.12 77.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.532 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -75.11 -56.99 4.18 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.341 -0.85 . . . . 0.0 108.903 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.798 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -119.05 176.88 5.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 108.825 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.66 43.68 1.17 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 59' ' ' TYR . 10.5 t -93.79 158.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.418 ' C ' ' HD3' ' A' ' 64' ' ' PRO . 3.0 tt0 -70.8 99.83 1.8 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 109.416 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.935 HD21 HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -134.45 68.44 72.76 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 0.0 109.276 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.635 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.9 Cg_endo -82.05 -168.02 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.959 2.439 . . . . 0.0 109.964 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.664 HD21 ' CG ' ' A' ' 49' ' ' MET . 0.4 OUTLIER -89.26 -37.14 15.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.136 -0.977 . . . . 0.0 109.311 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.547 ' HG3' ' N ' ' A' ' 67' ' ' VAL . 5.7 pttt -56.66 -37.64 71.09 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.955 HG13 ' NE2' ' A' ' 71' ' ' GLN . 58.5 t -69.72 -47.24 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.992 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.82 -35.98 64.51 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.454 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 5.8 m-85 -74.45 -39.27 62.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 108.769 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.99 84.16 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.885 0.85 . . . . 0.0 108.863 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.955 ' NE2' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -135.09 70.87 69.41 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.146 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.58 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 30.4 Cg_endo -75.0 59.85 5.29 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.787 2.325 . . . . 0.0 112.224 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.913 HG21 HD23 ' A' ' 35' ' ' LEU . 1.9 t -153.18 167.53 28.99 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 117.337 -1.745 . . . . 0.0 112.453 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.822 HD12 ' O ' ' A' ' 33' ' ' GLY . 2.4 mt -63.07 -72.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.592 -0.693 . . . . 0.0 111.195 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.528 ' HB2' ' CG1' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -40.08 -57.86 1.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.554 -0.716 . . . . 0.0 109.468 -178.428 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.582 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -57.55 -52.33 65.83 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.379 -0.825 . . . . 0.0 109.527 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.935 HD13 HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -55.1 -65.37 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.706 -1.246 . . . . 0.0 108.708 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.667 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -44.78 -30.89 1.04 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.57 ' HG2' ' N ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -77.94 -43.9 28.49 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 108.633 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.57 ' N ' ' HG2' ' A' ' 79' ' ' GLN . 2.3 t80 -58.8 -32.6 69.49 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.996 -1.065 . . . . 0.0 108.244 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -88.6 -67.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 122.46 1.124 . . . . 0.0 109.16 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 1.024 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -54.13 -48.65 70.58 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.802 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 79' ' ' GLN . 5.6 t . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.871 -1.143 . . . . 0.0 109.765 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.985 HG21 ' CB ' ' A' ' 82' ' ' ALA . 2.4 t -49.12 -44.45 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.632 ' HG2' HG23 ' A' ' 34' ' ' ILE . 4.2 mt-10 -72.65 -35.59 67.8 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 53.9 p -55.56 -48.77 74.23 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.416 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.605 ' O ' HG22 ' A' ' 22' ' ' ILE . 8.6 tptm -68.69 -55.92 9.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.95 -1.094 . . . . 0.0 109.415 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.749 ' HA ' HG23 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -54.71 -31.06 57.54 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.062 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.06 -50.16 67.27 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 31.9 tt0 -59.79 -54.54 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.901 HD11 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -51.43 -54.24 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.872 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.7 m95 -41.19 -60.14 1.32 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.463 0.649 . . . . 0.0 110.334 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.626 ' CA ' HD11 ' A' ' 32' ' ' ILE . 5.1 pt-20 -64.52 -30.86 71.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.95 . . . . 0.0 109.606 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 tpp85 -70.06 -66.19 0.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.507 -0.746 . . . . 0.0 110.039 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.842 HG11 ' HB3' ' A' ' 50' ' ' ALA . 53.6 t -68.41 -34.45 65.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.366 -0.834 . . . . 0.0 111.102 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 24.9 mt -84.18 -8.65 59.01 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.869 -1.144 . . . . 0.0 110.155 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.8 51.7 44.27 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.778 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -122.71 -166.21 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.016 -1.285 . . . . 0.0 108.965 178.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.411 ' H ' HG12 ' A' ' 29' ' ' VAL . 2.0 p -143.62 64.38 1.33 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.156 -1.018 . . . . 0.0 109.863 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 136.89 -72.86 0.45 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.286 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.872 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.8 mp 59.53 147.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -1.154 . . . . 0.0 109.309 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 1.0 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -78.34 -153.41 6.66 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 34' ' ' ILE . 30.0 mm -113.56 15.67 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.035 -1.273 . . . . 0.0 109.626 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.857 HD23 ' O ' ' A' ' 35' ' ' LEU . 7.3 tt -167.65 66.67 0.08 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.598 ' N ' ' HG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -101.55 169.74 8.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.584 0.707 . . . . 0.0 110.103 -179.603 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' O ' ' C ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -96.03 104.36 16.3 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.294 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.729 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 63.8 m-85 . . . . . 0 N--CA 1.519 3.002 0 O-C-N 121.78 -0.575 . . . . 0.0 112.293 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 46' ' ' LEU . 1.4 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 46' ' ' LEU . 14.2 tp -53.59 -44.39 69.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.107 -0.995 . . . . 0.0 108.835 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.648 ' HB3' HG12 ' A' ' 26' ' ' VAL . 6.8 mttm -48.25 -60.3 2.76 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.041 ' HB1' HD11 ' A' ' 68' ' ' LEU . . . -46.99 -48.9 21.57 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.927 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.86 -50.17 27.23 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.842 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -49.24 -43.41 42.75 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.901 HG22 HD11 ' A' ' 22' ' ' ILE . 12.0 t -58.93 -64.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.027 ' HB2' HD23 ' A' ' 68' ' ' LEU . . . -45.58 -39.99 8.27 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.709 ' HB2' ' CE ' ' A' ' 49' ' ' MET . . . -63.83 -45.34 90.0 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.538 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 5.2 tp60 -48.28 -34.4 10.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.792 HG11 HD12 ' A' ' 63' ' ' LEU . 2.5 t -71.24 -31.68 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ALA . 9.3 t60 -81.62 -35.04 30.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.415 -0.803 . . . . 0.0 109.12 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -75.73 -35.32 60.27 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 1.2 mp0 -78.87 -50.98 10.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.669 ' HB2' HG12 ' A' ' 61' ' ' VAL . 2.4 m-85 -113.83 -178.54 3.4 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.895 0.855 . . . . 0.0 109.71 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -112.51 38.4 2.76 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.998 HG11 HG13 ' A' ' 81' ' ' VAL . 5.0 p -93.17 149.28 4.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.378 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -90.15 97.11 11.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.194 -0.941 . . . . 0.0 110.549 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.966 ' CD2' HG11 ' A' ' 67' ' ' VAL . 4.9 mt -113.47 98.95 48.31 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.6 Cg_endo -78.99 164.13 25.21 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.866 2.378 . . . . 0.0 111.238 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.927 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.9 mm? -63.7 -34.85 78.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.535 ' HD3' ' N ' ' A' ' 66' ' ' LYS . 1.1 mmtt -56.08 -60.61 3.24 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.966 HG11 ' CD2' ' A' ' 63' ' ' LEU . 2.7 t -48.32 -52.81 7.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.041 HD11 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -47.1 -33.21 4.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 66' ' ' LYS . 1.7 m-85 -88.28 -36.34 16.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.524 -0.735 . . . . 0.0 109.969 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . -65.13 -32.32 73.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.775 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -140.53 71.85 31.19 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.1 Cg_endo -76.82 60.64 6.8 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.772 2.315 . . . . 0.0 112.052 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.689 HG22 ' HB3' ' A' ' 76' ' ' ALA . 13.5 t -154.66 170.86 20.54 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.569 -1.252 . . . . 0.0 110.816 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.0 HD12 ' O ' ' A' ' 33' ' ' GLY . 3.5 mt -65.71 -74.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.255 -0.903 . . . . 0.0 111.214 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB3' HD12 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -42.6 -58.86 2.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.286 -178.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.689 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -47.61 -61.92 1.69 Allowed 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.173 -0.955 . . . . 0.0 110.04 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.775 HD23 ' O ' ' A' ' 71' ' ' GLN . 0.2 OUTLIER -53.53 -66.94 0.3 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.127 -0.983 . . . . 0.0 109.496 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.553 ' CB ' ' HG3' ' A' ' 16' ' ' GLU . . . -47.01 -35.94 7.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.183 -0.948 . . . . 0.0 108.837 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 78.0 mm-40 -70.19 -40.15 74.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -55.28 -35.46 65.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.998 HG13 HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -87.69 -68.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.411 1.101 . . . . 0.0 108.301 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.985 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -43.93 -50.65 8.05 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.45 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 79' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.534 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.616 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.034 ' CG1' ' HB2' ' A' ' 82' ' ' ALA . 40.5 t -46.4 -54.49 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.8 ' OE2' HG22 ' A' ' 34' ' ' ILE . 12.8 mt-10 -68.12 -37.74 81.44 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.616 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.7 m -48.95 -54.0 17.39 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.17 -1.012 . . . . 0.0 108.562 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.675 ' O ' HG23 ' A' ' 22' ' ' ILE . 1.2 tptt -60.05 -69.28 0.22 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.335 -0.853 . . . . 0.0 108.837 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.474 ' HB3' HG23 ' A' ' 74' ' ' ILE . 8.3 mt -38.76 -48.25 1.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.604 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -51.52 -52.4 47.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.766 -1.209 . . . . 0.0 108.216 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.08 -60.31 4.03 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.086 ' CD1' HG13 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -44.27 -47.42 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.751 ' CB ' HG21 ' A' ' 32' ' ' ILE . 3.7 m95 -49.43 -63.05 1.22 Allowed 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.797 -0.564 . . . . 0.0 109.912 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.693 ' HB2' HD12 ' A' ' 32' ' ' ILE . 1.6 tt0 -61.49 -42.37 98.69 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.377 -0.827 . . . . 0.0 110.046 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -65.13 0.73 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 110.779 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.661 HG11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 t -69.82 -32.62 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.393 -0.817 . . . . 0.0 111.717 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 33.8 mt -87.36 -33.46 19.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.681 -1.262 . . . . 0.0 110.249 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.58 58.4 1.74 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.339 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.607 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -130.4 177.1 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.207 -1.173 . . . . 0.0 108.582 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.81 38.22 3.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.027 -1.045 . . . . 0.0 109.764 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -150.24 -96.75 0.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.751 HG21 ' CB ' ' A' ' 23' ' ' TRP . 10.3 mt 52.7 103.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.923 -1.339 . . . . 0.0 109.877 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.687 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -107.86 -77.69 1.05 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' OE2' ' A' ' 16' ' ' GLU . 1.1 pp -166.03 101.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -1.195 . . . . 0.0 109.931 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.63 ' CB ' ' O ' ' A' ' 34' ' ' ILE . 22.4 tp 103.44 35.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.722 0.772 . . . . 0.0 109.237 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.459 ' O ' ' OG1' ' A' ' 73' ' ' THR . 0.7 OUTLIER -83.0 177.87 8.42 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.7 t30 -109.52 116.94 32.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.723 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 52.4 m-85 . . . . . 0 N--CA 1.502 2.138 0 O-C-N 121.273 -0.892 . . . . 0.0 110.315 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.545 ' HA ' HD13 ' A' ' 46' ' ' LEU . 4.1 mm? -53.35 -36.34 61.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.107 -0.995 . . . . 0.0 109.013 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.637 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -66.5 -60.5 2.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -0.912 . . . . 0.0 109.042 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.064 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -52.37 -49.71 63.85 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.132 -0.98 . . . . 0.0 108.636 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.854 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.29 -45.61 45.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.82 ' O ' ' HB3' ' A' ' 53' ' ' ALA . . . -49.23 -44.59 43.64 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.086 HG13 ' CD1' ' A' ' 22' ' ' ILE . 18.3 t -60.14 -58.46 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.838 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.58 -26.96 2.48 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -73.24 -43.54 60.99 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.533 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -54.65 -28.49 47.5 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.184 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.623 HG11 ' HG ' ' A' ' 63' ' ' LEU . 2.6 t -73.77 -53.88 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 1.3 t-80 -56.3 -43.04 78.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.123 -0.986 . . . . 0.0 109.103 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -46.3 83.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 109.014 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.566 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -66.07 -50.15 65.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 108.855 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.724 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -129.63 154.58 46.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.451 -0.781 . . . . 0.0 109.009 179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -94.53 40.04 1.09 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.11 HG11 HG13 ' A' ' 81' ' ' VAL . 7.0 p -93.09 162.75 2.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.272 0.558 . . . . 0.0 109.7 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.524 ' N ' HG22 ' A' ' 61' ' ' VAL . 5.1 tt0 -69.39 117.85 11.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.865 . . . . 0.0 110.138 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.908 HD23 HG22 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -142.73 69.46 19.78 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.555 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.4 Cg_endo -80.23 154.66 22.01 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.866 2.378 . . . . 0.0 110.632 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.854 HD21 ' SD ' ' A' ' 49' ' ' MET . 4.4 mt -57.19 -40.68 77.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.782 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -49.91 -44.94 50.44 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.58 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.555 HG23 ' HG2' ' A' ' 64' ' ' PRO . 6.7 t -64.86 -41.98 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.064 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -62.58 -26.39 68.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.472 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 m-85 -87.86 -36.0 17.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.431 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -67.43 -32.0 72.57 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.959 0.885 . . . . 0.0 108.614 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.431 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -147.34 70.06 11.68 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.0 Cg_endo -75.11 60.26 5.47 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.812 2.342 . . . . 0.0 111.305 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.77 ' CG2' ' HB3' ' A' ' 76' ' ' ALA . 5.8 t -153.07 165.62 35.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.712 -1.195 . . . . 0.0 110.828 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.644 HG13 ' CZ2' ' A' ' 23' ' ' TRP . 2.9 mt -66.47 -64.87 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.602 -0.686 . . . . 0.0 110.501 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -49.75 -60.58 2.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.867 -1.145 . . . . 0.0 109.859 -179.157 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.77 ' HB3' ' CG2' ' A' ' 73' ' ' THR . . . -56.74 -67.84 0.27 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.958 -1.089 . . . . 0.0 110.372 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.712 HD11 HD12 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -49.42 -58.45 5.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.808 -1.182 . . . . 0.0 108.763 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' ILE . . . -44.94 -55.98 5.0 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 34.6 mm-40 -50.49 -49.83 54.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 108.844 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -48.3 -45.67 35.21 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.669 0.747 . . . . 0.0 109.302 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.11 HG13 HG11 ' A' ' 61' ' ' VAL . 3.5 t -81.73 -59.43 2.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 122.432 1.11 . . . . 0.0 109.313 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 1.034 ' HB2' ' CG1' ' A' ' 15' ' ' VAL . . . -53.73 -68.09 0.21 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.238 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.414 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.556 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.97 HG21 ' CB ' ' A' ' 82' ' ' ALA . 3.6 t -48.35 -43.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -72.08 -43.79 64.28 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 53.5 p -47.12 -50.1 20.83 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.391 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.54 ' H ' ' HG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -61.03 -70.35 0.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 108.706 179.06 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.844 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 4.3 mp -40.79 -35.12 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.371 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -61.89 -51.82 66.61 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.995 -1.066 . . . . 0.0 108.399 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -61.25 -56.06 24.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.298 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.844 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -52.67 -50.47 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.889 -1.132 . . . . 0.0 108.862 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.651 ' HB3' HD13 ' A' ' 32' ' ' ILE . 5.2 m95 -46.15 -59.82 2.66 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.413 0.625 . . . . 0.0 110.227 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.626 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -61.77 -37.06 82.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.227 -0.921 . . . . 0.0 110.021 -178.525 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -60.89 -49.42 77.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.289 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.07 HG11 ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -87.79 -48.9 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.241 -0.912 . . . . 0.0 110.778 -179.069 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 47' ' ' LYS . 45.7 mt -63.76 -9.97 17.32 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.363 -0.836 . . . . 0.0 109.87 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.07 58.63 11.89 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.581 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.32 167.48 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -1.196 . . . . 0.0 109.45 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 t -126.78 81.43 2.01 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.249 -0.907 . . . . 0.0 109.185 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . 139.4 -73.55 0.4 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.693 ' CG2' HD11 ' A' ' 74' ' ' ILE . 14.7 mt 60.89 143.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -1.105 . . . . 0.0 109.628 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.46 -119.45 1.14 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.945 ' HA ' HD12 ' A' ' 74' ' ' ILE . 1.5 tt -149.28 -64.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.812 -1.405 . . . . 0.0 109.831 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.044 HD23 HG21 ' A' ' 73' ' ' THR . 0.6 OUTLIER -88.38 32.1 0.79 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.365 -1.46 . . . . 0.0 109.66 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.652 ' O ' HG23 ' A' ' 73' ' ' THR . 15.5 m-20 -59.73 167.12 2.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.343 -0.848 . . . . 0.0 110.753 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -110.53 40.37 2.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.681 ' CZ ' ' HA ' ' A' ' 72' ' ' PRO . 8.7 m-30 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.769 -0.582 . . . . 0.0 111.008 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.342 0.591 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 46' ' ' LEU . 1.1 mm? -57.84 -39.63 78.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.856 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.9 tptt -64.84 -64.14 0.94 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.099 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -47.9 -47.5 32.01 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.085 -1.009 . . . . 0.0 108.32 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.907 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.25 -49.93 31.5 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.07 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -46.81 -46.67 20.87 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.555 ' HA ' HG12 ' A' ' 22' ' ' ILE . 15.0 t -56.92 -54.16 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.882 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.42 -38.77 20.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -61.58 -44.05 97.73 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.528 ' CB ' HG12 ' A' ' 22' ' ' ILE . 3.0 tp-100 -48.7 -36.14 15.54 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.645 HG21 HD22 ' A' ' 63' ' ' LEU . 6.8 t -68.03 -45.71 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 59' ' ' TYR . 1.3 t-80 -69.94 -33.64 72.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.077 -1.015 . . . . 0.0 109.098 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -41.4 39.49 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 12.8 mm-40 -71.91 -46.06 59.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.946 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -124.87 168.85 12.7 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.608 0.718 . . . . 0.0 109.41 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -99.18 31.84 2.92 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.946 HG12 ' HB2' ' A' ' 59' ' ' TYR . 6.5 p -93.59 123.13 45.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 4.6 tt0 -69.21 97.76 0.96 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 110.856 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -103.05 106.65 51.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.133 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 35.8 Cg_endo -79.88 166.6 21.11 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.445 2.096 . . . . 0.0 111.292 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.907 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.4 mm? -69.02 -40.87 78.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -51.19 -51.7 51.29 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.424 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 3.0 t -55.93 -41.21 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.099 HD21 ' HB1' ' A' ' 48' ' ' ALA . 1.2 tp -62.43 -24.15 67.26 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.517 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 m-85 -87.62 -36.67 17.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.419 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.22 -32.55 74.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.52 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.08 71.74 18.42 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.681 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 30.5 Cg_endo -77.82 64.82 8.24 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.259 1.973 . . . . 0.0 108.209 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 1.044 HG21 HD23 ' A' ' 35' ' ' LEU . 81.4 m -152.68 165.11 36.29 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 117.961 -1.496 . . . . 0.0 111.939 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.945 HD12 ' HA ' ' A' ' 34' ' ' ILE . 7.3 mt -71.93 -72.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.14 -0.975 . . . . 0.0 109.286 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HB3' ' HG ' ' A' ' 35' ' ' LEU . 3.2 ttmm -45.21 -44.68 11.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.617 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -61.66 -55.02 35.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 108.955 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.006 HD11 HD12 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -59.11 -63.23 1.38 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.128 -0.983 . . . . 0.0 108.758 179.155 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.606 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . -44.87 -38.96 4.98 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.567 ' O ' HG22 ' A' ' 83' ' ' THR . 1.1 tp60 -68.89 -44.41 73.3 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.654 ' O ' HG22 ' A' ' 83' ' ' THR . 28.4 t80 -52.22 -35.56 49.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.14 -0.975 . . . . 0.0 108.386 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.607 HG11 ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.15 -70.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 122.375 1.084 . . . . 0.0 108.43 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.97 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -40.11 -27.77 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.06 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 80' ' ' TYR . 9.8 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.458 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.728 ' HA ' ' HB3' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.951 HG21 ' CB ' ' A' ' 82' ' ' ALA . 20.6 t -53.42 -47.66 58.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 119.939 -1.726 . . . . 0.0 106.674 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.558 ' HG3' ' CG2' ' A' ' 74' ' ' ILE . 3.6 tm-20 -69.16 -29.19 67.15 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.728 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 35.2 p -54.13 -49.36 69.37 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.302 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.842 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.95 -51.38 69.53 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.774 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 6.7 mt -58.71 -40.7 84.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.174 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.82 -46.45 67.73 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.859 -1.15 . . . . 0.0 108.122 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 22' ' ' ILE . 23.0 mt-10 -65.21 -66.43 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.489 -0.757 . . . . 0.0 109.214 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -45.34 -46.51 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.966 . . . . 0.0 108.851 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.796 ' CE3' HG21 ' A' ' 32' ' ' ILE . 5.4 m95 -50.72 -64.49 0.79 Allowed 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.437 0.636 . . . . 0.0 110.867 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.761 ' HA ' HD11 ' A' ' 32' ' ' ILE . 2.6 pt-20 -59.53 -38.09 80.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.17 -61.59 2.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 110.413 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.057 HG11 ' HB3' ' A' ' 50' ' ' ALA . 4.8 t -75.2 -33.23 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.135 -0.978 . . . . 0.0 111.337 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 41.9 mt -81.9 -8.07 59.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.706 -1.246 . . . . 0.0 109.829 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.19 53.29 45.91 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -137.38 -172.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.265 . . . . 0.0 109.03 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 t -153.29 121.0 5.99 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.467 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.24 20.81 54.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.796 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.2 mt -42.08 150.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -1.199 . . . . 0.0 109.298 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.74 -170.43 21.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.724 ' HA ' HG21 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -106.33 12.3 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -1.047 . . . . 0.0 109.743 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.763 HD12 ' CG2' ' A' ' 73' ' ' THR . 10.4 tp -169.24 62.24 0.05 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.084 -1.01 . . . . 0.0 109.39 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.645 ' O ' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -89.59 -161.96 0.83 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.249 -0.907 . . . . 0.0 109.916 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -129.66 29.76 4.99 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.226 -0.921 . . . . 0.0 110.132 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.74 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 1.9 m-85 . . . . . 0 N--CA 1.5 2.041 0 O-C-N 121.961 -0.462 . . . . 0.0 111.144 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 46' ' ' LEU . 9.9 tp -47.64 -41.11 21.41 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.167 -0.958 . . . . 0.0 108.982 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 8.0 mttt -50.29 -61.18 2.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.101 -1.0 . . . . 0.0 108.567 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.038 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -48.42 -46.32 37.32 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.928 ' SD ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.59 -52.39 30.58 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.057 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -46.87 -42.75 17.93 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.621 HG13 HG13 ' A' ' 22' ' ' ILE . 7.6 t -58.79 -61.2 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.933 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -45.9 -48.78 16.1 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -51.95 -47.4 64.78 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 6.5 tp60 -46.29 -37.05 6.83 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.551 HG21 HD22 ' A' ' 63' ' ' LEU . 2.2 t -73.04 -32.96 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.687 -0.633 . . . . 0.0 109.565 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 59' ' ' TYR . 2.5 t-80 -78.1 -44.18 26.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.784 -1.198 . . . . 0.0 108.38 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -34.01 73.86 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -78.31 -48.35 15.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -128.87 170.09 13.81 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.45 51.59 0.74 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 177.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 59' ' ' TYR . 96.5 t -91.24 161.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-O 121.845 0.831 . . . . 0.0 110.798 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.615 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 12.6 pt-20 -75.26 49.05 0.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.797 -0.565 . . . . 0.0 110.16 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.59 HD21 HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -111.01 86.82 6.37 Favored Pre-proline 0 C--N 1.295 -1.796 0 O-C-N 121.108 -0.995 . . . . 0.0 110.986 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 37.3 Cg_endo -83.05 -152.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.745 2.297 . . . . 0.0 107.985 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.928 HD13 ' SD ' ' A' ' 49' ' ' MET . 7.9 tp -90.87 -41.55 11.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.457 -1.402 . . . . 0.0 109.611 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.562 ' HG3' ' N ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -50.29 -39.59 45.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.91 -1.119 . . . . 0.0 108.426 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.577 HG11 ' HG ' ' A' ' 63' ' ' LEU . 4.3 t -63.12 -34.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.038 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -65.6 -27.65 68.56 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.465 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 27.6 m-85 -86.92 -35.48 18.9 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.415 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.37 -35.34 80.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.415 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -142.72 71.93 19.91 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.641 ' C ' ' CE1' ' A' ' 38' ' ' PHE . 32.9 Cg_endo -77.59 64.65 8.1 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.52 2.147 . . . . 0.0 107.955 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.763 ' CG2' HD12 ' A' ' 35' ' ' LEU . 94.5 m -152.87 158.75 42.62 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.243 -1.383 . . . . 0.0 111.716 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.724 HG21 ' HA ' ' A' ' 34' ' ' ILE . 5.3 mm -64.1 -77.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.438 -0.789 . . . . 0.0 110.314 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.677 ' HB3' HD13 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -42.24 -49.4 4.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.65 -0.656 . . . . 0.0 110.002 -178.33 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -58.88 -69.15 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 109.13 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -47.57 -49.47 26.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.718 -1.239 . . . . 0.0 108.817 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -55.64 -27.57 50.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 1.5 pt20 -78.84 -32.56 46.17 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.545 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -67.79 -34.5 76.9 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -88.14 -63.12 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.317 1.056 . . . . 0.0 108.484 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.951 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -59.2 -31.24 68.85 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.425 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 13.4 m . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.517 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.643 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.042 HG11 ' HB2' ' A' ' 82' ' ' ALA . 1.1 m -50.55 -56.56 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.761 ' HG3' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.68 -26.67 65.41 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.643 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 73.5 m -57.03 -51.11 70.57 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.555 ' HD3' ' CG ' ' A' ' 58' ' ' GLU . 1.3 tptm -61.43 -66.18 0.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.792 ' HA ' HG23 ' A' ' 22' ' ' ILE . 4.3 mm? -41.04 -47.44 3.1 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.84 -48.27 64.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.864 -1.148 . . . . 0.0 108.502 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 4.3 mt-10 -64.82 -64.55 0.84 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.307 -0.871 . . . . 0.0 108.709 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.944 HD11 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -43.39 -47.08 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.71 ' CE3' HG21 ' A' ' 32' ' ' ILE . 3.7 m95 -50.25 -70.82 0.08 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.427 0.632 . . . . 0.0 110.741 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.629 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -55.27 -29.95 59.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.336 -0.852 . . . . 0.0 110.549 -178.199 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.423 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -76.23 -67.77 0.65 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 109.907 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.918 HG12 ' HG3' ' A' ' 47' ' ' LYS . 94.8 t -62.29 -31.55 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 110.11 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 19.4 mt -93.41 -4.68 50.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 110.121 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.52 56.27 25.41 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -136.97 -179.0 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 108.965 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.9 t -153.1 137.03 16.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.361 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.64 6.46 87.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.026 HG22 HD11 ' A' ' 74' ' ' ILE . 3.4 mt -42.83 131.05 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -1.094 . . . . 0.0 109.301 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.87 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -71.29 -135.37 0.14 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.83 HD13 ' N ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -119.1 -55.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.961 -1.317 . . . . 0.0 110.185 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -92.09 39.97 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.184 -1.573 . . . . 0.0 108.878 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.599 ' OD2' HG23 ' A' ' 32' ' ' ILE . 1.3 m-20 -58.67 -172.06 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.612 0.72 . . . . 0.0 109.908 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 38' ' ' PHE . 54.7 m-20 -126.29 115.39 19.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.705 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 25.4 m-85 . . . . . 0 N--CA 1.499 1.996 0 O-C-N 121.11 -0.994 . . . . 0.0 110.342 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.277 0.561 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -50.27 -44.49 53.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.633 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.918 ' HG3' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -58.88 -71.37 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 109.23 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.075 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -46.98 -44.61 20.28 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.886 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.53 -51.03 29.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.812 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -47.36 -44.23 23.87 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.944 HG22 HD11 ' A' ' 22' ' ' ILE . 15.2 t -58.62 -58.03 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.055 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.46 -40.13 25.24 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -59.4 -46.41 88.77 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.53 ' HG2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -51.87 -31.17 26.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.41 HG21 HD22 ' A' ' 63' ' ' LEU . 3.3 t -74.21 -48.36 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.638 -0.664 . . . . 0.0 109.38 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 59' ' ' TYR . 4.6 t-80 -67.91 -34.59 76.92 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.155 -0.966 . . . . 0.0 109.189 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -76.02 -31.7 59.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 0.0 108.712 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.555 ' CG ' ' HD3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -82.67 -44.45 15.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.453 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.836 ' HB2' HG23 ' A' ' 61' ' ' VAL . 10.4 m-85 -120.51 -173.8 2.66 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.873 0.844 . . . . 0.0 109.639 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -117.95 39.96 3.25 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.836 HG23 ' HB2' ' A' ' 59' ' ' TYR . 1.3 t -93.09 137.91 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.33 0.586 . . . . 0.0 109.626 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 48.4 tt0 -69.37 95.46 0.8 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.327 -0.858 . . . . 0.0 109.292 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.777 HD23 ' HB1' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -116.4 91.57 33.78 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.484 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 35.6 Cg_endo -79.28 159.98 26.21 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.548 2.166 . . . . 0.0 110.215 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.886 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.3 mm? -57.83 -39.75 78.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.127 -0.983 . . . . 0.0 108.711 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -53.37 -52.22 59.97 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.09 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.484 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 2.6 t -51.07 -39.9 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.075 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -64.28 -26.83 68.67 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.495 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 4.3 m-30 -84.2 -36.38 22.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.44 -30.41 68.33 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.483 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -145.36 66.88 12.68 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.564 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.7 Cg_endo -76.46 53.15 3.85 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.86 2.374 . . . . 0.0 112.15 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 4.3 t -151.63 175.39 12.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.72 -1.237 . . . . 0.0 110.873 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.026 HD11 HG22 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -72.57 -67.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.687 -0.633 . . . . 0.0 110.794 -179.021 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.557 ' HE2' HD12 ' A' ' 35' ' ' LEU . 4.0 tttt -39.91 -56.87 1.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.575 -0.703 . . . . 0.0 109.303 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.489 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -59.44 -54.49 46.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 108.886 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.693 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -49.99 -64.49 0.79 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.731 -1.231 . . . . 0.0 108.585 179.032 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.716 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -46.15 -33.78 3.8 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.459 -0.776 . . . . 0.0 109.022 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -77.57 -40.26 42.98 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.947 -1.095 . . . . 0.0 109.142 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CE1' ' NE2' ' A' ' 71' ' ' GLN . 3.1 t80 -60.16 -34.27 73.34 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.933 -1.104 . . . . 0.0 108.127 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.699 HG12 HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -89.12 -66.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.386 1.088 . . . . 0.0 108.977 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 1.042 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -57.52 -28.17 63.24 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.81 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 79' ' ' GLN . 4.3 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 109.371 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.671 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 121.005 0.431 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.854 HG21 ' CB ' ' A' ' 82' ' ' ALA . 2.2 t -47.07 -65.68 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.518 ' N ' HG12 ' A' ' 15' ' ' VAL . 4.0 pt-20 -70.76 -23.72 62.47 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.671 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 6.6 m -60.86 -44.85 96.47 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.394 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 22' ' ' ILE . 3.4 tptm -69.93 -61.57 1.73 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.964 -1.094 . . . . 0.0 108.351 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.898 HD21 HD12 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -48.34 -37.32 16.35 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.069 -1.052 . . . . 0.0 108.414 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' GLU . . . -58.19 -47.81 82.26 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.486 ' OE1' ' NH1' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -65.38 -51.99 56.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.378 -0.826 . . . . 0.0 108.785 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.951 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -54.37 -44.13 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.744 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.8 m95 -54.25 -68.57 0.17 Allowed 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.962 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.652 ' HA ' HD11 ' A' ' 32' ' ' ILE . 9.2 pt-20 -59.32 -33.21 70.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.486 ' NH1' ' OE1' ' A' ' 21' ' ' GLU . 24.1 ttm180 -71.17 -71.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 109.448 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.025 HG11 ' HB3' ' A' ' 50' ' ' ALA . 60.8 t -54.71 -33.78 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.556 -0.715 . . . . 0.0 110.232 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.466 ' CG ' ' O ' ' A' ' 23' ' ' TRP . 13.1 mt -91.43 -9.05 46.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 0.0 110.197 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.67 52.81 48.37 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.123 -0.986 . . . . 0.0 110.977 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -129.84 -173.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.249 . . . . 0.0 108.469 178.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.0 t -154.47 120.18 5.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.073 -1.017 . . . . 0.0 109.947 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.45 20.89 50.45 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.578 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 24' ' ' GLU . 2.8 mp -50.8 161.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.117 -1.225 . . . . 0.0 109.74 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.835 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -81.05 -153.01 9.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.719 ' O ' HG22 ' A' ' 34' ' ' ILE . 48.8 mm -121.37 19.85 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.78 -1.423 . . . . 0.0 109.762 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.816 HD12 ' HB3' ' A' ' 75' ' ' LYS . 1.7 tt -165.62 53.72 0.11 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.902 -1.124 . . . . 0.0 110.523 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.557 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 1.4 m-20 -84.76 160.08 20.34 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.42 45.91 1.33 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.833 -1.167 . . . . 0.0 108.787 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.744 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 13.4 m-85 . . . . . 0 N--CA 1.511 2.621 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.307 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.314 0.578 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.469 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -52.59 -52.6 54.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.409 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 16.4 mttp -53.37 -51.45 62.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.066 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -53.62 -44.69 69.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.404 -1.435 . . . . 0.0 108.02 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.907 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.71 -48.98 49.53 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.432 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.025 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -48.88 -52.37 24.74 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.951 ' CG1' HD11 ' A' ' 22' ' ' ILE . 41.8 t -46.25 -59.5 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.92 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -52.52 -52.95 52.12 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 52' ' ' ALA . . . -47.34 -49.09 25.02 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.613 ' HB3' HD12 ' A' ' 22' ' ' ILE . 6.3 tp-100 -50.9 -37.66 45.23 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.872 HG11 HD23 ' A' ' 63' ' ' LEU . 21.0 t -63.52 -60.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -54.86 -46.85 74.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.209 -0.932 . . . . 0.0 110.504 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.529 ' HG3' ' N ' ' A' ' 58' ' ' GLU . 0.8 OUTLIER -61.43 -36.69 81.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.659 -1.276 . . . . 0.0 109.01 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -75.69 -53.67 8.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 108.934 179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.656 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -120.99 157.49 29.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.6 41.0 1.09 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 81' ' ' VAL . 5.8 p -92.5 159.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.441 0.638 . . . . 0.0 109.672 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.471 ' N ' HG22 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -69.22 105.98 2.7 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.455 -0.778 . . . . 0.0 110.213 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.872 HD23 HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -132.93 69.59 78.98 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.572 ' HG2' HG23 ' A' ' 67' ' ' VAL . 34.9 Cg_endo -77.92 156.96 30.95 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.683 2.255 . . . . 0.0 110.856 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.907 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.5 mm? -57.88 -39.67 78.38 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -55.37 -53.16 59.69 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.615 HG21 ' CE2' ' A' ' 80' ' ' TYR . 2.9 t -50.84 -48.45 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.066 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -55.03 -23.62 20.68 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 66' ' ' LYS . 6.2 m-85 -87.58 -39.67 14.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.05 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.17 -33.6 76.13 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.423 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -143.15 71.27 18.33 Favored Pre-proline 0 C--N 1.296 -1.749 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.62 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 32.3 Cg_endo -77.24 56.05 5.31 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.881 2.388 . . . . 0.0 112.236 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.734 HG22 ' HB3' ' A' ' 76' ' ' ALA . 15.3 t -154.11 174.91 14.08 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 117.34 -1.744 . . . . 0.0 112.725 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.835 HD12 ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -66.12 -72.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.207 -0.933 . . . . 0.0 111.516 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.816 ' HB3' HD12 ' A' ' 35' ' ' LEU . 32.2 ttmt -45.73 -49.33 14.88 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.133 -0.979 . . . . 0.0 109.766 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.734 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -66.38 -71.64 0.19 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.453 -0.78 . . . . 0.0 110.081 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.898 HD12 HD21 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -42.14 -55.85 3.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.309 -0.87 . . . . 0.0 108.952 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.757 ' HA ' HD13 ' A' ' 19' ' ' LEU . . . -50.28 -56.24 12.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 108.502 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 4.0 tp60 -50.35 -45.27 54.98 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.615 ' CE2' HG21 ' A' ' 67' ' ' VAL . 5.7 t80 -54.46 -35.82 63.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.166 -0.959 . . . . 0.0 108.613 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.749 HG21 HD11 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -79.78 -62.17 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 122.563 1.173 . . . . 0.0 108.976 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.854 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -53.01 -63.55 1.11 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.566 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.049 -1.032 . . . . 0.0 109.712 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.606 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.107 0.479 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.977 HG21 ' HB2' ' A' ' 82' ' ' ALA . 53.0 t -61.03 -48.66 88.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.957 ' OE1' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -71.84 -23.6 61.56 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.628 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.606 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 20.9 m -56.09 -50.08 72.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.687 ' O ' HG22 ' A' ' 22' ' ' ILE . 5.6 tptm -68.36 -52.44 33.12 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.745 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 2.3 mt -54.25 -37.35 64.56 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.696 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.957 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . . . -61.61 -45.83 92.42 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 22' ' ' ILE . 2.7 tt0 -61.82 -60.25 3.94 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.916 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -48.08 -57.57 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.906 ' HB3' HD13 ' A' ' 32' ' ' ILE . 1.9 m95 -38.24 -66.83 0.23 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.916 0.865 . . . . 0.0 110.308 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.661 ' HA ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -58.32 -43.43 88.19 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.443 0.64 . . . . 0.0 109.578 -178.313 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.429 ' HG3' ' N ' ' A' ' 26' ' ' VAL . 4.2 tpp180 -63.07 -71.93 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.517 -0.74 . . . . 0.0 110.511 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.673 HG11 ' HB3' ' A' ' 50' ' ' ALA . 91.1 t -63.17 -31.6 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 0.0 111.27 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 13.9 mt -93.05 -12.16 31.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.682 -1.261 . . . . 0.0 110.584 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 69.42 66.72 2.15 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.283 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.728 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -133.22 -168.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -1.09 . . . . 0.0 109.327 179.421 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.529 ' H ' HG12 ' A' ' 29' ' ' VAL . 3.3 m -153.42 69.26 0.81 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.428 -0.795 . . . . 0.0 109.04 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 142.16 -76.87 0.3 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.906 HD13 ' HB3' ' A' ' 23' ' ' TRP . 9.8 mt 60.07 128.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.397 -1.061 . . . . 0.0 110.768 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.529 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -75.19 -143.45 1.02 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -113.55 -62.93 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.122 -1.223 . . . . 0.0 109.763 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.559 ' C ' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -89.68 39.89 0.97 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.561 -1.337 . . . . 0.0 108.861 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.624 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 2.6 m-20 -60.05 -165.15 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.64 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -129.22 122.82 30.5 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CE1' ' N ' ' A' ' 73' ' ' THR . 7.9 m-30 . . . . . 0 N--CA 1.5 2.049 0 O-C-N 121.098 -1.001 . . . . 0.0 109.07 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.146 0.498 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -48.44 69.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.704 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.9 mttt -56.81 -59.64 4.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.847 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.028 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -47.69 -51.87 20.33 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.975 -1.078 . . . . 0.0 109.141 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.886 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.72 -50.02 26.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.673 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -47.69 -41.86 23.55 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.916 HG13 ' CG1' ' A' ' 22' ' ' ILE . 17.9 t -61.12 -57.26 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.055 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -49.15 -46.16 44.79 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -57.58 -40.69 79.56 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.531 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 25.8 tp60 -54.75 -33.76 61.66 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.986 HG11 HD12 ' A' ' 63' ' ' LEU . 3.5 t -68.95 -51.79 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' TYR . 4.3 t-160 -65.7 -37.46 86.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 109.252 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 53' ' ' ALA . 5.4 mtt180 -70.42 -32.33 69.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 108.727 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.504 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -81.47 -54.81 5.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.81 . . . . 0.0 108.864 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.835 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -118.38 -179.6 3.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.371 -0.831 . . . . 0.0 109.174 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.69 44.57 1.03 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.835 HG23 ' HB2' ' A' ' 59' ' ' TYR . 13.4 t -93.39 129.91 43.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.503 0.668 . . . . 0.0 109.734 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.76 104.05 2.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.729 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.986 HD12 HG11 ' A' ' 55' ' ' VAL . 6.5 mt -124.23 100.99 35.26 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 108.981 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.6 Cg_endo -80.18 157.4 23.15 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.548 2.166 . . . . 0.0 110.451 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.886 HD21 ' SD ' ' A' ' 49' ' ' MET . 1.9 mm? -57.03 -44.22 82.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.079 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HG3' ' HB2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -50.86 -51.24 53.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.0 -1.063 . . . . 0.0 108.337 179.295 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.931 HG11 ' CD2' ' A' ' 63' ' ' LEU . 2.7 t -50.76 -45.34 27.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.055 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -57.56 -25.02 59.33 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 66' ' ' LYS . 19.0 m-85 -86.72 -37.23 18.12 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.464 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.16 -30.68 68.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.78 . . . . 0.0 109.305 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.657 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -144.82 66.11 12.86 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.178 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.596 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 34.3 Cg_endo -77.52 54.37 4.71 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.895 2.397 . . . . 0.0 110.588 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.622 ' N ' ' CE1' ' A' ' 38' ' ' PHE . 9.7 t -151.93 159.35 43.82 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.215 -0.928 . . . . 0.0 110.024 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.606 HG12 ' NE1' ' A' ' 23' ' ' TRP . 2.4 mt -64.49 -60.0 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.163 -0.961 . . . . 0.0 112.005 -178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 9.2 tttm -40.29 -53.85 2.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.318 -0.864 . . . . 0.0 108.912 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 77' ' ' LEU . . . -69.71 -60.93 2.0 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.666 -0.646 . . . . 0.0 110.051 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.3 OUTLIER -45.15 -59.17 2.76 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.707 -1.245 . . . . 0.0 108.623 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -50.22 -40.58 47.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -70.56 -34.91 72.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.05 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.719 ' CD1' HD21 ' A' ' 63' ' ' LEU . 7.7 t80 -63.14 -37.42 87.17 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.15 -0.969 . . . . 0.0 108.634 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.783 HG12 HG21 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -86.39 -62.19 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.367 1.08 . . . . 0.0 108.566 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.977 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -60.68 -54.24 47.63 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.031 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.334 179.855 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.606 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.186 0.517 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.907 HG21 ' CB ' ' A' ' 82' ' ' ALA . 3.7 t -53.33 -51.84 36.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.53 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -68.79 -33.87 74.59 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.378 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.606 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.8 m -49.8 -52.2 33.9 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.407 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.866 ' O ' HG22 ' A' ' 22' ' ' ILE . 27.6 tptt -59.23 -49.46 77.75 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.293 -0.879 . . . . 0.0 108.728 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.779 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 9.9 mt -61.9 -41.76 98.28 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.512 ' O ' ' CG ' ' A' ' 24' ' ' GLU . . . -52.72 -45.38 66.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.792 -1.192 . . . . 0.0 108.036 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -64.56 -66.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 108.898 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.866 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -44.94 -48.12 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.785 ' HB3' HD12 ' A' ' 32' ' ' ILE . 3.3 m95 -46.69 -66.98 0.32 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.428 0.633 . . . . 0.0 110.504 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -63.73 -30.0 71.15 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.339 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -71.05 -64.18 0.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.037 -1.039 . . . . 0.0 110.223 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.06 HG11 ' HB3' ' A' ' 50' ' ' ALA . 99.3 t -71.37 -34.42 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 111.086 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.516 ' HB2' HG23 ' A' ' 29' ' ' VAL . 47.3 mt -79.33 4.78 14.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.669 -1.269 . . . . 0.0 110.052 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.34 49.12 61.47 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -134.1 -179.97 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.074 -1.251 . . . . 0.0 109.167 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.91 115.46 10.03 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.289 -0.882 . . . . 0.0 109.367 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 119.67 -69.64 0.36 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.785 HD12 ' HB3' ' A' ' 23' ' ' TRP . 10.2 mm 57.05 113.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -1.071 . . . . 0.0 109.656 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.45 -145.48 1.78 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.64 ' O ' ' N ' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -108.75 -50.81 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -1.22 . . . . 0.0 110.2 -179.307 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.592 ' HG ' HG21 ' A' ' 73' ' ' THR . 0.5 OUTLIER -109.81 45.21 1.11 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 119.775 -1.828 . . . . 0.0 109.174 179.234 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 73' ' ' THR . 2.5 m-20 -61.2 -164.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -135.27 118.8 16.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.8 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 70.5 m-85 . . . . . 0 N--CA 1.504 2.257 0 O-C-N 120.924 -1.11 . . . . 0.0 109.31 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 49' ' ' MET . 16.6 tp -64.35 -55.79 18.8 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.091 -1.006 . . . . 0.0 109.568 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 26' ' ' VAL . 1.9 mmtm -43.3 -58.35 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.046 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -51.62 -43.33 62.53 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.95 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.44 -50.63 51.66 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 178.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.06 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -47.37 -43.12 22.99 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.759 HG13 HG13 ' A' ' 22' ' ' ILE . 11.2 t -61.18 -60.76 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.995 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -47.74 -42.98 26.63 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 57' ' ' ARG . . . -58.23 -41.17 83.51 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.563 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 6.8 tp60 -55.47 -29.99 59.74 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.641 HG11 HD23 ' A' ' 63' ' ' LEU . 6.6 t -75.19 -59.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 59' ' ' TYR . 64.8 t-80 -57.33 -31.68 65.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 0.0 109.246 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -78.76 -38.58 38.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.122 -0.986 . . . . 0.0 108.737 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.478 ' OE2' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -71.94 -48.61 44.03 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.775 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -127.47 -178.82 4.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.481 -0.762 . . . . 0.0 109.17 178.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -110.72 44.97 1.19 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.775 HG23 ' HB2' ' A' ' 59' ' ' TYR . 13.9 t -93.14 153.9 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.799 -0.563 . . . . 0.0 109.723 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' C ' ' HD3' ' A' ' 64' ' ' PRO . 11.3 tt0 -70.78 94.85 1.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.641 HD23 HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -125.35 74.14 68.0 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.551 ' HG2' HG23 ' A' ' 67' ' ' VAL . 35.4 Cg_endo -77.2 -176.92 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.771 2.314 . . . . 0.0 110.885 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.95 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.9 mm? -81.27 -41.88 21.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.352 -0.843 . . . . 0.0 109.134 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -59.88 -37.66 79.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.263 -0.898 . . . . 0.0 108.701 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.551 HG23 ' HG2' ' A' ' 64' ' ' PRO . 8.9 t -65.11 -47.08 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.046 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -52.74 -25.84 12.34 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.298 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.491 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.7 m-85 -79.17 -42.2 26.68 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.492 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -70.28 -26.18 63.68 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.841 0.829 . . . . 0.0 108.783 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.615 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -147.02 65.76 9.9 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.2 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.567 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 34.4 Cg_endo -78.81 55.73 5.67 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 123.074 2.516 . . . . 0.0 112.722 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.592 HG21 ' HG ' ' A' ' 35' ' ' LEU . 4.7 t -153.18 172.65 16.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.259 -1.526 . . . . 0.0 111.996 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.635 HG12 ' CE2' ' A' ' 23' ' ' TRP . 0.9 OUTLIER -64.36 -54.83 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.616 -0.677 . . . . 0.0 110.78 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.64 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -55.49 -65.2 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.019 -1.051 . . . . 0.0 109.497 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -48.04 -53.93 14.73 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.585 -0.697 . . . . 0.0 110.206 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -57.64 -65.11 0.69 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.714 -1.241 . . . . 0.0 109.155 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.59 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -44.05 -34.92 1.91 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.478 ' HG3' ' N ' ' A' ' 80' ' ' TYR . 0.6 OUTLIER -71.71 -44.45 64.15 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 108.657 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.478 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 2.3 t80 -57.58 -34.91 69.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.105 -0.997 . . . . 0.0 109.015 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.614 HG12 HG21 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -87.65 -63.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.289 1.042 . . . . 0.0 108.219 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.907 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -51.69 -59.57 4.14 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.024 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.405 ' HB ' ' OE1' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.514 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.559 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.09 ' CG1' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -54.08 -36.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.469 ' HG2' ' CB ' ' A' ' 78' ' ' ALA . 2.9 mt-10 -77.98 -36.16 49.33 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.8 m -56.3 -49.09 75.27 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.794 ' O ' HG22 ' A' ' 22' ' ' ILE . 10.0 tptt -67.64 -59.47 3.31 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.778 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -54.24 -27.37 34.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 109.38 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.12 -52.23 37.17 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -55.28 36.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.769 -0.772 . . . . 0.0 108.925 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.794 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -53.52 -53.51 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 108.758 179.451 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.826 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.7 m95 -40.49 -57.74 1.74 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.449 0.642 . . . . 0.0 109.72 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.595 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -61.49 -49.97 74.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.492 -0.755 . . . . 0.0 109.69 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -52.26 -47.69 65.65 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.48 -0.762 . . . . 0.0 110.683 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.928 HG11 ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -85.92 -50.38 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.093 -1.004 . . . . 0.0 110.371 -178.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.7 mt -68.86 -6.66 28.39 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.598 -0.689 . . . . 0.0 109.977 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.83 60.02 9.17 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -129.9 -178.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -1.162 . . . . 0.0 109.167 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 30' ' ' SER . 1.3 p -148.91 40.0 0.87 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.59 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.37 59.86 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.826 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.2 mt -85.18 136.49 22.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.445 -1.032 . . . . 0.0 109.416 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.98 -120.92 0.04 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.506 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -138.59 -61.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.815 -1.403 . . . . 0.0 109.773 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.585 ' CD2' HG21 ' A' ' 73' ' ' THR . 0.3 OUTLIER -90.02 37.82 0.9 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.676 -1.265 . . . . 0.0 108.544 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.476 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -58.99 -167.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.785 0.802 . . . . 0.0 109.484 178.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -131.72 110.96 11.25 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.466 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.737 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 53.6 m-85 . . . . . 0 N--CA 1.507 2.401 0 O-C-N 121.562 -0.711 . . . . 0.0 110.197 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 46' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -45.15 -47.2 12.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.151 -0.968 . . . . 0.0 109.294 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 7.0 tptt -47.83 -62.51 1.42 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 109.202 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.035 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.77 -48.79 50.21 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.045 -1.034 . . . . 0.0 108.594 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.86 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.4 -47.81 47.51 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.782 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.928 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -48.36 -42.12 30.69 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.701 HG22 HG21 ' A' ' 26' ' ' VAL . 14.8 t -62.67 -52.99 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.817 ' HB3' ' SD ' ' A' ' 49' ' ' MET . . . -48.4 -45.5 36.01 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.28 77.4 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.562 ' CG ' ' OE2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -51.91 -31.88 30.38 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.028 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.788 HG11 HD13 ' A' ' 63' ' ' LEU . 21.2 t -68.37 -42.03 83.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 59' ' ' TYR . 12.5 t-80 -71.16 -40.77 71.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.368 -0.832 . . . . 0.0 109.033 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -41.66 68.46 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.562 ' OE2' ' CG ' ' A' ' 54' ' ' GLN . 71.2 mt-10 -63.91 -49.4 72.81 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.865 ' CD1' HG11 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -139.96 172.63 12.49 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.74 45.87 0.94 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.835 HG23 ' HB2' ' A' ' 59' ' ' TYR . 21.2 t -92.97 145.66 7.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.437 0.637 . . . . 0.0 109.837 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.85 111.43 5.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 109.461 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.788 HD13 HG11 ' A' ' 55' ' ' VAL . 1.3 tt -147.01 85.37 6.99 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.299 -0.876 . . . . 0.0 109.436 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.1 Cg_endo -79.56 172.18 14.75 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.793 2.329 . . . . 0.0 109.589 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.86 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.1 mt -68.17 -43.23 78.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.716 -1.24 . . . . 0.0 109.116 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.416 ' CG ' ' N ' ' A' ' 67' ' ' VAL . 12.5 ptmm? -47.05 -37.9 10.19 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 80' ' ' TYR . 2.1 t -70.91 -42.21 77.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.035 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -61.28 -22.38 64.8 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.469 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 46.1 m-85 -83.55 -40.46 19.09 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.453 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -68.39 -29.61 68.34 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.994 0.902 . . . . 0.0 108.797 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.539 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -140.58 68.42 31.03 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.451 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.573 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.9 Cg_endo -76.9 55.23 4.86 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.989 2.459 . . . . 0.0 113.069 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.586 ' HA ' ' CZ2' ' A' ' 23' ' ' TRP . 10.2 t -153.39 174.44 14.35 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.736 -1.227 . . . . 0.0 110.887 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.815 HD11 ' CG2' ' A' ' 32' ' ' ILE . 21.0 mt -72.71 -65.07 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.311 -0.868 . . . . 0.0 109.883 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -39.76 -54.43 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.645 -0.659 . . . . 0.0 109.577 -179.564 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' H ' HG23 ' A' ' 73' ' ' THR . . . -62.76 -59.84 4.33 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.358 -0.839 . . . . 0.0 109.068 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.85 HD11 HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -44.54 -62.6 1.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.021 -1.049 . . . . 0.0 108.739 179.309 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.513 ' N ' HD13 ' A' ' 19' ' ' LEU . . . -48.7 -39.83 26.05 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.79 -40.82 79.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.913 . . . . 0.0 108.868 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.607 ' HD2' HD12 ' A' ' 63' ' ' LEU . 4.3 t80 -56.12 -35.12 66.73 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.865 HG11 ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.21 -69.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 122.334 1.064 . . . . 0.0 109.135 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 1.09 ' HB2' ' CG1' ' A' ' 15' ' ' VAL . . . -48.44 -25.99 1.9 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.341 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.06 . . . . 0.0 109.6 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.602 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 C--O 1.209 -1.049 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.892 HG21 ' CB ' ' A' ' 82' ' ' ALA . 2.2 t -52.0 -49.44 38.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.677 ' HG3' ' HB1' ' A' ' 78' ' ' ALA . 2.3 mt-10 -73.08 -38.25 66.47 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.602 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 16.6 m -53.27 -48.63 68.12 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.31 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.763 ' O ' HG22 ' A' ' 22' ' ' ILE . 6.9 tptt -63.28 -56.66 14.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -0.985 . . . . 0.0 108.861 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.792 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 1.3 tp -52.9 -37.54 60.78 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.432 -0.792 . . . . 0.0 109.15 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.68 84.13 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -61.89 -65.27 0.72 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.534 -0.729 . . . . 0.0 109.056 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.792 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -45.81 -45.91 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.951 -1.093 . . . . 0.0 108.895 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.738 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.5 m95 -47.37 -65.12 0.62 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.66 0.743 . . . . 0.0 109.938 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.613 ' CB ' HD11 ' A' ' 32' ' ' ILE . 8.0 pt-20 -60.22 -32.62 71.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 110.65 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -65.47 -61.66 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.128 -0.982 . . . . 0.0 110.664 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.108 HG11 ' HB3' ' A' ' 50' ' ' ALA . 22.0 t -77.44 -31.83 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.1 -1.0 . . . . 0.0 110.762 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 38.0 mt -78.83 -3.6 45.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.984 -1.073 . . . . 0.0 110.008 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.89 54.67 36.04 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.58 -172.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.186 -1.185 . . . . 0.0 109.374 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 t -143.29 38.22 1.4 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.386 -0.821 . . . . 0.0 109.073 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.612 ' O ' HD12 ' A' ' 32' ' ' ILE . . . -157.14 -94.84 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.659 HG22 ' CB ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER 19.76 86.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 117.746 0.773 . . . . 0.0 110.922 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -135.62 20.23 3.7 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 118.624 -1.751 . . . . 0.0 112.139 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.737 ' H ' HD12 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -174.69 114.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 120.222 -1.752 . . . . 0.0 110.979 178.726 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.563 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 1.9 tp 37.81 42.47 0.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.348 0.594 . . . . 0.0 110.639 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.659 ' CB ' HG22 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -76.7 -178.42 4.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.827 . . . . 0.0 109.043 178.396 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 38' ' ' PHE . 7.2 m120 -114.03 112.42 23.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.727 -1.233 . . . . 0.0 109.062 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.738 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 55.1 m-85 . . . . . 0 N--CA 1.505 2.314 0 O-C-N 121.165 -0.959 . . . . 0.0 109.452 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.144 0.497 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -50.95 -62.81 1.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 109.519 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 18.2 mttp -46.52 -54.86 8.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.082 -1.011 . . . . 0.0 108.782 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.07 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -48.92 -44.33 40.28 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.774 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.63 -46.14 58.04 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.301 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.108 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -48.64 -47.58 40.22 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.721 HG13 HG13 ' A' ' 22' ' ' ILE . 10.8 t -56.63 -56.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.76 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.89 -35.64 15.28 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -66.36 -39.93 89.45 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.558 ' NE2' ' HB ' ' A' ' 22' ' ' ILE . 5.8 tp60 -54.78 -29.53 54.48 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.811 HG21 ' CD2' ' A' ' 63' ' ' LEU . 5.0 t -73.97 -61.66 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 59' ' ' TYR . 71.3 t60 -52.4 -36.32 53.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.904 -1.123 . . . . 0.0 109.435 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.49 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -75.13 -44.8 44.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.044 . . . . 0.0 109.158 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.479 ' HG3' ' HG2' ' A' ' 18' ' ' LYS . 35.4 mm-40 -69.74 -33.47 72.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.408 -0.808 . . . . 0.0 109.217 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.575 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -143.91 162.34 36.38 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.539 -0.725 . . . . 0.0 109.436 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -96.57 39.94 1.15 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.025 HG11 HG13 ' A' ' 81' ' ' VAL . 7.1 p -92.96 153.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -82.78 111.27 18.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.034 HD21 HD13 ' A' ' 77' ' ' LEU . 4.9 tp -145.24 78.28 12.37 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.488 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 35.1 Cg_endo -79.0 -172.04 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.883 2.389 . . . . 0.0 110.284 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.774 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.4 mt -78.67 -37.63 41.34 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.033 -1.042 . . . . 0.0 109.278 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -53.08 -36.67 60.94 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.557 HG11 HD12 ' A' ' 63' ' ' LEU . 2.6 t -72.75 -45.2 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.07 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -62.26 -24.16 67.11 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.395 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.4 m-85 -87.52 -35.98 17.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 108.896 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.473 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -70.74 -30.31 66.79 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.545 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.94 66.82 15.13 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -178.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.3 Cg_endo -75.88 59.37 5.75 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.915 2.41 . . . . 0.0 112.235 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.563 ' OG1' ' HA ' ' A' ' 35' ' ' LEU . 4.1 t -153.8 174.37 14.65 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 117.559 -1.656 . . . . 0.0 112.584 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.737 HD12 ' H ' ' A' ' 34' ' ' ILE . 29.0 mt -67.72 -56.94 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.452 ' H ' ' H ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -61.85 -57.51 11.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.672 -1.268 . . . . 0.0 108.84 -178.353 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.404 ' HB3' HG23 ' A' ' 73' ' ' THR . . . -48.51 -55.09 11.96 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.572 -0.705 . . . . 0.0 109.144 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.034 HD13 HD21 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -55.17 -65.42 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.0 -1.062 . . . . 0.0 109.076 179.354 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.677 ' HB1' ' HG3' ' A' ' 16' ' ' GLU . . . -43.59 -46.13 7.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.492 ' O ' HG22 ' A' ' 83' ' ' THR . 47.5 mm-40 -61.78 -53.14 60.03 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.514 ' CD1' ' CD1' ' A' ' 63' ' ' LEU . 2.5 t80 -43.18 -39.2 2.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.327 -0.858 . . . . 0.0 109.252 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.025 HG13 HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -87.93 -67.31 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.433 1.111 . . . . 0.0 109.041 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.892 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -40.03 -25.94 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.868 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 79' ' ' GLN . 2.1 t . . . . . 0 N--CA 1.492 1.666 0 O-C-N 120.858 -1.151 . . . . 0.0 109.572 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.575 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.992 HG11 ' HB2' ' A' ' 82' ' ' ALA . 43.5 t -49.92 -48.93 22.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HG2' ' CB ' ' A' ' 78' ' ' ALA . 31.6 mt-10 -71.17 -29.36 65.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.575 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 35.4 m -53.04 -51.12 62.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.038 -1.039 . . . . 0.0 108.679 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.599 ' O ' HG22 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -68.93 -54.61 14.45 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.02 -1.072 . . . . 0.0 108.818 179.6 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.059 HD21 HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -48.35 -38.43 19.2 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.78 -1.168 . . . . 0.0 108.063 179.128 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.03 -50.57 73.6 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.66 -62.94 1.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.922 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -45.78 -52.23 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.173 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.626 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 2.2 m95 -41.51 -62.41 0.88 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.425 0.631 . . . . 0.0 109.727 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.693 ' HA ' HD11 ' A' ' 32' ' ' ILE . 4.8 pt-20 -66.25 -33.41 75.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.437 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HG3' ' N ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -62.38 -63.9 1.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.349 -179.001 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.842 HG11 ' HB3' ' A' ' 50' ' ' ALA . 11.8 t -79.23 -35.01 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.918 . . . . 0.0 111.606 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 38.4 mt -75.64 -2.79 31.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.884 -1.135 . . . . 0.0 109.955 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.88 59.06 10.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.644 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -131.45 -174.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -1.154 . . . . 0.0 109.083 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t -150.79 49.94 0.86 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.256 -0.902 . . . . 0.0 109.208 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 168.18 -73.05 0.14 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.807 HG22 HD11 ' A' ' 74' ' ' ILE . 5.1 mt 59.43 143.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.433 -1.04 . . . . 0.0 109.776 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.665 ' O ' HD13 ' A' ' 74' ' ' ILE . . . -83.73 -143.53 5.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 34' ' ' ILE . 5.3 tt -127.64 25.2 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -1.231 . . . . 0.0 109.388 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.843 ' HA ' HG22 ' A' ' 73' ' ' THR . 6.2 tp -179.52 61.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.155 -0.965 . . . . 0.0 109.516 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.904 ' O ' HG23 ' A' ' 73' ' ' THR . 0.6 OUTLIER -91.57 -160.48 0.73 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.488 -0.757 . . . . 0.0 109.32 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -126.84 29.85 5.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.878 -1.139 . . . . 0.0 109.953 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 63.0 m-85 . . . . . 0 N--CA 1.507 2.395 0 O-C-N 122.139 -0.351 . . . . 0.0 110.216 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.237 0.542 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -57.09 -43.31 82.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.961 . . . . 0.0 109.335 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.717 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -61.13 -65.29 0.72 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -0.969 . . . . 0.0 109.625 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.934 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.68 -47.96 49.94 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.888 -1.132 . . . . 0.0 108.227 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.896 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.41 -37.93 18.28 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.012 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.842 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -57.22 -49.75 75.01 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.922 HG13 ' CG1' ' A' ' 22' ' ' ILE . 9.4 t -57.13 -57.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.97 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.67 -35.08 13.08 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -67.58 -45.19 76.27 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.598 ' O ' ' CB ' ' A' ' 58' ' ' GLU . 35.4 tp60 -49.18 -31.8 9.13 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.874 HG11 HD23 ' A' ' 63' ' ' LEU . 3.4 t -68.75 -30.77 48.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.593 -0.692 . . . . 0.0 109.314 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 53' ' ' ALA . 2.8 t60 -81.57 -43.36 18.78 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.183 -0.948 . . . . 0.0 109.509 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -77.4 -34.05 54.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.956 -1.09 . . . . 0.0 108.611 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.598 ' CB ' ' O ' ' A' ' 54' ' ' GLN . 42.3 tp10 -77.1 -37.66 53.87 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.906 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -137.64 157.71 45.93 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 4.3 tt0 -93.78 32.02 1.5 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.964 HG11 ' CG1' ' A' ' 81' ' ' VAL . 6.7 p -93.64 144.33 9.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 3.1 pt-20 -69.75 136.24 50.7 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.05 -1.031 . . . . 0.0 109.456 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.874 HD23 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -143.22 92.24 6.79 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.567 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.2 Cg_endo -78.79 162.19 26.99 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.554 2.169 . . . . 0.0 110.762 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.896 HD21 ' SD ' ' A' ' 49' ' ' MET . 4.1 mm? -70.3 -29.62 66.42 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -63.67 -55.07 26.33 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.671 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 3.9 t -49.97 -42.03 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.97 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -61.78 -32.14 72.39 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.499 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 23.4 m-85 -80.43 -37.7 31.53 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.4 -35.07 79.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.469 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -144.98 69.56 14.47 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -178.883 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.587 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 30.4 Cg_endo -77.67 66.84 8.02 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.712 2.275 . . . . 0.0 109.115 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 36' ' ' ASP . 22.2 m -153.31 161.98 41.78 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 117.088 -1.845 . . . . 0.0 113.108 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.807 HD11 HG22 ' A' ' 32' ' ' ILE . 87.2 mt -57.8 -70.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 110.007 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 21.8 ttpp -57.67 -49.39 76.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.259 -0.901 . . . . 0.0 109.305 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -58.65 -71.35 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.854 -1.154 . . . . 0.0 109.369 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.059 HD12 HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -42.76 -58.21 2.44 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.247 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.594 ' HA ' HD13 ' A' ' 19' ' ' LEU . . . -49.67 -60.65 2.68 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 12.5 mm100 -45.37 -42.09 9.74 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.227 -0.92 . . . . 0.0 108.865 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.671 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 7.8 t80 -54.39 -39.01 66.82 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.964 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -87.46 -66.78 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.386 1.089 . . . . 0.0 108.659 179.227 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.992 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -45.01 -40.96 6.97 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.089 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.397 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.577 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.084 HG11 ' HB2' ' A' ' 82' ' ' ALA . 16.0 m -49.5 -37.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.518 ' HG2' HG23 ' A' ' 15' ' ' VAL . 1.1 mt-10 -82.99 -38.45 22.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.577 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 24.8 p -53.47 -38.99 64.14 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.691 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -71.49 -57.89 4.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.587 -0.695 . . . . 0.0 109.23 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.744 ' HB3' HG23 ' A' ' 74' ' ' ILE . 3.9 mm? -54.2 -42.4 69.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.941 -1.099 . . . . 0.0 108.422 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 24' ' ' GLU . . . -56.0 -46.75 78.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -60.48 -63.64 1.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.918 HG12 HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -46.98 -51.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.965 ' CE3' HG21 ' A' ' 32' ' ' ILE . 2.1 m95 -39.38 -66.73 0.27 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.607 0.718 . . . . 0.0 109.929 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.609 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -63.68 -25.63 68.3 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.972 -178.738 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.478 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . 4.5 tpp180 -74.06 -67.12 0.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.115 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.799 HG11 ' HB3' ' A' ' 50' ' ' ALA . 72.4 t -71.36 -31.63 44.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 111.0 -178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 21.6 mt -85.58 -7.95 58.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.992 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.58 56.44 9.78 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.484 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.9 179.3 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.886 -1.361 . . . . 0.0 108.724 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -140.98 74.09 1.45 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.157 -0.964 . . . . 0.0 108.984 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 146.32 -80.35 0.22 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.965 HG21 ' CE3' ' A' ' 23' ' ' TRP . 9.8 mt 59.58 150.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.223 -1.163 . . . . 0.0 109.64 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.53 -122.52 0.72 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.696 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -147.11 -52.51 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.717 -1.46 . . . . 0.0 111.079 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.82 HD23 HG21 ' A' ' 73' ' ' THR . 5.5 mt -95.5 31.14 2.07 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.049 -1.657 . . . . 0.0 110.976 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.729 ' O ' HG23 ' A' ' 73' ' ' THR . 2.9 m-20 -59.15 -166.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.113 -0.992 . . . . 0.0 109.616 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.509 ' CG ' ' O ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -133.98 30.62 3.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.086 -1.009 . . . . 0.0 109.245 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.599 ' CD1' ' CZ2' ' A' ' 23' ' ' TRP . 6.5 m-30 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.362 -0.836 . . . . 0.0 109.64 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 46' ' ' LEU . 4.2 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.981 0.419 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 49' ' ' MET . 0.4 OUTLIER -43.97 -51.02 8.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.014 -1.054 . . . . 0.0 109.246 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -44.91 -47.44 11.24 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.018 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -57.2 -45.41 83.82 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.813 ' HG2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -46.68 -51.77 15.28 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.366 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.799 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -48.3 -50.0 31.76 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.918 HG13 HG12 ' A' ' 22' ' ' ILE . 21.2 t -51.22 -55.49 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.066 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -50.18 -46.2 54.09 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -52.05 -38.35 56.75 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.567 ' HG2' ' HB ' ' A' ' 22' ' ' ILE . 24.0 tp60 -58.63 -41.04 85.03 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.9 HG21 HD22 ' A' ' 63' ' ' LEU . 14.7 t -61.5 -40.54 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 59' ' ' TYR . 10.5 t-80 -69.15 -53.27 20.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.056 -1.027 . . . . 0.0 109.149 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -38.57 84.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.037 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.543 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 13.3 mm-40 -71.82 -56.64 5.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.305 -0.872 . . . . 0.0 108.651 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.843 ' CD1' HG11 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -127.03 165.04 20.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.767 0.794 . . . . 0.0 109.532 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -95.78 46.18 1.09 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.6 t -91.44 138.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.514 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.63 103.16 1.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 109.765 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.9 HD22 HG21 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -138.94 82.58 19.81 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.055 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.564 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 34.5 Cg_endo -77.81 -178.84 4.91 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.78 2.32 . . . . 0.0 110.418 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.813 HD21 ' HG2' ' A' ' 49' ' ' MET . 2.5 mm? -65.22 -37.93 88.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 109.089 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -56.26 -60.99 2.71 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.564 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 15.2 t -47.04 -43.07 6.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.066 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -61.81 -48.68 79.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.356 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -65.51 -19.84 66.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -76.31 -52.11 10.62 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.271 1.034 . . . . 0.0 108.838 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.558 ' NE2' ' CD1' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -132.58 72.35 77.91 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.034 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.581 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 31.2 Cg_endo -76.4 67.43 7.06 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.397 2.064 . . . . 0.0 108.207 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.82 HG21 HD23 ' A' ' 35' ' ' LEU . 22.2 m -151.4 165.77 33.11 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.227 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 19' ' ' LEU . 6.1 mt -76.79 -69.58 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.331 -0.856 . . . . 0.0 109.798 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -45.84 -47.54 15.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.182 -0.948 . . . . 0.0 108.867 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.457 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -59.5 -55.48 34.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.387 -0.821 . . . . 0.0 109.147 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -56.23 -65.6 0.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.102 -0.999 . . . . 0.0 108.876 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.69 ' HB1' HG23 ' A' ' 15' ' ' VAL . . . -43.35 -37.42 2.26 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.46 -0.775 . . . . 0.0 109.054 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.447 ' O ' ' O ' ' A' ' 83' ' ' THR . 10.1 tp60 -69.95 -43.85 70.74 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.002 -1.061 . . . . 0.0 108.548 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.558 ' CD1' ' NE2' ' A' ' 71' ' ' GLN . 10.4 t80 -59.84 -33.4 71.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.33 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.843 HG11 ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -86.93 -60.74 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 122.48 1.133 . . . . 0.0 108.196 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 1.084 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -54.35 -65.32 0.6 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.418 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.585 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.622 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.892 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 2.7 t -49.37 -49.62 17.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -29.51 48.54 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.622 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 7.3 m -60.84 -42.31 97.53 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.664 -1.215 . . . . 0.0 108.684 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.475 ' HG2' ' HG3' ' A' ' 58' ' ' GLU . 0.7 OUTLIER -69.1 -51.31 39.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.712 ' HA ' HD11 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -61.11 -46.7 89.53 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.733 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.36 -45.43 55.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 22' ' ' ILE . 1.7 mm-40 -62.76 -69.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.537 -0.727 . . . . 0.0 109.541 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.973 HD12 ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -47.06 -40.58 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.872 -1.143 . . . . 0.0 108.919 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.727 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.6 m95 -49.25 -67.44 0.26 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.369 -0.832 . . . . 0.0 109.507 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.774 ' HA ' HD11 ' A' ' 32' ' ' ILE . 4.0 pt-20 -58.85 -39.29 80.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.439 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -69.51 -70.85 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.795 -1.191 . . . . 0.0 109.744 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 50' ' ' ALA . 55.3 t -55.92 -31.41 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 110.85 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.771 HD23 ' HG3' ' A' ' 47' ' ' LYS . 14.2 mt -96.53 15.0 22.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.115 -0.991 . . . . 0.0 110.8 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.42 44.77 45.65 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 121.208 -0.932 . . . . 0.0 110.978 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.771 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -117.82 -170.3 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.093 -1.239 . . . . 0.0 108.885 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 p -145.99 49.4 1.2 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.184 -0.948 . . . . 0.0 109.48 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 143.37 -66.8 0.46 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.774 HD11 ' HA ' ' A' ' 24' ' ' GLU . 1.7 mp 57.61 156.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -1.171 . . . . 0.0 109.776 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.817 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -80.31 -157.73 15.65 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -102.7 -49.08 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.272 . . . . 0.0 110.346 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.708 HD23 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -93.06 34.95 1.08 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.801 -1.187 . . . . 0.0 109.294 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -64.77 155.19 34.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.689 -0.632 . . . . 0.0 109.902 179.034 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.8 m-20 -97.84 122.12 40.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.1 -1.0 . . . . 0.0 108.626 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.727 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 79.0 m-85 . . . . . 0 N--CA 1.504 2.233 0 O-C-N 121.109 -0.995 . . . . 0.0 109.319 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.0 mm? -53.92 -34.65 60.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.771 ' HG3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -56.46 -51.98 66.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.114 -0.991 . . . . 0.0 108.39 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.704 ' HB1' ' CD2' ' A' ' 68' ' ' LEU . . . -58.73 -46.15 88.03 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.909 ' HG2' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -52.99 -32.91 48.99 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.257 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 47' ' ' LYS . . . -60.94 -44.57 97.06 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.973 ' CG1' HD12 ' A' ' 22' ' ' ILE . 4.3 t -62.13 -69.97 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.014 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -44.81 -50.14 10.39 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.264 -0.897 . . . . 0.0 108.679 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 49' ' ' MET . . . -55.89 -46.04 78.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.891 ' HG2' HG21 ' A' ' 22' ' ' ILE . 59.7 tp60 -48.21 -33.54 8.73 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.536 HG13 HG11 ' A' ' 81' ' ' VAL . 3.5 t -67.26 -67.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 59' ' ' TYR . 2.3 t-80 -46.86 -36.25 7.27 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.792 -1.192 . . . . 0.0 109.593 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -72.1 -42.66 65.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.792 -1.193 . . . . 0.0 108.717 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 18' ' ' LYS . 52.8 mm-40 -71.58 -50.76 27.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.778 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -116.91 160.14 21.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -93.67 36.95 1.07 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.798 HG11 ' CG1' ' A' ' 81' ' ' VAL . 6.3 p -94.11 145.56 7.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -82.78 112.61 19.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.5 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.071 HD21 HD13 ' A' ' 77' ' ' LEU . 15.9 tp -133.14 94.7 19.79 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.8 Cg_endo -80.91 163.66 20.53 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.784 2.323 . . . . 0.0 110.771 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.909 HD11 ' HG2' ' A' ' 49' ' ' MET . 4.5 mt -65.15 -39.1 92.51 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.385 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -48.45 -53.33 18.28 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.737 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.902 HG11 ' CD1' ' A' ' 63' ' ' LEU . 1.2 t -56.01 -46.13 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.014 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -58.13 -22.32 50.5 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.65 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.477 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.3 m-85 -86.03 -37.66 18.68 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.45 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.7 -31.57 69.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.463 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.15 67.4 21.55 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.758 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.559 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 33.0 Cg_endo -77.13 61.58 7.28 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.912 2.408 . . . . 0.0 111.933 -178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.708 HG21 HD23 ' A' ' 35' ' ' LEU . 4.4 t -152.95 176.06 12.26 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.198 -1.401 . . . . 0.0 112.053 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.817 HD12 ' O ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -73.64 -69.22 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.904 -0.498 . . . . 0.0 110.411 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.557 ' CG ' HG12 ' A' ' 34' ' ' ILE . 11.6 tmtt? -39.91 -56.53 1.79 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB3' HG23 ' A' ' 73' ' ' THR . . . -58.05 -64.33 0.95 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.514 -0.742 . . . . 0.0 109.884 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.071 HD13 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -46.27 -62.98 1.11 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.781 -1.2 . . . . 0.0 108.974 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 82' ' ' ALA . . . -44.78 -48.82 10.91 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 51.2 mm-40 -61.55 -44.5 96.93 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.464 ' CD2' HD13 ' A' ' 63' ' ' LEU . 1.1 t80 -53.29 -37.11 61.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.891 -1.13 . . . . 0.0 108.927 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.798 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -88.24 -65.43 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.431 1.11 . . . . 0.0 108.535 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.892 ' HB2' ' CB ' ' A' ' 15' ' ' VAL . . . -49.09 -20.7 0.6 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.355 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.531 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.615 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.868 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 35.3 t -48.07 -58.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.69 ' HG3' ' HB1' ' A' ' 78' ' ' ALA . 1.2 mp0 -66.01 -36.67 83.9 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.615 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 70.7 m -48.55 -55.92 9.77 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.302 177.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.816 ' O ' HG23 ' A' ' 22' ' ' ILE . 20.1 tttm -52.44 -67.43 0.25 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.811 HD12 ' NZ ' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -43.0 -46.48 5.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.336 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -49.82 -57.98 6.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.78 -1.2 . . . . 0.0 109.08 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -51.08 71.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 109.4 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.972 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -54.69 -44.06 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.78 ' HB3' HD13 ' A' ' 32' ' ' ILE . 3.3 m95 -52.22 -66.2 0.42 Allowed 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.619 0.723 . . . . 0.0 109.721 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.651 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -58.9 -53.73 55.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.463 -0.773 . . . . 0.0 110.046 -178.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -54.15 -66.08 0.46 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 109.982 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.968 HG11 ' HB3' ' A' ' 50' ' ' ALA . 21.6 t -58.56 -43.73 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.797 . . . . 0.0 110.719 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 42.3 mt -78.69 -12.38 60.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.996 -1.065 . . . . 0.0 110.347 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 72.73 53.27 8.45 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.409 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.36 -178.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.125 -1.221 . . . . 0.0 109.127 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.08 39.71 1.34 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.209 -0.932 . . . . 0.0 109.472 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -156.17 -91.2 0.08 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.78 HD13 ' HB3' ' A' ' 23' ' ' TRP . 14.7 mt 58.63 149.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -1.164 . . . . 0.0 109.721 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.38 -154.96 19.41 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.618 ' HA ' HG21 ' A' ' 74' ' ' ILE . 9.1 pt -98.84 2.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.139 -1.212 . . . . 0.0 110.024 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 35' ' ' LEU . 1.3 tt -162.41 69.1 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.979 -1.076 . . . . 0.0 108.986 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.512 ' N ' ' HG1' ' A' ' 73' ' ' THR . 1.8 m-20 -98.49 160.68 14.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.679 -0.638 . . . . 0.0 109.562 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.5 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.2 t-20 -89.49 106.83 18.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.726 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 43.4 m-85 . . . . . 0 N--CA 1.511 2.595 0 O-C-N 121.789 -0.569 . . . . 0.0 111.111 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.2 0.524 . . . . 0.0 109.821 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -46.15 -58.86 3.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.08 -1.012 . . . . 0.0 109.51 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.0 tptt -47.0 -59.35 3.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 109.854 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.073 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -58.06 -45.26 87.38 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.032 -1.042 . . . . 0.0 109.137 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.72 ' HG2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.77 -49.6 37.87 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.331 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.968 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -50.38 -55.63 14.86 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.972 ' CG1' HD11 ' A' ' 22' ' ' ILE . 21.6 t -43.13 -60.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.072 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -49.95 -54.89 16.96 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.527 ' HB2' ' CE ' ' A' ' 49' ' ' MET . . . -47.36 -50.63 21.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.73 ' HB3' HD12 ' A' ' 22' ' ' ILE . 35.5 tp60 -46.91 -38.6 10.76 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.008 HG11 HD13 ' A' ' 63' ' ' LEU . 17.0 t -60.23 -62.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 59' ' ' TYR . 53.9 t-80 -58.34 -32.82 68.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.419 -0.801 . . . . 0.0 110.046 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -74.29 -39.33 62.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.046 -1.034 . . . . 0.0 109.548 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.551 ' HB2' ' CE ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -78.29 -44.59 24.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 109.295 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.883 ' HB2' HG12 ' A' ' 61' ' ' VAL . 5.4 m-85 -110.96 -174.43 2.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 54.5 tp60 -113.54 29.15 8.22 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.883 HG12 ' HB2' ' A' ' 59' ' ' TYR . 3.4 p -93.85 134.3 31.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.654 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -74.34 103.61 4.78 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.465 -0.772 . . . . 0.0 110.097 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.008 HD13 HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -116.81 95.79 47.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.118 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.518 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 37.4 Cg_endo -82.88 169.17 13.43 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.721 2.281 . . . . 0.0 110.157 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.72 HD21 ' HG2' ' A' ' 49' ' ' MET . 1.9 mt -66.52 -37.73 85.65 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.076 -1.015 . . . . 0.0 109.045 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -40.69 64.84 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.518 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 4.6 t -65.53 -43.6 94.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.073 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -58.06 -26.14 62.12 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.115 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.5 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 10.2 m-85 -86.29 -34.73 20.27 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.72 -25.39 64.73 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.915 0.864 . . . . 0.0 108.736 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.682 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -154.58 66.76 5.28 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -177.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.568 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.7 Cg_endo -75.1 53.99 3.55 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.767 2.311 . . . . 0.0 112.338 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 76' ' ' ALA . 14.6 t -153.23 170.03 21.58 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.591 -1.318 . . . . 0.0 111.238 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.684 HD11 ' CG ' ' A' ' 23' ' ' TRP . 9.4 mm -60.25 -71.69 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.869 -0.519 . . . . 0.0 111.776 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -50.22 -54.04 23.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.057 -1.027 . . . . 0.0 110.362 -178.049 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -53.45 -67.93 0.22 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.664 ' HB3' HD21 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -53.27 -59.32 4.72 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.479 -0.889 . . . . 0.0 109.323 -179.276 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.69 ' HB1' ' HG3' ' A' ' 16' ' ' GLU . . . -45.78 -44.68 14.17 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -61.71 -42.42 98.92 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.056 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.04 -33.82 65.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 108.856 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.869 HG13 HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -86.98 -60.98 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.481 1.134 . . . . 0.0 108.898 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.868 ' HB2' ' CB ' ' A' ' 15' ' ' VAL . . . -53.61 -41.24 66.46 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.688 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.478 ' HB ' ' OE1' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 120.927 -1.108 . . . . 0.0 109.598 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.593 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.963 0.411 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.134 HG21 ' HB2' ' A' ' 82' ' ' ALA . 57.5 t -51.62 -51.68 25.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.501 ' OE1' ' CD1' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -70.45 -27.92 64.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.125 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.593 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 49.5 m -53.4 -51.68 61.81 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.799 -1.161 . . . . 0.0 108.166 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.606 ' O ' HG23 ' A' ' 22' ' ' ILE . 5.7 tptm -66.53 -62.74 1.3 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.361 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.488 ' CA ' HG23 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -39.93 -49.72 2.46 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -51.23 -51.48 53.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' LYS . 4.0 mt-10 -58.64 -62.79 1.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.97 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -42.89 -46.36 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.068 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.644 ' CE2' HG12 ' A' ' 74' ' ' ILE . 4.1 m95 -54.93 -70.77 0.09 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 121.702 0.763 . . . . 0.0 110.194 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.615 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -57.83 -47.33 82.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 110.272 -178.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.449 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 14.2 ttm180 -62.41 -65.18 0.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.015 -1.053 . . . . 0.0 110.302 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' ' 50' ' ' ALA . 29.5 t -61.76 -36.13 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.372 -0.83 . . . . 0.0 111.007 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 42.2 mt -84.54 -35.78 22.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.974 -1.079 . . . . 0.0 110.01 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 92.59 56.55 1.53 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.208 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.53 172.49 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -1.203 . . . . 0.0 109.159 179.507 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.2 t -131.8 39.23 3.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.198 -0.939 . . . . 0.0 109.174 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -157.36 -89.0 0.07 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 24' ' ' GLU . 10.8 mt 59.07 141.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -1.158 . . . . 0.0 109.804 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.769 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -101.77 -147.26 19.71 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.501 ' CD1' ' OE1' ' A' ' 16' ' ' GLU . 20.2 tt -113.1 9.58 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.116 -1.226 . . . . 0.0 110.285 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.004 HD23 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -163.01 60.28 0.19 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.778 -1.202 . . . . 0.0 110.029 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 4.1 m-20 -92.76 148.86 21.69 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -83.4 52.27 2.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.687 -1.258 . . . . 0.0 109.272 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.635 ' CE2' ' HA ' ' A' ' 72' ' ' PRO . 22.6 m-85 . . . . . 0 N--CA 1.502 2.138 0 O-C-N 121.63 -0.669 . . . . 0.0 110.322 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -51.24 -54.75 22.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.761 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -55.44 -60.35 3.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 109.826 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.834 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -52.49 -44.57 65.72 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.797 -1.189 . . . . 0.0 108.73 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.947 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.38 -45.72 55.55 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.676 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -51.83 -56.04 16.36 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.97 ' CG1' HD11 ' A' ' 22' ' ' ILE . 34.2 t -43.82 -66.19 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.034 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.23 -44.27 32.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 108.721 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -58.96 -47.3 85.58 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.577 ' HG2' ' HB ' ' A' ' 22' ' ' ILE . 11.5 tp60 -47.56 -33.24 6.24 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.593 HG21 ' HG ' ' A' ' 63' ' ' LEU . 15.0 t -67.53 -37.52 78.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 53' ' ' ALA . 36.5 t60 -77.48 -42.14 36.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.163 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -39.19 78.92 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.616 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 8.2 tp10 -74.53 -48.79 24.93 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.779 ' CD2' HG11 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -125.13 159.01 32.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 179.041 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -94.55 37.54 1.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.911 HG11 ' CG1' ' A' ' 81' ' ' VAL . 7.3 p -94.51 159.31 2.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.305 0.574 . . . . 0.0 109.834 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.458 ' N ' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -75.34 119.09 18.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 0.0 109.662 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -143.21 74.11 17.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.93 . . . . 0.0 108.8 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.2 Cg_endo -79.82 165.47 22.19 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.778 2.318 . . . . 0.0 110.267 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.947 HD21 ' SD ' ' A' ' 49' ' ' MET . 7.5 mt -65.18 -39.3 92.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.055 -1.028 . . . . 0.0 109.115 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -51.61 -45.34 63.19 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 2.7 t -61.59 -45.46 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.034 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -57.49 -28.9 63.83 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.321 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.441 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 49.4 m-85 -79.19 -42.91 24.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.013 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.45 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.64 -34.9 79.29 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.907 0.86 . . . . 0.0 109.153 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.45 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -144.02 71.46 16.66 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.635 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 33.7 Cg_endo -77.09 56.01 5.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.829 2.353 . . . . 0.0 111.959 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 1.004 HG21 HD23 ' A' ' 35' ' ' LEU . 4.8 t -152.26 178.82 9.1 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 117.664 -1.614 . . . . 0.0 113.094 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.769 HD12 ' O ' ' A' ' 33' ' ' GLY . 1.4 mt -69.97 -78.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.514 -178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.495 ' HB2' HG12 ' A' ' 34' ' ' ILE . 5.2 tttm -41.05 -54.86 2.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.503 -0.748 . . . . 0.0 109.388 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.722 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -52.65 -63.05 1.27 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.612 -0.835 . . . . 0.0 108.826 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.574 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -48.81 -63.64 1.03 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.448 -1.407 . . . . 0.0 108.245 178.765 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.688 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -43.18 -31.66 0.62 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.6 OUTLIER -79.18 -46.46 17.87 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -55.4 -33.14 63.25 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.911 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -89.02 -68.3 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 122.269 1.033 . . . . 0.0 109.014 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 1.134 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -55.94 -55.3 34.28 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.648 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' GLN . 76.1 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.41 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.63 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.959 HG21 ' HB2' ' A' ' 82' ' ' ALA . 48.4 t -44.72 -54.78 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.689 ' OE1' HD11 ' A' ' 34' ' ' ILE . 2.4 mt-10 -70.88 -30.1 66.38 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 69.8 m -55.94 -49.61 73.05 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.062 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.697 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -70.67 -56.28 6.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.4 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.721 ' HA ' HG23 ' A' ' 22' ' ' ILE . 3.4 mm? -50.14 -43.23 51.91 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -56.54 -49.05 75.93 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -60.67 -62.35 1.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.799 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -45.91 -52.26 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 1.169 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.9 m95 -40.53 -67.26 0.25 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.946 0.879 . . . . 0.0 110.417 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.628 ' HA ' HD11 ' A' ' 32' ' ' ILE . 14.6 pt-20 -63.02 -28.05 69.84 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.494 0.664 . . . . 0.0 109.903 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -73.05 -65.29 0.82 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.543 -0.723 . . . . 0.0 110.501 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.91 HG12 ' HB2' ' A' ' 47' ' ' LYS . 76.8 t -69.68 -30.98 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 110.356 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 21.9 mt -86.88 -20.66 27.12 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.118 -0.989 . . . . 0.0 110.019 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.04 62.4 2.35 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.126 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -138.39 -167.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.284 . . . . 0.0 108.906 179.038 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.01 70.09 1.26 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.186 -0.946 . . . . 0.0 109.301 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 132.0 -73.15 0.47 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.169 HG21 ' CE3' ' A' ' 23' ' ' TRP . 6.1 mt 61.49 133.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.24 -1.153 . . . . 0.0 109.29 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.992 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -52.35 -171.64 0.03 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.689 HD11 ' OE1' ' A' ' 16' ' ' GLU . 6.4 tt -106.2 8.49 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.102 -1.234 . . . . 0.0 109.188 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.823 HD12 ' CG2' ' A' ' 73' ' ' THR . 22.2 tp -157.52 48.98 0.42 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.081 -1.012 . . . . 0.0 109.872 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.642 ' O ' HG23 ' A' ' 73' ' ' THR . 5.9 m-20 -74.04 -166.38 0.39 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.117 -0.989 . . . . 0.0 110.29 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.48 33.35 3.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.453 -0.78 . . . . 0.0 109.122 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 72' ' ' PRO . 5.8 m-30 . . . . . 0 N--CA 1.5 2.053 0 O-C-N 121.875 -0.516 . . . . 0.0 111.245 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -43.09 -59.11 2.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.368 -0.833 . . . . 0.0 109.463 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.91 ' HB2' HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -54.56 -42.82 71.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.053 -1.029 . . . . 0.0 109.115 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.011 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -52.43 -52.88 51.7 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.868 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.95 -41.79 25.85 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.906 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -50.47 -48.52 56.63 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.799 HG13 ' CG1' ' A' ' 22' ' ' ILE . 10.0 t -54.51 -55.57 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.913 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -49.27 -47.92 46.29 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -53.63 -42.63 67.96 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 8.3 tp-100 -56.47 -30.38 62.86 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.945 HG21 HD22 ' A' ' 63' ' ' LEU . 21.2 t -70.63 -43.43 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -0.825 . . . . 0.0 109.208 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 59' ' ' TYR . 12.1 t-80 -77.28 -32.74 55.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.019 . . . . 0.0 109.293 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.409 ' NE ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -80.5 -39.22 28.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 108.956 179.637 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -74.65 -44.78 48.72 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.076 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.771 ' HB2' HG12 ' A' ' 61' ' ' VAL . 1.1 m-85 -122.27 -176.8 3.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.918 . . . . 0.0 109.233 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -114.28 35.2 4.28 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.981 HG11 HG13 ' A' ' 81' ' ' VAL . 3.2 p -93.7 158.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.572 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' N ' HG22 ' A' ' 61' ' ' VAL . 1.7 tt0 -96.65 102.36 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.923 . . . . 0.0 110.453 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.945 HD22 HG21 ' A' ' 55' ' ' VAL . 3.2 tp -115.83 99.89 53.0 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.53 ' HG2' HG23 ' A' ' 67' ' ' VAL . 33.7 Cg_endo -77.15 152.82 31.51 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.378 2.052 . . . . 0.0 111.035 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.868 HD21 ' SD ' ' A' ' 49' ' ' MET . 1.9 mm? -52.74 -41.7 64.24 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' PHE . 1.5 ttmt -53.44 -57.1 11.84 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.53 HG23 ' HG2' ' A' ' 64' ' ' PRO . 4.0 t -50.08 -38.69 15.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.011 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -63.87 -31.11 72.18 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.712 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 66' ' ' LYS . 2.0 m-85 -84.25 -35.07 23.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.4 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.77 -38.59 89.46 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.781 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.2 69.14 27.69 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 31.9 Cg_endo -78.95 69.28 7.97 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.361 2.041 . . . . 0.0 108.001 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.823 ' CG2' HD12 ' A' ' 35' ' ' LEU . 98.5 m -151.83 167.2 29.04 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.013 -1.475 . . . . 0.0 111.633 -177.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.992 HD12 ' O ' ' A' ' 33' ' ' GLY . 5.5 mt -67.41 -77.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.352 -0.842 . . . . 0.0 110.99 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.8 ' HB3' HD13 ' A' ' 35' ' ' LEU . 16.7 ttpp -45.91 -46.6 16.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.333 -0.854 . . . . 0.0 109.517 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -58.73 -68.54 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.96 . . . . 0.0 109.75 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.781 HD23 ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -44.55 -59.21 2.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.772 -1.205 . . . . 0.0 108.522 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.753 ' HB1' HG12 ' A' ' 15' ' ' VAL . . . -47.26 -32.91 5.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -77.84 -44.17 28.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 0.0 109.042 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.401 ' CD2' ' NE2' ' A' ' 71' ' ' GLN . 3.3 t80 -64.83 -29.29 70.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.312 -0.868 . . . . 0.0 108.974 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.981 HG13 HG11 ' A' ' 61' ' ' VAL . 21.3 t -86.68 -59.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.332 1.063 . . . . 0.0 109.309 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.959 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -58.28 -26.67 63.26 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.458 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.056 -1.028 . . . . 0.0 109.661 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.624 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.71 0.29 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.074 HG12 ' HB1' ' A' ' 78' ' ' ALA . 40.2 t -65.29 -55.97 17.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 78' ' ' ALA . 42.1 mt-10 -77.59 -32.01 53.35 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.624 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -63.02 -42.89 99.92 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.837 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.621 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -66.32 -63.71 1.02 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.552 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 19' ' ' LEU . 5.5 mp -45.76 -45.07 14.36 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -47.54 -51.78 19.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.791 -1.193 . . . . 0.0 108.347 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.458 ' OE1' ' NH1' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -61.43 -62.08 2.08 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.974 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -43.46 -43.44 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-O 122.27 1.033 . . . . 0.0 108.331 178.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.795 ' CE3' HG21 ' A' ' 32' ' ' ILE . 3.7 m95 -53.19 -67.88 0.22 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.987 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.438 ' HA ' HG23 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -64.31 -35.14 79.89 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.378 -0.826 . . . . 0.0 110.288 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' NH1' ' OE1' ' A' ' 21' ' ' GLU . 27.1 ttm180 -68.83 -58.64 3.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.489 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.667 HG11 ' HB3' ' A' ' 50' ' ' ALA . 65.7 t -74.19 -37.24 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 0.0 110.823 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.46 ' CG ' ' O ' ' A' ' 23' ' ' TRP . 36.9 mt -77.22 -51.99 9.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.902 -1.124 . . . . 0.0 109.946 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.2 53.22 0.28 Allowed Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.184 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.653 ' CG2' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -137.42 -171.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -1.185 . . . . 0.0 108.716 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.81 39.87 0.96 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.3 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -161.06 -80.58 0.04 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.795 HG21 ' CE3' ' A' ' 23' ' ' TRP . 6.9 mt 40.83 94.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.52 -0.988 . . . . 0.0 109.932 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.864 ' C ' HD12 ' A' ' 34' ' ' ILE . . . -59.22 -88.49 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.864 HD12 ' C ' ' A' ' 33' ' ' GLY . 5.0 mp -151.1 -58.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.994 -1.298 . . . . 0.0 110.599 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -87.25 34.93 0.69 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.16 -1.588 . . . . 0.0 109.501 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -63.34 166.97 5.74 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.438 0.637 . . . . 0.0 109.634 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.6 m120 -106.52 116.79 32.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.213 -0.93 . . . . 0.0 108.525 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.729 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 46.6 m-85 . . . . . 0 N--CA 1.501 2.105 0 O-C-N 121.284 -0.885 . . . . 0.0 109.793 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 46' ' ' LEU . 2.9 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.546 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -42.52 -51.07 5.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.653 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -51.99 -61.96 1.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 109.77 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.002 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.34 -51.26 35.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.082 -1.011 . . . . 0.0 109.414 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.914 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -46.45 -47.05 19.19 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.269 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.667 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -50.86 -54.57 22.7 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.974 ' CG1' HD11 ' A' ' 22' ' ' ILE . 38.2 t -44.65 -59.13 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.962 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -51.76 -46.62 64.17 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -53.44 -49.62 66.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.612 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.9 tp-100 -45.6 -39.9 8.21 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.836 HG11 HD12 ' A' ' 63' ' ' LEU . 2.6 t -66.36 -34.45 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.55 0.69 . . . . 0.0 109.471 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 53' ' ' ALA . 13.4 t-160 -82.13 -32.68 29.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.879 -1.138 . . . . 0.0 109.825 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -76.68 -37.01 56.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.982 -1.074 . . . . 0.0 108.566 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.501 ' HG3' ' HE2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -76.65 -51.23 11.92 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.32 -0.863 . . . . 0.0 108.859 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.613 ' HB2' HG12 ' A' ' 61' ' ' VAL . 2.0 m-85 -112.33 179.02 4.11 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.762 0.791 . . . . 0.0 109.439 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -109.85 40.51 1.89 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.028 HG11 HG13 ' A' ' 81' ' ' VAL . 4.3 p -92.9 127.06 45.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.763 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -71.19 97.09 1.47 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.722 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.836 HD12 HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -112.36 102.12 53.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.508 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.497 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 36.4 Cg_endo -79.64 160.47 25.05 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.428 2.085 . . . . 0.0 110.688 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.914 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.2 mm? -61.69 -45.45 93.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.274 -0.891 . . . . 0.0 108.943 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HE3' ' HB2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -52.02 -44.21 64.07 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.097 -1.002 . . . . 0.0 108.827 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.503 ' CG1' ' CD2' ' A' ' 63' ' ' LEU . 2.0 t -56.09 -42.99 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.002 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -60.29 -24.9 65.32 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.482 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 14.1 m-85 -87.31 -38.87 15.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.359 -0.838 . . . . 0.0 108.904 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.85 -31.74 72.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.516 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -144.59 70.34 15.42 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.758 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.576 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 33.2 Cg_endo -76.91 53.06 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.791 2.327 . . . . 0.0 111.887 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.642 ' HA ' ' CZ2' ' A' ' 23' ' ' TRP . 6.2 t -152.24 167.62 28.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.699 -1.251 . . . . 0.0 110.769 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.632 HD11 HG22 ' A' ' 32' ' ' ILE . 14.0 mt -68.68 -60.58 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.961 -1.087 . . . . 0.0 110.014 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.739 ' CB ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -42.13 -58.03 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.517 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -64.88 -66.81 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 110.245 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.792 HD11 HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -47.77 -64.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.017 . . . . 0.0 109.309 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 1.074 ' HB1' HG12 ' A' ' 15' ' ' VAL . . . -43.69 -45.28 6.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 3.4 tp60 -62.17 -39.67 93.44 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.487 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -57.56 -34.19 68.92 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.929 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.028 HG13 HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -84.47 -69.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.856 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -43.46 -36.04 1.84 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.256 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.47 ' HB ' ' NE2' ' A' ' 79' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.025 -1.047 . . . . 0.0 109.686 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.639 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.94 HG11 ' HB2' ' A' ' 82' ' ' ALA . 30.9 t -51.58 -54.02 14.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -70.85 -27.34 63.77 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.639 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 68.3 m -58.21 -50.39 73.71 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.916 -1.114 . . . . 0.0 108.514 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HE3' ' OE2' ' A' ' 58' ' ' GLU . 4.0 tptt -64.26 -51.36 63.96 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.647 -0.658 . . . . 0.0 109.654 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.871 ' HA ' HG22 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -60.89 -49.06 79.01 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.571 -1.252 . . . . 0.0 108.344 179.717 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -47.31 -42.41 21.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.339 -1.476 . . . . 0.0 107.498 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.48 -63.01 1.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.928 HG23 HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.94 -38.94 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.881 -1.137 . . . . 0.0 108.243 179.354 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.799 ' HB3' HD13 ' A' ' 32' ' ' ILE . 3.0 m95 -49.15 -66.96 0.31 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.884 0.849 . . . . 0.0 109.129 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.625 ' HA ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -53.86 -47.25 71.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.827 -0.545 . . . . 0.0 110.459 -178.743 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -60.06 -68.53 0.28 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.039 -1.038 . . . . 0.0 110.629 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.062 HG11 ' HB3' ' A' ' 50' ' ' ALA . 47.5 t -61.93 -34.67 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 110.979 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' CD1' ' CE3' ' A' ' 23' ' ' TRP . 64.7 mt -83.14 -43.67 15.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.802 -1.186 . . . . 0.0 109.991 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 106.45 49.63 0.91 Allowed Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.789 -1.196 . . . . 0.0 110.685 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.625 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.59 176.57 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.983 -1.304 . . . . 0.0 109.22 179.378 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 t -132.68 35.48 3.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 108.549 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -149.83 -98.39 0.19 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.002 HG22 HD11 ' A' ' 74' ' ' ILE . 1.3 mt 53.6 104.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.054 -1.262 . . . . 0.0 108.434 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.2 -88.12 1.95 Allowed Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.571 -1.3 . . . . 0.0 111.535 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.575 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 1.7 mt -142.36 111.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.053 -1.263 . . . . 0.0 109.531 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.818 ' C ' HG22 ' A' ' 73' ' ' THR . 0.3 OUTLIER 88.62 46.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.734 0.778 . . . . 0.0 109.737 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.684 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -83.97 -148.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -128.26 114.3 16.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.542 -1.349 . . . . 0.0 110.8 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.772 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 66.6 m-85 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 120.973 -1.079 . . . . 0.0 108.436 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.501 ' N ' HD22 ' A' ' 46' ' ' LEU . 3.2 mm? -52.39 -31.29 33.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.038 -1.038 . . . . 0.0 109.07 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.1 tptt -64.91 -71.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.025 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -46.99 -48.47 21.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.897 -1.127 . . . . 0.0 108.245 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.933 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.55 -45.23 37.36 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.425 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.062 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -49.67 -47.99 49.77 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.928 HG13 HG23 ' A' ' 22' ' ' ILE . 7.1 t -58.34 -55.81 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.865 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.65 -53.38 18.82 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.99 -43.72 50.59 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.588 ' CG ' HG13 ' A' ' 22' ' ' ILE . 45.5 tp60 -52.51 -34.96 51.97 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.84 HG21 HD22 ' A' ' 63' ' ' LEU . 18.9 t -65.66 -49.27 78.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.567 -0.708 . . . . 0.0 109.759 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' TYR . 18.7 t60 -68.42 -33.61 74.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.969 -1.082 . . . . 0.0 109.589 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.12 -37.08 34.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.964 -1.085 . . . . 0.0 108.441 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.502 ' HG2' ' HG3' ' A' ' 54' ' ' GLN . 58.6 mm-40 -70.48 -44.38 67.81 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.889 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -136.04 175.93 9.15 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.33 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.46 40.95 1.18 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 59' ' ' TYR . 7.9 t -93.03 125.93 45.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 19.9 tt0 -68.89 92.04 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 0.0 109.292 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.84 HD22 HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -112.31 95.64 31.87 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 35.4 Cg_endo -78.57 169.73 19.38 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.354 2.036 . . . . 0.0 110.553 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.933 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.5 mm? -66.91 -37.17 83.86 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -56.13 -55.82 28.36 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.499 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 4.4 t -48.45 -46.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.025 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -58.49 -38.08 76.9 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.729 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.488 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 8.1 m-85 -74.84 -36.56 62.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 109.291 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.408 ' C ' ' HD3' ' A' ' 72' ' ' PRO . . . -66.88 -38.77 86.93 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.324 -0.86 . . . . 0.0 109.217 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -139.23 66.06 36.83 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -178.547 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.536 ' CA ' ' O ' ' A' ' 68' ' ' LEU . 33.3 Cg_endo -77.19 61.31 7.23 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.973 2.448 . . . . 0.0 112.462 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.818 HG22 ' C ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -152.13 150.09 29.51 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.881 -1.137 . . . . 0.0 110.657 178.478 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.002 HD11 HG22 ' A' ' 32' ' ' ILE . 9.4 mt -53.73 -54.04 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.854 -1.154 . . . . 0.0 109.669 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -51.26 -65.68 0.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.97 -1.081 . . . . 0.0 109.17 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.71 -63.45 1.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 0.0 109.661 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.732 HD21 HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -45.54 -67.04 0.32 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.541 -0.724 . . . . 0.0 109.128 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 74' ' ' ILE . . . -45.69 -49.84 14.16 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -56.7 -40.02 74.88 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.222 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -56.31 -37.75 70.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 108.573 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.705 HG11 ' CD1' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -86.73 -63.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.619 1.199 . . . . 0.0 108.981 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.94 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -49.7 -20.77 0.88 Allowed 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.209 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.47 ' CB ' ' OE1' ' A' ' 79' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.449 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.609 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.952 0.406 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.879 HG11 ' HB2' ' A' ' 82' ' ' ALA . 56.8 t -49.74 -52.48 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 178.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.653 ' OE1' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -72.72 -22.48 60.88 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.079 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.609 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 60.5 m -58.64 -48.21 81.78 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.226 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.746 ' O ' HG22 ' A' ' 22' ' ' ILE . 7.8 tptt -68.85 -51.89 35.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.304 -0.872 . . . . 0.0 108.723 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.754 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 3.4 mm? -54.99 -36.86 65.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.653 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . . . -56.79 -48.3 78.23 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 23.7 mt-10 -64.25 -63.09 1.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.174 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.754 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -47.86 -45.94 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.836 -1.165 . . . . 0.0 108.405 179.58 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.746 ' HB3' HD13 ' A' ' 32' ' ' ILE . 2.9 m95 -49.34 -68.44 0.18 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.449 0.642 . . . . 0.0 110.228 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.675 ' HA ' HD11 ' A' ' 32' ' ' ILE . 8.8 pt-20 -61.04 -31.5 71.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 110.218 -178.545 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -68.56 -68.32 0.4 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 110.333 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.91 HG11 ' HB3' ' A' ' 50' ' ' ALA . 77.6 t -67.99 -33.38 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 -178.763 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 37.2 mt -82.13 0.08 42.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.951 -1.093 . . . . 0.0 110.033 -179.182 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.79 56.9 22.61 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -136.84 -174.47 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -1.189 . . . . 0.0 109.161 179.518 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 t -153.02 60.35 0.78 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.272 -0.893 . . . . 0.0 109.322 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 165.43 -76.65 0.14 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.141 -1.983 . . . . 0.0 108.141 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.746 HD13 ' HB3' ' A' ' 23' ' ' TRP . 6.8 mt 58.37 151.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.426 -1.044 . . . . 0.0 109.952 178.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.97 -164.26 37.66 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.557 ' HA ' HG21 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -100.94 -2.02 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.381 -1.07 . . . . 0.0 110.326 -179.727 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.611 HD12 ' HB2' ' A' ' 75' ' ' LYS . 1.6 tp -156.19 53.28 0.56 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.826 -1.171 . . . . 0.0 109.94 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.573 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.5 OUTLIER -71.45 -154.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.776 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -138.14 35.06 2.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.03 -1.044 . . . . 0.0 108.601 178.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.706 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 12.5 m-85 . . . . . 0 N--CA 1.509 2.497 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.3 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 46' ' ' LEU . 81.0 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.447 ' HA ' HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -48.24 -36.7 14.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 109.387 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -60.5 -63.58 1.25 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.883 . . . . 0.0 109.515 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.077 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.82 -47.02 51.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.89 -1.131 . . . . 0.0 108.214 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.943 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.43 -42.28 42.33 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.323 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.91 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -51.04 -49.0 61.37 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.214 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.733 HG13 ' CG1' ' A' ' 22' ' ' ILE . 15.6 t -56.23 -54.33 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.554 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.824 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.17 -44.27 32.33 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.646 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -56.81 -44.84 82.36 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 62.7 tp60 -47.71 -39.96 18.95 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.022 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.853 HG21 HD22 ' A' ' 63' ' ' LEU . 3.1 t -64.79 -32.2 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.328 0.585 . . . . 0.0 109.661 179.253 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 53' ' ' ALA . 7.6 t60 -82.16 -33.23 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.928 -1.108 . . . . 0.0 109.02 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -39.86 35.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.055 -1.028 . . . . 0.0 108.581 179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 1.1 mm-40 -75.92 -42.76 47.92 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.917 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -126.33 169.27 13.1 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.782 0.801 . . . . 0.0 109.771 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -103.23 33.21 3.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.698 -1.594 . . . . 0.0 106.698 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.918 HG11 HG13 ' A' ' 81' ' ' VAL . 6.2 p -93.35 121.5 44.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -68.82 99.26 1.01 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 110.297 -178.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.853 HD22 HG21 ' A' ' 55' ' ' VAL . 9.1 tp -100.9 110.17 60.17 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.563 ' HG2' ' CG2' ' A' ' 67' ' ' VAL . 35.1 Cg_endo -78.78 154.77 26.75 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.29 1.993 . . . . 0.0 110.719 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.943 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.4 mm? -63.67 -42.03 98.1 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -56.72 -32.56 65.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.288 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.563 ' CG2' ' HG2' ' A' ' 64' ' ' PRO . 2.2 t -71.42 -36.2 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.371 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.077 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -66.85 -25.23 66.32 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.271 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.458 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 m-85 -87.54 -35.9 17.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 108.989 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.41 ' C ' ' HD3' ' A' ' 72' ' ' PRO . . . -67.98 -37.36 81.41 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.07 0.938 . . . . 0.0 108.543 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.56 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -138.09 68.45 48.85 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -178.989 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 34.5 Cg_endo -78.24 52.93 4.29 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 123.306 2.671 . . . . 0.0 113.105 -177.249 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.573 ' HB ' ' O ' ' A' ' 36' ' ' ASP . 15.2 t -154.65 169.37 24.05 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 116.729 -1.988 . . . . 0.0 114.042 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.557 ' N ' ' CZ2' ' A' ' 23' ' ' TRP . 9.3 mm -51.14 -64.63 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.033 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.611 ' HB2' HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -55.08 -72.98 0.06 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.099 -1.001 . . . . 0.0 109.742 -178.451 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.56 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -48.16 -62.37 1.51 Allowed 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.268 -0.895 . . . . 0.0 110.648 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.569 ' CB ' ' O ' ' A' ' 73' ' ' THR . 0.5 OUTLIER -52.29 -64.8 0.7 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.963 -1.086 . . . . 0.0 109.553 -179.442 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.626 ' HB1' HG12 ' A' ' 15' ' ' VAL . . . -46.14 -43.11 14.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.064 -1.022 . . . . 0.0 109.16 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 25.2 mm-40 -65.99 -52.16 51.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.315 -0.865 . . . . 0.0 108.842 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.558 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 18.8 t80 -43.07 -41.83 3.71 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.918 HG13 HG11 ' A' ' 61' ' ' VAL . 18.4 t -74.59 -59.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.316 1.055 . . . . 0.0 108.991 179.241 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.879 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -58.77 -73.27 0.08 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.282 -179.058 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.468 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.623 ' HB2' ' HA2' ' A' ' 33' ' ' GLY . 53.2 t80 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.052 0.453 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.672 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 29.3 m -103.67 6.53 10.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.023 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 165.67 148.85 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.905 0 O-C-N 121.581 -0.699 . . . . 0.0 109.892 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 35.8 Cg_endo -81.23 -171.68 1.3 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.596 2.197 . . . . 0.0 109.117 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.457 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -115.45 -12.11 11.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.895 -1.128 . . . . 0.0 109.789 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 12' ' ' THR . 8.7 m120 -156.19 151.12 26.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.542 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -62.26 -15.19 45.65 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.353 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.063 HG21 ' HB2' ' A' ' 82' ' ' ALA . 2.1 t -65.76 -46.74 88.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HG2' ' HB3' ' A' ' 78' ' ' ALA . 7.5 mt-10 -70.98 -25.05 62.53 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.542 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 28.2 m -59.11 -48.93 79.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.689 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -68.37 -57.29 6.12 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.397 -0.814 . . . . 0.0 109.034 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.708 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -54.55 -19.26 5.56 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.276 -0.97 . . . . 0.0 108.956 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -74.79 -51.4 14.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.527 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 2.9 mt-10 -58.24 -63.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.826 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -43.55 -54.73 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.149 -0.969 . . . . 0.0 108.88 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.758 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.8 m95 -42.68 -57.54 2.68 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.58 -0.7 . . . . 0.0 110.924 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.724 ' HA ' HD11 ' A' ' 32' ' ' ILE . 6.8 pt-20 -65.83 -30.86 71.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.943 -1.098 . . . . 0.0 111.167 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.447 ' N ' ' HG3' ' A' ' 24' ' ' GLU . 17.8 ttm180 -75.15 -71.38 0.36 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.846 -1.159 . . . . 0.0 109.865 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.033 HG11 ' HB3' ' A' ' 50' ' ' ALA . 69.0 t -55.09 -34.5 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.536 -0.727 . . . . 0.0 110.555 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.512 ' HB2' HG23 ' A' ' 29' ' ' VAL . 39.2 mt -86.08 -17.63 34.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.894 -1.129 . . . . 0.0 109.883 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.94 27.61 60.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -102.96 -176.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -1.216 . . . . 0.0 108.886 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 t -142.3 83.24 1.82 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.131 -0.98 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 130.41 -74.87 0.43 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.868 ' CG2' HD11 ' A' ' 74' ' ' ILE . 3.8 mt 58.35 152.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -1.174 . . . . 0.0 109.781 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.933 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -96.61 -133.19 7.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.941 HG22 ' HB2' ' A' ' 75' ' ' LYS . 9.9 mt -120.42 -67.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.863 -1.375 . . . . 0.0 110.159 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.75 ' O ' HD23 ' A' ' 35' ' ' LEU . 2.4 tt -85.12 35.64 0.59 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.74 -1.225 . . . . 0.0 109.657 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.496 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -59.07 -166.47 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 109.588 178.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.534 ' CB ' ' HG2' ' A' ' 40' ' ' GLN . 1.1 m-20 -134.17 115.81 14.64 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.727 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 72.1 m-85 -41.54 -23.1 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.12 -0.988 . . . . 0.0 110.904 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.482 ' N ' ' O ' ' A' ' 37' ' ' ASN . 5.0 t80 -108.33 44.0 1.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.551 -1.343 . . . . 0.0 109.061 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.534 ' HG2' ' CB ' ' A' ' 37' ' ' ASN . 13.1 mm-40 -86.62 -14.29 43.16 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.5 tt 168.89 64.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.13 -120.08 1.83 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 44' ' ' HIS . . . 176.7 133.99 1.9 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 10.7 m170 61.56 -178.18 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -1.228 . . . . 0.0 109.026 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.99 -8.37 11.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.125 -0.985 . . . . 0.0 109.482 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.441 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -53.61 -23.92 12.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 109.498 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 26' ' ' VAL . 1.7 mptt -71.33 -68.32 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.038 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -46.9 -44.69 19.94 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.965 -1.085 . . . . 0.0 108.362 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.849 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.24 -53.88 31.09 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.399 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.033 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -43.65 -42.31 5.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.826 HG13 ' CG1' ' A' ' 22' ' ' ILE . 17.1 t -59.56 -48.31 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.961 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -58.08 -31.9 67.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.029 -1.045 . . . . 0.0 108.43 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.04 70.89 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.562 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 6.8 tp-100 -63.07 -31.21 72.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.61 HG21 HD22 ' A' ' 63' ' ' LEU . 2.6 t -75.9 -28.8 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' TYR . 39.4 t-80 -77.72 -33.63 52.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.204 -0.935 . . . . 0.0 110.047 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -80.92 -46.5 15.1 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.493 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -62.97 -36.33 83.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.677 ' CD2' HG11 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -141.71 156.6 45.61 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.586 0.708 . . . . 0.0 109.434 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -95.29 43.94 1.09 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.011 HG11 ' CG1' ' A' ' 81' ' ' VAL . 4.8 p -91.91 149.12 4.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.422 0.63 . . . . 0.0 110.014 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -80.73 97.32 7.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 110.384 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.78 HD21 ' CD1' ' A' ' 77' ' ' LEU . 1.1 tp -126.7 86.22 59.02 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 35.6 Cg_endo -77.47 175.67 11.0 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.696 2.264 . . . . 0.0 110.983 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.849 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.5 mm? -67.56 -41.87 83.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.435 -0.79 . . . . 0.0 109.299 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.44 -29.14 65.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.07 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.531 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 3.7 t -76.84 -34.05 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.038 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -69.88 -21.2 63.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.426 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -87.4 -34.63 18.7 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.488 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -72.85 -28.31 62.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.993 0.902 . . . . 0.0 108.735 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.595 ' CB ' ' HB1' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -146.13 65.66 10.87 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.157 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.572 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.7 Cg_endo -77.38 60.74 7.15 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.903 2.402 . . . . 0.0 112.674 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.666 HG23 ' H ' ' A' ' 76' ' ' ALA . 6.3 t -154.03 176.04 12.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.512 -1.368 . . . . 0.0 111.164 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.933 HD12 ' O ' ' A' ' 33' ' ' GLY . 9.6 mt -74.28 -42.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.268 -0.895 . . . . 0.0 111.606 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.941 ' HB2' HG22 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -70.39 -45.24 66.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.583 -1.323 . . . . 0.0 108.666 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.666 ' H ' HG23 ' A' ' 73' ' ' THR . . . -66.27 -35.01 79.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.647 -0.658 . . . . 0.0 109.945 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.78 ' CD1' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -73.04 -62.03 1.61 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.9 -1.125 . . . . 0.0 108.589 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.707 ' HB1' ' HB ' ' A' ' 15' ' ' VAL . . . -51.15 -28.04 10.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 2.0 tp60 -81.15 -34.47 32.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.8 -1.187 . . . . 0.0 108.564 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.689 ' CD2' HD12 ' A' ' 63' ' ' LEU . 11.5 t80 -61.89 -33.16 73.7 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.011 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -88.94 -73.65 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 122.44 1.114 . . . . 0.0 108.198 178.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 1.063 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -39.0 -27.05 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.156 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 81' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.059 -1.025 . . . . 0.0 109.523 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 76.6 t80 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.5 m -119.94 51.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.173 -0.954 . . . . 0.0 110.015 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -179.09 141.53 0.37 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.136 -0.978 . . . . 0.0 109.895 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 36.3 Cg_endo -82.92 -158.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.862 2.375 . . . . 0.0 110.345 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.88 -43.81 1.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.139 -0.976 . . . . 0.0 109.867 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -133.84 169.21 17.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.9 -1.125 . . . . 0.0 108.382 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.633 ' HA ' ' HB2' ' A' ' 17' ' ' SER . . . -73.21 -33.6 65.46 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.699 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.024 HG21 ' CB ' ' A' ' 82' ' ' ALA . 28.1 t -54.55 -49.62 65.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.662 ' OE2' HD12 ' A' ' 34' ' ' ILE . 3.9 tt0 -69.68 -26.84 64.57 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.633 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 32.7 t -53.66 -52.29 60.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.947 -1.096 . . . . 0.0 108.796 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.684 ' O ' HG22 ' A' ' 22' ' ' ILE . 1.3 tppm? -65.68 -53.07 46.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 109.251 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HA ' HG23 ' A' ' 22' ' ' ILE . 3.5 mp -57.67 -31.62 66.51 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.653 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 16' ' ' GLU . . . -59.84 -51.67 68.73 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -59.52 -64.74 0.84 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.811 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -44.49 -53.6 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.774 ' HE3' HG21 ' A' ' 32' ' ' ILE . 3.6 m95 -43.52 -61.93 1.23 Allowed 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.469 0.652 . . . . 0.0 110.523 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.772 ' CA ' HD11 ' A' ' 32' ' ' ILE . 3.5 pt-20 -64.01 -36.42 83.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.363 -0.836 . . . . 0.0 110.664 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -68.66 -63.34 1.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.314 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.029 HG11 ' HB3' ' A' ' 50' ' ' ALA . 61.3 t -68.52 -34.49 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 111.12 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.526 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 40.7 mt -83.84 4.75 27.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.867 -1.146 . . . . 0.0 109.939 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.21 51.77 48.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.645 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -129.09 171.76 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -1.161 . . . . 0.0 109.249 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.1 t -139.51 70.63 1.37 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.103 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.6 68.94 0.31 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.774 HG21 ' HE3' ' A' ' 23' ' ' TRP . 2.9 mp -85.87 146.17 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -1.093 . . . . 0.0 109.615 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.822 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -66.88 -135.16 0.04 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.662 HD12 ' OE2' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -123.73 -54.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.013 -1.286 . . . . 0.0 109.973 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.913 HD23 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -96.6 44.46 1.06 Allowed 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.275 -1.516 . . . . 0.0 108.17 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.81 114.9 12.62 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 40' ' ' GLN . 1.7 t30 -62.75 113.51 3.07 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.385 -1.447 . . . . 0.0 108.649 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.721 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 90.7 m-85 -38.94 -38.1 0.41 Allowed 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.119 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -90.23 33.97 0.88 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.44 -0.787 . . . . 0.0 109.833 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.555 ' O ' HD12 ' A' ' 41' ' ' ILE . 7.2 mt-30 -80.89 63.21 5.19 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.555 HD12 ' O ' ' A' ' 40' ' ' GLN . 2.2 mt 80.54 43.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.72 -131.59 1.08 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.87 -38.81 0.02 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -135.88 174.49 10.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.324 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.03 -34.61 7.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.11 -0.993 . . . . 0.0 109.444 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 46' ' ' LEU . 6.5 tp -52.08 -38.88 58.69 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.262 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.3 mttp -50.78 -62.79 1.39 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.113 -0.992 . . . . 0.0 108.615 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.992 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -50.29 -44.57 54.03 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.664 ' CG ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.89 -45.7 64.25 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.339 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.029 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -49.09 -42.97 40.66 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.811 HG13 ' CG1' ' A' ' 22' ' ' ILE . 4.6 t -64.07 -64.34 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.97 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -45.35 -40.33 7.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -63.32 -47.01 84.03 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.501 ' HG3' ' OE2' ' A' ' 58' ' ' GLU . 2.2 tp60 -50.32 -28.16 7.41 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.594 HG21 ' HG ' ' A' ' 63' ' ' LEU . 3.8 t -75.49 -62.43 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 59' ' ' TYR . 20.9 t-80 -54.05 -37.91 64.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.03 -1.044 . . . . 0.0 108.773 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 53' ' ' ALA . 4.0 mtt180 -69.37 -38.12 77.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.532 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -75.11 -56.99 4.18 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.341 -0.85 . . . . 0.0 108.903 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.798 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -119.05 176.88 5.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 108.825 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.66 43.68 1.17 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 59' ' ' TYR . 10.5 t -93.79 158.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.418 ' C ' ' HD3' ' A' ' 64' ' ' PRO . 3.0 tt0 -70.8 99.83 1.8 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 109.416 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.935 HD21 HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -134.45 68.44 72.76 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 0.0 109.276 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.635 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.9 Cg_endo -82.05 -168.02 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.959 2.439 . . . . 0.0 109.964 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.664 HD21 ' CG ' ' A' ' 49' ' ' MET . 0.4 OUTLIER -89.26 -37.14 15.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.136 -0.977 . . . . 0.0 109.311 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.547 ' HG3' ' N ' ' A' ' 67' ' ' VAL . 5.7 pttt -56.66 -37.64 71.09 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.955 HG13 ' NE2' ' A' ' 71' ' ' GLN . 58.5 t -69.72 -47.24 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.992 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.82 -35.98 64.51 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.454 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 5.8 m-85 -74.45 -39.27 62.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 108.769 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.99 84.16 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.885 0.85 . . . . 0.0 108.863 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.955 ' NE2' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -135.09 70.87 69.41 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.146 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.58 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 30.4 Cg_endo -75.0 59.85 5.29 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.787 2.325 . . . . 0.0 112.224 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.913 HG21 HD23 ' A' ' 35' ' ' LEU . 1.9 t -153.18 167.53 28.99 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 117.337 -1.745 . . . . 0.0 112.453 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.822 HD12 ' O ' ' A' ' 33' ' ' GLY . 2.4 mt -63.07 -72.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.592 -0.693 . . . . 0.0 111.195 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.528 ' HB2' ' CG1' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -40.08 -57.86 1.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.554 -0.716 . . . . 0.0 109.468 -178.428 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.582 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -57.55 -52.33 65.83 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.379 -0.825 . . . . 0.0 109.527 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.935 HD13 HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -55.1 -65.37 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.706 -1.246 . . . . 0.0 108.708 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.667 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -44.78 -30.89 1.04 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.57 ' HG2' ' N ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -77.94 -43.9 28.49 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 108.633 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.57 ' N ' ' HG2' ' A' ' 79' ' ' GLN . 2.3 t80 -58.8 -32.6 69.49 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.996 -1.065 . . . . 0.0 108.244 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -88.6 -67.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 122.46 1.124 . . . . 0.0 109.16 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 1.024 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -54.13 -48.65 70.58 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.802 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 79' ' ' GLN . 5.6 t . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.871 -1.143 . . . . 0.0 109.765 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.0 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 34' ' ' ILE . 8.0 m -104.36 127.14 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.39 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.815 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -50.52 169.97 0.19 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.835 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.815 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 34.4 Cg_endo -76.86 159.07 34.78 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.843 2.362 . . . . 0.0 110.581 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.45 -0.89 10.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 110.053 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -156.51 152.65 27.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.978 -1.076 . . . . 0.0 108.303 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -62.46 -32.01 72.82 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.847 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.985 HG21 ' CB ' ' A' ' 82' ' ' ALA . 2.4 t -49.12 -44.45 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.632 ' HG2' HG23 ' A' ' 34' ' ' ILE . 4.2 mt-10 -72.65 -35.59 67.8 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 53.9 p -55.56 -48.77 74.23 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.416 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.605 ' O ' HG22 ' A' ' 22' ' ' ILE . 8.6 tptm -68.69 -55.92 9.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.95 -1.094 . . . . 0.0 109.415 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.749 ' HA ' HG23 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -54.71 -31.06 57.54 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.062 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.06 -50.16 67.27 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 31.9 tt0 -59.79 -54.54 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.901 HD11 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -51.43 -54.24 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.872 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.7 m95 -41.19 -60.14 1.32 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.463 0.649 . . . . 0.0 110.334 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.626 ' CA ' HD11 ' A' ' 32' ' ' ILE . 5.1 pt-20 -64.52 -30.86 71.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.95 . . . . 0.0 109.606 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 tpp85 -70.06 -66.19 0.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.507 -0.746 . . . . 0.0 110.039 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.842 HG11 ' HB3' ' A' ' 50' ' ' ALA . 53.6 t -68.41 -34.45 65.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.366 -0.834 . . . . 0.0 111.102 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 24.9 mt -84.18 -8.65 59.01 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.869 -1.144 . . . . 0.0 110.155 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.8 51.7 44.27 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.778 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -122.71 -166.21 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.016 -1.285 . . . . 0.0 108.965 178.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.411 ' H ' HG12 ' A' ' 29' ' ' VAL . 2.0 p -143.62 64.38 1.33 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.156 -1.018 . . . . 0.0 109.863 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 136.89 -72.86 0.45 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.286 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.872 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.8 mp 59.53 147.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -1.154 . . . . 0.0 109.309 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 1.0 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -78.34 -153.41 6.66 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 34' ' ' ILE . 30.0 mm -113.56 15.67 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.035 -1.273 . . . . 0.0 109.626 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.857 ' O ' HD23 ' A' ' 35' ' ' LEU . 7.3 tt -167.65 66.67 0.08 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.598 ' N ' ' HG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -101.55 169.74 8.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.584 0.707 . . . . 0.0 110.103 -179.603 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.572 ' O ' ' N ' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -96.03 104.36 16.3 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.294 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.729 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 63.8 m-85 -26.83 -38.22 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.002 0 O-C-N 121.78 -0.575 . . . . 0.0 112.293 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.571 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 52.6 t80 -88.18 28.57 1.05 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.303 -1.498 . . . . 0.0 110.128 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 37' ' ' ASN . 18.0 mm100 -84.13 78.62 9.73 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 108.504 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 40' ' ' GLN . 1.3 mt 71.62 54.46 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . 129.24 168.74 12.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' SER . . . 103.56 -49.57 0.93 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 26.2 m170 55.53 -86.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -1.137 . . . . 0.0 109.369 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 43' ' ' GLY . 1.4 p -166.55 -61.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 109.34 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 46' ' ' LEU . 14.2 tp -53.59 -44.39 69.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.107 -0.995 . . . . 0.0 108.835 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.648 ' HB3' HG12 ' A' ' 26' ' ' VAL . 6.8 mttm -48.25 -60.3 2.76 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.041 ' HB1' HD11 ' A' ' 68' ' ' LEU . . . -46.99 -48.9 21.57 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.927 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.86 -50.17 27.23 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.842 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -49.24 -43.41 42.75 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.901 HG22 HD11 ' A' ' 22' ' ' ILE . 12.0 t -58.93 -64.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.027 ' HB2' HD23 ' A' ' 68' ' ' LEU . . . -45.58 -39.99 8.27 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.709 ' HB2' ' CE ' ' A' ' 49' ' ' MET . . . -63.83 -45.34 90.0 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.538 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 5.2 tp60 -48.28 -34.4 10.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.792 HG11 HD12 ' A' ' 63' ' ' LEU . 2.5 t -71.24 -31.68 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ALA . 9.3 t60 -81.62 -35.04 30.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.415 -0.803 . . . . 0.0 109.12 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -75.73 -35.32 60.27 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 1.2 mp0 -78.87 -50.98 10.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.669 ' HB2' HG12 ' A' ' 61' ' ' VAL . 2.4 m-85 -113.83 -178.54 3.4 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.895 0.855 . . . . 0.0 109.71 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -112.51 38.4 2.76 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.998 HG11 HG13 ' A' ' 81' ' ' VAL . 5.0 p -93.17 149.28 4.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.378 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -90.15 97.11 11.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.194 -0.941 . . . . 0.0 110.549 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.966 ' CD2' HG11 ' A' ' 67' ' ' VAL . 4.9 mt -113.47 98.95 48.31 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.6 Cg_endo -78.99 164.13 25.21 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.866 2.378 . . . . 0.0 111.238 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.927 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.9 mm? -63.7 -34.85 78.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.535 ' N ' ' HD3' ' A' ' 66' ' ' LYS . 1.1 mmtt -56.08 -60.61 3.24 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.966 HG11 ' CD2' ' A' ' 63' ' ' LEU . 2.7 t -48.32 -52.81 7.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.041 HD11 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -47.1 -33.21 4.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 66' ' ' LYS . 1.7 m-85 -88.28 -36.34 16.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.524 -0.735 . . . . 0.0 109.969 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . -65.13 -32.32 73.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.775 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -140.53 71.85 31.19 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.1 Cg_endo -76.82 60.64 6.8 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.772 2.315 . . . . 0.0 112.052 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.689 HG22 ' HB3' ' A' ' 76' ' ' ALA . 13.5 t -154.66 170.86 20.54 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.569 -1.252 . . . . 0.0 110.816 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.0 HD12 ' O ' ' A' ' 33' ' ' GLY . 3.5 mt -65.71 -74.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.255 -0.903 . . . . 0.0 111.214 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB3' HD12 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -42.6 -58.86 2.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.286 -178.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.689 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -47.61 -61.92 1.69 Allowed 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.173 -0.955 . . . . 0.0 110.04 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.775 HD23 ' O ' ' A' ' 71' ' ' GLN . 0.2 OUTLIER -53.53 -66.94 0.3 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.127 -0.983 . . . . 0.0 109.496 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.553 ' CB ' ' HG3' ' A' ' 16' ' ' GLU . . . -47.01 -35.94 7.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.183 -0.948 . . . . 0.0 108.837 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 78.0 mm-40 -70.19 -40.15 74.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -55.28 -35.46 65.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.998 HG13 HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -87.69 -68.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.411 1.101 . . . . 0.0 108.301 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.985 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -43.93 -50.65 8.05 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.45 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 79' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.534 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.258 0.552 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.8 m -105.25 140.03 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 108.991 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -70.89 152.14 95.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.089 -1.007 . . . . 0.0 109.552 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 34.9 Cg_endo -78.12 -177.32 3.79 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.627 2.218 . . . . 0.0 110.763 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 12' ' ' THR . 0.4 OUTLIER -123.18 -3.25 8.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.866 . . . . 0.0 109.692 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -131.83 129.18 40.11 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.904 -1.123 . . . . 0.0 108.021 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.616 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -50.99 -31.7 18.83 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.54 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.034 ' CG1' ' HB2' ' A' ' 82' ' ' ALA . 40.5 t -46.4 -54.49 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.8 ' OE2' HG22 ' A' ' 34' ' ' ILE . 12.8 mt-10 -68.12 -37.74 81.44 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.616 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.7 m -48.95 -54.0 17.39 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.17 -1.012 . . . . 0.0 108.562 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.675 ' O ' HG23 ' A' ' 22' ' ' ILE . 1.2 tptt -60.05 -69.28 0.22 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.335 -0.853 . . . . 0.0 108.837 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.474 ' HB3' HG23 ' A' ' 74' ' ' ILE . 8.3 mt -38.76 -48.25 1.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.604 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -51.52 -52.4 47.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.766 -1.209 . . . . 0.0 108.216 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.08 -60.31 4.03 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.086 ' CD1' HG13 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -44.27 -47.42 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.751 ' CB ' HG21 ' A' ' 32' ' ' ILE . 3.7 m95 -49.43 -63.05 1.22 Allowed 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.797 -0.564 . . . . 0.0 109.912 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.693 ' HB2' HD12 ' A' ' 32' ' ' ILE . 1.6 tt0 -61.49 -42.37 98.69 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.377 -0.827 . . . . 0.0 110.046 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -65.13 0.73 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 110.779 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.661 HG11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 t -69.82 -32.62 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.393 -0.817 . . . . 0.0 111.717 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 33.8 mt -87.36 -33.46 19.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.681 -1.262 . . . . 0.0 110.249 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.58 58.4 1.74 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.339 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.607 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -130.4 177.1 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.207 -1.173 . . . . 0.0 108.582 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.81 38.22 3.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.027 -1.045 . . . . 0.0 109.764 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -150.24 -96.75 0.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.751 HG21 ' CB ' ' A' ' 23' ' ' TRP . 10.3 mt 52.7 103.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.923 -1.339 . . . . 0.0 109.877 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.687 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -107.86 -77.69 1.05 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' OE2' ' A' ' 16' ' ' GLU . 1.1 pp -166.03 101.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -1.195 . . . . 0.0 109.931 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.63 ' CB ' ' O ' ' A' ' 34' ' ' ILE . 22.4 tp 103.44 35.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.722 0.772 . . . . 0.0 109.237 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.459 ' O ' ' OG1' ' A' ' 73' ' ' THR . 0.7 OUTLIER -83.0 177.87 8.42 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.563 ' CB ' ' HG2' ' A' ' 40' ' ' GLN . 1.7 t30 -109.52 116.94 32.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.723 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 52.4 m-85 -41.54 -24.6 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.273 -0.892 . . . . 0.0 110.315 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 37' ' ' ASN . 19.0 t80 -98.25 27.15 4.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.489 -1.382 . . . . 0.0 109.778 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.754 ' C ' HD12 ' A' ' 41' ' ' ILE . 10.8 mm100 -82.62 76.88 9.45 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.754 HD12 ' C ' ' A' ' 40' ' ' GLN . 5.2 mp 64.12 65.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.137 -0.977 . . . . 0.0 108.518 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . 129.48 156.67 8.9 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.95 135.63 7.37 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.98 -76.76 0.21 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -1.096 . . . . 0.0 109.403 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.09 -71.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.937 . . . . 0.0 109.402 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.545 ' HA ' HD13 ' A' ' 46' ' ' LEU . 4.1 mm? -53.35 -36.34 61.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.107 -0.995 . . . . 0.0 109.013 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.637 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -66.5 -60.5 2.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -0.912 . . . . 0.0 109.042 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.064 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -52.37 -49.71 63.85 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.132 -0.98 . . . . 0.0 108.636 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.854 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.29 -45.61 45.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.82 ' O ' ' HB3' ' A' ' 53' ' ' ALA . . . -49.23 -44.59 43.64 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.086 HG13 ' CD1' ' A' ' 22' ' ' ILE . 18.3 t -60.14 -58.46 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.838 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.58 -26.96 2.48 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -73.24 -43.54 60.99 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.533 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -54.65 -28.49 47.5 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.184 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.623 HG11 ' HG ' ' A' ' 63' ' ' LEU . 2.6 t -73.77 -53.88 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 1.3 t-80 -56.3 -43.04 78.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.123 -0.986 . . . . 0.0 109.103 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -46.3 83.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 109.014 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.566 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -66.07 -50.15 65.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 108.855 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.724 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -129.63 154.58 46.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.451 -0.781 . . . . 0.0 109.009 179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -94.53 40.04 1.09 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.11 HG11 HG13 ' A' ' 81' ' ' VAL . 7.0 p -93.09 162.75 2.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.272 0.558 . . . . 0.0 109.7 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.524 ' N ' HG22 ' A' ' 61' ' ' VAL . 5.1 tt0 -69.39 117.85 11.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.865 . . . . 0.0 110.138 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.908 HD23 HG22 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -142.73 69.46 19.78 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.555 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.4 Cg_endo -80.23 154.66 22.01 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.866 2.378 . . . . 0.0 110.632 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.854 HD21 ' SD ' ' A' ' 49' ' ' MET . 4.4 mt -57.19 -40.68 77.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.782 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -49.91 -44.94 50.44 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.58 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.555 HG23 ' HG2' ' A' ' 64' ' ' PRO . 6.7 t -64.86 -41.98 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.064 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -62.58 -26.39 68.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.472 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 m-85 -87.86 -36.0 17.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.431 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -67.43 -32.0 72.57 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.959 0.885 . . . . 0.0 108.614 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.431 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -147.34 70.06 11.68 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.0 Cg_endo -75.11 60.26 5.47 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.812 2.342 . . . . 0.0 111.305 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.77 ' CG2' ' HB3' ' A' ' 76' ' ' ALA . 5.8 t -153.07 165.62 35.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.712 -1.195 . . . . 0.0 110.828 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.644 HG13 ' CZ2' ' A' ' 23' ' ' TRP . 2.9 mt -66.47 -64.87 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.602 -0.686 . . . . 0.0 110.501 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -49.75 -60.58 2.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.867 -1.145 . . . . 0.0 109.859 -179.157 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.77 ' HB3' ' CG2' ' A' ' 73' ' ' THR . . . -56.74 -67.84 0.27 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.958 -1.089 . . . . 0.0 110.372 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.712 HD11 HD12 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -49.42 -58.45 5.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.808 -1.182 . . . . 0.0 108.763 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' ILE . . . -44.94 -55.98 5.0 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 34.6 mm-40 -50.49 -49.83 54.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 108.844 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -48.3 -45.67 35.21 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.669 0.747 . . . . 0.0 109.302 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.11 HG13 HG11 ' A' ' 61' ' ' VAL . 3.5 t -81.73 -59.43 2.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 122.432 1.11 . . . . 0.0 109.313 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 1.034 ' HB2' ' CG1' ' A' ' 15' ' ' VAL . . . -53.73 -68.09 0.21 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.238 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.414 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.516 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 6.0 t80 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.3 0.571 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.7 HG23 HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -103.95 129.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.22 155.19 1.24 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.929 . . . . 0.0 109.639 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.01 150.77 34.36 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.65 2.234 . . . . 0.0 110.692 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.666 ' O ' HG22 ' A' ' 12' ' ' THR . 91.9 m -116.0 7.21 14.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 0.0 109.757 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.47 133.47 18.16 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.556 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -54.65 -29.99 54.02 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.996 -1.065 . . . . 0.0 109.459 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.97 HG21 ' CB ' ' A' ' 82' ' ' ALA . 3.6 t -48.35 -43.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -72.08 -43.79 64.28 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 53.5 p -47.12 -50.1 20.83 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.391 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' H ' ' HG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -61.03 -70.35 0.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 108.706 179.06 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.844 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 4.3 mp -40.79 -35.12 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.371 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -61.89 -51.82 66.61 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.995 -1.066 . . . . 0.0 108.399 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -61.25 -56.06 24.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.298 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.844 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -52.67 -50.47 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.889 -1.132 . . . . 0.0 108.862 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.651 ' HB3' HD13 ' A' ' 32' ' ' ILE . 5.2 m95 -46.15 -59.82 2.66 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.413 0.625 . . . . 0.0 110.227 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.626 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -61.77 -37.06 82.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.227 -0.921 . . . . 0.0 110.021 -178.525 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -60.89 -49.42 77.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.289 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.07 HG11 ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -87.79 -48.9 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.241 -0.912 . . . . 0.0 110.778 -179.069 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 47' ' ' LYS . 45.7 mt -63.76 -9.97 17.32 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.363 -0.836 . . . . 0.0 109.87 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.07 58.63 11.89 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.581 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.32 167.48 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -1.196 . . . . 0.0 109.45 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 t -126.78 81.43 2.01 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.249 -0.907 . . . . 0.0 109.185 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . 139.4 -73.55 0.4 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.693 ' CG2' HD11 ' A' ' 74' ' ' ILE . 14.7 mt 60.89 143.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -1.105 . . . . 0.0 109.628 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' HA2' ' CD1' ' A' ' 8' ' ' TYR . . . -86.46 -119.45 1.14 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.945 ' HA ' HD12 ' A' ' 74' ' ' ILE . 1.5 tt -149.28 -64.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.812 -1.405 . . . . 0.0 109.831 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.044 HD23 HG21 ' A' ' 73' ' ' THR . 0.6 OUTLIER -88.38 32.1 0.79 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.365 -1.46 . . . . 0.0 109.66 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.652 ' O ' HG23 ' A' ' 73' ' ' THR . 15.5 m-20 -59.73 167.12 2.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.343 -0.848 . . . . 0.0 110.753 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 39' ' ' PHE . 36.6 t30 -110.53 40.37 2.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.681 ' CZ ' ' HA ' ' A' ' 72' ' ' PRO . 8.7 m-30 62.76 -56.3 0.15 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.769 -0.582 . . . . 0.0 111.008 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.499 ' N ' ' O ' ' A' ' 37' ' ' ASN . 2.8 t80 -86.47 22.14 1.94 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.443 -1.411 . . . . 0.0 110.238 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 9.9 mm-40 -81.4 -1.84 47.16 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 41' ' ' ILE . 9.9 tp 174.8 57.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.49 116.77 0.51 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 44' ' ' HIS . . . -150.12 -74.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.498 ' CB ' ' O ' ' A' ' 43' ' ' GLY . 0.5 OUTLIER 77.36 -156.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -1.089 . . . . 0.0 109.514 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -121.53 -51.62 2.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.925 . . . . 0.0 109.553 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 46' ' ' LEU . 1.1 mm? -57.84 -39.63 78.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.856 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.9 tptt -64.84 -64.14 0.94 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.099 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -47.9 -47.5 32.01 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.085 -1.009 . . . . 0.0 108.32 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.907 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.25 -49.93 31.5 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.07 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -46.81 -46.67 20.87 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.555 ' HA ' HG12 ' A' ' 22' ' ' ILE . 15.0 t -56.92 -54.16 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.882 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.42 -38.77 20.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -61.58 -44.05 97.73 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.528 ' CB ' HG12 ' A' ' 22' ' ' ILE . 3.0 tp-100 -48.7 -36.14 15.54 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG21 HD22 ' A' ' 63' ' ' LEU . 6.8 t -68.03 -45.71 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 59' ' ' TYR . 1.3 t-80 -69.94 -33.64 72.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.077 -1.015 . . . . 0.0 109.098 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -41.4 39.49 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 12.8 mm-40 -71.91 -46.06 59.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.946 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -124.87 168.85 12.7 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.608 0.718 . . . . 0.0 109.41 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -99.18 31.84 2.92 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.946 HG12 ' HB2' ' A' ' 59' ' ' TYR . 6.5 p -93.59 123.13 45.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 4.6 tt0 -69.21 97.76 0.96 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 110.856 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -103.05 106.65 51.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.133 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 35.8 Cg_endo -79.88 166.6 21.11 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.445 2.096 . . . . 0.0 111.292 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.907 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.4 mm? -69.02 -40.87 78.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -51.19 -51.7 51.29 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.424 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 3.0 t -55.93 -41.21 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.099 HD21 ' HB1' ' A' ' 48' ' ' ALA . 1.2 tp -62.43 -24.15 67.26 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.517 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 m-85 -87.62 -36.67 17.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.419 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.22 -32.55 74.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.52 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.08 71.74 18.42 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.681 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 30.5 Cg_endo -77.82 64.82 8.24 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.259 1.973 . . . . 0.0 108.209 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 1.044 HG21 HD23 ' A' ' 35' ' ' LEU . 81.4 m -152.68 165.11 36.29 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 117.961 -1.496 . . . . 0.0 111.939 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.945 HD12 ' HA ' ' A' ' 34' ' ' ILE . 7.3 mt -71.93 -72.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.14 -0.975 . . . . 0.0 109.286 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HB3' ' HG ' ' A' ' 35' ' ' LEU . 3.2 ttmm -45.21 -44.68 11.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.617 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -61.66 -55.02 35.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 108.955 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.006 HD11 HD12 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -59.11 -63.23 1.38 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.128 -0.983 . . . . 0.0 108.758 179.155 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.606 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . -44.87 -38.96 4.98 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.567 ' O ' HG22 ' A' ' 83' ' ' THR . 1.1 tp60 -68.89 -44.41 73.3 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.654 ' O ' HG22 ' A' ' 83' ' ' THR . 28.4 t80 -52.22 -35.56 49.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.14 -0.975 . . . . 0.0 108.386 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.607 HG11 ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.15 -70.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 122.375 1.084 . . . . 0.0 108.43 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.97 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -40.11 -27.77 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.06 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 80' ' ' TYR . 9.8 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.458 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.73 ' OH ' HG23 ' A' ' 34' ' ' ILE . 52.5 t80 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.583 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 15.3 m -121.34 54.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 109.966 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 171.02 146.3 0.13 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 110.131 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 36.3 Cg_endo -81.37 -154.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.937 2.425 . . . . 0.0 110.413 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.733 HG22 ' CG2' ' A' ' 34' ' ' ILE . 1.8 t -126.63 -57.26 1.36 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.911 -1.118 . . . . 0.0 110.1 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.633 ' H ' HG23 ' A' ' 12' ' ' THR . 45.8 p30 -131.56 175.93 8.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.831 -1.168 . . . . 0.0 108.209 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.728 ' HA ' ' HB3' ' A' ' 17' ' ' SER . . . -74.92 -36.53 62.16 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.626 -1.296 . . . . 0.0 110.068 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.951 HG21 ' CB ' ' A' ' 82' ' ' ALA . 20.6 t -53.42 -47.66 58.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 119.939 -1.726 . . . . 0.0 106.674 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.558 ' HG3' ' CG2' ' A' ' 74' ' ' ILE . 3.6 tm-20 -69.16 -29.19 67.15 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.728 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 35.2 p -54.13 -49.36 69.37 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.302 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.842 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.95 -51.38 69.53 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.774 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 6.7 mt -58.71 -40.7 84.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.174 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.82 -46.45 67.73 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.859 -1.15 . . . . 0.0 108.122 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 22' ' ' ILE . 23.0 mt-10 -65.21 -66.43 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.489 -0.757 . . . . 0.0 109.214 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -45.34 -46.51 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.966 . . . . 0.0 108.851 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.796 ' CE3' HG21 ' A' ' 32' ' ' ILE . 5.4 m95 -50.72 -64.49 0.79 Allowed 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.437 0.636 . . . . 0.0 110.867 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.761 ' HA ' HD11 ' A' ' 32' ' ' ILE . 2.6 pt-20 -59.53 -38.09 80.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.17 -61.59 2.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 110.413 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.057 HG11 ' HB3' ' A' ' 50' ' ' ALA . 4.8 t -75.2 -33.23 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.135 -0.978 . . . . 0.0 111.337 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 41.9 mt -81.9 -8.07 59.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.706 -1.246 . . . . 0.0 109.829 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.19 53.29 45.91 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -137.38 -172.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.265 . . . . 0.0 109.03 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 t -153.29 121.0 5.99 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.467 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.24 20.81 54.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.796 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.2 mt -42.08 150.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -1.199 . . . . 0.0 109.298 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.74 -170.43 21.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.733 ' CG2' HG22 ' A' ' 12' ' ' THR . 1.0 OUTLIER -106.33 12.3 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -1.047 . . . . 0.0 109.743 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.763 HD12 ' CG2' ' A' ' 73' ' ' THR . 10.4 tp -169.24 62.24 0.05 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.084 -1.01 . . . . 0.0 109.39 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.645 ' O ' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -89.59 -161.96 0.83 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.249 -0.907 . . . . 0.0 109.916 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 39' ' ' PHE . 6.9 t-20 -129.66 29.76 4.99 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.226 -0.921 . . . . 0.0 110.132 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.74 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 1.9 m-85 57.64 -65.01 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.961 -0.462 . . . . 0.0 111.144 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 37' ' ' ASN . 13.4 t80 -86.46 29.94 0.74 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.685 -1.259 . . . . 0.0 110.251 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.519 ' HG3' ' CB ' ' A' ' 37' ' ' ASN . 13.8 mt-30 -80.99 -4.55 55.5 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 0.3 OUTLIER 165.64 66.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.89 -130.48 2.45 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.48 -118.86 0.46 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -49.72 157.33 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -1.101 . . . . 0.0 109.618 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.8 p -94.0 -24.03 17.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.327 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 46' ' ' LEU . 9.9 tp -47.64 -41.11 21.41 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.167 -0.958 . . . . 0.0 108.982 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 8.0 mttt -50.29 -61.18 2.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.101 -1.0 . . . . 0.0 108.567 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.038 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -48.42 -46.32 37.32 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.928 ' SD ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.59 -52.39 30.58 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.057 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -46.87 -42.75 17.93 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.621 HG13 HG13 ' A' ' 22' ' ' ILE . 7.6 t -58.79 -61.2 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.933 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -45.9 -48.78 16.1 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -51.95 -47.4 64.78 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 6.5 tp60 -46.29 -37.05 6.83 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.551 HG21 HD22 ' A' ' 63' ' ' LEU . 2.2 t -73.04 -32.96 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.687 -0.633 . . . . 0.0 109.565 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 59' ' ' TYR . 2.5 t-80 -78.1 -44.18 26.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.784 -1.198 . . . . 0.0 108.38 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -34.01 73.86 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -78.31 -48.35 15.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -128.87 170.09 13.81 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.45 51.59 0.74 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 177.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 59' ' ' TYR . 96.5 t -91.24 161.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-O 121.845 0.831 . . . . 0.0 110.798 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.615 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 12.6 pt-20 -75.26 49.05 0.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.797 -0.565 . . . . 0.0 110.16 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.59 HD21 HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -111.01 86.82 6.37 Favored Pre-proline 0 C--N 1.295 -1.796 0 O-C-N 121.108 -0.995 . . . . 0.0 110.986 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 37.3 Cg_endo -83.05 -152.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.745 2.297 . . . . 0.0 107.985 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.928 HD13 ' SD ' ' A' ' 49' ' ' MET . 7.9 tp -90.87 -41.55 11.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.457 -1.402 . . . . 0.0 109.611 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.562 ' HG3' ' N ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -50.29 -39.59 45.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.91 -1.119 . . . . 0.0 108.426 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.577 HG11 ' HG ' ' A' ' 63' ' ' LEU . 4.3 t -63.12 -34.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.038 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -65.6 -27.65 68.56 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.465 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 27.6 m-85 -86.92 -35.48 18.9 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.415 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.37 -35.34 80.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.415 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -142.72 71.93 19.91 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.641 ' C ' ' CE1' ' A' ' 38' ' ' PHE . 32.9 Cg_endo -77.59 64.65 8.1 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.52 2.147 . . . . 0.0 107.955 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.763 ' CG2' HD12 ' A' ' 35' ' ' LEU . 94.5 m -152.87 158.75 42.62 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.243 -1.383 . . . . 0.0 111.716 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.724 HG21 ' HA ' ' A' ' 34' ' ' ILE . 5.3 mm -64.1 -77.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.438 -0.789 . . . . 0.0 110.314 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.677 ' HB3' HD13 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -42.24 -49.4 4.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.65 -0.656 . . . . 0.0 110.002 -178.33 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -58.88 -69.15 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 109.13 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -47.57 -49.47 26.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.718 -1.239 . . . . 0.0 108.817 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -55.64 -27.57 50.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 1.5 pt20 -78.84 -32.56 46.17 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.545 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -67.79 -34.5 76.9 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -88.14 -63.12 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.317 1.056 . . . . 0.0 108.484 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.951 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -59.2 -31.24 68.85 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.425 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 13.4 m . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.517 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' A' ' 10' ' ' ALA . 37.0 t80 . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.608 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 9.9 m -114.93 40.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.886 . . . . 0.0 109.535 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 169.81 145.85 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.317 -0.865 . . . . 0.0 109.676 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.508 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 36.3 Cg_endo -80.62 -161.39 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.708 2.272 . . . . 0.0 110.45 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.55 -55.76 1.41 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.099 -1.001 . . . . 0.0 110.094 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.756 ' OD1' HG22 ' A' ' 15' ' ' VAL . 22.4 t-20 -119.36 169.84 9.65 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.643 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -73.26 -35.61 66.24 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.336 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.042 HG11 ' HB2' ' A' ' 82' ' ' ALA . 1.1 m -50.55 -56.56 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.761 ' HG3' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.68 -26.67 65.41 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.643 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 73.5 m -57.03 -51.11 70.57 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.555 ' HD3' ' CG ' ' A' ' 58' ' ' GLU . 1.3 tptm -61.43 -66.18 0.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.792 ' HA ' HG23 ' A' ' 22' ' ' ILE . 4.3 mm? -41.04 -47.44 3.1 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.84 -48.27 64.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.864 -1.148 . . . . 0.0 108.502 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 4.3 mt-10 -64.82 -64.55 0.84 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.307 -0.871 . . . . 0.0 108.709 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.944 HD11 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -43.39 -47.08 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.71 ' CE3' HG21 ' A' ' 32' ' ' ILE . 3.7 m95 -50.25 -70.82 0.08 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.427 0.632 . . . . 0.0 110.741 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.629 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -55.27 -29.95 59.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.336 -0.852 . . . . 0.0 110.549 -178.199 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.423 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -76.23 -67.77 0.65 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 109.907 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.918 HG12 ' HG3' ' A' ' 47' ' ' LYS . 94.8 t -62.29 -31.55 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 110.11 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 19.4 mt -93.41 -4.68 50.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 110.121 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.52 56.27 25.41 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -136.97 -179.0 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 108.965 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.9 t -153.1 137.03 16.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.361 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.64 6.46 87.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.026 HG22 HD11 ' A' ' 74' ' ' ILE . 3.4 mt -42.83 131.05 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -1.094 . . . . 0.0 109.301 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.87 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -71.29 -135.37 0.14 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.83 HD13 ' N ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -119.1 -55.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.961 -1.317 . . . . 0.0 110.185 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -92.09 39.97 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.184 -1.573 . . . . 0.0 108.878 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.599 ' OD2' HG23 ' A' ' 32' ' ' ILE . 1.3 m-20 -58.67 -172.06 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.612 0.72 . . . . 0.0 109.908 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 54.7 m-20 -126.29 115.39 19.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.705 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 25.4 m-85 -41.52 -24.9 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.11 -0.994 . . . . 0.0 110.342 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -99.65 37.42 1.6 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.501 -1.375 . . . . 0.0 109.585 179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.525 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 17.4 mm100 -81.33 -10.65 59.52 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 0.3 OUTLIER 165.71 60.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.68 74.78 0.31 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 45' ' ' SER . . . -124.45 -81.73 0.5 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 43' ' ' GLY . 46.5 t-80 63.26 -75.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -1.115 . . . . 0.0 109.457 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER 174.26 -61.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 109.515 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -50.27 -44.49 53.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.633 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.918 ' HG3' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -58.88 -71.37 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 109.23 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.075 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -46.98 -44.61 20.28 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.886 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.53 -51.03 29.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.812 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -47.36 -44.23 23.87 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.944 HG22 HD11 ' A' ' 22' ' ' ILE . 15.2 t -58.62 -58.03 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.055 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.46 -40.13 25.24 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -59.4 -46.41 88.77 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.53 ' HG2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -51.87 -31.17 26.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.41 HG21 HD22 ' A' ' 63' ' ' LEU . 3.3 t -74.21 -48.36 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.638 -0.664 . . . . 0.0 109.38 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 59' ' ' TYR . 4.6 t-80 -67.91 -34.59 76.92 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.155 -0.966 . . . . 0.0 109.189 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -76.02 -31.7 59.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 0.0 108.712 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.555 ' CG ' ' HD3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -82.67 -44.45 15.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.453 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.836 ' HB2' HG23 ' A' ' 61' ' ' VAL . 10.4 m-85 -120.51 -173.8 2.66 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.873 0.844 . . . . 0.0 109.639 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -117.95 39.96 3.25 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.836 HG23 ' HB2' ' A' ' 59' ' ' TYR . 1.3 t -93.09 137.91 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.33 0.586 . . . . 0.0 109.626 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 48.4 tt0 -69.37 95.46 0.8 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.327 -0.858 . . . . 0.0 109.292 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.777 HD23 ' HB1' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -116.4 91.57 33.78 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.484 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 35.6 Cg_endo -79.28 159.98 26.21 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.548 2.166 . . . . 0.0 110.215 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.886 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.3 mm? -57.83 -39.75 78.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.127 -0.983 . . . . 0.0 108.711 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -53.37 -52.22 59.97 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.09 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.484 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 2.6 t -51.07 -39.9 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.075 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -64.28 -26.83 68.67 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.495 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 4.3 m-30 -84.2 -36.38 22.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.44 -30.41 68.33 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.483 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -145.36 66.88 12.68 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.564 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.7 Cg_endo -76.46 53.15 3.85 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.86 2.374 . . . . 0.0 112.15 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 4.3 t -151.63 175.39 12.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.72 -1.237 . . . . 0.0 110.873 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.026 HD11 HG22 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -72.57 -67.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.687 -0.633 . . . . 0.0 110.794 -179.021 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.557 ' HE2' HD12 ' A' ' 35' ' ' LEU . 4.0 tttt -39.91 -56.87 1.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.575 -0.703 . . . . 0.0 109.303 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.489 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -59.44 -54.49 46.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 108.886 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.693 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -49.99 -64.49 0.79 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.731 -1.231 . . . . 0.0 108.585 179.032 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.716 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -46.15 -33.78 3.8 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.459 -0.776 . . . . 0.0 109.022 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -77.57 -40.26 42.98 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.947 -1.095 . . . . 0.0 109.142 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CE1' ' NE2' ' A' ' 71' ' ' GLN . 3.1 t80 -60.16 -34.27 73.34 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.933 -1.104 . . . . 0.0 108.127 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.699 HG12 HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -89.12 -66.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.386 1.088 . . . . 0.0 108.977 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 1.042 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -57.52 -28.17 63.24 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.81 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 79' ' ' GLN . 4.3 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 109.371 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.52 ' CE2' ' HA2' ' A' ' 33' ' ' GLY . 34.8 t80 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -108.92 118.03 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.442 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.621 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -51.2 163.67 0.52 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.071 -1.018 . . . . 0.0 109.301 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.621 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 36.2 Cg_endo -78.85 157.12 27.47 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.576 2.184 . . . . 0.0 110.776 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.478 ' N ' ' OE2' ' A' ' 16' ' ' GLU . 1.2 m -130.67 1.11 4.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 110.709 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.555 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 2.3 p-10 -145.43 150.42 36.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.702 -1.248 . . . . 0.0 108.779 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.671 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -57.57 -25.42 59.95 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.019 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.854 HG21 ' CB ' ' A' ' 82' ' ' ALA . 2.2 t -47.07 -65.68 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.518 ' N ' HG12 ' A' ' 15' ' ' VAL . 4.0 pt-20 -70.76 -23.72 62.47 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.671 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 6.6 m -60.86 -44.85 96.47 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.394 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 22' ' ' ILE . 3.4 tptm -69.93 -61.57 1.73 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.964 -1.094 . . . . 0.0 108.351 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.898 HD21 HD12 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -48.34 -37.32 16.35 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.069 -1.052 . . . . 0.0 108.414 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' GLU . . . -58.19 -47.81 82.26 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.486 ' OE1' ' NH1' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -65.38 -51.99 56.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.378 -0.826 . . . . 0.0 108.785 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.951 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -54.37 -44.13 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.744 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.8 m95 -54.25 -68.57 0.17 Allowed 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.962 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.652 ' HA ' HD11 ' A' ' 32' ' ' ILE . 9.2 pt-20 -59.32 -33.21 70.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.486 ' NH1' ' OE1' ' A' ' 21' ' ' GLU . 24.1 ttm180 -71.17 -71.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 109.448 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.025 HG11 ' HB3' ' A' ' 50' ' ' ALA . 60.8 t -54.71 -33.78 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.556 -0.715 . . . . 0.0 110.232 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.466 ' CG ' ' O ' ' A' ' 23' ' ' TRP . 13.1 mt -91.43 -9.05 46.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 0.0 110.197 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.67 52.81 48.37 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.123 -0.986 . . . . 0.0 110.977 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -129.84 -173.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.249 . . . . 0.0 108.469 178.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.0 t -154.47 120.18 5.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.073 -1.017 . . . . 0.0 109.947 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.45 20.89 50.45 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.578 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 24' ' ' GLU . 2.8 mp -50.8 161.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.117 -1.225 . . . . 0.0 109.74 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.835 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -81.05 -153.01 9.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.719 ' O ' HG22 ' A' ' 34' ' ' ILE . 48.8 mm -121.37 19.85 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.78 -1.423 . . . . 0.0 109.762 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.816 HD12 ' HB3' ' A' ' 75' ' ' LYS . 1.7 tt -165.62 53.72 0.11 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.902 -1.124 . . . . 0.0 110.523 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.557 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 1.4 m-20 -84.76 160.08 20.34 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.653 ' O ' ' N ' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -88.42 45.91 1.33 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.833 -1.167 . . . . 0.0 108.787 179.06 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.744 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 13.4 m-85 51.01 -65.73 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.307 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.653 ' N ' ' O ' ' A' ' 37' ' ' ASN . 4.2 t80 -86.43 37.24 0.73 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.622 -1.299 . . . . 0.0 108.83 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.501 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 1.1 mm-40 -80.42 -7.76 59.26 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.2 tt 166.09 74.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.437 -0.789 . . . . 0.0 109.012 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.24 -118.95 0.95 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.972 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.545 ' CA ' ' HD3' ' A' ' 47' ' ' LYS . . . -58.11 162.33 9.91 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -116.27 -59.5 1.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 109.224 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.57 -59.57 0.67 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.91 . . . . 0.0 109.444 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.469 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -52.59 -52.6 54.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.409 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.545 ' HD3' ' CA ' ' A' ' 43' ' ' GLY . 16.4 mttp -53.37 -51.45 62.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.066 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -53.62 -44.69 69.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.404 -1.435 . . . . 0.0 108.02 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.907 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.71 -48.98 49.53 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.432 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.025 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -48.88 -52.37 24.74 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.951 ' CG1' HD11 ' A' ' 22' ' ' ILE . 41.8 t -46.25 -59.5 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.92 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -52.52 -52.95 52.12 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 52' ' ' ALA . . . -47.34 -49.09 25.02 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.613 ' HB3' HD12 ' A' ' 22' ' ' ILE . 6.3 tp-100 -50.9 -37.66 45.23 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.872 HG11 HD23 ' A' ' 63' ' ' LEU . 21.0 t -63.52 -60.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -54.86 -46.85 74.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.209 -0.932 . . . . 0.0 110.504 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.529 ' HG3' ' N ' ' A' ' 58' ' ' GLU . 0.8 OUTLIER -61.43 -36.69 81.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.659 -1.276 . . . . 0.0 109.01 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -75.69 -53.67 8.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 108.934 179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.656 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -120.99 157.49 29.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.6 41.0 1.09 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 81' ' ' VAL . 5.8 p -92.5 159.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.441 0.638 . . . . 0.0 109.672 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.471 ' N ' HG22 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -69.22 105.98 2.7 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.455 -0.778 . . . . 0.0 110.213 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.872 HD23 HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -132.93 69.59 78.98 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.572 ' HG2' HG23 ' A' ' 67' ' ' VAL . 34.9 Cg_endo -77.92 156.96 30.95 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.683 2.255 . . . . 0.0 110.856 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.907 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.5 mm? -57.88 -39.67 78.38 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -55.37 -53.16 59.69 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.615 HG21 ' CE2' ' A' ' 80' ' ' TYR . 2.9 t -50.84 -48.45 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.066 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -55.03 -23.62 20.68 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 66' ' ' LYS . 6.2 m-85 -87.58 -39.67 14.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.05 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.17 -33.6 76.13 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.423 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -143.15 71.27 18.33 Favored Pre-proline 0 C--N 1.296 -1.749 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.62 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 32.3 Cg_endo -77.24 56.05 5.31 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.881 2.388 . . . . 0.0 112.236 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.734 HG22 ' HB3' ' A' ' 76' ' ' ALA . 15.3 t -154.11 174.91 14.08 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 117.34 -1.744 . . . . 0.0 112.725 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.835 HD12 ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -66.12 -72.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.207 -0.933 . . . . 0.0 111.516 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.816 ' HB3' HD12 ' A' ' 35' ' ' LEU . 32.2 ttmt -45.73 -49.33 14.88 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.133 -0.979 . . . . 0.0 109.766 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.734 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -66.38 -71.64 0.19 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.453 -0.78 . . . . 0.0 110.081 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.898 HD12 HD21 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -42.14 -55.85 3.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.309 -0.87 . . . . 0.0 108.952 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.757 ' HA ' HD13 ' A' ' 19' ' ' LEU . . . -50.28 -56.24 12.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 108.502 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 4.0 tp60 -50.35 -45.27 54.98 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.615 ' CE2' HG21 ' A' ' 67' ' ' VAL . 5.7 t80 -54.46 -35.82 63.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.166 -0.959 . . . . 0.0 108.613 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.749 HG21 HD11 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -79.78 -62.17 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 122.563 1.173 . . . . 0.0 108.976 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.854 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -53.01 -63.55 1.11 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.566 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.049 -1.032 . . . . 0.0 109.712 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.674 ' CE2' ' HA2' ' A' ' 33' ' ' GLY . 7.9 t80 . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.292 0.568 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -115.82 51.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.607 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.895 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -168.73 174.52 2.09 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.895 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 36.5 Cg_endo -81.45 174.13 10.86 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.597 2.198 . . . . 0.0 110.888 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.437 ' H ' ' CG ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -118.15 -52.52 2.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.465 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.71 176.83 4.88 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.606 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -79.81 -33.13 40.66 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.917 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.977 HG21 ' HB2' ' A' ' 82' ' ' ALA . 53.0 t -61.03 -48.66 88.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.957 ' OE1' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -71.84 -23.6 61.56 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.606 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 20.9 m -56.09 -50.08 72.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.687 ' O ' HG22 ' A' ' 22' ' ' ILE . 5.6 tptm -68.36 -52.44 33.12 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.745 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 2.3 mt -54.25 -37.35 64.56 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.696 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.957 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . . . -61.61 -45.83 92.42 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 22' ' ' ILE . 2.7 tt0 -61.82 -60.25 3.94 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.916 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -48.08 -57.57 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.906 ' HB3' HD13 ' A' ' 32' ' ' ILE . 1.9 m95 -38.24 -66.83 0.23 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.916 0.865 . . . . 0.0 110.308 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.661 ' HA ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -58.32 -43.43 88.19 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.443 0.64 . . . . 0.0 109.578 -178.313 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.429 ' HG3' ' N ' ' A' ' 26' ' ' VAL . 4.2 tpp180 -63.07 -71.93 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.517 -0.74 . . . . 0.0 110.511 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.673 HG11 ' HB3' ' A' ' 50' ' ' ALA . 91.1 t -63.17 -31.6 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 0.0 111.27 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 13.9 mt -93.05 -12.16 31.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.682 -1.261 . . . . 0.0 110.584 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 69.42 66.72 2.15 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.283 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.728 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -133.22 -168.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -1.09 . . . . 0.0 109.327 179.421 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.529 ' H ' HG12 ' A' ' 29' ' ' VAL . 3.3 m -153.42 69.26 0.81 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.428 -0.795 . . . . 0.0 109.04 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 142.16 -76.87 0.3 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.906 HD13 ' HB3' ' A' ' 23' ' ' TRP . 9.8 mt 60.07 128.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.397 -1.061 . . . . 0.0 110.768 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.674 ' HA2' ' CE2' ' A' ' 8' ' ' TYR . . . -75.19 -143.45 1.02 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -113.55 -62.93 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.122 -1.223 . . . . 0.0 109.763 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.559 ' C ' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -89.68 39.89 0.97 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.561 -1.337 . . . . 0.0 108.861 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.624 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 2.6 m-20 -60.05 -165.15 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.64 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -129.22 122.82 30.5 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CE1' ' N ' ' A' ' 73' ' ' THR . 7.9 m-30 -49.97 -21.37 1.19 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.098 -1.001 . . . . 0.0 109.07 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -97.71 39.86 1.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.025 -1.047 . . . . 0.0 108.323 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.546 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 4.4 mm-40 -80.73 83.03 6.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 40' ' ' GLN . 21.8 pt 46.2 62.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.655 0.74 . . . . 0.0 109.885 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.66 -103.23 1.8 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.33 -137.57 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -165.46 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -1.095 . . . . 0.0 109.407 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.0 m -86.46 -10.57 53.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 109.66 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -48.44 69.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.704 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.9 mttt -56.81 -59.64 4.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.847 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.028 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -47.69 -51.87 20.33 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.975 -1.078 . . . . 0.0 109.141 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.886 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.72 -50.02 26.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.673 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -47.69 -41.86 23.55 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.916 HG13 ' CG1' ' A' ' 22' ' ' ILE . 17.9 t -61.12 -57.26 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.055 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -49.15 -46.16 44.79 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -57.58 -40.69 79.56 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.531 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 25.8 tp60 -54.75 -33.76 61.66 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.986 HG11 HD12 ' A' ' 63' ' ' LEU . 3.5 t -68.95 -51.79 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' TYR . 4.3 t-160 -65.7 -37.46 86.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 109.252 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 53' ' ' ALA . 5.4 mtt180 -70.42 -32.33 69.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 108.727 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.504 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -81.47 -54.81 5.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.81 . . . . 0.0 108.864 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.835 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -118.38 -179.6 3.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.371 -0.831 . . . . 0.0 109.174 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.69 44.57 1.03 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.835 HG23 ' HB2' ' A' ' 59' ' ' TYR . 13.4 t -93.39 129.91 43.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.503 0.668 . . . . 0.0 109.734 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.76 104.05 2.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.729 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.986 HD12 HG11 ' A' ' 55' ' ' VAL . 6.5 mt -124.23 100.99 35.26 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 108.981 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.6 Cg_endo -80.18 157.4 23.15 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.548 2.166 . . . . 0.0 110.451 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.886 HD21 ' SD ' ' A' ' 49' ' ' MET . 1.9 mm? -57.03 -44.22 82.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.079 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HG3' ' HB2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -50.86 -51.24 53.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.0 -1.063 . . . . 0.0 108.337 179.295 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.931 HG11 ' CD2' ' A' ' 63' ' ' LEU . 2.7 t -50.76 -45.34 27.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.055 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -57.56 -25.02 59.33 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 66' ' ' LYS . 19.0 m-85 -86.72 -37.23 18.12 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.464 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.16 -30.68 68.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.78 . . . . 0.0 109.305 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.657 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -144.82 66.11 12.86 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.178 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.596 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 34.3 Cg_endo -77.52 54.37 4.71 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.895 2.397 . . . . 0.0 110.588 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.622 ' N ' ' CE1' ' A' ' 38' ' ' PHE . 9.7 t -151.93 159.35 43.82 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.215 -0.928 . . . . 0.0 110.024 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.606 HG12 ' NE1' ' A' ' 23' ' ' TRP . 2.4 mt -64.49 -60.0 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.163 -0.961 . . . . 0.0 112.005 -178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 9.2 tttm -40.29 -53.85 2.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.318 -0.864 . . . . 0.0 108.912 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 77' ' ' LEU . . . -69.71 -60.93 2.0 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.666 -0.646 . . . . 0.0 110.051 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.3 OUTLIER -45.15 -59.17 2.76 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.707 -1.245 . . . . 0.0 108.623 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -50.22 -40.58 47.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -70.56 -34.91 72.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.05 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.719 ' CD1' HD21 ' A' ' 63' ' ' LEU . 7.7 t80 -63.14 -37.42 87.17 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.15 -0.969 . . . . 0.0 108.634 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.783 HG12 HG21 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -86.39 -62.19 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.367 1.08 . . . . 0.0 108.566 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.977 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -60.68 -54.24 47.63 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.031 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.334 179.855 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.466 ' CD2' ' O ' ' A' ' 8' ' ' TYR . 34.5 t80 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 11.4 m -121.71 39.43 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.16 -0.962 . . . . 0.0 109.781 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 169.35 145.36 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.88 . . . . 0.0 109.949 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.547 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 36.8 Cg_endo -82.16 -167.69 0.51 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.743 2.295 . . . . 0.0 110.267 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.12 -45.69 2.11 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.094 -1.004 . . . . 0.0 109.769 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -122.89 153.63 39.39 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.606 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -67.81 -30.51 69.95 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.678 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.907 HG21 ' CB ' ' A' ' 82' ' ' ALA . 3.7 t -53.33 -51.84 36.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.547 ' OE1' ' HB3' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -68.79 -33.87 74.59 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.378 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.606 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.8 m -49.8 -52.2 33.9 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.407 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.866 ' O ' HG22 ' A' ' 22' ' ' ILE . 27.6 tptt -59.23 -49.46 77.75 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.293 -0.879 . . . . 0.0 108.728 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.779 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 9.9 mt -61.9 -41.76 98.28 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.512 ' O ' ' CG ' ' A' ' 24' ' ' GLU . . . -52.72 -45.38 66.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.792 -1.192 . . . . 0.0 108.036 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -64.56 -66.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 108.898 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.866 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -44.94 -48.12 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.785 ' HB3' HD12 ' A' ' 32' ' ' ILE . 3.3 m95 -46.69 -66.98 0.32 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.428 0.633 . . . . 0.0 110.504 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -63.73 -30.0 71.15 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.339 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -71.05 -64.18 0.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.037 -1.039 . . . . 0.0 110.223 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.06 HG11 ' HB3' ' A' ' 50' ' ' ALA . 99.3 t -71.37 -34.42 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 111.086 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.516 ' HB2' HG23 ' A' ' 29' ' ' VAL . 47.3 mt -79.33 4.78 14.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.669 -1.269 . . . . 0.0 110.052 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.34 49.12 61.47 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -134.1 -179.97 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.074 -1.251 . . . . 0.0 109.167 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.91 115.46 10.03 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.289 -0.882 . . . . 0.0 109.367 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 119.67 -69.64 0.36 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.785 HD12 ' HB3' ' A' ' 23' ' ' TRP . 10.2 mm 57.05 113.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -1.071 . . . . 0.0 109.656 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.45 -145.48 1.78 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.64 ' O ' ' N ' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -108.75 -50.81 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -1.22 . . . . 0.0 110.2 -179.307 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.592 ' HG ' HG21 ' A' ' 73' ' ' THR . 0.5 OUTLIER -109.81 45.21 1.11 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 119.775 -1.828 . . . . 0.0 109.174 179.234 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 73' ' ' THR . 2.5 m-20 -61.2 -164.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.471 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 1.6 m-20 -135.27 118.8 16.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.8 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 70.5 m-85 -48.69 -22.3 0.76 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.924 -1.11 . . . . 0.0 109.31 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.444 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 55.4 t80 -98.25 38.4 1.33 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.93 -1.106 . . . . 0.0 108.989 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.919 ' O ' HG22 ' A' ' 41' ' ' ILE . 10.9 mm-40 -81.07 77.03 8.01 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.919 HG22 ' O ' ' A' ' 40' ' ' GLN . 2.5 tt 60.75 39.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.549 0.69 . . . . 0.0 109.531 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.43 -113.18 1.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.36 -57.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.68 -169.06 2.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -1.137 . . . . 0.0 109.353 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.8 t -94.07 -5.59 47.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.307 -0.87 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 49' ' ' MET . 16.6 tp -64.35 -55.79 18.8 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.091 -1.006 . . . . 0.0 109.568 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 26' ' ' VAL . 1.9 mmtm -43.3 -58.35 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.046 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -51.62 -43.33 62.53 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.95 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.44 -50.63 51.66 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 178.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.06 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -47.37 -43.12 22.99 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.759 HG13 HG13 ' A' ' 22' ' ' ILE . 11.2 t -61.18 -60.76 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.995 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -47.74 -42.98 26.63 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 57' ' ' ARG . . . -58.23 -41.17 83.51 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.563 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 6.8 tp60 -55.47 -29.99 59.74 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.641 HG11 HD23 ' A' ' 63' ' ' LEU . 6.6 t -75.19 -59.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 59' ' ' TYR . 64.8 t-80 -57.33 -31.68 65.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 0.0 109.246 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -78.76 -38.58 38.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.122 -0.986 . . . . 0.0 108.737 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.478 ' OE2' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -71.94 -48.61 44.03 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.775 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -127.47 -178.82 4.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.481 -0.762 . . . . 0.0 109.17 178.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -110.72 44.97 1.19 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.775 HG23 ' HB2' ' A' ' 59' ' ' TYR . 13.9 t -93.14 153.9 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.799 -0.563 . . . . 0.0 109.723 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' C ' ' HD3' ' A' ' 64' ' ' PRO . 11.3 tt0 -70.78 94.85 1.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.641 HD23 HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -125.35 74.14 68.0 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.551 ' HG2' HG23 ' A' ' 67' ' ' VAL . 35.4 Cg_endo -77.2 -176.92 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.771 2.314 . . . . 0.0 110.885 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.95 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.9 mm? -81.27 -41.88 21.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.352 -0.843 . . . . 0.0 109.134 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -59.88 -37.66 79.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.263 -0.898 . . . . 0.0 108.701 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.551 HG23 ' HG2' ' A' ' 64' ' ' PRO . 8.9 t -65.11 -47.08 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.046 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -52.74 -25.84 12.34 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.298 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.491 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.7 m-85 -79.17 -42.2 26.68 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.492 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -70.28 -26.18 63.68 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.841 0.829 . . . . 0.0 108.783 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.615 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -147.02 65.76 9.9 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.2 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.567 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 34.4 Cg_endo -78.81 55.73 5.67 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 123.074 2.516 . . . . 0.0 112.722 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.592 HG21 ' HG ' ' A' ' 35' ' ' LEU . 4.7 t -153.18 172.65 16.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.259 -1.526 . . . . 0.0 111.996 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.635 HG12 ' CE2' ' A' ' 23' ' ' TRP . 0.9 OUTLIER -64.36 -54.83 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.616 -0.677 . . . . 0.0 110.78 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.64 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -55.49 -65.2 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.019 -1.051 . . . . 0.0 109.497 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -48.04 -53.93 14.73 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.585 -0.697 . . . . 0.0 110.206 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -57.64 -65.11 0.69 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.714 -1.241 . . . . 0.0 109.155 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.59 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -44.05 -34.92 1.91 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.478 ' HG3' ' N ' ' A' ' 80' ' ' TYR . 0.6 OUTLIER -71.71 -44.45 64.15 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 108.657 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.478 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 2.3 t80 -57.58 -34.91 69.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.105 -0.997 . . . . 0.0 109.015 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.614 HG12 HG21 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -87.65 -63.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.289 1.042 . . . . 0.0 108.219 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.907 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -51.69 -59.57 4.14 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.024 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.405 ' HB ' ' OE1' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.514 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.32 0.581 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.475 ' HB ' ' CG1' ' A' ' 34' ' ' ILE . 1.6 t -103.11 106.71 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.15 156.56 1.8 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.447 -0.783 . . . . 0.0 110.147 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.66 ' HA ' HG21 ' A' ' 34' ' ' ILE . 36.4 Cg_endo -79.78 162.72 23.97 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.905 2.403 . . . . 0.0 110.52 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -124.26 -0.19 8.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.803 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.404 ' HB3' HG22 ' A' ' 15' ' ' VAL . 9.1 m120 -147.84 162.32 39.48 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.559 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -73.92 -29.98 62.33 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.534 -1.267 . . . . 0.0 109.328 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.09 ' CG1' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -54.08 -36.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.469 ' HG2' ' CB ' ' A' ' 78' ' ' ALA . 2.9 mt-10 -77.98 -36.16 49.33 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.8 m -56.3 -49.09 75.27 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.794 ' O ' HG22 ' A' ' 22' ' ' ILE . 10.0 tptt -67.64 -59.47 3.31 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.778 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -54.24 -27.37 34.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 109.38 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.12 -52.23 37.17 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -55.28 36.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.769 -0.772 . . . . 0.0 108.925 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.794 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -53.52 -53.51 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 108.758 179.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.826 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.7 m95 -40.49 -57.74 1.74 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.449 0.642 . . . . 0.0 109.72 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.595 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -61.49 -49.97 74.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.492 -0.755 . . . . 0.0 109.69 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -52.26 -47.69 65.65 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.48 -0.762 . . . . 0.0 110.683 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.928 HG11 ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -85.92 -50.38 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.093 -1.004 . . . . 0.0 110.371 -178.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.7 mt -68.86 -6.66 28.39 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.598 -0.689 . . . . 0.0 109.977 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.83 60.02 9.17 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -129.9 -178.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -1.162 . . . . 0.0 109.167 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 30' ' ' SER . 1.3 p -148.91 40.0 0.87 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.59 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.37 59.86 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.826 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.2 mt -85.18 136.49 22.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.445 -1.032 . . . . 0.0 109.416 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.98 -120.92 0.04 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.66 HG21 ' HA ' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -138.59 -61.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.815 -1.403 . . . . 0.0 109.773 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.585 ' CD2' HG21 ' A' ' 73' ' ' THR . 0.3 OUTLIER -90.02 37.82 0.9 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.676 -1.265 . . . . 0.0 108.544 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.476 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -58.99 -167.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.785 0.802 . . . . 0.0 109.484 178.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -131.72 110.96 11.25 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.466 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.737 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 53.6 m-85 -37.3 -28.87 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.562 -0.711 . . . . 0.0 110.197 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 37' ' ' ASN . 19.9 t80 -91.57 34.42 0.97 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.765 -1.209 . . . . 0.0 109.052 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 37' ' ' ASN . 6.7 mm-40 -81.78 -12.39 58.58 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 41' ' ' ILE . 10.0 tt 170.36 79.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.445 -0.784 . . . . 0.0 108.918 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.92 -127.62 1.18 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.614 -1.279 . . . . 0.0 109.95 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.34 -48.43 0.19 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -107.59 117.26 33.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.422 -1.046 . . . . 0.0 109.223 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -53.16 -19.6 3.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.855 . . . . 0.0 109.639 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -45.15 -47.2 12.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.151 -0.968 . . . . 0.0 109.294 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 7.0 tptt -47.83 -62.51 1.42 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 109.202 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.035 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.77 -48.79 50.21 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.045 -1.034 . . . . 0.0 108.594 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.86 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.4 -47.81 47.51 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.782 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.928 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -48.36 -42.12 30.69 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.701 HG22 HG21 ' A' ' 26' ' ' VAL . 14.8 t -62.67 -52.99 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.817 ' HB3' ' SD ' ' A' ' 49' ' ' MET . . . -48.4 -45.5 36.01 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.28 77.4 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.562 ' CG ' ' OE2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -51.91 -31.88 30.38 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.028 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.788 HG11 HD13 ' A' ' 63' ' ' LEU . 21.2 t -68.37 -42.03 83.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 59' ' ' TYR . 12.5 t-80 -71.16 -40.77 71.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.368 -0.832 . . . . 0.0 109.033 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -41.66 68.46 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.562 ' OE2' ' CG ' ' A' ' 54' ' ' GLN . 71.2 mt-10 -63.91 -49.4 72.81 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.865 ' CD1' HG11 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -139.96 172.63 12.49 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.74 45.87 0.94 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.835 HG23 ' HB2' ' A' ' 59' ' ' TYR . 21.2 t -92.97 145.66 7.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.437 0.637 . . . . 0.0 109.837 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.85 111.43 5.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 109.461 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.788 HD13 HG11 ' A' ' 55' ' ' VAL . 1.3 tt -147.01 85.37 6.99 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.299 -0.876 . . . . 0.0 109.436 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.1 Cg_endo -79.56 172.18 14.75 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.793 2.329 . . . . 0.0 109.589 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.86 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.1 mt -68.17 -43.23 78.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.716 -1.24 . . . . 0.0 109.116 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.416 ' CG ' ' N ' ' A' ' 67' ' ' VAL . 12.5 ptmm? -47.05 -37.9 10.19 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 80' ' ' TYR . 2.1 t -70.91 -42.21 77.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.035 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -61.28 -22.38 64.8 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.469 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 46.1 m-85 -83.55 -40.46 19.09 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.453 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -68.39 -29.61 68.34 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.994 0.902 . . . . 0.0 108.797 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.539 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -140.58 68.42 31.03 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.573 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.9 Cg_endo -76.9 55.23 4.86 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.989 2.459 . . . . 0.0 113.069 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.586 ' HA ' ' CZ2' ' A' ' 23' ' ' TRP . 10.2 t -153.39 174.44 14.35 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.736 -1.227 . . . . 0.0 110.887 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.815 HD11 ' CG2' ' A' ' 32' ' ' ILE . 21.0 mt -72.71 -65.07 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.311 -0.868 . . . . 0.0 109.883 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -39.76 -54.43 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.645 -0.659 . . . . 0.0 109.577 -179.564 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' H ' HG23 ' A' ' 73' ' ' THR . . . -62.76 -59.84 4.33 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.358 -0.839 . . . . 0.0 109.068 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.85 HD11 HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -44.54 -62.6 1.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.021 -1.049 . . . . 0.0 108.739 179.309 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.513 ' N ' HD13 ' A' ' 19' ' ' LEU . . . -48.7 -39.83 26.05 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.79 -40.82 79.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.913 . . . . 0.0 108.868 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.607 ' HD2' HD12 ' A' ' 63' ' ' LEU . 4.3 t80 -56.12 -35.12 66.73 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.865 HG11 ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.21 -69.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 122.334 1.064 . . . . 0.0 109.135 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 1.09 ' HB2' ' CG1' ' A' ' 15' ' ' VAL . . . -48.44 -25.99 1.9 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.341 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.06 . . . . 0.0 109.6 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.487 ' CE1' ' HA3' ' A' ' 33' ' ' GLY . 2.5 t80 . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.06 129.76 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -49.1 157.25 0.84 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.182 -0.949 . . . . 0.0 109.753 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.474 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 35.1 Cg_endo -76.2 -170.05 0.8 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.699 2.266 . . . . 0.0 110.717 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.05 -3.5 11.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 0.0 109.848 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.65 165.97 27.17 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.975 -1.078 . . . . 0.0 108.637 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.602 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -77.38 -22.36 51.81 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.02 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.892 HG21 ' CB ' ' A' ' 82' ' ' ALA . 2.2 t -52.0 -49.44 38.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.677 ' HG3' ' HB1' ' A' ' 78' ' ' ALA . 2.3 mt-10 -73.08 -38.25 66.47 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.602 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 16.6 m -53.27 -48.63 68.12 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.31 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.763 ' O ' HG22 ' A' ' 22' ' ' ILE . 6.9 tptt -63.28 -56.66 14.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -0.985 . . . . 0.0 108.861 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.792 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 1.3 tp -52.9 -37.54 60.78 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.432 -0.792 . . . . 0.0 109.15 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.68 84.13 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -61.89 -65.27 0.72 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.534 -0.729 . . . . 0.0 109.056 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.792 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -45.81 -45.91 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.951 -1.093 . . . . 0.0 108.895 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.738 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.5 m95 -47.37 -65.12 0.62 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.66 0.743 . . . . 0.0 109.938 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.613 ' CB ' HD11 ' A' ' 32' ' ' ILE . 8.0 pt-20 -60.22 -32.62 71.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 110.65 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -65.47 -61.66 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.128 -0.982 . . . . 0.0 110.664 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.108 HG11 ' HB3' ' A' ' 50' ' ' ALA . 22.0 t -77.44 -31.83 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.1 -1.0 . . . . 0.0 110.762 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 38.0 mt -78.83 -3.6 45.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.984 -1.073 . . . . 0.0 110.008 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.89 54.67 36.04 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.58 -172.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.186 -1.185 . . . . 0.0 109.374 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 t -143.29 38.22 1.4 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.386 -0.821 . . . . 0.0 109.073 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.612 ' O ' HD12 ' A' ' 32' ' ' ILE . . . -157.14 -94.84 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.659 HG22 ' CB ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER 19.76 86.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 117.746 0.773 . . . . 0.0 110.922 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.487 ' HA3' ' CE1' ' A' ' 8' ' ' TYR . . . -135.62 20.23 3.7 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 118.624 -1.751 . . . . 0.0 112.139 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.737 ' H ' HD12 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -174.69 114.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 120.222 -1.752 . . . . 0.0 110.979 178.726 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.563 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 1.9 tp 37.81 42.47 0.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.348 0.594 . . . . 0.0 110.639 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.659 ' CB ' HG22 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -76.7 -178.42 4.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.827 . . . . 0.0 109.043 178.396 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.548 ' HB2' ' HG2' ' A' ' 40' ' ' GLN . 7.2 m120 -114.03 112.42 23.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.727 -1.233 . . . . 0.0 109.062 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.738 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 55.1 m-85 -42.31 -26.52 0.11 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.165 -0.959 . . . . 0.0 109.452 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 37' ' ' ASN . 16.8 t80 -92.3 36.24 0.99 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.943 -1.098 . . . . 0.0 108.697 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.548 ' HG2' ' HB2' ' A' ' 37' ' ' ASN . 9.2 mm100 -80.66 -12.31 59.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.5 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.3 tt 168.94 64.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.47 -170.58 12.11 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.5 -53.44 1.06 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -141.84 -118.51 0.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -1.182 . . . . 0.0 109.426 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.14 -5.47 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.791 -1.193 . . . . 0.0 109.795 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -50.95 -62.81 1.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 109.519 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 18.2 mttp -46.52 -54.86 8.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.082 -1.011 . . . . 0.0 108.782 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.07 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -48.92 -44.33 40.28 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.774 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.63 -46.14 58.04 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.301 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.108 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -48.64 -47.58 40.22 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.721 HG13 HG13 ' A' ' 22' ' ' ILE . 10.8 t -56.63 -56.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.76 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.89 -35.64 15.28 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -66.36 -39.93 89.45 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.558 ' NE2' ' HB ' ' A' ' 22' ' ' ILE . 5.8 tp60 -54.78 -29.53 54.48 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.811 HG21 ' CD2' ' A' ' 63' ' ' LEU . 5.0 t -73.97 -61.66 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 59' ' ' TYR . 71.3 t60 -52.4 -36.32 53.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.904 -1.123 . . . . 0.0 109.435 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.49 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -75.13 -44.8 44.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.044 . . . . 0.0 109.158 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.479 ' HG3' ' HG2' ' A' ' 18' ' ' LYS . 35.4 mm-40 -69.74 -33.47 72.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.408 -0.808 . . . . 0.0 109.217 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.575 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -143.91 162.34 36.38 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.539 -0.725 . . . . 0.0 109.436 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -96.57 39.94 1.15 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.025 HG11 HG13 ' A' ' 81' ' ' VAL . 7.1 p -92.96 153.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -82.78 111.27 18.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.034 HD21 HD13 ' A' ' 77' ' ' LEU . 4.9 tp -145.24 78.28 12.37 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.488 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 35.1 Cg_endo -79.0 -172.04 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.883 2.389 . . . . 0.0 110.284 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.774 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.4 mt -78.67 -37.63 41.34 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.033 -1.042 . . . . 0.0 109.278 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -53.08 -36.67 60.94 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.557 HG11 HD12 ' A' ' 63' ' ' LEU . 2.6 t -72.75 -45.2 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.07 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -62.26 -24.16 67.11 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.395 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.4 m-85 -87.52 -35.98 17.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 108.896 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.473 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -70.74 -30.31 66.79 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.545 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.94 66.82 15.13 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -178.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.3 Cg_endo -75.88 59.37 5.75 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.915 2.41 . . . . 0.0 112.235 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.563 ' OG1' ' HA ' ' A' ' 35' ' ' LEU . 4.1 t -153.8 174.37 14.65 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 117.559 -1.656 . . . . 0.0 112.584 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.737 HD12 ' H ' ' A' ' 34' ' ' ILE . 29.0 mt -67.72 -56.94 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.452 ' H ' ' H ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -61.85 -57.51 11.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.672 -1.268 . . . . 0.0 108.84 -178.353 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.404 ' HB3' HG23 ' A' ' 73' ' ' THR . . . -48.51 -55.09 11.96 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.572 -0.705 . . . . 0.0 109.144 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.034 HD13 HD21 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -55.17 -65.42 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.0 -1.062 . . . . 0.0 109.076 179.354 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.677 ' HB1' ' HG3' ' A' ' 16' ' ' GLU . . . -43.59 -46.13 7.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.492 ' O ' HG22 ' A' ' 83' ' ' THR . 47.5 mm-40 -61.78 -53.14 60.03 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.514 ' CD1' ' CD1' ' A' ' 63' ' ' LEU . 2.5 t80 -43.18 -39.2 2.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.327 -0.858 . . . . 0.0 109.252 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.025 HG13 HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -87.93 -67.31 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.433 1.111 . . . . 0.0 109.041 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.892 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -40.03 -25.94 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.868 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 79' ' ' GLN . 2.1 t . . . . . 0 N--CA 1.492 1.666 0 O-C-N 120.858 -1.151 . . . . 0.0 109.572 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.559 ' CD2' ' O ' ' A' ' 8' ' ' TYR . 33.0 t80 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 19.8 m -109.61 28.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.965 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 168.39 147.22 0.08 OUTLIER Pre-proline 0 C--N 1.296 -1.72 0 O-C-N 121.363 -0.836 . . . . 0.0 109.867 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 36.7 Cg_endo -81.24 -172.23 1.45 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.665 2.244 . . . . 0.0 110.357 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.46 HG22 ' OE2' ' A' ' 16' ' ' GLU . 5.6 t -115.78 -28.72 6.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.557 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.48 ' OD1' ' HB2' ' A' ' 16' ' ' GLU . 10.1 p30 -141.14 156.31 45.97 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.575 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -62.35 -34.76 77.29 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.838 -1.164 . . . . 0.0 109.758 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.992 HG11 ' HB2' ' A' ' 82' ' ' ALA . 43.5 t -49.92 -48.93 22.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HG2' ' CB ' ' A' ' 78' ' ' ALA . 31.6 mt-10 -71.17 -29.36 65.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.575 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 35.4 m -53.04 -51.12 62.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.038 -1.039 . . . . 0.0 108.679 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.599 ' O ' HG22 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -68.93 -54.61 14.45 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.02 -1.072 . . . . 0.0 108.818 179.6 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.059 HD21 HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -48.35 -38.43 19.2 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.78 -1.168 . . . . 0.0 108.063 179.128 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.03 -50.57 73.6 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.66 -62.94 1.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.922 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -45.78 -52.23 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.173 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.626 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 2.2 m95 -41.51 -62.41 0.88 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.425 0.631 . . . . 0.0 109.727 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.693 ' HA ' HD11 ' A' ' 32' ' ' ILE . 4.8 pt-20 -66.25 -33.41 75.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.437 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HG3' ' N ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -62.38 -63.9 1.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.349 -179.001 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.842 HG11 ' HB3' ' A' ' 50' ' ' ALA . 11.8 t -79.23 -35.01 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.918 . . . . 0.0 111.606 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 38.4 mt -75.64 -2.79 31.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.884 -1.135 . . . . 0.0 109.955 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.88 59.06 10.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.644 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -131.45 -174.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -1.154 . . . . 0.0 109.083 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t -150.79 49.94 0.86 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.256 -0.902 . . . . 0.0 109.208 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 168.18 -73.05 0.14 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.807 HG22 HD11 ' A' ' 74' ' ' ILE . 5.1 mt 59.43 143.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.433 -1.04 . . . . 0.0 109.776 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.665 ' O ' HD13 ' A' ' 74' ' ' ILE . . . -83.73 -143.53 5.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.508 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 5.3 tt -127.64 25.2 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -1.231 . . . . 0.0 109.388 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.843 ' HA ' HG22 ' A' ' 73' ' ' THR . 6.2 tp -179.52 61.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.155 -0.965 . . . . 0.0 109.516 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.904 ' O ' HG23 ' A' ' 73' ' ' THR . 0.6 OUTLIER -91.57 -160.48 0.73 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.488 -0.757 . . . . 0.0 109.32 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.621 ' O ' ' N ' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -126.84 29.85 5.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.878 -1.139 . . . . 0.0 109.953 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 63.0 m-85 58.24 -56.17 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 O-C-N 122.139 -0.351 . . . . 0.0 110.216 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.621 ' N ' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -84.91 26.17 0.87 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.631 -1.293 . . . . 0.0 109.809 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.519 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 7.7 mm100 -80.59 76.69 7.44 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 41' ' ' ILE . 9.2 mt 66.93 74.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.83 96.71 2.46 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 47' ' ' LYS . . . -167.93 -59.73 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.7 m170 53.25 -161.16 0.12 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.121 -1.223 . . . . 0.0 109.489 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -109.92 -50.01 3.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -57.09 -43.31 82.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.961 . . . . 0.0 109.335 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.717 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -61.13 -65.29 0.72 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -0.969 . . . . 0.0 109.625 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.934 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.68 -47.96 49.94 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.888 -1.132 . . . . 0.0 108.227 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.896 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.41 -37.93 18.28 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.012 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.842 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -57.22 -49.75 75.01 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.922 HG13 ' CG1' ' A' ' 22' ' ' ILE . 9.4 t -57.13 -57.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.97 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.67 -35.08 13.08 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -67.58 -45.19 76.27 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.598 ' O ' ' CB ' ' A' ' 58' ' ' GLU . 35.4 tp60 -49.18 -31.8 9.13 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.874 HG11 HD23 ' A' ' 63' ' ' LEU . 3.4 t -68.75 -30.77 48.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.593 -0.692 . . . . 0.0 109.314 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 53' ' ' ALA . 2.8 t60 -81.57 -43.36 18.78 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.183 -0.948 . . . . 0.0 109.509 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -77.4 -34.05 54.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.956 -1.09 . . . . 0.0 108.611 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.598 ' CB ' ' O ' ' A' ' 54' ' ' GLN . 42.3 tp10 -77.1 -37.66 53.87 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.906 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -137.64 157.71 45.93 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 4.3 tt0 -93.78 32.02 1.5 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.964 HG11 ' CG1' ' A' ' 81' ' ' VAL . 6.7 p -93.64 144.33 9.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 3.1 pt-20 -69.75 136.24 50.7 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.05 -1.031 . . . . 0.0 109.456 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.874 HD23 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -143.22 92.24 6.79 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.567 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.2 Cg_endo -78.79 162.19 26.99 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.554 2.169 . . . . 0.0 110.762 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.896 HD21 ' SD ' ' A' ' 49' ' ' MET . 4.1 mm? -70.3 -29.62 66.42 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -63.67 -55.07 26.33 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.671 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 3.9 t -49.97 -42.03 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.97 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -61.78 -32.14 72.39 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.499 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 23.4 m-85 -80.43 -37.7 31.53 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.4 -35.07 79.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.469 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -144.98 69.56 14.47 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -178.883 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.587 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 30.4 Cg_endo -77.67 66.84 8.02 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.712 2.275 . . . . 0.0 109.115 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 36' ' ' ASP . 22.2 m -153.31 161.98 41.78 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 117.088 -1.845 . . . . 0.0 113.108 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.807 HD11 HG22 ' A' ' 32' ' ' ILE . 87.2 mt -57.8 -70.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 110.007 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 21.8 ttpp -57.67 -49.39 76.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.259 -0.901 . . . . 0.0 109.305 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -58.65 -71.35 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.854 -1.154 . . . . 0.0 109.369 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.059 HD12 HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -42.76 -58.21 2.44 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.247 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.594 ' HA ' HD13 ' A' ' 19' ' ' LEU . . . -49.67 -60.65 2.68 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 12.5 mm100 -45.37 -42.09 9.74 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.227 -0.92 . . . . 0.0 108.865 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.671 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 7.8 t80 -54.39 -39.01 66.82 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.964 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -87.46 -66.78 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.386 1.089 . . . . 0.0 108.659 179.227 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.992 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -45.01 -40.96 6.97 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.089 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.397 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.409 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 21.6 t80 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.03 118.04 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.762 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.877 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -56.0 172.71 0.31 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.872 . . . . 0.0 109.536 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.877 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 36.3 Cg_endo -77.9 156.05 30.64 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.876 2.384 . . . . 0.0 110.96 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.503 ' O ' HG22 ' A' ' 12' ' ' THR . 26.3 m -109.98 3.66 20.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 109.608 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.577 ' HB3' HG22 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -169.53 173.11 6.61 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.577 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -73.48 -28.08 61.74 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.658 -1.217 . . . . 0.0 109.746 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.084 HG11 ' HB2' ' A' ' 82' ' ' ALA . 16.0 m -49.5 -37.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.518 ' HG2' HG23 ' A' ' 15' ' ' VAL . 1.1 mt-10 -82.99 -38.45 22.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.577 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 24.8 p -53.47 -38.99 64.14 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.691 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -71.49 -57.89 4.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.587 -0.695 . . . . 0.0 109.23 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.744 ' HB3' HG23 ' A' ' 74' ' ' ILE . 3.9 mm? -54.2 -42.4 69.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.941 -1.099 . . . . 0.0 108.422 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 24' ' ' GLU . . . -56.0 -46.75 78.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -60.48 -63.64 1.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.918 HG12 HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -46.98 -51.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.965 ' CE3' HG21 ' A' ' 32' ' ' ILE . 2.1 m95 -39.38 -66.73 0.27 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.607 0.718 . . . . 0.0 109.929 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.609 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -63.68 -25.63 68.3 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.972 -178.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.478 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . 4.5 tpp180 -74.06 -67.12 0.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.115 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.799 HG11 ' HB3' ' A' ' 50' ' ' ALA . 72.4 t -71.36 -31.63 44.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 111.0 -178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 21.6 mt -85.58 -7.95 58.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.992 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.58 56.44 9.78 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.484 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.9 179.3 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.886 -1.361 . . . . 0.0 108.724 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -140.98 74.09 1.45 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.157 -0.964 . . . . 0.0 108.984 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 146.32 -80.35 0.22 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.965 HG21 ' CE3' ' A' ' 23' ' ' TRP . 9.8 mt 59.58 150.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.223 -1.163 . . . . 0.0 109.64 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.53 -122.52 0.72 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.696 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -147.11 -52.51 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.717 -1.46 . . . . 0.0 111.079 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.82 HD23 HG21 ' A' ' 73' ' ' THR . 5.5 mt -95.5 31.14 2.07 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.049 -1.657 . . . . 0.0 110.976 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.729 ' O ' HG23 ' A' ' 73' ' ' THR . 2.9 m-20 -59.15 -166.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.113 -0.992 . . . . 0.0 109.616 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -133.98 30.62 3.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.086 -1.009 . . . . 0.0 109.245 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.599 ' CD1' ' CZ2' ' A' ' 23' ' ' TRP . 6.5 m-30 63.91 -61.88 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.362 -0.836 . . . . 0.0 109.64 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 37' ' ' ASN . 51.5 t80 -83.43 21.37 1.18 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.903 -1.123 . . . . 0.0 110.737 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.856 ' O ' HG23 ' A' ' 41' ' ' ILE . 8.1 mm-40 -79.13 0.75 26.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.772 -1.205 . . . . 0.0 108.342 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 40' ' ' GLN . 0.1 OUTLIER 170.66 59.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.35 -132.43 1.9 Allowed Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.116 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -170.55 124.55 1.14 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.78 -176.41 0.2 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.429 -1.042 . . . . 0.0 109.752 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 46' ' ' LEU . 4.2 t -124.25 -21.56 4.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.14 -0.975 . . . . 0.0 110.351 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 49' ' ' MET . 0.4 OUTLIER -43.97 -51.02 8.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.014 -1.054 . . . . 0.0 109.246 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -44.91 -47.44 11.24 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.018 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -57.2 -45.41 83.82 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.813 ' HG2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -46.68 -51.77 15.28 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.366 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.799 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -48.3 -50.0 31.76 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.918 HG13 HG12 ' A' ' 22' ' ' ILE . 21.2 t -51.22 -55.49 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.066 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -50.18 -46.2 54.09 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -52.05 -38.35 56.75 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.567 ' HG2' ' HB ' ' A' ' 22' ' ' ILE . 24.0 tp60 -58.63 -41.04 85.03 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.9 HG21 HD22 ' A' ' 63' ' ' LEU . 14.7 t -61.5 -40.54 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 59' ' ' TYR . 10.5 t-80 -69.15 -53.27 20.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.056 -1.027 . . . . 0.0 109.149 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -38.57 84.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.037 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.543 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 13.3 mm-40 -71.82 -56.64 5.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.305 -0.872 . . . . 0.0 108.651 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.843 ' CD1' HG11 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -127.03 165.04 20.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.767 0.794 . . . . 0.0 109.532 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -95.78 46.18 1.09 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.6 t -91.44 138.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.514 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.63 103.16 1.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 109.765 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.9 HD22 HG21 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -138.94 82.58 19.81 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.055 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.564 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 34.5 Cg_endo -77.81 -178.84 4.91 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.78 2.32 . . . . 0.0 110.418 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.813 HD21 ' HG2' ' A' ' 49' ' ' MET . 2.5 mm? -65.22 -37.93 88.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 109.089 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -56.26 -60.99 2.71 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.564 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 15.2 t -47.04 -43.07 6.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.066 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -61.81 -48.68 79.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.356 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -65.51 -19.84 66.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -76.31 -52.11 10.62 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.271 1.034 . . . . 0.0 108.838 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.558 ' NE2' ' CD1' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -132.58 72.35 77.91 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.034 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.581 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 31.2 Cg_endo -76.4 67.43 7.06 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.397 2.064 . . . . 0.0 108.207 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.82 HG21 HD23 ' A' ' 35' ' ' LEU . 22.2 m -151.4 165.77 33.11 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.227 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 19' ' ' LEU . 6.1 mt -76.79 -69.58 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.331 -0.856 . . . . 0.0 109.798 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -45.84 -47.54 15.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.182 -0.948 . . . . 0.0 108.867 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.457 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -59.5 -55.48 34.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.387 -0.821 . . . . 0.0 109.147 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -56.23 -65.6 0.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.102 -0.999 . . . . 0.0 108.876 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.69 ' HB1' HG23 ' A' ' 15' ' ' VAL . . . -43.35 -37.42 2.26 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.46 -0.775 . . . . 0.0 109.054 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.447 ' O ' ' O ' ' A' ' 83' ' ' THR . 10.1 tp60 -69.95 -43.85 70.74 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.002 -1.061 . . . . 0.0 108.548 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.558 ' CD1' ' NE2' ' A' ' 71' ' ' GLN . 10.4 t80 -59.84 -33.4 71.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.33 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.843 HG11 ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -86.93 -60.74 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 122.48 1.133 . . . . 0.0 108.196 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 1.084 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -54.35 -65.32 0.6 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.418 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.585 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.485 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 2.1 t80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.36 0.6 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 9' ' ' VAL . 13.5 m -103.66 125.03 58.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.991 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -48.58 176.2 0.04 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.461 -0.774 . . . . 0.0 109.578 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.991 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 34.8 Cg_endo -76.63 136.52 17.28 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.612 2.208 . . . . 0.0 110.792 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.05 -9.01 13.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.35 -0.844 . . . . 0.0 109.323 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 15.6 m120 -141.36 153.88 45.34 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.622 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -64.98 -27.68 69.0 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.452 -1.299 . . . . 0.0 110.081 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.892 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 2.7 t -49.37 -49.62 17.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -78.18 -29.51 48.54 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.786 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.622 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 7.3 m -60.84 -42.31 97.53 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.664 -1.215 . . . . 0.0 108.684 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.475 ' HG2' ' HG3' ' A' ' 58' ' ' GLU . 0.7 OUTLIER -69.1 -51.31 39.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.712 ' HA ' HD11 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -61.11 -46.7 89.53 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.733 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.36 -45.43 55.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 22' ' ' ILE . 1.7 mm-40 -62.76 -69.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.537 -0.727 . . . . 0.0 109.541 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.973 HD12 ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -47.06 -40.58 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.872 -1.143 . . . . 0.0 108.919 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.727 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.6 m95 -49.25 -67.44 0.26 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.369 -0.832 . . . . 0.0 109.507 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.774 ' HA ' HD11 ' A' ' 32' ' ' ILE . 4.0 pt-20 -58.85 -39.29 80.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.439 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -69.51 -70.85 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.795 -1.191 . . . . 0.0 109.744 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 50' ' ' ALA . 55.3 t -55.92 -31.41 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 110.85 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.771 HD23 ' HG3' ' A' ' 47' ' ' LYS . 14.2 mt -96.53 15.0 22.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.115 -0.991 . . . . 0.0 110.8 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.42 44.77 45.65 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 121.208 -0.932 . . . . 0.0 110.978 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.771 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -117.82 -170.3 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.093 -1.239 . . . . 0.0 108.885 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 p -145.99 49.4 1.2 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.184 -0.948 . . . . 0.0 109.48 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 143.37 -66.8 0.46 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.774 HD11 ' HA ' ' A' ' 24' ' ' GLU . 1.7 mp 57.61 156.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -1.171 . . . . 0.0 109.776 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.817 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -80.31 -157.73 15.65 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -102.7 -49.08 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.272 . . . . 0.0 110.346 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.708 HD23 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -93.06 34.95 1.08 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.801 -1.187 . . . . 0.0 109.294 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -64.77 155.19 34.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.689 -0.632 . . . . 0.0 109.902 179.034 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.444 ' H ' ' CG ' ' A' ' 40' ' ' GLN . 1.8 m-20 -97.84 122.12 40.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.1 -1.0 . . . . 0.0 108.626 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.727 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 79.0 m-85 -44.5 -25.55 0.27 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.109 -0.995 . . . . 0.0 109.319 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 37' ' ' ASN . 11.9 t80 -102.05 41.26 1.23 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 108.846 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.516 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 16.5 mm-40 -79.88 -22.63 42.62 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 41' ' ' ILE . 8.4 tt 171.0 66.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.23 -104.94 2.04 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.18 49.15 0.05 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 173.38 -167.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -1.153 . . . . 0.0 109.377 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -141.01 -38.99 0.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 109.192 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.0 mm? -53.92 -34.65 60.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.771 ' HG3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -56.46 -51.98 66.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.114 -0.991 . . . . 0.0 108.39 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.704 ' HB1' ' CD2' ' A' ' 68' ' ' LEU . . . -58.73 -46.15 88.03 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.909 ' HG2' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -52.99 -32.91 48.99 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.257 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 47' ' ' LYS . . . -60.94 -44.57 97.06 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.973 ' CG1' HD12 ' A' ' 22' ' ' ILE . 4.3 t -62.13 -69.97 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.014 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -44.81 -50.14 10.39 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.264 -0.897 . . . . 0.0 108.679 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 49' ' ' MET . . . -55.89 -46.04 78.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.891 ' HG2' HG21 ' A' ' 22' ' ' ILE . 59.7 tp60 -48.21 -33.54 8.73 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.536 HG13 HG11 ' A' ' 81' ' ' VAL . 3.5 t -67.26 -67.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 59' ' ' TYR . 2.3 t-80 -46.86 -36.25 7.27 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.792 -1.192 . . . . 0.0 109.593 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -72.1 -42.66 65.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.792 -1.193 . . . . 0.0 108.717 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 18' ' ' LYS . 52.8 mm-40 -71.58 -50.76 27.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.778 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -116.91 160.14 21.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -93.67 36.95 1.07 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.798 HG11 ' CG1' ' A' ' 81' ' ' VAL . 6.3 p -94.11 145.56 7.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -82.78 112.61 19.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.5 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.071 HD21 HD13 ' A' ' 77' ' ' LEU . 15.9 tp -133.14 94.7 19.79 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.8 Cg_endo -80.91 163.66 20.53 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.784 2.323 . . . . 0.0 110.771 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.909 HD11 ' HG2' ' A' ' 49' ' ' MET . 4.5 mt -65.15 -39.1 92.51 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.385 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -48.45 -53.33 18.28 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.737 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.902 HG11 ' CD1' ' A' ' 63' ' ' LEU . 1.2 t -56.01 -46.13 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.014 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -58.13 -22.32 50.5 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.65 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.477 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.3 m-85 -86.03 -37.66 18.68 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.45 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.7 -31.57 69.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.463 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.15 67.4 21.55 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.758 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.559 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 33.0 Cg_endo -77.13 61.58 7.28 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.912 2.408 . . . . 0.0 111.933 -178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.708 HG21 HD23 ' A' ' 35' ' ' LEU . 4.4 t -152.95 176.06 12.26 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.198 -1.401 . . . . 0.0 112.053 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.817 HD12 ' O ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -73.64 -69.22 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.904 -0.498 . . . . 0.0 110.411 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.557 ' CG ' HG12 ' A' ' 34' ' ' ILE . 11.6 tmtt? -39.91 -56.53 1.79 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB3' HG23 ' A' ' 73' ' ' THR . . . -58.05 -64.33 0.95 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.514 -0.742 . . . . 0.0 109.884 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.071 HD13 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -46.27 -62.98 1.11 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.781 -1.2 . . . . 0.0 108.974 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 82' ' ' ALA . . . -44.78 -48.82 10.91 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 51.2 mm-40 -61.55 -44.5 96.93 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.464 ' CD2' HD13 ' A' ' 63' ' ' LEU . 1.1 t80 -53.29 -37.11 61.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.891 -1.13 . . . . 0.0 108.927 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.798 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -88.24 -65.43 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.431 1.11 . . . . 0.0 108.535 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.892 ' HB2' ' CB ' ' A' ' 15' ' ' VAL . . . -49.09 -20.7 0.6 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.355 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.531 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.541 ' CD1' ' O ' ' A' ' 32' ' ' ILE . 10.8 t80 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.433 0.635 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.41 130.47 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.596 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -48.94 160.63 0.47 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.118 -0.988 . . . . 0.0 110.02 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 33.3 Cg_endo -74.56 -159.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.855 2.37 . . . . 0.0 110.837 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -116.42 -7.3 11.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.456 ' O ' ' OE1' ' A' ' 16' ' ' GLU . 57.8 m-20 -140.66 149.45 42.27 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.878 -1.139 . . . . 0.0 108.267 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.615 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -61.61 -26.52 68.04 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.444 -1.302 . . . . 0.0 109.409 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.868 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 35.3 t -48.07 -58.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.69 ' HG3' ' HB1' ' A' ' 78' ' ' ALA . 1.2 mp0 -66.01 -36.67 83.9 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.615 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 70.7 m -48.55 -55.92 9.77 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.302 177.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.816 ' O ' HG23 ' A' ' 22' ' ' ILE . 20.1 tttm -52.44 -67.43 0.25 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.811 HD12 ' NZ ' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -43.0 -46.48 5.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.336 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -49.82 -57.98 6.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.78 -1.2 . . . . 0.0 109.08 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -51.08 71.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 109.4 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.972 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -54.69 -44.06 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.78 ' HB3' HD13 ' A' ' 32' ' ' ILE . 3.3 m95 -52.22 -66.2 0.42 Allowed 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.619 0.723 . . . . 0.0 109.721 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.651 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -58.9 -53.73 55.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.463 -0.773 . . . . 0.0 110.046 -178.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -54.15 -66.08 0.46 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 109.982 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.968 HG11 ' HB3' ' A' ' 50' ' ' ALA . 21.6 t -58.56 -43.73 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.797 . . . . 0.0 110.719 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 42.3 mt -78.69 -12.38 60.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.996 -1.065 . . . . 0.0 110.347 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 72.73 53.27 8.45 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.409 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.36 -178.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.125 -1.221 . . . . 0.0 109.127 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.08 39.71 1.34 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.209 -0.932 . . . . 0.0 109.472 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -156.17 -91.2 0.08 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.78 HD13 ' HB3' ' A' ' 23' ' ' TRP . 14.7 mt 58.63 149.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -1.164 . . . . 0.0 109.721 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.38 -154.96 19.41 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.618 ' HA ' HG21 ' A' ' 74' ' ' ILE . 9.1 pt -98.84 2.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.139 -1.212 . . . . 0.0 110.024 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 35' ' ' LEU . 1.3 tt -162.41 69.1 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.979 -1.076 . . . . 0.0 108.986 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.512 ' N ' ' HG1' ' A' ' 73' ' ' THR . 1.8 m-20 -98.49 160.68 14.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.679 -0.638 . . . . 0.0 109.562 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 40' ' ' GLN . 1.2 t-20 -89.49 106.83 18.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.726 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 43.4 m-85 -31.73 -34.02 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.595 0 O-C-N 121.789 -0.569 . . . . 0.0 111.111 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 37' ' ' ASN . 12.6 t80 -99.59 38.28 1.46 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.734 -1.229 . . . . 0.0 109.784 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.833 ' O ' HG23 ' A' ' 41' ' ' ILE . 5.3 mm-40 -81.27 -22.0 38.99 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.833 HG23 ' O ' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -172.67 52.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.427 -0.795 . . . . 0.0 109.082 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.04 -138.24 3.8 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.56 132.13 2.0 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 69.12 162.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -1.162 . . . . 0.0 109.263 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.81 -10.3 31.85 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 109.821 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -46.15 -58.86 3.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.08 -1.012 . . . . 0.0 109.51 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.0 tptt -47.0 -59.35 3.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 109.854 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.073 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -58.06 -45.26 87.38 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.032 -1.042 . . . . 0.0 109.137 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.72 ' HG2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.77 -49.6 37.87 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.331 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.968 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -50.38 -55.63 14.86 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.972 ' CG1' HD11 ' A' ' 22' ' ' ILE . 21.6 t -43.13 -60.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.072 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -49.95 -54.89 16.96 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.527 ' HB2' ' CE ' ' A' ' 49' ' ' MET . . . -47.36 -50.63 21.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.73 ' HB3' HD12 ' A' ' 22' ' ' ILE . 35.5 tp60 -46.91 -38.6 10.76 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.008 HG11 HD13 ' A' ' 63' ' ' LEU . 17.0 t -60.23 -62.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 59' ' ' TYR . 53.9 t-80 -58.34 -32.82 68.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.419 -0.801 . . . . 0.0 110.046 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -74.29 -39.33 62.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.046 -1.034 . . . . 0.0 109.548 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.551 ' HB2' ' CE ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -78.29 -44.59 24.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 109.295 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.883 ' HB2' HG12 ' A' ' 61' ' ' VAL . 5.4 m-85 -110.96 -174.43 2.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 54.5 tp60 -113.54 29.15 8.22 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.883 HG12 ' HB2' ' A' ' 59' ' ' TYR . 3.4 p -93.85 134.3 31.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.654 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -74.34 103.61 4.78 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.465 -0.772 . . . . 0.0 110.097 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.008 HD13 HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -116.81 95.79 47.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.118 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.518 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 37.4 Cg_endo -82.88 169.17 13.43 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.721 2.281 . . . . 0.0 110.157 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.72 HD21 ' HG2' ' A' ' 49' ' ' MET . 1.9 mt -66.52 -37.73 85.65 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.076 -1.015 . . . . 0.0 109.045 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -40.69 64.84 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.518 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 4.6 t -65.53 -43.6 94.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.073 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -58.06 -26.14 62.12 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.115 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.5 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 10.2 m-85 -86.29 -34.73 20.27 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.72 -25.39 64.73 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.915 0.864 . . . . 0.0 108.736 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.682 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -154.58 66.76 5.28 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -177.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.568 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.7 Cg_endo -75.1 53.99 3.55 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.767 2.311 . . . . 0.0 112.338 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 76' ' ' ALA . 14.6 t -153.23 170.03 21.58 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.591 -1.318 . . . . 0.0 111.238 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.684 HD11 ' CG ' ' A' ' 23' ' ' TRP . 9.4 mm -60.25 -71.69 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.869 -0.519 . . . . 0.0 111.776 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -50.22 -54.04 23.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.057 -1.027 . . . . 0.0 110.362 -178.049 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -53.45 -67.93 0.22 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.664 ' HB3' HD21 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -53.27 -59.32 4.72 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.479 -0.889 . . . . 0.0 109.323 -179.276 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.69 ' HB1' ' HG3' ' A' ' 16' ' ' GLU . . . -45.78 -44.68 14.17 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -61.71 -42.42 98.92 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.056 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.04 -33.82 65.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 108.856 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.869 HG13 HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -86.98 -60.98 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.481 1.134 . . . . 0.0 108.898 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.868 ' HB2' ' CB ' ' A' ' 15' ' ' VAL . . . -53.61 -41.24 66.46 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.688 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.478 ' HB ' ' OE1' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 120.927 -1.108 . . . . 0.0 109.598 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' A' ' 32' ' ' ILE . 47.8 t80 . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.693 ' O ' HG12 ' A' ' 9' ' ' VAL . 46.3 t -108.69 36.39 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.967 . . . . 0.0 110.38 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 169.27 142.73 0.07 OUTLIER Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.195 -0.941 . . . . 0.0 110.354 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 37.1 Cg_endo -84.64 -158.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.94 2.427 . . . . 0.0 110.442 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.457 ' OG1' ' OE1' ' A' ' 16' ' ' GLU . 0.6 OUTLIER -128.71 -41.93 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.429 -0.794 . . . . 0.0 109.105 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -131.8 171.73 13.17 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.593 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -73.1 -33.87 65.84 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.681 -1.262 . . . . 0.0 110.165 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.134 HG21 ' HB2' ' A' ' 82' ' ' ALA . 57.5 t -51.62 -51.68 25.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.501 ' OE1' ' CD1' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -70.45 -27.92 64.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.125 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.593 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 49.5 m -53.4 -51.68 61.81 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.799 -1.161 . . . . 0.0 108.166 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.606 ' O ' HG23 ' A' ' 22' ' ' ILE . 5.7 tptm -66.53 -62.74 1.3 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.361 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.488 ' CA ' HG23 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -39.93 -49.72 2.46 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -51.23 -51.48 53.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' LYS . 4.0 mt-10 -58.64 -62.79 1.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.97 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -42.89 -46.36 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.068 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.644 ' CE2' HG12 ' A' ' 74' ' ' ILE . 4.1 m95 -54.93 -70.77 0.09 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 121.702 0.763 . . . . 0.0 110.194 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.615 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -57.83 -47.33 82.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 110.272 -178.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.449 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 14.2 ttm180 -62.41 -65.18 0.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.015 -1.053 . . . . 0.0 110.302 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' ' 50' ' ' ALA . 29.5 t -61.76 -36.13 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.372 -0.83 . . . . 0.0 111.007 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 42.2 mt -84.54 -35.78 22.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.974 -1.079 . . . . 0.0 110.01 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 92.59 56.55 1.53 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.208 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.53 172.49 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -1.203 . . . . 0.0 109.159 179.507 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.2 t -131.8 39.23 3.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.198 -0.939 . . . . 0.0 109.174 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -157.36 -89.0 0.07 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 24' ' ' GLU . 10.8 mt 59.07 141.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -1.158 . . . . 0.0 109.804 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.769 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -101.77 -147.26 19.71 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.501 ' CD1' ' OE1' ' A' ' 16' ' ' GLU . 20.2 tt -113.1 9.58 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.116 -1.226 . . . . 0.0 110.285 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.004 HD23 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -163.01 60.28 0.19 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.778 -1.202 . . . . 0.0 110.029 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 4.1 m-20 -92.76 148.86 21.69 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -83.4 52.27 2.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.687 -1.258 . . . . 0.0 109.272 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.635 ' CE2' ' HA ' ' A' ' 72' ' ' PRO . 22.6 m-85 37.84 26.26 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.63 -0.669 . . . . 0.0 110.322 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 37' ' ' ASN . 17.3 t80 -162.52 27.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.864 -1.147 . . . . 0.0 110.57 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.486 ' HG3' ' OD1' ' A' ' 36' ' ' ASP . 62.2 mm-40 -80.53 -7.7 59.31 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER 178.04 56.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.8 134.76 4.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 44' ' ' HIS . . . -160.17 -98.89 0.14 Allowed Glycine 0 N--CA 1.489 2.21 0 O-C-N 120.949 -1.324 . . . . 0.0 109.891 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 43' ' ' GLY . 2.6 t-160 77.64 132.44 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -1.066 . . . . 0.0 109.146 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 t -58.53 -53.93 52.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.61 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -51.24 -54.75 22.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.761 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -55.44 -60.35 3.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 109.826 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.834 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -52.49 -44.57 65.72 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.797 -1.189 . . . . 0.0 108.73 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.947 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.38 -45.72 55.55 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.676 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -51.83 -56.04 16.36 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.97 ' CG1' HD11 ' A' ' 22' ' ' ILE . 34.2 t -43.82 -66.19 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.034 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.23 -44.27 32.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 108.721 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -58.96 -47.3 85.58 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.577 ' HG2' ' HB ' ' A' ' 22' ' ' ILE . 11.5 tp60 -47.56 -33.24 6.24 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.593 HG21 ' HG ' ' A' ' 63' ' ' LEU . 15.0 t -67.53 -37.52 78.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 53' ' ' ALA . 36.5 t60 -77.48 -42.14 36.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.163 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -39.19 78.92 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.616 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 8.2 tp10 -74.53 -48.79 24.93 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.779 ' CD2' HG11 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -125.13 159.01 32.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 179.041 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -94.55 37.54 1.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.911 HG11 ' CG1' ' A' ' 81' ' ' VAL . 7.3 p -94.51 159.31 2.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.305 0.574 . . . . 0.0 109.834 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.458 ' N ' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -75.34 119.09 18.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 0.0 109.662 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -143.21 74.11 17.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.93 . . . . 0.0 108.8 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.2 Cg_endo -79.82 165.47 22.19 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.778 2.318 . . . . 0.0 110.267 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.947 HD21 ' SD ' ' A' ' 49' ' ' MET . 7.5 mt -65.18 -39.3 92.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.055 -1.028 . . . . 0.0 109.115 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -51.61 -45.34 63.19 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 2.7 t -61.59 -45.46 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.034 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -57.49 -28.9 63.83 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.321 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.441 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 49.4 m-85 -79.19 -42.91 24.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.013 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.45 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.64 -34.9 79.29 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.907 0.86 . . . . 0.0 109.153 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.45 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -144.02 71.46 16.66 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.635 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 33.7 Cg_endo -77.09 56.01 5.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.829 2.353 . . . . 0.0 111.959 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 1.004 HG21 HD23 ' A' ' 35' ' ' LEU . 4.8 t -152.26 178.82 9.1 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 117.664 -1.614 . . . . 0.0 113.094 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.769 HD12 ' O ' ' A' ' 33' ' ' GLY . 1.4 mt -69.97 -78.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.514 -178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.495 ' HB2' HG12 ' A' ' 34' ' ' ILE . 5.2 tttm -41.05 -54.86 2.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.503 -0.748 . . . . 0.0 109.388 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.722 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -52.65 -63.05 1.27 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.612 -0.835 . . . . 0.0 108.826 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.574 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -48.81 -63.64 1.03 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.448 -1.407 . . . . 0.0 108.245 178.765 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.688 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -43.18 -31.66 0.62 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.6 OUTLIER -79.18 -46.46 17.87 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -55.4 -33.14 63.25 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.911 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -89.02 -68.3 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 122.269 1.033 . . . . 0.0 109.014 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 1.134 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -55.94 -55.3 34.28 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.648 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' GLN . 76.1 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.41 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.505 ' CD2' ' HA2' ' A' ' 33' ' ' GLY . 59.8 t80 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.305 0.574 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 t -104.12 123.74 58.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 108.719 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.824 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -49.22 170.15 0.15 Allowed Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.175 -0.953 . . . . 0.0 109.358 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.824 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 34.4 Cg_endo -77.27 139.09 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.654 2.236 . . . . 0.0 110.742 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.9 0.51 17.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.5 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' ALA . 1.1 m-80 -136.22 130.6 33.37 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.63 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -48.82 -34.87 13.26 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.552 -1.259 . . . . 0.0 109.711 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.959 HG21 ' HB2' ' A' ' 82' ' ' ALA . 48.4 t -44.72 -54.78 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.689 ' OE1' HD11 ' A' ' 34' ' ' ILE . 2.4 mt-10 -70.88 -30.1 66.38 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 69.8 m -55.94 -49.61 73.05 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.062 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.697 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -70.67 -56.28 6.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.4 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.721 ' HA ' HG23 ' A' ' 22' ' ' ILE . 3.4 mm? -50.14 -43.23 51.91 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -56.54 -49.05 75.93 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -60.67 -62.35 1.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.799 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -45.91 -52.26 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 1.169 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.9 m95 -40.53 -67.26 0.25 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.946 0.879 . . . . 0.0 110.417 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.628 ' HA ' HD11 ' A' ' 32' ' ' ILE . 14.6 pt-20 -63.02 -28.05 69.84 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.494 0.664 . . . . 0.0 109.903 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -73.05 -65.29 0.82 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.543 -0.723 . . . . 0.0 110.501 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.91 HG12 ' HB2' ' A' ' 47' ' ' LYS . 76.8 t -69.68 -30.98 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 110.356 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 21.9 mt -86.88 -20.66 27.12 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.118 -0.989 . . . . 0.0 110.019 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.04 62.4 2.35 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.126 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -138.39 -167.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.284 . . . . 0.0 108.906 179.038 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.01 70.09 1.26 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.186 -0.946 . . . . 0.0 109.301 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 132.0 -73.15 0.47 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.169 HG21 ' CE3' ' A' ' 23' ' ' TRP . 6.1 mt 61.49 133.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.24 -1.153 . . . . 0.0 109.29 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.992 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -52.35 -171.64 0.03 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.689 HD11 ' OE1' ' A' ' 16' ' ' GLU . 6.4 tt -106.2 8.49 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.102 -1.234 . . . . 0.0 109.188 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.823 HD12 ' CG2' ' A' ' 73' ' ' THR . 22.2 tp -157.52 48.98 0.42 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.081 -1.012 . . . . 0.0 109.872 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.642 ' O ' HG23 ' A' ' 73' ' ' THR . 5.9 m-20 -74.04 -166.38 0.39 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.117 -0.989 . . . . 0.0 110.29 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -132.48 33.35 3.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.453 -0.78 . . . . 0.0 109.122 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 72' ' ' PRO . 5.8 m-30 61.76 -52.07 0.13 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.875 -0.516 . . . . 0.0 111.245 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -81.27 25.64 0.48 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.684 -1.26 . . . . 0.0 110.925 -178.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.484 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 13.9 mm100 -80.74 -0.05 36.74 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 41' ' ' ILE . 0.8 OUTLIER 167.97 63.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.16 -137.63 2.69 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.71 -67.35 0.04 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.79 169.68 9.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -1.188 . . . . 0.0 109.465 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -98.19 -13.01 21.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.38 -0.825 . . . . 0.0 109.197 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -43.09 -59.11 2.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.368 -0.833 . . . . 0.0 109.463 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.91 ' HB2' HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -54.56 -42.82 71.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.053 -1.029 . . . . 0.0 109.115 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.011 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -52.43 -52.88 51.7 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.868 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.95 -41.79 25.85 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.906 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -50.47 -48.52 56.63 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.799 HG13 ' CG1' ' A' ' 22' ' ' ILE . 10.0 t -54.51 -55.57 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.913 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -49.27 -47.92 46.29 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -53.63 -42.63 67.96 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 8.3 tp-100 -56.47 -30.38 62.86 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.945 HG21 HD22 ' A' ' 63' ' ' LEU . 21.2 t -70.63 -43.43 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -0.825 . . . . 0.0 109.208 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 59' ' ' TYR . 12.1 t-80 -77.28 -32.74 55.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.019 . . . . 0.0 109.293 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.409 ' NE ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -80.5 -39.22 28.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 108.956 179.637 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -74.65 -44.78 48.72 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.076 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.771 ' HB2' HG12 ' A' ' 61' ' ' VAL . 1.1 m-85 -122.27 -176.8 3.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.918 . . . . 0.0 109.233 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -114.28 35.2 4.28 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.981 HG11 HG13 ' A' ' 81' ' ' VAL . 3.2 p -93.7 158.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.572 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' N ' HG22 ' A' ' 61' ' ' VAL . 1.7 tt0 -96.65 102.36 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.923 . . . . 0.0 110.453 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.945 HD22 HG21 ' A' ' 55' ' ' VAL . 3.2 tp -115.83 99.89 53.0 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.53 ' HG2' HG23 ' A' ' 67' ' ' VAL . 33.7 Cg_endo -77.15 152.82 31.51 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.378 2.052 . . . . 0.0 111.035 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.868 HD21 ' SD ' ' A' ' 49' ' ' MET . 1.9 mm? -52.74 -41.7 64.24 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' PHE . 1.5 ttmt -53.44 -57.1 11.84 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.53 HG23 ' HG2' ' A' ' 64' ' ' PRO . 4.0 t -50.08 -38.69 15.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.011 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -63.87 -31.11 72.18 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.712 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 66' ' ' LYS . 2.0 m-85 -84.25 -35.07 23.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.4 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.77 -38.59 89.46 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.781 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.2 69.14 27.69 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 31.9 Cg_endo -78.95 69.28 7.97 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.361 2.041 . . . . 0.0 108.001 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.823 ' CG2' HD12 ' A' ' 35' ' ' LEU . 98.5 m -151.83 167.2 29.04 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.013 -1.475 . . . . 0.0 111.633 -177.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.992 HD12 ' O ' ' A' ' 33' ' ' GLY . 5.5 mt -67.41 -77.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.352 -0.842 . . . . 0.0 110.99 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.8 ' HB3' HD13 ' A' ' 35' ' ' LEU . 16.7 ttpp -45.91 -46.6 16.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.333 -0.854 . . . . 0.0 109.517 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -58.73 -68.54 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.96 . . . . 0.0 109.75 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.781 HD23 ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -44.55 -59.21 2.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.772 -1.205 . . . . 0.0 108.522 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.753 ' HB1' HG12 ' A' ' 15' ' ' VAL . . . -47.26 -32.91 5.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -77.84 -44.17 28.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 0.0 109.042 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.401 ' CD2' ' NE2' ' A' ' 71' ' ' GLN . 3.3 t80 -64.83 -29.29 70.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.312 -0.868 . . . . 0.0 108.974 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.981 HG13 HG11 ' A' ' 61' ' ' VAL . 21.3 t -86.68 -59.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.332 1.063 . . . . 0.0 109.309 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.959 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -58.28 -26.67 63.26 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.458 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.056 -1.028 . . . . 0.0 109.661 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.566 ' CE1' ' HA2' ' A' ' 33' ' ' GLY . 82.6 t80 . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.6 m -103.23 120.63 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 0.0 109.559 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.957 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -59.04 175.76 0.32 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.334 -0.854 . . . . 0.0 109.951 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.957 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 34.8 Cg_endo -77.63 -158.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.861 2.374 . . . . 0.0 110.896 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 p -126.62 -34.1 2.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.111 -0.993 . . . . 0.0 110.852 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 17' ' ' SER . 38.8 p-10 -122.29 169.04 11.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.841 -1.162 . . . . 0.0 109.131 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.624 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -74.65 -2.89 28.16 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.304 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.074 HG12 ' HB1' ' A' ' 78' ' ' ALA . 40.2 t -65.29 -55.97 17.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 78' ' ' ALA . 42.1 mt-10 -77.59 -32.01 53.35 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.624 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -63.02 -42.89 99.92 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.837 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.621 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -66.32 -63.71 1.02 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.552 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 19' ' ' LEU . 5.5 mp -45.76 -45.07 14.36 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -47.54 -51.78 19.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.791 -1.193 . . . . 0.0 108.347 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.458 ' OE1' ' NH1' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -61.43 -62.08 2.08 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.974 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -43.46 -43.44 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-O 122.27 1.033 . . . . 0.0 108.331 178.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.795 ' CE3' HG21 ' A' ' 32' ' ' ILE . 3.7 m95 -53.19 -67.88 0.22 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.987 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.438 ' HA ' HG23 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -64.31 -35.14 79.89 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.378 -0.826 . . . . 0.0 110.288 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' NH1' ' OE1' ' A' ' 21' ' ' GLU . 27.1 ttm180 -68.83 -58.64 3.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.489 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.667 HG11 ' HB3' ' A' ' 50' ' ' ALA . 65.7 t -74.19 -37.24 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 0.0 110.823 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.46 ' CG ' ' O ' ' A' ' 23' ' ' TRP . 36.9 mt -77.22 -51.99 9.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.902 -1.124 . . . . 0.0 109.946 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.2 53.22 0.28 Allowed Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.184 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.653 ' CG2' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -137.42 -171.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -1.185 . . . . 0.0 108.716 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.81 39.87 0.96 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.3 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -161.06 -80.58 0.04 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.795 HG21 ' CE3' ' A' ' 23' ' ' TRP . 6.9 mt 40.83 94.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.52 -0.988 . . . . 0.0 109.932 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.864 ' C ' HD12 ' A' ' 34' ' ' ILE . . . -59.22 -88.49 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.864 HD12 ' C ' ' A' ' 33' ' ' GLY . 5.0 mp -151.1 -58.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.994 -1.298 . . . . 0.0 110.599 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -87.25 34.93 0.69 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.16 -1.588 . . . . 0.0 109.501 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -63.34 166.97 5.74 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.438 0.637 . . . . 0.0 109.634 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 40' ' ' GLN . 1.6 m120 -106.52 116.79 32.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.213 -0.93 . . . . 0.0 108.525 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.729 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 46.6 m-85 -41.45 -27.27 0.08 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.284 -0.885 . . . . 0.0 109.793 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.454 ' N ' ' O ' ' A' ' 37' ' ' ASN . 6.5 t80 -93.02 35.96 1.05 Allowed 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.581 -1.248 . . . . 0.0 108.942 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.565 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 13.3 mm-40 -80.26 -12.96 59.57 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER 157.82 90.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.603 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.21 -137.83 2.79 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.18 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -139.01 -82.16 0.09 OUTLIER Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.152 -1.205 . . . . 0.0 110.215 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.75 -175.48 2.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.038 -1.272 . . . . 0.0 110.227 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 46' ' ' LEU . 2.9 p -75.18 -29.45 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -0.753 . . . . 0.0 109.601 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.546 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -42.52 -51.07 5.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.653 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -51.99 -61.96 1.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 109.77 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.002 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.34 -51.26 35.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.082 -1.011 . . . . 0.0 109.414 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.914 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -46.45 -47.05 19.19 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.269 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.667 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -50.86 -54.57 22.7 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.974 ' CG1' HD11 ' A' ' 22' ' ' ILE . 38.2 t -44.65 -59.13 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.962 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -51.76 -46.62 64.17 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -53.44 -49.62 66.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.612 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.9 tp-100 -45.6 -39.9 8.21 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.836 HG11 HD12 ' A' ' 63' ' ' LEU . 2.6 t -66.36 -34.45 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.55 0.69 . . . . 0.0 109.471 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 53' ' ' ALA . 13.4 t-160 -82.13 -32.68 29.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.879 -1.138 . . . . 0.0 109.825 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -76.68 -37.01 56.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.982 -1.074 . . . . 0.0 108.566 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.501 ' HG3' ' HE2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -76.65 -51.23 11.92 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.32 -0.863 . . . . 0.0 108.859 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.613 ' HB2' HG12 ' A' ' 61' ' ' VAL . 2.0 m-85 -112.33 179.02 4.11 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.762 0.791 . . . . 0.0 109.439 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -109.85 40.51 1.89 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.028 HG11 HG13 ' A' ' 81' ' ' VAL . 4.3 p -92.9 127.06 45.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.763 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -71.19 97.09 1.47 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.722 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.836 HD12 HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -112.36 102.12 53.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.508 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.497 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 36.4 Cg_endo -79.64 160.47 25.05 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.428 2.085 . . . . 0.0 110.688 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.914 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.2 mm? -61.69 -45.45 93.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.274 -0.891 . . . . 0.0 108.943 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HE3' ' HB2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -52.02 -44.21 64.07 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.097 -1.002 . . . . 0.0 108.827 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.503 ' CG1' ' CD2' ' A' ' 63' ' ' LEU . 2.0 t -56.09 -42.99 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.002 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -60.29 -24.9 65.32 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.482 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 14.1 m-85 -87.31 -38.87 15.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.359 -0.838 . . . . 0.0 108.904 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.85 -31.74 72.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.516 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -144.59 70.34 15.42 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.758 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.576 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 33.2 Cg_endo -76.91 53.06 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.791 2.327 . . . . 0.0 111.887 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.642 ' HA ' ' CZ2' ' A' ' 23' ' ' TRP . 6.2 t -152.24 167.62 28.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.699 -1.251 . . . . 0.0 110.769 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.632 HD11 HG22 ' A' ' 32' ' ' ILE . 14.0 mt -68.68 -60.58 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.961 -1.087 . . . . 0.0 110.014 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.739 ' CB ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -42.13 -58.03 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.517 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -64.88 -66.81 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 110.245 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.792 HD11 HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -47.77 -64.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.017 . . . . 0.0 109.309 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 1.074 ' HB1' HG12 ' A' ' 15' ' ' VAL . . . -43.69 -45.28 6.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 3.4 tp60 -62.17 -39.67 93.44 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.487 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -57.56 -34.19 68.92 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.028 HG13 HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -84.47 -69.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.856 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -43.46 -36.04 1.84 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.256 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.47 ' HB ' ' NE2' ' A' ' 79' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.025 -1.047 . . . . 0.0 109.686 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.589 ' CZ ' ' HA2' ' A' ' 33' ' ' GLY . 55.8 t80 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 15.3 m -126.22 41.43 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.134 -0.979 . . . . 0.0 109.945 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 169.71 144.06 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.919 . . . . 0.0 109.827 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 36.3 Cg_endo -82.55 -159.94 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.776 2.317 . . . . 0.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.45 ' N ' ' OE2' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -119.41 -44.69 2.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 109.403 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.465 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -126.59 168.35 14.43 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.133 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.639 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -76.47 -32.09 58.18 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.088 -1.445 . . . . 0.0 109.586 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.94 HG11 ' HB2' ' A' ' 82' ' ' ALA . 30.9 t -51.58 -54.02 14.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 13' ' ' ASN . 3.1 pt-20 -70.85 -27.34 63.77 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.639 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 68.3 m -58.21 -50.39 73.71 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.916 -1.114 . . . . 0.0 108.514 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HE3' ' OE2' ' A' ' 58' ' ' GLU . 4.0 tptt -64.26 -51.36 63.96 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.647 -0.658 . . . . 0.0 109.654 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.871 ' HA ' HG22 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -60.89 -49.06 79.01 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.571 -1.252 . . . . 0.0 108.344 179.717 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -47.31 -42.41 21.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.339 -1.476 . . . . 0.0 107.498 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.48 -63.01 1.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.928 HG23 HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.94 -38.94 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.881 -1.137 . . . . 0.0 108.243 179.354 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.799 ' HB3' HD13 ' A' ' 32' ' ' ILE . 3.0 m95 -49.15 -66.96 0.31 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.884 0.849 . . . . 0.0 109.129 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.625 ' HA ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -53.86 -47.25 71.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.827 -0.545 . . . . 0.0 110.459 -178.743 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -60.06 -68.53 0.28 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.039 -1.038 . . . . 0.0 110.629 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.062 HG11 ' HB3' ' A' ' 50' ' ' ALA . 47.5 t -61.93 -34.67 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 110.979 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' CD1' ' CE3' ' A' ' 23' ' ' TRP . 64.7 mt -83.14 -43.67 15.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.802 -1.186 . . . . 0.0 109.991 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 106.45 49.63 0.91 Allowed Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.789 -1.196 . . . . 0.0 110.685 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.625 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.59 176.57 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.983 -1.304 . . . . 0.0 109.22 179.378 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 t -132.68 35.48 3.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 108.549 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -149.83 -98.39 0.19 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.002 HG22 HD11 ' A' ' 74' ' ' ILE . 1.3 mt 53.6 104.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.054 -1.262 . . . . 0.0 108.434 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.589 ' HA2' ' CZ ' ' A' ' 8' ' ' TYR . . . -99.2 -88.12 1.95 Allowed Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.571 -1.3 . . . . 0.0 111.535 -178.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.575 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 1.7 mt -142.36 111.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.053 -1.263 . . . . 0.0 109.531 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.818 ' C ' HG22 ' A' ' 73' ' ' THR . 0.3 OUTLIER 88.62 46.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.734 0.778 . . . . 0.0 109.737 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.684 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -83.97 -148.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 40' ' ' GLN . 26.2 m-20 -128.26 114.3 16.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.542 -1.349 . . . . 0.0 110.8 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.772 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 66.6 m-85 -67.51 -67.56 0.45 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.973 -1.079 . . . . 0.0 108.436 178.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.552 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 30.1 t80 -126.23 30.25 5.65 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.589 -0.694 . . . . 0.0 110.441 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 37' ' ' ASN . 16.9 mm-40 -79.91 -8.13 59.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -175.83 52.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.245 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.19 -101.45 1.76 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 44' ' ' HIS . . . 170.99 113.09 0.29 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER 70.03 120.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -1.11 . . . . 0.0 109.94 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.8 p -66.12 -15.74 63.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.925 . . . . 0.0 109.599 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.501 ' N ' HD22 ' A' ' 46' ' ' LEU . 3.2 mm? -52.39 -31.29 33.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.038 -1.038 . . . . 0.0 109.07 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.1 tptt -64.91 -71.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.025 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -46.99 -48.47 21.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.897 -1.127 . . . . 0.0 108.245 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.933 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.55 -45.23 37.36 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.425 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.062 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -49.67 -47.99 49.77 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.928 HG13 HG23 ' A' ' 22' ' ' ILE . 7.1 t -58.34 -55.81 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.865 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.65 -53.38 18.82 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.99 -43.72 50.59 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.588 ' CG ' HG13 ' A' ' 22' ' ' ILE . 45.5 tp60 -52.51 -34.96 51.97 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.84 HG21 HD22 ' A' ' 63' ' ' LEU . 18.9 t -65.66 -49.27 78.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.567 -0.708 . . . . 0.0 109.759 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' TYR . 18.7 t60 -68.42 -33.61 74.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.969 -1.082 . . . . 0.0 109.589 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.12 -37.08 34.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.964 -1.085 . . . . 0.0 108.441 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.502 ' HG2' ' HG3' ' A' ' 54' ' ' GLN . 58.6 mm-40 -70.48 -44.38 67.81 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.889 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -136.04 175.93 9.15 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.33 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.46 40.95 1.18 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 59' ' ' TYR . 7.9 t -93.03 125.93 45.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 19.9 tt0 -68.89 92.04 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 0.0 109.292 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.84 HD22 HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -112.31 95.64 31.87 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 35.4 Cg_endo -78.57 169.73 19.38 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.354 2.036 . . . . 0.0 110.553 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.933 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.5 mm? -66.91 -37.17 83.86 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -56.13 -55.82 28.36 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.499 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 4.4 t -48.45 -46.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.025 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -58.49 -38.08 76.9 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.729 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.488 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 8.1 m-85 -74.84 -36.56 62.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 109.291 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.408 ' C ' ' HD3' ' A' ' 72' ' ' PRO . . . -66.88 -38.77 86.93 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.324 -0.86 . . . . 0.0 109.217 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -139.23 66.06 36.83 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -178.547 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.536 ' CA ' ' O ' ' A' ' 68' ' ' LEU . 33.3 Cg_endo -77.19 61.31 7.23 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.973 2.448 . . . . 0.0 112.462 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.818 HG22 ' C ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -152.13 150.09 29.51 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.881 -1.137 . . . . 0.0 110.657 178.478 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.002 HD11 HG22 ' A' ' 32' ' ' ILE . 9.4 mt -53.73 -54.04 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.854 -1.154 . . . . 0.0 109.669 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -51.26 -65.68 0.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.97 -1.081 . . . . 0.0 109.17 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.71 -63.45 1.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 0.0 109.661 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.732 HD21 HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -45.54 -67.04 0.32 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.541 -0.724 . . . . 0.0 109.128 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 74' ' ' ILE . . . -45.69 -49.84 14.16 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -56.7 -40.02 74.88 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.222 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -56.31 -37.75 70.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 108.573 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.705 HG11 ' CD1' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -86.73 -63.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.619 1.199 . . . . 0.0 108.981 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.94 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -49.7 -20.77 0.88 Allowed 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.209 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.47 ' CB ' ' OE1' ' A' ' 79' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.449 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.514 ' HE2' HG23 ' A' ' 34' ' ' ILE . 41.0 t80 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 23.0 m -121.0 30.63 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.916 . . . . 0.0 109.67 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 169.02 157.82 0.17 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.472 -0.767 . . . . 0.0 109.767 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.431 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 35.2 Cg_endo -78.74 -159.33 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.741 2.294 . . . . 0.0 110.516 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.1 m -124.55 -51.15 1.73 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.63 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 2.6 t-20 -137.37 177.29 7.98 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.609 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -71.3 -37.54 71.82 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.654 -1.218 . . . . 0.0 109.937 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.879 HG11 ' HB2' ' A' ' 82' ' ' ALA . 56.8 t -49.74 -52.48 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 178.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.653 ' OE1' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -72.72 -22.48 60.88 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.079 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.609 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 60.5 m -58.64 -48.21 81.78 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.226 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.746 ' O ' HG22 ' A' ' 22' ' ' ILE . 7.8 tptt -68.85 -51.89 35.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.304 -0.872 . . . . 0.0 108.723 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.754 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 3.4 mm? -54.99 -36.86 65.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.653 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . . . -56.79 -48.3 78.23 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 23.7 mt-10 -64.25 -63.09 1.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.174 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.754 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -47.86 -45.94 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.836 -1.165 . . . . 0.0 108.405 179.58 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.746 ' HB3' HD13 ' A' ' 32' ' ' ILE . 2.9 m95 -49.34 -68.44 0.18 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.449 0.642 . . . . 0.0 110.228 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.675 ' HA ' HD11 ' A' ' 32' ' ' ILE . 8.8 pt-20 -61.04 -31.5 71.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 110.218 -178.545 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -68.56 -68.32 0.4 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 110.333 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.91 HG11 ' HB3' ' A' ' 50' ' ' ALA . 77.6 t -67.99 -33.38 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 -178.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 37.2 mt -82.13 0.08 42.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.951 -1.093 . . . . 0.0 110.033 -179.182 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.79 56.9 22.61 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -136.84 -174.47 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -1.189 . . . . 0.0 109.161 179.518 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 t -153.02 60.35 0.78 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.272 -0.893 . . . . 0.0 109.322 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 165.43 -76.65 0.14 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.141 -1.983 . . . . 0.0 108.141 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.746 HD13 ' HB3' ' A' ' 23' ' ' TRP . 6.8 mt 58.37 151.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.426 -1.044 . . . . 0.0 109.952 178.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.97 -164.26 37.66 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.557 ' HA ' HG21 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -100.94 -2.02 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.381 -1.07 . . . . 0.0 110.326 -179.727 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.611 HD12 ' HB2' ' A' ' 75' ' ' LYS . 1.6 tp -156.19 53.28 0.56 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.826 -1.171 . . . . 0.0 109.94 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.573 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.5 OUTLIER -71.45 -154.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.776 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 39' ' ' PHE . 95.2 m-20 -138.14 35.06 2.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.03 -1.044 . . . . 0.0 108.601 178.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.706 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 12.5 m-85 56.37 -52.36 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.3 -179.321 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.625 ' N ' ' O ' ' A' ' 37' ' ' ASN . 72.1 t80 -83.88 29.19 0.55 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.284 -1.51 . . . . 0.0 109.945 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.565 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 5.3 mm-40 -80.4 87.82 5.62 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.565 ' CG1' ' O ' ' A' ' 40' ' ' GLN . 33.8 pt 44.52 70.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.405 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 43' ' ' GLY . . . 167.5 -128.0 1.66 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 39' ' ' PHE . . . -42.64 161.31 0.04 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -141.82 -41.93 0.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -1.116 . . . . 0.0 109.615 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 46' ' ' LEU . 81.0 p -155.24 -86.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -0.916 . . . . 0.0 109.466 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.447 ' HA ' HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -48.24 -36.7 14.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 109.387 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -60.5 -63.58 1.25 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.883 . . . . 0.0 109.515 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.077 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.82 -47.02 51.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.89 -1.131 . . . . 0.0 108.214 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.943 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.43 -42.28 42.33 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.323 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.91 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -51.04 -49.0 61.37 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.214 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.733 HG13 ' CG1' ' A' ' 22' ' ' ILE . 15.6 t -56.23 -54.33 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.554 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.824 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.17 -44.27 32.33 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -56.81 -44.84 82.36 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 62.7 tp60 -47.71 -39.96 18.95 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.022 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.853 HG21 HD22 ' A' ' 63' ' ' LEU . 3.1 t -64.79 -32.2 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.328 0.585 . . . . 0.0 109.661 179.253 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 53' ' ' ALA . 7.6 t60 -82.16 -33.23 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.928 -1.108 . . . . 0.0 109.02 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -39.86 35.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.055 -1.028 . . . . 0.0 108.581 179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 1.1 mm-40 -75.92 -42.76 47.92 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.917 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -126.33 169.27 13.1 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.782 0.801 . . . . 0.0 109.771 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -103.23 33.21 3.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.698 -1.594 . . . . 0.0 106.698 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.918 HG11 HG13 ' A' ' 81' ' ' VAL . 6.2 p -93.35 121.5 44.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -68.82 99.26 1.01 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 110.297 -178.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.853 HD22 HG21 ' A' ' 55' ' ' VAL . 9.1 tp -100.9 110.17 60.17 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.563 ' HG2' ' CG2' ' A' ' 67' ' ' VAL . 35.1 Cg_endo -78.78 154.77 26.75 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.29 1.993 . . . . 0.0 110.719 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.943 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.4 mm? -63.67 -42.03 98.1 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -56.72 -32.56 65.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.288 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.563 ' CG2' ' HG2' ' A' ' 64' ' ' PRO . 2.2 t -71.42 -36.2 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.371 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.077 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -66.85 -25.23 66.32 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.271 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.458 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 m-85 -87.54 -35.9 17.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 108.989 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.41 ' C ' ' HD3' ' A' ' 72' ' ' PRO . . . -67.98 -37.36 81.41 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.07 0.938 . . . . 0.0 108.543 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.56 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -138.09 68.45 48.85 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -178.989 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 34.5 Cg_endo -78.24 52.93 4.29 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 123.306 2.671 . . . . 0.0 113.105 -177.249 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.573 ' HB ' ' O ' ' A' ' 36' ' ' ASP . 15.2 t -154.65 169.37 24.05 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 116.729 -1.988 . . . . 0.0 114.042 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.557 ' N ' ' CZ2' ' A' ' 23' ' ' TRP . 9.3 mm -51.14 -64.63 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.033 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.611 ' HB2' HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -55.08 -72.98 0.06 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.099 -1.001 . . . . 0.0 109.742 -178.451 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.56 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -48.16 -62.37 1.51 Allowed 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.268 -0.895 . . . . 0.0 110.648 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.569 ' CB ' ' O ' ' A' ' 73' ' ' THR . 0.5 OUTLIER -52.29 -64.8 0.7 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.963 -1.086 . . . . 0.0 109.553 -179.442 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.626 ' HB1' HG12 ' A' ' 15' ' ' VAL . . . -46.14 -43.11 14.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.064 -1.022 . . . . 0.0 109.16 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 25.2 mm-40 -65.99 -52.16 51.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.315 -0.865 . . . . 0.0 108.842 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.558 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 18.8 t80 -43.07 -41.83 3.71 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.918 HG13 HG11 ' A' ' 61' ' ' VAL . 18.4 t -74.59 -59.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.316 1.055 . . . . 0.0 108.991 179.241 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.879 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -58.77 -73.27 0.08 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.282 -179.058 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.468 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.542 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.063 HG21 ' HB2' ' A' ' 82' ' ' ALA . 2.1 t -65.76 -46.74 88.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HG2' ' HB3' ' A' ' 78' ' ' ALA . 7.5 mt-10 -70.98 -25.05 62.53 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.542 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 28.2 m -59.11 -48.93 79.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.689 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -68.37 -57.29 6.12 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.397 -0.814 . . . . 0.0 109.034 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.708 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -54.55 -19.26 5.56 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.276 -0.97 . . . . 0.0 108.956 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -74.79 -51.4 14.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.527 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 2.9 mt-10 -58.24 -63.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.826 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -43.55 -54.73 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.149 -0.969 . . . . 0.0 108.88 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.758 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.8 m95 -42.68 -57.54 2.68 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.58 -0.7 . . . . 0.0 110.924 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.724 ' HA ' HD11 ' A' ' 32' ' ' ILE . 6.8 pt-20 -65.83 -30.86 71.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.943 -1.098 . . . . 0.0 111.167 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.447 ' N ' ' HG3' ' A' ' 24' ' ' GLU . 17.8 ttm180 -75.15 -71.38 0.36 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.846 -1.159 . . . . 0.0 109.865 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.033 HG11 ' HB3' ' A' ' 50' ' ' ALA . 69.0 t -55.09 -34.5 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.536 -0.727 . . . . 0.0 110.555 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.512 ' HB2' HG23 ' A' ' 29' ' ' VAL . 39.2 mt -86.08 -17.63 34.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.894 -1.129 . . . . 0.0 109.883 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.94 27.61 60.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -102.96 -176.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -1.216 . . . . 0.0 108.886 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 t -142.3 83.24 1.82 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.131 -0.98 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 130.41 -74.87 0.43 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.868 ' CG2' HD11 ' A' ' 74' ' ' ILE . 3.8 mt 58.35 152.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -1.174 . . . . 0.0 109.781 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.933 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -96.61 -133.19 7.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.941 HG22 ' HB2' ' A' ' 75' ' ' LYS . 9.9 mt -120.42 -67.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.863 -1.375 . . . . 0.0 110.159 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.75 HD23 ' O ' ' A' ' 35' ' ' LEU . 2.4 tt -85.12 35.64 0.59 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.74 -1.225 . . . . 0.0 109.657 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.496 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -59.07 -166.47 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 109.588 178.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.1 m-20 -134.17 115.81 14.64 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.727 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 72.1 m-85 . . . . . 0 N--CA 1.506 2.374 0 O-C-N 121.12 -0.988 . . . . 0.0 110.904 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.309 0.576 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.441 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -53.61 -23.92 12.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 109.498 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 26' ' ' VAL . 1.7 mptt -71.33 -68.32 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.038 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -46.9 -44.69 19.94 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.965 -1.085 . . . . 0.0 108.362 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.849 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.24 -53.88 31.09 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.033 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -43.65 -42.31 5.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.826 HG13 ' CG1' ' A' ' 22' ' ' ILE . 17.1 t -59.56 -48.31 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.961 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -58.08 -31.9 67.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.029 -1.045 . . . . 0.0 108.43 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.04 70.89 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.562 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 6.8 tp-100 -63.07 -31.21 72.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.61 HG21 HD22 ' A' ' 63' ' ' LEU . 2.6 t -75.9 -28.8 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' TYR . 6.1 t60 -77.72 -33.63 52.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.204 -0.935 . . . . 0.0 110.047 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -80.92 -46.5 15.1 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.493 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -62.97 -36.33 83.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.677 ' CD2' HG11 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -141.71 156.6 45.61 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.586 0.708 . . . . 0.0 109.434 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -95.29 43.94 1.09 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.011 HG11 ' CG1' ' A' ' 81' ' ' VAL . 4.8 p -91.91 149.12 4.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.422 0.63 . . . . 0.0 110.014 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -80.73 97.32 7.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 110.384 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.78 HD21 ' CD1' ' A' ' 77' ' ' LEU . 1.1 tp -126.7 86.22 59.02 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 35.6 Cg_endo -77.47 175.67 11.0 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.696 2.264 . . . . 0.0 110.983 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.849 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.5 mm? -67.56 -41.87 83.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.435 -0.79 . . . . 0.0 109.299 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.44 -29.14 65.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.07 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.531 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 3.7 t -76.84 -34.05 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.038 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -69.88 -21.2 63.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -87.4 -34.63 18.7 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.488 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -72.85 -28.31 62.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.993 0.902 . . . . 0.0 108.735 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.595 ' CB ' ' HB1' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -146.13 65.66 10.87 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.572 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.7 Cg_endo -77.38 60.74 7.15 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.903 2.402 . . . . 0.0 112.674 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.666 HG23 ' H ' ' A' ' 76' ' ' ALA . 6.3 t -154.03 176.04 12.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.512 -1.368 . . . . 0.0 111.164 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.933 HD12 ' O ' ' A' ' 33' ' ' GLY . 9.6 mt -74.28 -42.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.268 -0.895 . . . . 0.0 111.606 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.941 ' HB2' HG22 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -70.39 -45.24 66.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.583 -1.323 . . . . 0.0 108.666 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.666 ' H ' HG23 ' A' ' 73' ' ' THR . . . -66.27 -35.01 79.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.647 -0.658 . . . . 0.0 109.945 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.78 ' CD1' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -73.04 -62.03 1.61 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.9 -1.125 . . . . 0.0 108.589 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.707 ' HB1' ' HB ' ' A' ' 15' ' ' VAL . . . -51.15 -28.04 10.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 2.0 tp60 -81.15 -34.47 32.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.8 -1.187 . . . . 0.0 108.564 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.689 ' CD2' HD12 ' A' ' 63' ' ' LEU . 11.5 t80 -61.89 -33.16 73.7 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.011 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -88.94 -73.65 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 122.44 1.114 . . . . 0.0 108.198 178.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 1.063 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -39.0 -27.05 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.156 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 81' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.059 -1.025 . . . . 0.0 109.523 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.633 ' HA ' ' HB2' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 121.153 0.502 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.024 HG21 ' CB ' ' A' ' 82' ' ' ALA . 28.1 t -54.55 -49.62 65.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.662 ' OE2' HD12 ' A' ' 34' ' ' ILE . 3.9 tt0 -69.68 -26.84 64.57 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.633 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 32.7 t -53.66 -52.29 60.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.947 -1.096 . . . . 0.0 108.796 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.684 ' O ' HG22 ' A' ' 22' ' ' ILE . 1.3 tppm? -65.68 -53.07 46.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 109.251 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HA ' HG23 ' A' ' 22' ' ' ILE . 3.5 mp -57.67 -31.62 66.51 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.653 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 16' ' ' GLU . . . -59.84 -51.67 68.73 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -59.52 -64.74 0.84 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.811 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -44.49 -53.6 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.774 ' HE3' HG21 ' A' ' 32' ' ' ILE . 3.6 m95 -43.52 -61.93 1.23 Allowed 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.469 0.652 . . . . 0.0 110.523 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.772 ' CA ' HD11 ' A' ' 32' ' ' ILE . 3.5 pt-20 -64.01 -36.42 83.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.363 -0.836 . . . . 0.0 110.664 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -68.66 -63.34 1.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.314 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.029 HG11 ' HB3' ' A' ' 50' ' ' ALA . 61.3 t -68.52 -34.49 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 111.12 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.526 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 40.7 mt -83.84 4.75 27.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.867 -1.146 . . . . 0.0 109.939 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.21 51.77 48.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.645 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -129.09 171.76 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -1.161 . . . . 0.0 109.249 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.1 t -139.51 70.63 1.37 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.103 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.6 68.94 0.31 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.774 HG21 ' HE3' ' A' ' 23' ' ' TRP . 2.9 mp -85.87 146.17 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -1.093 . . . . 0.0 109.615 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.822 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -66.88 -135.16 0.04 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.662 HD12 ' OE2' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -123.73 -54.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.013 -1.286 . . . . 0.0 109.973 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.913 HD23 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -96.6 44.46 1.06 Allowed 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.275 -1.516 . . . . 0.0 108.17 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.81 114.9 12.62 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.485 ' O ' ' C ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -62.75 113.51 3.07 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.385 -1.447 . . . . 0.0 108.649 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.721 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 90.7 m-85 . . . . . 0 N--CA 1.511 2.622 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.119 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.317 0.579 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 46' ' ' LEU . 6.5 tp -52.08 -38.88 58.69 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.262 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.3 mttp -50.78 -62.79 1.39 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.113 -0.992 . . . . 0.0 108.615 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.992 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -50.29 -44.57 54.03 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.664 ' CG ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.89 -45.7 64.25 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.029 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -49.09 -42.97 40.66 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.811 HG13 ' CG1' ' A' ' 22' ' ' ILE . 4.6 t -64.07 -64.34 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.97 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -45.35 -40.33 7.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -63.32 -47.01 84.03 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.501 ' HG3' ' OE2' ' A' ' 58' ' ' GLU . 2.2 tp60 -50.32 -28.16 7.41 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.594 HG21 ' HG ' ' A' ' 63' ' ' LEU . 3.8 t -75.49 -62.43 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 59' ' ' TYR . 20.9 t-80 -54.05 -37.91 64.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.03 -1.044 . . . . 0.0 108.773 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 53' ' ' ALA . 4.0 mtt180 -69.37 -38.12 77.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.532 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -75.11 -56.99 4.18 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.341 -0.85 . . . . 0.0 108.903 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.798 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -119.05 176.88 5.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 108.825 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.66 43.68 1.17 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 59' ' ' TYR . 10.5 t -93.79 158.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.418 ' C ' ' HD3' ' A' ' 64' ' ' PRO . 3.0 tt0 -70.8 99.83 1.8 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 109.416 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.935 HD21 HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -134.45 68.44 72.76 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 0.0 109.276 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.635 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.9 Cg_endo -82.05 -168.02 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.959 2.439 . . . . 0.0 109.964 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.664 HD21 ' CG ' ' A' ' 49' ' ' MET . 0.4 OUTLIER -89.26 -37.14 15.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.136 -0.977 . . . . 0.0 109.311 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.547 ' HG3' ' N ' ' A' ' 67' ' ' VAL . 5.7 pttt -56.66 -37.64 71.09 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.955 HG13 ' NE2' ' A' ' 71' ' ' GLN . 58.5 t -69.72 -47.24 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.992 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.82 -35.98 64.51 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.454 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 5.8 m-85 -74.45 -39.27 62.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 108.769 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.99 84.16 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.885 0.85 . . . . 0.0 108.863 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.955 ' NE2' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -135.09 70.87 69.41 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.58 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 30.4 Cg_endo -75.0 59.85 5.29 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.787 2.325 . . . . 0.0 112.224 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.913 HG21 HD23 ' A' ' 35' ' ' LEU . 1.9 t -153.18 167.53 28.99 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 117.337 -1.745 . . . . 0.0 112.453 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.822 HD12 ' O ' ' A' ' 33' ' ' GLY . 2.4 mt -63.07 -72.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.592 -0.693 . . . . 0.0 111.195 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.528 ' HB2' ' CG1' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -40.08 -57.86 1.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.554 -0.716 . . . . 0.0 109.468 -178.428 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.582 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -57.55 -52.33 65.83 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.379 -0.825 . . . . 0.0 109.527 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.935 HD13 HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -55.1 -65.37 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.706 -1.246 . . . . 0.0 108.708 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.667 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -44.78 -30.89 1.04 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.57 ' HG2' ' N ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -77.94 -43.9 28.49 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 108.633 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.57 ' N ' ' HG2' ' A' ' 79' ' ' GLN . 2.3 t80 -58.8 -32.6 69.49 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.996 -1.065 . . . . 0.0 108.244 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -88.6 -67.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 122.46 1.124 . . . . 0.0 109.16 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 1.024 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -54.13 -48.65 70.58 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.802 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 79' ' ' GLN . 5.6 t . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.871 -1.143 . . . . 0.0 109.765 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.985 HG21 ' CB ' ' A' ' 82' ' ' ALA . 2.4 t -49.12 -44.45 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.632 ' HG2' HG23 ' A' ' 34' ' ' ILE . 4.2 mt-10 -72.65 -35.59 67.8 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 53.9 p -55.56 -48.77 74.23 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.416 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.605 ' O ' HG22 ' A' ' 22' ' ' ILE . 8.6 tptm -68.69 -55.92 9.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.95 -1.094 . . . . 0.0 109.415 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.749 ' HA ' HG23 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -54.71 -31.06 57.54 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.062 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.06 -50.16 67.27 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 31.9 tt0 -59.79 -54.54 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.901 HD11 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -51.43 -54.24 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.872 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.7 m95 -41.19 -60.14 1.32 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.463 0.649 . . . . 0.0 110.334 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.626 ' CA ' HD11 ' A' ' 32' ' ' ILE . 5.1 pt-20 -64.52 -30.86 71.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.95 . . . . 0.0 109.606 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 tpp85 -70.06 -66.19 0.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.507 -0.746 . . . . 0.0 110.039 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.842 HG11 ' HB3' ' A' ' 50' ' ' ALA . 53.6 t -68.41 -34.45 65.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.366 -0.834 . . . . 0.0 111.102 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 24.9 mt -84.18 -8.65 59.01 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.869 -1.144 . . . . 0.0 110.155 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.8 51.7 44.27 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.778 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -122.71 -166.21 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.016 -1.285 . . . . 0.0 108.965 178.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.411 ' H ' HG12 ' A' ' 29' ' ' VAL . 2.0 p -143.62 64.38 1.33 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.156 -1.018 . . . . 0.0 109.863 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 136.89 -72.86 0.45 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.286 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.872 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.8 mp 59.53 147.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -1.154 . . . . 0.0 109.309 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 1.0 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -78.34 -153.41 6.66 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 34' ' ' ILE . 30.0 mm -113.56 15.67 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.035 -1.273 . . . . 0.0 109.626 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.857 HD23 ' O ' ' A' ' 35' ' ' LEU . 7.3 tt -167.65 66.67 0.08 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.598 ' N ' ' HG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -101.55 169.74 8.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.584 0.707 . . . . 0.0 110.103 -179.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' O ' ' C ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -96.03 104.36 16.3 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.729 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 63.8 m-85 . . . . . 0 N--CA 1.519 3.002 0 O-C-N 121.78 -0.575 . . . . 0.0 112.293 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 46' ' ' LEU . 1.4 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 46' ' ' LEU . 14.2 tp -53.59 -44.39 69.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.107 -0.995 . . . . 0.0 108.835 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.648 ' HB3' HG12 ' A' ' 26' ' ' VAL . 6.8 mttm -48.25 -60.3 2.76 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.041 ' HB1' HD11 ' A' ' 68' ' ' LEU . . . -46.99 -48.9 21.57 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.927 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.86 -50.17 27.23 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.842 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -49.24 -43.41 42.75 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.901 HG22 HD11 ' A' ' 22' ' ' ILE . 12.0 t -58.93 -64.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.027 ' HB2' HD23 ' A' ' 68' ' ' LEU . . . -45.58 -39.99 8.27 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.709 ' HB2' ' CE ' ' A' ' 49' ' ' MET . . . -63.83 -45.34 90.0 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.538 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -48.28 -34.4 10.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.792 HG11 HD12 ' A' ' 63' ' ' LEU . 2.5 t -71.24 -31.68 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ALA . 9.3 t60 -81.62 -35.04 30.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.415 -0.803 . . . . 0.0 109.12 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -75.73 -35.32 60.27 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 1.2 mp0 -78.87 -50.98 10.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.669 ' HB2' HG12 ' A' ' 61' ' ' VAL . 2.4 m-85 -113.83 -178.54 3.4 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.895 0.855 . . . . 0.0 109.71 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -112.51 38.4 2.76 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.998 HG11 HG13 ' A' ' 81' ' ' VAL . 5.0 p -93.17 149.28 4.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.378 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -90.15 97.11 11.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.194 -0.941 . . . . 0.0 110.549 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.966 ' CD2' HG11 ' A' ' 67' ' ' VAL . 4.9 mt -113.47 98.95 48.31 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.6 Cg_endo -78.99 164.13 25.21 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.866 2.378 . . . . 0.0 111.238 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.927 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.9 mm? -63.7 -34.85 78.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.535 ' HD3' ' N ' ' A' ' 66' ' ' LYS . 1.1 mmtt -56.08 -60.61 3.24 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.966 HG11 ' CD2' ' A' ' 63' ' ' LEU . 2.7 t -48.32 -52.81 7.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.041 HD11 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -47.1 -33.21 4.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 66' ' ' LYS . 1.7 m-85 -88.28 -36.34 16.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.524 -0.735 . . . . 0.0 109.969 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . -65.13 -32.32 73.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.775 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -140.53 71.85 31.19 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.1 Cg_endo -76.82 60.64 6.8 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.772 2.315 . . . . 0.0 112.052 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.689 HG22 ' HB3' ' A' ' 76' ' ' ALA . 13.5 t -154.66 170.86 20.54 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.569 -1.252 . . . . 0.0 110.816 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.0 HD12 ' O ' ' A' ' 33' ' ' GLY . 3.5 mt -65.71 -74.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.255 -0.903 . . . . 0.0 111.214 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB3' HD12 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -42.6 -58.86 2.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.286 -178.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.689 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -47.61 -61.92 1.69 Allowed 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.173 -0.955 . . . . 0.0 110.04 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.775 HD23 ' O ' ' A' ' 71' ' ' GLN . 0.2 OUTLIER -53.53 -66.94 0.3 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.127 -0.983 . . . . 0.0 109.496 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.553 ' CB ' ' HG3' ' A' ' 16' ' ' GLU . . . -47.01 -35.94 7.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.183 -0.948 . . . . 0.0 108.837 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 78.0 mm-40 -70.19 -40.15 74.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -55.28 -35.46 65.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.998 HG13 HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -87.69 -68.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.411 1.101 . . . . 0.0 108.301 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.985 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -43.93 -50.65 8.05 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.45 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 79' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.534 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.616 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.034 ' CG1' ' HB2' ' A' ' 82' ' ' ALA . 40.5 t -46.4 -54.49 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.8 ' OE2' HG22 ' A' ' 34' ' ' ILE . 12.8 mt-10 -68.12 -37.74 81.44 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.616 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.7 m -48.95 -54.0 17.39 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.17 -1.012 . . . . 0.0 108.562 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.675 ' O ' HG23 ' A' ' 22' ' ' ILE . 1.2 tptt -60.05 -69.28 0.22 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.335 -0.853 . . . . 0.0 108.837 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.474 ' HB3' HG23 ' A' ' 74' ' ' ILE . 8.3 mt -38.76 -48.25 1.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.604 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -51.52 -52.4 47.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.766 -1.209 . . . . 0.0 108.216 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.08 -60.31 4.03 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.086 ' CD1' HG13 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -44.27 -47.42 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.751 ' CB ' HG21 ' A' ' 32' ' ' ILE . 3.7 m95 -49.43 -63.05 1.22 Allowed 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.797 -0.564 . . . . 0.0 109.912 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.693 ' HB2' HD12 ' A' ' 32' ' ' ILE . 1.6 tt0 -61.49 -42.37 98.69 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.377 -0.827 . . . . 0.0 110.046 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -65.13 0.73 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 110.779 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.661 HG11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 t -69.82 -32.62 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.393 -0.817 . . . . 0.0 111.717 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 33.8 mt -87.36 -33.46 19.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.681 -1.262 . . . . 0.0 110.249 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.58 58.4 1.74 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.339 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.607 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -130.4 177.1 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.207 -1.173 . . . . 0.0 108.582 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.81 38.22 3.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.027 -1.045 . . . . 0.0 109.764 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -150.24 -96.75 0.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.751 HG21 ' CB ' ' A' ' 23' ' ' TRP . 10.3 mt 52.7 103.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.923 -1.339 . . . . 0.0 109.877 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.687 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -107.86 -77.69 1.05 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' OE2' ' A' ' 16' ' ' GLU . 1.1 pp -166.03 101.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -1.195 . . . . 0.0 109.931 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.63 ' CB ' ' O ' ' A' ' 34' ' ' ILE . 22.4 tp 103.44 35.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.722 0.772 . . . . 0.0 109.237 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.459 ' O ' ' OG1' ' A' ' 73' ' ' THR . 0.7 OUTLIER -83.0 177.87 8.42 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.7 t30 -109.52 116.94 32.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.723 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 52.4 m-85 . . . . . 0 N--CA 1.502 2.138 0 O-C-N 121.273 -0.892 . . . . 0.0 110.315 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.545 ' HA ' HD13 ' A' ' 46' ' ' LEU . 4.1 mm? -53.35 -36.34 61.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.107 -0.995 . . . . 0.0 109.013 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.637 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -66.5 -60.5 2.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -0.912 . . . . 0.0 109.042 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.064 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -52.37 -49.71 63.85 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.132 -0.98 . . . . 0.0 108.636 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.854 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.29 -45.61 45.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.82 ' O ' ' HB3' ' A' ' 53' ' ' ALA . . . -49.23 -44.59 43.64 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.086 HG13 ' CD1' ' A' ' 22' ' ' ILE . 18.3 t -60.14 -58.46 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.838 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.58 -26.96 2.48 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -73.24 -43.54 60.99 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.533 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -54.65 -28.49 47.5 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.623 HG11 ' HG ' ' A' ' 63' ' ' LEU . 2.6 t -73.77 -53.88 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 1.3 t-80 -56.3 -43.04 78.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.123 -0.986 . . . . 0.0 109.103 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -46.3 83.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 109.014 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.566 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -66.07 -50.15 65.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 108.855 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.724 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -129.63 154.58 46.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.451 -0.781 . . . . 0.0 109.009 179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -94.53 40.04 1.09 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.11 HG11 HG13 ' A' ' 81' ' ' VAL . 7.0 p -93.09 162.75 2.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.272 0.558 . . . . 0.0 109.7 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.524 ' N ' HG22 ' A' ' 61' ' ' VAL . 5.1 tt0 -69.39 117.85 11.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.865 . . . . 0.0 110.138 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.908 HD23 HG22 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -142.73 69.46 19.78 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.555 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.4 Cg_endo -80.23 154.66 22.01 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.866 2.378 . . . . 0.0 110.632 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.854 HD21 ' SD ' ' A' ' 49' ' ' MET . 4.4 mt -57.19 -40.68 77.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.782 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -49.91 -44.94 50.44 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.555 HG23 ' HG2' ' A' ' 64' ' ' PRO . 6.7 t -64.86 -41.98 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.064 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -62.58 -26.39 68.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.472 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 m-85 -87.86 -36.0 17.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.431 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -67.43 -32.0 72.57 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.959 0.885 . . . . 0.0 108.614 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.431 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -147.34 70.06 11.68 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.0 Cg_endo -75.11 60.26 5.47 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.812 2.342 . . . . 0.0 111.305 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.77 ' CG2' ' HB3' ' A' ' 76' ' ' ALA . 5.8 t -153.07 165.62 35.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.712 -1.195 . . . . 0.0 110.828 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.644 HG13 ' CZ2' ' A' ' 23' ' ' TRP . 2.9 mt -66.47 -64.87 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.602 -0.686 . . . . 0.0 110.501 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -49.75 -60.58 2.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.867 -1.145 . . . . 0.0 109.859 -179.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.77 ' HB3' ' CG2' ' A' ' 73' ' ' THR . . . -56.74 -67.84 0.27 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.958 -1.089 . . . . 0.0 110.372 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.712 HD11 HD12 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -49.42 -58.45 5.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.808 -1.182 . . . . 0.0 108.763 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' ILE . . . -44.94 -55.98 5.0 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 34.6 mm-40 -50.49 -49.83 54.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 108.844 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -48.3 -45.67 35.21 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.669 0.747 . . . . 0.0 109.302 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.11 HG13 HG11 ' A' ' 61' ' ' VAL . 3.5 t -81.73 -59.43 2.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 122.432 1.11 . . . . 0.0 109.313 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 1.034 ' HB2' ' CG1' ' A' ' 15' ' ' VAL . . . -53.73 -68.09 0.21 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.238 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.414 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.556 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.97 HG21 ' CB ' ' A' ' 82' ' ' ALA . 3.6 t -48.35 -43.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -72.08 -43.79 64.28 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 53.5 p -47.12 -50.1 20.83 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.391 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.54 ' H ' ' HG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -61.03 -70.35 0.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 108.706 179.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.844 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 4.3 mp -40.79 -35.12 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.371 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -61.89 -51.82 66.61 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.995 -1.066 . . . . 0.0 108.399 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -61.25 -56.06 24.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.298 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.844 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -52.67 -50.47 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.889 -1.132 . . . . 0.0 108.862 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.651 ' HB3' HD13 ' A' ' 32' ' ' ILE . 5.2 m95 -46.15 -59.82 2.66 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.413 0.625 . . . . 0.0 110.227 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.626 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -61.77 -37.06 82.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.227 -0.921 . . . . 0.0 110.021 -178.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -60.89 -49.42 77.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.289 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.07 HG11 ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -87.79 -48.9 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.241 -0.912 . . . . 0.0 110.778 -179.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 47' ' ' LYS . 45.7 mt -63.76 -9.97 17.32 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.363 -0.836 . . . . 0.0 109.87 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.07 58.63 11.89 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.581 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.32 167.48 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -1.196 . . . . 0.0 109.45 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 t -126.78 81.43 2.01 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.249 -0.907 . . . . 0.0 109.185 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . 139.4 -73.55 0.4 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.693 ' CG2' HD11 ' A' ' 74' ' ' ILE . 14.7 mt 60.89 143.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -1.105 . . . . 0.0 109.628 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.46 -119.45 1.14 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.945 ' HA ' HD12 ' A' ' 74' ' ' ILE . 1.5 tt -149.28 -64.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.812 -1.405 . . . . 0.0 109.831 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.044 HD23 HG21 ' A' ' 73' ' ' THR . 0.6 OUTLIER -88.38 32.1 0.79 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.365 -1.46 . . . . 0.0 109.66 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.652 ' O ' HG23 ' A' ' 73' ' ' THR . 15.5 m-20 -59.73 167.12 2.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.343 -0.848 . . . . 0.0 110.753 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -110.53 40.37 2.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.681 ' CZ ' ' HA ' ' A' ' 72' ' ' PRO . 8.7 m-30 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.769 -0.582 . . . . 0.0 111.008 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.342 0.591 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 46' ' ' LEU . 1.1 mm? -57.84 -39.63 78.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.856 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.9 tptt -64.84 -64.14 0.94 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.099 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -47.9 -47.5 32.01 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.085 -1.009 . . . . 0.0 108.32 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.907 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.25 -49.93 31.5 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.07 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -46.81 -46.67 20.87 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.555 ' HA ' HG12 ' A' ' 22' ' ' ILE . 15.0 t -56.92 -54.16 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.882 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.42 -38.77 20.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -61.58 -44.05 97.73 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.528 ' CB ' HG12 ' A' ' 22' ' ' ILE . 3.0 tp-100 -48.7 -36.14 15.54 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.645 HG21 HD22 ' A' ' 63' ' ' LEU . 6.8 t -68.03 -45.71 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 59' ' ' TYR . 5.7 t-160 -69.94 -33.64 72.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.077 -1.015 . . . . 0.0 109.098 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -41.4 39.49 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 12.8 mm-40 -71.91 -46.06 59.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.946 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -124.87 168.85 12.7 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.608 0.718 . . . . 0.0 109.41 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -99.18 31.84 2.92 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.946 HG12 ' HB2' ' A' ' 59' ' ' TYR . 6.5 p -93.59 123.13 45.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 4.6 tt0 -69.21 97.76 0.96 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 110.856 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -103.05 106.65 51.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.133 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 35.8 Cg_endo -79.88 166.6 21.11 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.445 2.096 . . . . 0.0 111.292 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.907 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.4 mm? -69.02 -40.87 78.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -51.19 -51.7 51.29 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.424 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 3.0 t -55.93 -41.21 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.099 HD21 ' HB1' ' A' ' 48' ' ' ALA . 1.2 tp -62.43 -24.15 67.26 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.517 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 m-85 -87.62 -36.67 17.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.419 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.22 -32.55 74.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.52 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.08 71.74 18.42 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.681 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 30.5 Cg_endo -77.82 64.82 8.24 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.259 1.973 . . . . 0.0 108.209 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 1.044 HG21 HD23 ' A' ' 35' ' ' LEU . 81.4 m -152.68 165.11 36.29 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 117.961 -1.496 . . . . 0.0 111.939 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.945 HD12 ' HA ' ' A' ' 34' ' ' ILE . 7.3 mt -71.93 -72.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.14 -0.975 . . . . 0.0 109.286 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HB3' ' HG ' ' A' ' 35' ' ' LEU . 3.2 ttmm -45.21 -44.68 11.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.617 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -61.66 -55.02 35.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 108.955 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.006 HD11 HD12 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -59.11 -63.23 1.38 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.128 -0.983 . . . . 0.0 108.758 179.155 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.606 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . -44.87 -38.96 4.98 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.567 ' O ' HG22 ' A' ' 83' ' ' THR . 1.1 tp60 -68.89 -44.41 73.3 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.654 ' O ' HG22 ' A' ' 83' ' ' THR . 28.4 t80 -52.22 -35.56 49.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.14 -0.975 . . . . 0.0 108.386 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.607 HG11 ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.15 -70.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 122.375 1.084 . . . . 0.0 108.43 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.97 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -40.11 -27.77 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.06 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 80' ' ' TYR . 9.8 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.458 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.728 ' HA ' ' HB3' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.951 HG21 ' CB ' ' A' ' 82' ' ' ALA . 20.6 t -53.42 -47.66 58.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 119.939 -1.726 . . . . 0.0 106.674 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.558 ' HG3' ' CG2' ' A' ' 74' ' ' ILE . 3.6 tm-20 -69.16 -29.19 67.15 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.728 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 35.2 p -54.13 -49.36 69.37 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.302 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.842 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.95 -51.38 69.53 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.774 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 6.7 mt -58.71 -40.7 84.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.174 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.82 -46.45 67.73 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.859 -1.15 . . . . 0.0 108.122 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 22' ' ' ILE . 23.0 mt-10 -65.21 -66.43 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.489 -0.757 . . . . 0.0 109.214 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -45.34 -46.51 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.966 . . . . 0.0 108.851 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.796 ' CE3' HG21 ' A' ' 32' ' ' ILE . 5.4 m95 -50.72 -64.49 0.79 Allowed 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.437 0.636 . . . . 0.0 110.867 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.761 ' HA ' HD11 ' A' ' 32' ' ' ILE . 2.6 pt-20 -59.53 -38.09 80.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.17 -61.59 2.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 110.413 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.057 HG11 ' HB3' ' A' ' 50' ' ' ALA . 4.8 t -75.2 -33.23 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.135 -0.978 . . . . 0.0 111.337 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 41.9 mt -81.9 -8.07 59.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.706 -1.246 . . . . 0.0 109.829 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.19 53.29 45.91 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -137.38 -172.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.265 . . . . 0.0 109.03 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 t -153.29 121.0 5.99 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.467 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.24 20.81 54.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.796 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.2 mt -42.08 150.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -1.199 . . . . 0.0 109.298 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.74 -170.43 21.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.724 ' HA ' HG21 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -106.33 12.3 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -1.047 . . . . 0.0 109.743 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.763 HD12 ' CG2' ' A' ' 73' ' ' THR . 10.4 tp -169.24 62.24 0.05 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.084 -1.01 . . . . 0.0 109.39 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.645 ' O ' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -89.59 -161.96 0.83 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.249 -0.907 . . . . 0.0 109.916 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.461 ' ND2' ' HG2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -129.66 29.76 4.99 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.226 -0.921 . . . . 0.0 110.132 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.74 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 1.9 m-85 . . . . . 0 N--CA 1.5 2.041 0 O-C-N 121.961 -0.462 . . . . 0.0 111.144 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 46' ' ' LEU . 9.9 tp -47.64 -41.11 21.41 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.167 -0.958 . . . . 0.0 108.982 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 8.0 mttt -50.29 -61.18 2.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.101 -1.0 . . . . 0.0 108.567 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.038 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -48.42 -46.32 37.32 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.928 ' SD ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.59 -52.39 30.58 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.057 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -46.87 -42.75 17.93 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.621 HG13 HG13 ' A' ' 22' ' ' ILE . 7.6 t -58.79 -61.2 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.933 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -45.9 -48.78 16.1 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -51.95 -47.4 64.78 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -46.29 -37.05 6.83 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.551 HG21 HD22 ' A' ' 63' ' ' LEU . 2.2 t -73.04 -32.96 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.687 -0.633 . . . . 0.0 109.565 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 59' ' ' TYR . 2.5 t-80 -78.1 -44.18 26.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.784 -1.198 . . . . 0.0 108.38 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -34.01 73.86 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -78.31 -48.35 15.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -128.87 170.09 13.81 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.45 51.59 0.74 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 177.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 59' ' ' TYR . 96.5 t -91.24 161.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-O 121.845 0.831 . . . . 0.0 110.798 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.615 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 12.6 pt-20 -75.26 49.05 0.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.797 -0.565 . . . . 0.0 110.16 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.59 HD21 HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -111.01 86.82 6.37 Favored Pre-proline 0 C--N 1.295 -1.796 0 O-C-N 121.108 -0.995 . . . . 0.0 110.986 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 37.3 Cg_endo -83.05 -152.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.745 2.297 . . . . 0.0 107.985 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.928 HD13 ' SD ' ' A' ' 49' ' ' MET . 7.9 tp -90.87 -41.55 11.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.457 -1.402 . . . . 0.0 109.611 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.562 ' HG3' ' N ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -50.29 -39.59 45.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.91 -1.119 . . . . 0.0 108.426 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.577 HG11 ' HG ' ' A' ' 63' ' ' LEU . 4.3 t -63.12 -34.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.038 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -65.6 -27.65 68.56 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.465 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 27.6 m-85 -86.92 -35.48 18.9 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.415 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.37 -35.34 80.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.415 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -142.72 71.93 19.91 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.641 ' C ' ' CE1' ' A' ' 38' ' ' PHE . 32.9 Cg_endo -77.59 64.65 8.1 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.52 2.147 . . . . 0.0 107.955 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.763 ' CG2' HD12 ' A' ' 35' ' ' LEU . 94.5 m -152.87 158.75 42.62 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.243 -1.383 . . . . 0.0 111.716 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.724 HG21 ' HA ' ' A' ' 34' ' ' ILE . 5.3 mm -64.1 -77.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.438 -0.789 . . . . 0.0 110.314 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.677 ' HB3' HD13 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -42.24 -49.4 4.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.65 -0.656 . . . . 0.0 110.002 -178.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -58.88 -69.15 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 109.13 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -47.57 -49.47 26.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.718 -1.239 . . . . 0.0 108.817 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -55.64 -27.57 50.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 1.5 pt20 -78.84 -32.56 46.17 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.545 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -67.79 -34.5 76.9 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -88.14 -63.12 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.317 1.056 . . . . 0.0 108.484 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.951 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -59.2 -31.24 68.85 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.425 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 13.4 m . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.517 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.643 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.042 HG11 ' HB2' ' A' ' 82' ' ' ALA . 1.1 m -50.55 -56.56 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.761 ' HG3' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.68 -26.67 65.41 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.643 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 73.5 m -57.03 -51.11 70.57 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.555 ' HD3' ' CG ' ' A' ' 58' ' ' GLU . 1.3 tptm -61.43 -66.18 0.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.792 ' HA ' HG23 ' A' ' 22' ' ' ILE . 4.3 mm? -41.04 -47.44 3.1 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.84 -48.27 64.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.864 -1.148 . . . . 0.0 108.502 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 4.3 mt-10 -64.82 -64.55 0.84 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.307 -0.871 . . . . 0.0 108.709 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.944 HD11 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -43.39 -47.08 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.71 ' CE3' HG21 ' A' ' 32' ' ' ILE . 3.7 m95 -50.25 -70.82 0.08 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.427 0.632 . . . . 0.0 110.741 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.629 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -55.27 -29.95 59.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.336 -0.852 . . . . 0.0 110.549 -178.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.423 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -76.23 -67.77 0.65 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 109.907 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.918 HG12 ' HG3' ' A' ' 47' ' ' LYS . 94.8 t -62.29 -31.55 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 110.11 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 19.4 mt -93.41 -4.68 50.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 110.121 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.52 56.27 25.41 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -136.97 -179.0 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 108.965 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.9 t -153.1 137.03 16.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.361 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.64 6.46 87.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.026 HG22 HD11 ' A' ' 74' ' ' ILE . 3.4 mt -42.83 131.05 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -1.094 . . . . 0.0 109.301 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.87 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -71.29 -135.37 0.14 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.83 HD13 ' N ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -119.1 -55.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.961 -1.317 . . . . 0.0 110.185 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -92.09 39.97 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.184 -1.573 . . . . 0.0 108.878 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.599 ' OD2' HG23 ' A' ' 32' ' ' ILE . 1.3 m-20 -58.67 -172.06 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.612 0.72 . . . . 0.0 109.908 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 38' ' ' PHE . 54.7 m-20 -126.29 115.39 19.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.705 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 25.4 m-85 . . . . . 0 N--CA 1.499 1.996 0 O-C-N 121.11 -0.994 . . . . 0.0 110.342 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.277 0.561 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -50.27 -44.49 53.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.633 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.918 ' HG3' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -58.88 -71.37 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 109.23 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.075 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -46.98 -44.61 20.28 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.886 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.53 -51.03 29.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.812 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -47.36 -44.23 23.87 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.944 HG22 HD11 ' A' ' 22' ' ' ILE . 15.2 t -58.62 -58.03 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.055 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.46 -40.13 25.24 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -59.4 -46.41 88.77 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.53 ' HG2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -51.87 -31.17 26.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.41 HG21 HD22 ' A' ' 63' ' ' LEU . 3.3 t -74.21 -48.36 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.638 -0.664 . . . . 0.0 109.38 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 59' ' ' TYR . 4.6 t-80 -67.91 -34.59 76.92 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.155 -0.966 . . . . 0.0 109.189 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -76.02 -31.7 59.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 0.0 108.712 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.555 ' CG ' ' HD3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -82.67 -44.45 15.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.453 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.836 ' HB2' HG23 ' A' ' 61' ' ' VAL . 10.4 m-85 -120.51 -173.8 2.66 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.873 0.844 . . . . 0.0 109.639 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -117.95 39.96 3.25 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.836 HG23 ' HB2' ' A' ' 59' ' ' TYR . 1.3 t -93.09 137.91 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.33 0.586 . . . . 0.0 109.626 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 48.4 tt0 -69.37 95.46 0.8 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.327 -0.858 . . . . 0.0 109.292 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.777 HD23 ' HB1' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -116.4 91.57 33.78 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.484 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 35.6 Cg_endo -79.28 159.98 26.21 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.548 2.166 . . . . 0.0 110.215 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.886 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.3 mm? -57.83 -39.75 78.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.127 -0.983 . . . . 0.0 108.711 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -53.37 -52.22 59.97 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.484 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 2.6 t -51.07 -39.9 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.075 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -64.28 -26.83 68.67 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.495 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 4.3 m-30 -84.2 -36.38 22.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.44 -30.41 68.33 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.483 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -145.36 66.88 12.68 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.564 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.7 Cg_endo -76.46 53.15 3.85 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.86 2.374 . . . . 0.0 112.15 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 4.3 t -151.63 175.39 12.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.72 -1.237 . . . . 0.0 110.873 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.026 HD11 HG22 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -72.57 -67.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.687 -0.633 . . . . 0.0 110.794 -179.021 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.557 ' HE2' HD12 ' A' ' 35' ' ' LEU . 4.0 tttt -39.91 -56.87 1.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.575 -0.703 . . . . 0.0 109.303 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.489 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -59.44 -54.49 46.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 108.886 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.693 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -49.99 -64.49 0.79 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.731 -1.231 . . . . 0.0 108.585 179.032 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.716 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -46.15 -33.78 3.8 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.459 -0.776 . . . . 0.0 109.022 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -77.57 -40.26 42.98 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.947 -1.095 . . . . 0.0 109.142 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CE1' ' NE2' ' A' ' 71' ' ' GLN . 3.1 t80 -60.16 -34.27 73.34 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.933 -1.104 . . . . 0.0 108.127 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.699 HG12 HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -89.12 -66.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.386 1.088 . . . . 0.0 108.977 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 1.042 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -57.52 -28.17 63.24 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.81 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 79' ' ' GLN . 4.3 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 109.371 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.671 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 121.005 0.431 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.854 HG21 ' CB ' ' A' ' 82' ' ' ALA . 2.2 t -47.07 -65.68 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.518 ' N ' HG12 ' A' ' 15' ' ' VAL . 4.0 pt-20 -70.76 -23.72 62.47 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.671 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 6.6 m -60.86 -44.85 96.47 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.394 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 22' ' ' ILE . 3.4 tptm -69.93 -61.57 1.73 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.964 -1.094 . . . . 0.0 108.351 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.898 HD21 HD12 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -48.34 -37.32 16.35 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.069 -1.052 . . . . 0.0 108.414 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' GLU . . . -58.19 -47.81 82.26 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.486 ' OE1' ' NH1' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -65.38 -51.99 56.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.378 -0.826 . . . . 0.0 108.785 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.951 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -54.37 -44.13 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.744 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.8 m95 -54.25 -68.57 0.17 Allowed 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.962 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.652 ' HA ' HD11 ' A' ' 32' ' ' ILE . 9.2 pt-20 -59.32 -33.21 70.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.486 ' NH1' ' OE1' ' A' ' 21' ' ' GLU . 24.1 ttm180 -71.17 -71.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 109.448 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.025 HG11 ' HB3' ' A' ' 50' ' ' ALA . 60.8 t -54.71 -33.78 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.556 -0.715 . . . . 0.0 110.232 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.466 ' CG ' ' O ' ' A' ' 23' ' ' TRP . 13.1 mt -91.43 -9.05 46.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 0.0 110.197 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.67 52.81 48.37 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.123 -0.986 . . . . 0.0 110.977 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -129.84 -173.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.249 . . . . 0.0 108.469 178.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.0 t -154.47 120.18 5.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.073 -1.017 . . . . 0.0 109.947 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.45 20.89 50.45 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.578 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 24' ' ' GLU . 2.8 mp -50.8 161.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.117 -1.225 . . . . 0.0 109.74 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.835 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -81.05 -153.01 9.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.719 ' O ' HG22 ' A' ' 34' ' ' ILE . 48.8 mm -121.37 19.85 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.78 -1.423 . . . . 0.0 109.762 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.816 HD12 ' HB3' ' A' ' 75' ' ' LYS . 1.7 tt -165.62 53.72 0.11 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.902 -1.124 . . . . 0.0 110.523 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.557 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 1.4 m-20 -84.76 160.08 20.34 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.42 45.91 1.33 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.833 -1.167 . . . . 0.0 108.787 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.744 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 13.4 m-85 . . . . . 0 N--CA 1.511 2.621 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.307 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.314 0.578 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.469 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -52.59 -52.6 54.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.409 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 16.4 mttp -53.37 -51.45 62.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.066 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -53.62 -44.69 69.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.404 -1.435 . . . . 0.0 108.02 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.907 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.71 -48.98 49.53 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.025 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -48.88 -52.37 24.74 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.951 ' CG1' HD11 ' A' ' 22' ' ' ILE . 41.8 t -46.25 -59.5 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.92 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -52.52 -52.95 52.12 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 52' ' ' ALA . . . -47.34 -49.09 25.02 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.613 ' HB3' HD12 ' A' ' 22' ' ' ILE . 6.3 tp-100 -50.9 -37.66 45.23 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.872 HG11 HD23 ' A' ' 63' ' ' LEU . 21.0 t -63.52 -60.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -54.86 -46.85 74.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.209 -0.932 . . . . 0.0 110.504 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.529 ' HG3' ' N ' ' A' ' 58' ' ' GLU . 0.8 OUTLIER -61.43 -36.69 81.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.659 -1.276 . . . . 0.0 109.01 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -75.69 -53.67 8.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 108.934 179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.656 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -120.99 157.49 29.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.6 41.0 1.09 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 81' ' ' VAL . 5.8 p -92.5 159.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.441 0.638 . . . . 0.0 109.672 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.471 ' N ' HG22 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -69.22 105.98 2.7 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.455 -0.778 . . . . 0.0 110.213 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.872 HD23 HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -132.93 69.59 78.98 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.572 ' HG2' HG23 ' A' ' 67' ' ' VAL . 34.9 Cg_endo -77.92 156.96 30.95 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.683 2.255 . . . . 0.0 110.856 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.907 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.5 mm? -57.88 -39.67 78.38 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -55.37 -53.16 59.69 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.615 HG21 ' CE2' ' A' ' 80' ' ' TYR . 2.9 t -50.84 -48.45 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.066 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -55.03 -23.62 20.68 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 66' ' ' LYS . 6.2 m-85 -87.58 -39.67 14.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.05 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.17 -33.6 76.13 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.423 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -143.15 71.27 18.33 Favored Pre-proline 0 C--N 1.296 -1.749 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.62 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 32.3 Cg_endo -77.24 56.05 5.31 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.881 2.388 . . . . 0.0 112.236 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.734 HG22 ' HB3' ' A' ' 76' ' ' ALA . 15.3 t -154.11 174.91 14.08 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 117.34 -1.744 . . . . 0.0 112.725 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.835 HD12 ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -66.12 -72.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.207 -0.933 . . . . 0.0 111.516 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.816 ' HB3' HD12 ' A' ' 35' ' ' LEU . 32.2 ttmt -45.73 -49.33 14.88 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.133 -0.979 . . . . 0.0 109.766 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.734 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -66.38 -71.64 0.19 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.453 -0.78 . . . . 0.0 110.081 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.898 HD12 HD21 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -42.14 -55.85 3.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.309 -0.87 . . . . 0.0 108.952 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.757 ' HA ' HD13 ' A' ' 19' ' ' LEU . . . -50.28 -56.24 12.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 108.502 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 4.0 tp60 -50.35 -45.27 54.98 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.615 ' CE2' HG21 ' A' ' 67' ' ' VAL . 5.7 t80 -54.46 -35.82 63.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.166 -0.959 . . . . 0.0 108.613 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.749 HG21 HD11 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -79.78 -62.17 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 122.563 1.173 . . . . 0.0 108.976 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.854 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -53.01 -63.55 1.11 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.566 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.049 -1.032 . . . . 0.0 109.712 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.606 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.107 0.479 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.977 HG21 ' HB2' ' A' ' 82' ' ' ALA . 53.0 t -61.03 -48.66 88.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.957 ' OE1' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -71.84 -23.6 61.56 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.606 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 20.9 m -56.09 -50.08 72.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.687 ' O ' HG22 ' A' ' 22' ' ' ILE . 5.6 tptm -68.36 -52.44 33.12 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.745 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 2.3 mt -54.25 -37.35 64.56 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.696 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.957 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . . . -61.61 -45.83 92.42 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 22' ' ' ILE . 2.7 tt0 -61.82 -60.25 3.94 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.916 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -48.08 -57.57 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.906 ' HB3' HD13 ' A' ' 32' ' ' ILE . 1.9 m95 -38.24 -66.83 0.23 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.916 0.865 . . . . 0.0 110.308 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.661 ' HA ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -58.32 -43.43 88.19 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.443 0.64 . . . . 0.0 109.578 -178.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.429 ' HG3' ' N ' ' A' ' 26' ' ' VAL . 4.2 tpp180 -63.07 -71.93 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.517 -0.74 . . . . 0.0 110.511 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.673 HG11 ' HB3' ' A' ' 50' ' ' ALA . 91.1 t -63.17 -31.6 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 0.0 111.27 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 13.9 mt -93.05 -12.16 31.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.682 -1.261 . . . . 0.0 110.584 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 69.42 66.72 2.15 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.283 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.728 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -133.22 -168.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -1.09 . . . . 0.0 109.327 179.421 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.529 ' H ' HG12 ' A' ' 29' ' ' VAL . 3.3 m -153.42 69.26 0.81 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.428 -0.795 . . . . 0.0 109.04 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 142.16 -76.87 0.3 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.906 HD13 ' HB3' ' A' ' 23' ' ' TRP . 9.8 mt 60.07 128.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.397 -1.061 . . . . 0.0 110.768 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.529 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -75.19 -143.45 1.02 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -113.55 -62.93 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.122 -1.223 . . . . 0.0 109.763 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.559 ' C ' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -89.68 39.89 0.97 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.561 -1.337 . . . . 0.0 108.861 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.624 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 2.6 m-20 -60.05 -165.15 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.64 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -129.22 122.82 30.5 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CE1' ' N ' ' A' ' 73' ' ' THR . 7.9 m-30 . . . . . 0 N--CA 1.5 2.049 0 O-C-N 121.098 -1.001 . . . . 0.0 109.07 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.146 0.498 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -48.44 69.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.704 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.9 mttt -56.81 -59.64 4.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.847 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.028 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -47.69 -51.87 20.33 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.975 -1.078 . . . . 0.0 109.141 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.886 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.72 -50.02 26.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.673 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -47.69 -41.86 23.55 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.916 HG13 ' CG1' ' A' ' 22' ' ' ILE . 17.9 t -61.12 -57.26 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.055 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -49.15 -46.16 44.79 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -57.58 -40.69 79.56 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.6 HE21 HD13 ' A' ' 22' ' ' ILE . 2.7 tp-100 -54.75 -33.76 61.66 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.986 HG11 HD12 ' A' ' 63' ' ' LEU . 3.5 t -68.95 -51.79 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' TYR . 4.3 t-160 -65.7 -37.46 86.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 109.252 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 53' ' ' ALA . 5.4 mtt180 -70.42 -32.33 69.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 108.727 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.504 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -81.47 -54.81 5.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.81 . . . . 0.0 108.864 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.835 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -118.38 -179.6 3.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.371 -0.831 . . . . 0.0 109.174 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.69 44.57 1.03 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.835 HG23 ' HB2' ' A' ' 59' ' ' TYR . 13.4 t -93.39 129.91 43.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.503 0.668 . . . . 0.0 109.734 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.76 104.05 2.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.729 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.986 HD12 HG11 ' A' ' 55' ' ' VAL . 6.5 mt -124.23 100.99 35.26 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 108.981 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.6 Cg_endo -80.18 157.4 23.15 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.548 2.166 . . . . 0.0 110.451 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.886 HD21 ' SD ' ' A' ' 49' ' ' MET . 1.9 mm? -57.03 -44.22 82.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.079 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HG3' ' HB2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -50.86 -51.24 53.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.0 -1.063 . . . . 0.0 108.337 179.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.931 HG11 ' CD2' ' A' ' 63' ' ' LEU . 2.7 t -50.76 -45.34 27.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.055 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -57.56 -25.02 59.33 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 66' ' ' LYS . 19.0 m-85 -86.72 -37.23 18.12 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.464 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.16 -30.68 68.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.78 . . . . 0.0 109.305 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.657 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -144.82 66.11 12.86 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.596 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 34.3 Cg_endo -77.52 54.37 4.71 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.895 2.397 . . . . 0.0 110.588 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.622 ' N ' ' CE1' ' A' ' 38' ' ' PHE . 9.7 t -151.93 159.35 43.82 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.215 -0.928 . . . . 0.0 110.024 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.606 HG12 ' NE1' ' A' ' 23' ' ' TRP . 2.4 mt -64.49 -60.0 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.163 -0.961 . . . . 0.0 112.005 -178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 9.2 tttm -40.29 -53.85 2.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.318 -0.864 . . . . 0.0 108.912 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 77' ' ' LEU . . . -69.71 -60.93 2.0 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.666 -0.646 . . . . 0.0 110.051 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.3 OUTLIER -45.15 -59.17 2.76 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.707 -1.245 . . . . 0.0 108.623 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -50.22 -40.58 47.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -70.56 -34.91 72.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.05 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.719 ' CD1' HD21 ' A' ' 63' ' ' LEU . 7.7 t80 -63.14 -37.42 87.17 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.15 -0.969 . . . . 0.0 108.634 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.783 HG12 HG21 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -86.39 -62.19 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.367 1.08 . . . . 0.0 108.566 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.977 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -60.68 -54.24 47.63 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.031 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.334 179.855 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.606 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.186 0.517 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.907 HG21 ' CB ' ' A' ' 82' ' ' ALA . 3.7 t -53.33 -51.84 36.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.53 ' HA ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -68.79 -33.87 74.59 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.606 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.8 m -49.8 -52.2 33.9 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.407 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.866 ' O ' HG22 ' A' ' 22' ' ' ILE . 27.6 tptt -59.23 -49.46 77.75 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.293 -0.879 . . . . 0.0 108.728 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.779 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 9.9 mt -61.9 -41.76 98.28 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.512 ' O ' ' CG ' ' A' ' 24' ' ' GLU . . . -52.72 -45.38 66.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.792 -1.192 . . . . 0.0 108.036 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -64.56 -66.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 108.898 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.866 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -44.94 -48.12 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.785 ' HB3' HD12 ' A' ' 32' ' ' ILE . 3.3 m95 -46.69 -66.98 0.32 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.428 0.633 . . . . 0.0 110.504 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -63.73 -30.0 71.15 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.339 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -71.05 -64.18 0.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.037 -1.039 . . . . 0.0 110.223 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.06 HG11 ' HB3' ' A' ' 50' ' ' ALA . 99.3 t -71.37 -34.42 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 111.086 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.516 ' HB2' HG23 ' A' ' 29' ' ' VAL . 47.3 mt -79.33 4.78 14.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.669 -1.269 . . . . 0.0 110.052 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.34 49.12 61.47 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -134.1 -179.97 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.074 -1.251 . . . . 0.0 109.167 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.91 115.46 10.03 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.289 -0.882 . . . . 0.0 109.367 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 119.67 -69.64 0.36 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.785 HD12 ' HB3' ' A' ' 23' ' ' TRP . 10.2 mm 57.05 113.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -1.071 . . . . 0.0 109.656 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.45 -145.48 1.78 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.64 ' O ' ' N ' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -108.75 -50.81 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -1.22 . . . . 0.0 110.2 -179.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.592 ' HG ' HG21 ' A' ' 73' ' ' THR . 0.5 OUTLIER -109.81 45.21 1.11 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 119.775 -1.828 . . . . 0.0 109.174 179.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 73' ' ' THR . 2.5 m-20 -61.2 -164.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -135.27 118.8 16.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.8 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 70.5 m-85 . . . . . 0 N--CA 1.504 2.257 0 O-C-N 120.924 -1.11 . . . . 0.0 109.31 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 49' ' ' MET . 16.6 tp -64.35 -55.79 18.8 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.091 -1.006 . . . . 0.0 109.568 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 26' ' ' VAL . 1.9 mmtm -43.3 -58.35 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.046 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -51.62 -43.33 62.53 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.95 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.44 -50.63 51.66 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 178.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.06 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -47.37 -43.12 22.99 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.759 HG13 HG13 ' A' ' 22' ' ' ILE . 11.2 t -61.18 -60.76 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.995 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -47.74 -42.98 26.63 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 57' ' ' ARG . . . -58.23 -41.17 83.51 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.563 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -55.47 -29.99 59.74 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.641 HG11 HD23 ' A' ' 63' ' ' LEU . 6.6 t -75.19 -59.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 59' ' ' TYR . 64.8 t-80 -57.33 -31.68 65.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 0.0 109.246 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -78.76 -38.58 38.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.122 -0.986 . . . . 0.0 108.737 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.478 ' OE2' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -71.94 -48.61 44.03 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.775 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -127.47 -178.82 4.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.481 -0.762 . . . . 0.0 109.17 178.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -110.72 44.97 1.19 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.775 HG23 ' HB2' ' A' ' 59' ' ' TYR . 13.9 t -93.14 153.9 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.799 -0.563 . . . . 0.0 109.723 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' C ' ' HD3' ' A' ' 64' ' ' PRO . 11.3 tt0 -70.78 94.85 1.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.641 HD23 HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -125.35 74.14 68.0 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.551 ' HG2' HG23 ' A' ' 67' ' ' VAL . 35.4 Cg_endo -77.2 -176.92 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.771 2.314 . . . . 0.0 110.885 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.95 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.9 mm? -81.27 -41.88 21.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.352 -0.843 . . . . 0.0 109.134 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -59.88 -37.66 79.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.263 -0.898 . . . . 0.0 108.701 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.551 HG23 ' HG2' ' A' ' 64' ' ' PRO . 8.9 t -65.11 -47.08 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.046 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -52.74 -25.84 12.34 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.491 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.7 m-85 -79.17 -42.2 26.68 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.492 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -70.28 -26.18 63.68 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.841 0.829 . . . . 0.0 108.783 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.615 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -147.02 65.76 9.9 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.2 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.567 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 34.4 Cg_endo -78.81 55.73 5.67 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 123.074 2.516 . . . . 0.0 112.722 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.592 HG21 ' HG ' ' A' ' 35' ' ' LEU . 4.7 t -153.18 172.65 16.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.259 -1.526 . . . . 0.0 111.996 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.635 HG12 ' CE2' ' A' ' 23' ' ' TRP . 0.9 OUTLIER -64.36 -54.83 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.616 -0.677 . . . . 0.0 110.78 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.64 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -55.49 -65.2 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.019 -1.051 . . . . 0.0 109.497 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -48.04 -53.93 14.73 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.585 -0.697 . . . . 0.0 110.206 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -57.64 -65.11 0.69 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.714 -1.241 . . . . 0.0 109.155 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.59 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -44.05 -34.92 1.91 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.478 ' HG3' ' N ' ' A' ' 80' ' ' TYR . 0.6 OUTLIER -71.71 -44.45 64.15 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 108.657 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.478 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 2.3 t80 -57.58 -34.91 69.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.105 -0.997 . . . . 0.0 109.015 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.614 HG12 HG21 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -87.65 -63.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.289 1.042 . . . . 0.0 108.219 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.907 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -51.69 -59.57 4.14 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.024 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.405 ' HB ' ' OE1' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.514 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.559 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.09 ' CG1' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -54.08 -36.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.469 ' HG2' ' CB ' ' A' ' 78' ' ' ALA . 2.9 mt-10 -77.98 -36.16 49.33 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.8 m -56.3 -49.09 75.27 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.794 ' O ' HG22 ' A' ' 22' ' ' ILE . 10.0 tptt -67.64 -59.47 3.31 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.778 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -54.24 -27.37 34.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 109.38 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.12 -52.23 37.17 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -55.28 36.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.769 -0.772 . . . . 0.0 108.925 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.794 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -53.52 -53.51 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 108.758 179.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.826 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.7 m95 -40.49 -57.74 1.74 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.449 0.642 . . . . 0.0 109.72 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.595 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -61.49 -49.97 74.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.492 -0.755 . . . . 0.0 109.69 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -52.26 -47.69 65.65 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.48 -0.762 . . . . 0.0 110.683 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.928 HG11 ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -85.92 -50.38 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.093 -1.004 . . . . 0.0 110.371 -178.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.7 mt -68.86 -6.66 28.39 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.598 -0.689 . . . . 0.0 109.977 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.83 60.02 9.17 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -129.9 -178.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -1.162 . . . . 0.0 109.167 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 30' ' ' SER . 1.3 p -148.91 40.0 0.87 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.59 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.37 59.86 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.826 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.2 mt -85.18 136.49 22.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.445 -1.032 . . . . 0.0 109.416 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.98 -120.92 0.04 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.506 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -138.59 -61.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.815 -1.403 . . . . 0.0 109.773 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.585 ' CD2' HG21 ' A' ' 73' ' ' THR . 0.3 OUTLIER -90.02 37.82 0.9 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.676 -1.265 . . . . 0.0 108.544 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.476 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -58.99 -167.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.785 0.802 . . . . 0.0 109.484 178.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -131.72 110.96 11.25 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.737 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 53.6 m-85 . . . . . 0 N--CA 1.507 2.401 0 O-C-N 121.562 -0.711 . . . . 0.0 110.197 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 46' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -45.15 -47.2 12.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.151 -0.968 . . . . 0.0 109.294 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 7.0 tptt -47.83 -62.51 1.42 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 109.202 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.035 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.77 -48.79 50.21 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.045 -1.034 . . . . 0.0 108.594 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.86 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.4 -47.81 47.51 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.928 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -48.36 -42.12 30.69 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.701 HG22 HG21 ' A' ' 26' ' ' VAL . 14.8 t -62.67 -52.99 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.817 ' HB3' ' SD ' ' A' ' 49' ' ' MET . . . -48.4 -45.5 36.01 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.28 77.4 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.562 ' CG ' ' OE2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -51.91 -31.88 30.38 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.028 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.788 HG11 HD13 ' A' ' 63' ' ' LEU . 21.2 t -68.37 -42.03 83.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 59' ' ' TYR . 12.5 t-80 -71.16 -40.77 71.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.368 -0.832 . . . . 0.0 109.033 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -41.66 68.46 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.562 ' OE2' ' CG ' ' A' ' 54' ' ' GLN . 71.2 mt-10 -63.91 -49.4 72.81 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.865 ' CD1' HG11 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -139.96 172.63 12.49 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.74 45.87 0.94 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.835 HG23 ' HB2' ' A' ' 59' ' ' TYR . 21.2 t -92.97 145.66 7.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.437 0.637 . . . . 0.0 109.837 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.85 111.43 5.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 109.461 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.788 HD13 HG11 ' A' ' 55' ' ' VAL . 1.3 tt -147.01 85.37 6.99 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.299 -0.876 . . . . 0.0 109.436 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.1 Cg_endo -79.56 172.18 14.75 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.793 2.329 . . . . 0.0 109.589 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.86 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.1 mt -68.17 -43.23 78.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.716 -1.24 . . . . 0.0 109.116 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.416 ' CG ' ' N ' ' A' ' 67' ' ' VAL . 12.5 ptmm? -47.05 -37.9 10.19 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 80' ' ' TYR . 2.1 t -70.91 -42.21 77.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.035 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -61.28 -22.38 64.8 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.469 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 46.1 m-85 -83.55 -40.46 19.09 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.453 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -68.39 -29.61 68.34 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.994 0.902 . . . . 0.0 108.797 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.539 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -140.58 68.42 31.03 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.573 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.9 Cg_endo -76.9 55.23 4.86 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.989 2.459 . . . . 0.0 113.069 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.586 ' HA ' ' CZ2' ' A' ' 23' ' ' TRP . 10.2 t -153.39 174.44 14.35 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.736 -1.227 . . . . 0.0 110.887 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.815 HD11 ' CG2' ' A' ' 32' ' ' ILE . 21.0 mt -72.71 -65.07 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.311 -0.868 . . . . 0.0 109.883 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -39.76 -54.43 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.645 -0.659 . . . . 0.0 109.577 -179.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' H ' HG23 ' A' ' 73' ' ' THR . . . -62.76 -59.84 4.33 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.358 -0.839 . . . . 0.0 109.068 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.85 HD11 HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -44.54 -62.6 1.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.021 -1.049 . . . . 0.0 108.739 179.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.513 ' N ' HD13 ' A' ' 19' ' ' LEU . . . -48.7 -39.83 26.05 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.79 -40.82 79.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.913 . . . . 0.0 108.868 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.607 ' HD2' HD12 ' A' ' 63' ' ' LEU . 4.3 t80 -56.12 -35.12 66.73 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.865 HG11 ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.21 -69.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 122.334 1.064 . . . . 0.0 109.135 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 1.09 ' HB2' ' CG1' ' A' ' 15' ' ' VAL . . . -48.44 -25.99 1.9 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.341 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.06 . . . . 0.0 109.6 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.602 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 C--O 1.209 -1.049 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.892 HG21 ' CB ' ' A' ' 82' ' ' ALA . 2.2 t -52.0 -49.44 38.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.677 ' HG3' ' HB1' ' A' ' 78' ' ' ALA . 2.3 mt-10 -73.08 -38.25 66.47 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.602 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 16.6 m -53.27 -48.63 68.12 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.31 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.763 ' O ' HG22 ' A' ' 22' ' ' ILE . 6.9 tptt -63.28 -56.66 14.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -0.985 . . . . 0.0 108.861 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.792 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 1.3 tp -52.9 -37.54 60.78 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.432 -0.792 . . . . 0.0 109.15 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.68 84.13 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -61.89 -65.27 0.72 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.534 -0.729 . . . . 0.0 109.056 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.792 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -45.81 -45.91 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.951 -1.093 . . . . 0.0 108.895 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.738 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.5 m95 -47.37 -65.12 0.62 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.66 0.743 . . . . 0.0 109.938 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.613 ' CB ' HD11 ' A' ' 32' ' ' ILE . 8.0 pt-20 -60.22 -32.62 71.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 110.65 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -65.47 -61.66 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.128 -0.982 . . . . 0.0 110.664 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.108 HG11 ' HB3' ' A' ' 50' ' ' ALA . 22.0 t -77.44 -31.83 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.1 -1.0 . . . . 0.0 110.762 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 38.0 mt -78.83 -3.6 45.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.984 -1.073 . . . . 0.0 110.008 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.89 54.67 36.04 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.58 -172.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.186 -1.185 . . . . 0.0 109.374 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 t -143.29 38.22 1.4 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.386 -0.821 . . . . 0.0 109.073 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.612 ' O ' HD12 ' A' ' 32' ' ' ILE . . . -157.14 -94.84 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.659 HG22 ' CB ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER 19.76 86.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 117.746 0.773 . . . . 0.0 110.922 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -135.62 20.23 3.7 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 118.624 -1.751 . . . . 0.0 112.139 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.737 ' H ' HD12 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -174.69 114.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 120.222 -1.752 . . . . 0.0 110.979 178.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.563 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 1.9 tp 37.81 42.47 0.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.348 0.594 . . . . 0.0 110.639 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.659 ' CB ' HG22 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -76.7 -178.42 4.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.827 . . . . 0.0 109.043 178.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 38' ' ' PHE . 7.2 m120 -114.03 112.42 23.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.727 -1.233 . . . . 0.0 109.062 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.738 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 55.1 m-85 . . . . . 0 N--CA 1.505 2.314 0 O-C-N 121.165 -0.959 . . . . 0.0 109.452 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.144 0.497 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -50.95 -62.81 1.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 109.519 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 18.2 mttp -46.52 -54.86 8.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.082 -1.011 . . . . 0.0 108.782 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.07 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -48.92 -44.33 40.28 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.774 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.63 -46.14 58.04 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.301 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.108 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -48.64 -47.58 40.22 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.721 HG13 HG13 ' A' ' 22' ' ' ILE . 10.8 t -56.63 -56.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.76 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.89 -35.64 15.28 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -66.36 -39.93 89.45 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.526 ' CD ' ' HB ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -54.78 -29.53 54.48 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.811 HG21 ' CD2' ' A' ' 63' ' ' LEU . 5.0 t -73.97 -61.66 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 59' ' ' TYR . 71.3 t60 -52.4 -36.32 53.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.904 -1.123 . . . . 0.0 109.435 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.49 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -75.13 -44.8 44.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.044 . . . . 0.0 109.158 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.479 ' HG3' ' HG2' ' A' ' 18' ' ' LYS . 35.4 mm-40 -69.74 -33.47 72.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.408 -0.808 . . . . 0.0 109.217 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.575 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -143.91 162.34 36.38 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.539 -0.725 . . . . 0.0 109.436 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -96.57 39.94 1.15 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.025 HG11 HG13 ' A' ' 81' ' ' VAL . 7.1 p -92.96 153.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -82.78 111.27 18.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.034 HD21 HD13 ' A' ' 77' ' ' LEU . 4.9 tp -145.24 78.28 12.37 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.488 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 35.1 Cg_endo -79.0 -172.04 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.883 2.389 . . . . 0.0 110.284 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.774 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.4 mt -78.67 -37.63 41.34 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.033 -1.042 . . . . 0.0 109.278 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -53.08 -36.67 60.94 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.557 HG11 HD12 ' A' ' 63' ' ' LEU . 2.6 t -72.75 -45.2 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.07 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -62.26 -24.16 67.11 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.4 m-85 -87.52 -35.98 17.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 108.896 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.473 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -70.74 -30.31 66.79 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.545 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.94 66.82 15.13 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -178.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.3 Cg_endo -75.88 59.37 5.75 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.915 2.41 . . . . 0.0 112.235 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.563 ' OG1' ' HA ' ' A' ' 35' ' ' LEU . 4.1 t -153.8 174.37 14.65 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 117.559 -1.656 . . . . 0.0 112.584 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.737 HD12 ' H ' ' A' ' 34' ' ' ILE . 29.0 mt -67.72 -56.94 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.452 ' H ' ' H ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -61.85 -57.51 11.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.672 -1.268 . . . . 0.0 108.84 -178.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.404 ' HB3' HG23 ' A' ' 73' ' ' THR . . . -48.51 -55.09 11.96 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.572 -0.705 . . . . 0.0 109.144 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.034 HD13 HD21 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -55.17 -65.42 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.0 -1.062 . . . . 0.0 109.076 179.354 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.677 ' HB1' ' HG3' ' A' ' 16' ' ' GLU . . . -43.59 -46.13 7.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.492 ' O ' HG22 ' A' ' 83' ' ' THR . 47.5 mm-40 -61.78 -53.14 60.03 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.514 ' CD1' ' CD1' ' A' ' 63' ' ' LEU . 2.5 t80 -43.18 -39.2 2.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.327 -0.858 . . . . 0.0 109.252 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.025 HG13 HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -87.93 -67.31 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.433 1.111 . . . . 0.0 109.041 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.892 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -40.03 -25.94 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.868 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 79' ' ' GLN . 2.1 t . . . . . 0 N--CA 1.492 1.666 0 O-C-N 120.858 -1.151 . . . . 0.0 109.572 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.575 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.992 HG11 ' HB2' ' A' ' 82' ' ' ALA . 43.5 t -49.92 -48.93 22.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HG2' ' CB ' ' A' ' 78' ' ' ALA . 31.6 mt-10 -71.17 -29.36 65.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.575 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 35.4 m -53.04 -51.12 62.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.038 -1.039 . . . . 0.0 108.679 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.599 ' O ' HG22 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -68.93 -54.61 14.45 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.02 -1.072 . . . . 0.0 108.818 179.6 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.059 HD21 HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -48.35 -38.43 19.2 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.78 -1.168 . . . . 0.0 108.063 179.128 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.03 -50.57 73.6 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.66 -62.94 1.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.922 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -45.78 -52.23 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.626 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 2.2 m95 -41.51 -62.41 0.88 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.425 0.631 . . . . 0.0 109.727 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.693 ' HA ' HD11 ' A' ' 32' ' ' ILE . 4.8 pt-20 -66.25 -33.41 75.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.437 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HG3' ' N ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -62.38 -63.9 1.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.349 -179.001 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.842 HG11 ' HB3' ' A' ' 50' ' ' ALA . 11.8 t -79.23 -35.01 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.918 . . . . 0.0 111.606 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 38.4 mt -75.64 -2.79 31.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.884 -1.135 . . . . 0.0 109.955 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.88 59.06 10.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.644 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -131.45 -174.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -1.154 . . . . 0.0 109.083 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t -150.79 49.94 0.86 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.256 -0.902 . . . . 0.0 109.208 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 168.18 -73.05 0.14 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.807 HG22 HD11 ' A' ' 74' ' ' ILE . 5.1 mt 59.43 143.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.433 -1.04 . . . . 0.0 109.776 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.665 ' O ' HD13 ' A' ' 74' ' ' ILE . . . -83.73 -143.53 5.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 34' ' ' ILE . 5.3 tt -127.64 25.2 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -1.231 . . . . 0.0 109.388 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.843 ' HA ' HG22 ' A' ' 73' ' ' THR . 6.2 tp -179.52 61.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.155 -0.965 . . . . 0.0 109.516 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.904 ' O ' HG23 ' A' ' 73' ' ' THR . 0.6 OUTLIER -91.57 -160.48 0.73 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.488 -0.757 . . . . 0.0 109.32 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -126.84 29.85 5.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.878 -1.139 . . . . 0.0 109.953 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 63.0 m-85 . . . . . 0 N--CA 1.507 2.395 0 O-C-N 122.139 -0.351 . . . . 0.0 110.216 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.237 0.542 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -57.09 -43.31 82.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.961 . . . . 0.0 109.335 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.717 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -61.13 -65.29 0.72 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -0.969 . . . . 0.0 109.625 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.934 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.68 -47.96 49.94 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.888 -1.132 . . . . 0.0 108.227 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.896 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.41 -37.93 18.28 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.012 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.842 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -57.22 -49.75 75.01 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.922 HG13 ' CG1' ' A' ' 22' ' ' ILE . 9.4 t -57.13 -57.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.97 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.67 -35.08 13.08 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -67.58 -45.19 76.27 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.598 ' O ' ' CB ' ' A' ' 58' ' ' GLU . 4.4 tp-100 -49.18 -31.8 9.13 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.874 HG11 HD23 ' A' ' 63' ' ' LEU . 3.4 t -68.75 -30.77 48.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.593 -0.692 . . . . 0.0 109.314 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 53' ' ' ALA . 2.8 t60 -81.57 -43.36 18.78 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.183 -0.948 . . . . 0.0 109.509 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -77.4 -34.05 54.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.956 -1.09 . . . . 0.0 108.611 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.598 ' CB ' ' O ' ' A' ' 54' ' ' GLN . 42.3 tp10 -77.1 -37.66 53.87 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.906 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -137.64 157.71 45.93 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 60' ' ' GLN . 4.3 tt0 -93.78 32.02 1.5 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.964 HG11 ' CG1' ' A' ' 81' ' ' VAL . 6.7 p -93.64 144.33 9.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 3.1 pt-20 -69.75 136.24 50.7 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.05 -1.031 . . . . 0.0 109.456 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.874 HD23 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -143.22 92.24 6.79 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.567 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.2 Cg_endo -78.79 162.19 26.99 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.554 2.169 . . . . 0.0 110.762 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.896 HD21 ' SD ' ' A' ' 49' ' ' MET . 4.1 mm? -70.3 -29.62 66.42 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -63.67 -55.07 26.33 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.671 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 3.9 t -49.97 -42.03 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.97 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -61.78 -32.14 72.39 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.499 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 23.4 m-85 -80.43 -37.7 31.53 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.4 -35.07 79.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.469 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -144.98 69.56 14.47 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -178.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.587 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 30.4 Cg_endo -77.67 66.84 8.02 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.712 2.275 . . . . 0.0 109.115 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 36' ' ' ASP . 22.2 m -153.31 161.98 41.78 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 117.088 -1.845 . . . . 0.0 113.108 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.807 HD11 HG22 ' A' ' 32' ' ' ILE . 87.2 mt -57.8 -70.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 110.007 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 21.8 ttpp -57.67 -49.39 76.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.259 -0.901 . . . . 0.0 109.305 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -58.65 -71.35 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.854 -1.154 . . . . 0.0 109.369 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.059 HD12 HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -42.76 -58.21 2.44 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.594 ' HA ' HD13 ' A' ' 19' ' ' LEU . . . -49.67 -60.65 2.68 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 12.5 mm100 -45.37 -42.09 9.74 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.227 -0.92 . . . . 0.0 108.865 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.671 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 7.8 t80 -54.39 -39.01 66.82 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.964 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -87.46 -66.78 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.386 1.089 . . . . 0.0 108.659 179.227 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.992 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -45.01 -40.96 6.97 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.089 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.397 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.577 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.084 HG11 ' HB2' ' A' ' 82' ' ' ALA . 16.0 m -49.5 -37.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.518 ' HG2' HG23 ' A' ' 15' ' ' VAL . 1.1 mt-10 -82.99 -38.45 22.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.577 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 24.8 p -53.47 -38.99 64.14 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.691 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -71.49 -57.89 4.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.587 -0.695 . . . . 0.0 109.23 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.744 ' HB3' HG23 ' A' ' 74' ' ' ILE . 3.9 mm? -54.2 -42.4 69.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.941 -1.099 . . . . 0.0 108.422 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 24' ' ' GLU . . . -56.0 -46.75 78.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -60.48 -63.64 1.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.918 HG12 HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -46.98 -51.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.965 ' CE3' HG21 ' A' ' 32' ' ' ILE . 2.1 m95 -39.38 -66.73 0.27 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.607 0.718 . . . . 0.0 109.929 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.609 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -63.68 -25.63 68.3 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.972 -178.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.478 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . 4.5 tpp180 -74.06 -67.12 0.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.115 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.799 HG11 ' HB3' ' A' ' 50' ' ' ALA . 72.4 t -71.36 -31.63 44.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 111.0 -178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 21.6 mt -85.58 -7.95 58.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.992 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.58 56.44 9.78 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.484 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.9 179.3 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.886 -1.361 . . . . 0.0 108.724 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -140.98 74.09 1.45 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.157 -0.964 . . . . 0.0 108.984 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 146.32 -80.35 0.22 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.965 HG21 ' CE3' ' A' ' 23' ' ' TRP . 9.8 mt 59.58 150.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.223 -1.163 . . . . 0.0 109.64 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.53 -122.52 0.72 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.696 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -147.11 -52.51 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.717 -1.46 . . . . 0.0 111.079 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.82 HD23 HG21 ' A' ' 73' ' ' THR . 5.5 mt -95.5 31.14 2.07 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.049 -1.657 . . . . 0.0 110.976 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.729 ' O ' HG23 ' A' ' 73' ' ' THR . 2.9 m-20 -59.15 -166.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.113 -0.992 . . . . 0.0 109.616 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.509 ' CG ' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -133.98 30.62 3.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.086 -1.009 . . . . 0.0 109.245 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.599 ' CD1' ' CZ2' ' A' ' 23' ' ' TRP . 6.5 m-30 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.362 -0.836 . . . . 0.0 109.64 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 46' ' ' LEU . 4.2 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.981 0.419 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 49' ' ' MET . 0.4 OUTLIER -43.97 -51.02 8.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.014 -1.054 . . . . 0.0 109.246 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -44.91 -47.44 11.24 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.018 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -57.2 -45.41 83.82 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.813 ' HG2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -46.68 -51.77 15.28 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.799 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -48.3 -50.0 31.76 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.918 HG13 HG12 ' A' ' 22' ' ' ILE . 21.2 t -51.22 -55.49 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.066 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -50.18 -46.2 54.09 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -52.05 -38.35 56.75 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.567 ' HG2' ' HB ' ' A' ' 22' ' ' ILE . 3.4 tp-100 -58.63 -41.04 85.03 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.9 HG21 HD22 ' A' ' 63' ' ' LEU . 14.7 t -61.5 -40.54 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 59' ' ' TYR . 11.9 t60 -69.15 -53.27 20.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.056 -1.027 . . . . 0.0 109.149 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -38.57 84.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.037 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.543 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 13.3 mm-40 -71.82 -56.64 5.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.305 -0.872 . . . . 0.0 108.651 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.843 ' CD1' HG11 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -127.03 165.04 20.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.767 0.794 . . . . 0.0 109.532 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -95.78 46.18 1.09 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.6 t -91.44 138.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.514 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.63 103.16 1.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 109.765 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.9 HD22 HG21 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -138.94 82.58 19.81 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.055 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.564 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 34.5 Cg_endo -77.81 -178.84 4.91 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.78 2.32 . . . . 0.0 110.418 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.813 HD21 ' HG2' ' A' ' 49' ' ' MET . 2.5 mm? -65.22 -37.93 88.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 109.089 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -56.26 -60.99 2.71 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.587 HG12 HE22 ' A' ' 71' ' ' GLN . 15.2 t -47.04 -43.07 6.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.066 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -61.81 -48.68 79.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -65.51 -19.84 66.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -76.31 -52.11 10.62 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.271 1.034 . . . . 0.0 108.838 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.587 HE22 HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -132.58 72.35 77.91 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.034 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.581 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 31.2 Cg_endo -76.4 67.43 7.06 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.397 2.064 . . . . 0.0 108.207 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.82 HG21 HD23 ' A' ' 35' ' ' LEU . 22.2 m -151.4 165.77 33.11 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.227 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 19' ' ' LEU . 6.1 mt -76.79 -69.58 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.331 -0.856 . . . . 0.0 109.798 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -45.84 -47.54 15.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.182 -0.948 . . . . 0.0 108.867 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.457 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -59.5 -55.48 34.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.387 -0.821 . . . . 0.0 109.147 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -56.23 -65.6 0.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.102 -0.999 . . . . 0.0 108.876 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.69 ' HB1' HG23 ' A' ' 15' ' ' VAL . . . -43.35 -37.42 2.26 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.46 -0.775 . . . . 0.0 109.054 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.447 ' O ' ' O ' ' A' ' 83' ' ' THR . 10.1 tp60 -69.95 -43.85 70.74 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.002 -1.061 . . . . 0.0 108.548 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.537 ' CD2' HD12 ' A' ' 63' ' ' LEU . 10.4 t80 -59.84 -33.4 71.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.33 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.843 HG11 ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -86.93 -60.74 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 122.48 1.133 . . . . 0.0 108.196 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 1.084 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -54.35 -65.32 0.6 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.418 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.585 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.622 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.892 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 2.7 t -49.37 -49.62 17.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -29.51 48.54 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.622 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 7.3 m -60.84 -42.31 97.53 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.664 -1.215 . . . . 0.0 108.684 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.475 ' HG2' ' HG3' ' A' ' 58' ' ' GLU . 0.7 OUTLIER -69.1 -51.31 39.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.712 ' HA ' HD11 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -61.11 -46.7 89.53 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.733 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.36 -45.43 55.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 22' ' ' ILE . 1.7 mm-40 -62.76 -69.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.537 -0.727 . . . . 0.0 109.541 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.973 HD12 ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -47.06 -40.58 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.872 -1.143 . . . . 0.0 108.919 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.727 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.6 m95 -49.25 -67.44 0.26 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.369 -0.832 . . . . 0.0 109.507 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.774 ' HA ' HD11 ' A' ' 32' ' ' ILE . 4.0 pt-20 -58.85 -39.29 80.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.439 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -69.51 -70.85 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.795 -1.191 . . . . 0.0 109.744 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 50' ' ' ALA . 55.3 t -55.92 -31.41 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 110.85 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.771 HD23 ' HG3' ' A' ' 47' ' ' LYS . 14.2 mt -96.53 15.0 22.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.115 -0.991 . . . . 0.0 110.8 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.42 44.77 45.65 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 121.208 -0.932 . . . . 0.0 110.978 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.771 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -117.82 -170.3 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.093 -1.239 . . . . 0.0 108.885 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 p -145.99 49.4 1.2 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.184 -0.948 . . . . 0.0 109.48 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 143.37 -66.8 0.46 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.774 HD11 ' HA ' ' A' ' 24' ' ' GLU . 1.7 mp 57.61 156.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -1.171 . . . . 0.0 109.776 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.817 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -80.31 -157.73 15.65 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -102.7 -49.08 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.272 . . . . 0.0 110.346 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.708 HD23 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -93.06 34.95 1.08 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.801 -1.187 . . . . 0.0 109.294 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -64.77 155.19 34.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.689 -0.632 . . . . 0.0 109.902 179.034 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.8 m-20 -97.84 122.12 40.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.1 -1.0 . . . . 0.0 108.626 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.727 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 79.0 m-85 . . . . . 0 N--CA 1.504 2.233 0 O-C-N 121.109 -0.995 . . . . 0.0 109.319 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.0 mm? -53.92 -34.65 60.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.771 ' HG3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -56.46 -51.98 66.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.114 -0.991 . . . . 0.0 108.39 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.704 ' HB1' ' CD2' ' A' ' 68' ' ' LEU . . . -58.73 -46.15 88.03 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.909 ' HG2' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -52.99 -32.91 48.99 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.257 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 47' ' ' LYS . . . -60.94 -44.57 97.06 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.973 ' CG1' HD12 ' A' ' 22' ' ' ILE . 4.3 t -62.13 -69.97 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.014 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -44.81 -50.14 10.39 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.264 -0.897 . . . . 0.0 108.679 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 49' ' ' MET . . . -55.89 -46.04 78.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.891 ' HG2' HG21 ' A' ' 22' ' ' ILE . 8.1 tp-100 -48.21 -33.54 8.73 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.536 HG13 HG11 ' A' ' 81' ' ' VAL . 3.5 t -67.26 -67.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 59' ' ' TYR . 3.0 t-160 -46.86 -36.25 7.27 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.792 -1.192 . . . . 0.0 109.593 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -72.1 -42.66 65.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.792 -1.193 . . . . 0.0 108.717 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 18' ' ' LYS . 52.8 mm-40 -71.58 -50.76 27.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.778 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -116.91 160.14 21.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -93.67 36.95 1.07 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.798 HG11 ' CG1' ' A' ' 81' ' ' VAL . 6.3 p -94.11 145.56 7.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -82.78 112.61 19.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.5 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.071 HD21 HD13 ' A' ' 77' ' ' LEU . 15.9 tp -133.14 94.7 19.79 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.8 Cg_endo -80.91 163.66 20.53 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.784 2.323 . . . . 0.0 110.771 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.909 HD11 ' HG2' ' A' ' 49' ' ' MET . 4.5 mt -65.15 -39.1 92.51 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.385 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -48.45 -53.33 18.28 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.902 HG11 ' CD1' ' A' ' 63' ' ' LEU . 1.2 t -56.01 -46.13 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.014 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -58.13 -22.32 50.5 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.477 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.3 m-85 -86.03 -37.66 18.68 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.45 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.7 -31.57 69.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.463 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.15 67.4 21.55 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.559 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 33.0 Cg_endo -77.13 61.58 7.28 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.912 2.408 . . . . 0.0 111.933 -178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.708 HG21 HD23 ' A' ' 35' ' ' LEU . 4.4 t -152.95 176.06 12.26 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.198 -1.401 . . . . 0.0 112.053 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.817 HD12 ' O ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -73.64 -69.22 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.904 -0.498 . . . . 0.0 110.411 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.557 ' CG ' HG12 ' A' ' 34' ' ' ILE . 11.6 tmtt? -39.91 -56.53 1.79 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB3' HG23 ' A' ' 73' ' ' THR . . . -58.05 -64.33 0.95 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.514 -0.742 . . . . 0.0 109.884 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.071 HD13 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -46.27 -62.98 1.11 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.781 -1.2 . . . . 0.0 108.974 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 82' ' ' ALA . . . -44.78 -48.82 10.91 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 51.2 mm-40 -61.55 -44.5 96.93 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.464 ' CD2' HD13 ' A' ' 63' ' ' LEU . 1.1 t80 -53.29 -37.11 61.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.891 -1.13 . . . . 0.0 108.927 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.798 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -88.24 -65.43 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.431 1.11 . . . . 0.0 108.535 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.892 ' HB2' ' CB ' ' A' ' 15' ' ' VAL . . . -49.09 -20.7 0.6 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.355 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.531 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.615 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.868 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 35.3 t -48.07 -58.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.69 ' HG3' ' HB1' ' A' ' 78' ' ' ALA . 1.2 mp0 -66.01 -36.67 83.9 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.615 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 70.7 m -48.55 -55.92 9.77 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.302 177.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.816 ' O ' HG23 ' A' ' 22' ' ' ILE . 20.1 tttm -52.44 -67.43 0.25 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.811 HD12 ' NZ ' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -43.0 -46.48 5.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.336 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -49.82 -57.98 6.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.78 -1.2 . . . . 0.0 109.08 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -51.08 71.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 109.4 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.972 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -54.69 -44.06 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.78 ' HB3' HD13 ' A' ' 32' ' ' ILE . 3.3 m95 -52.22 -66.2 0.42 Allowed 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.619 0.723 . . . . 0.0 109.721 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.651 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -58.9 -53.73 55.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.463 -0.773 . . . . 0.0 110.046 -178.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -54.15 -66.08 0.46 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 109.982 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.968 HG11 ' HB3' ' A' ' 50' ' ' ALA . 21.6 t -58.56 -43.73 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.797 . . . . 0.0 110.719 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 42.3 mt -78.69 -12.38 60.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.996 -1.065 . . . . 0.0 110.347 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 72.73 53.27 8.45 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.409 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.36 -178.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.125 -1.221 . . . . 0.0 109.127 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.08 39.71 1.34 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.209 -0.932 . . . . 0.0 109.472 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -156.17 -91.2 0.08 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.78 HD13 ' HB3' ' A' ' 23' ' ' TRP . 14.7 mt 58.63 149.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -1.164 . . . . 0.0 109.721 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.38 -154.96 19.41 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.618 ' HA ' HG21 ' A' ' 74' ' ' ILE . 9.1 pt -98.84 2.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.139 -1.212 . . . . 0.0 110.024 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 35' ' ' LEU . 1.3 tt -162.41 69.1 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.979 -1.076 . . . . 0.0 108.986 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.512 ' N ' ' HG1' ' A' ' 73' ' ' THR . 1.8 m-20 -98.49 160.68 14.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.679 -0.638 . . . . 0.0 109.562 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.5 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.2 t-20 -89.49 106.83 18.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.726 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 43.4 m-85 . . . . . 0 N--CA 1.511 2.595 0 O-C-N 121.789 -0.569 . . . . 0.0 111.111 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.2 0.524 . . . . 0.0 109.821 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -46.15 -58.86 3.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.08 -1.012 . . . . 0.0 109.51 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.0 tptt -47.0 -59.35 3.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 109.854 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.073 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -58.06 -45.26 87.38 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.032 -1.042 . . . . 0.0 109.137 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.72 ' HG2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.77 -49.6 37.87 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.331 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.968 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -50.38 -55.63 14.86 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.972 ' CG1' HD11 ' A' ' 22' ' ' ILE . 21.6 t -43.13 -60.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.072 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -49.95 -54.89 16.96 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.527 ' HB2' ' CE ' ' A' ' 49' ' ' MET . . . -47.36 -50.63 21.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.73 ' HB3' HD12 ' A' ' 22' ' ' ILE . 7.3 tp-100 -46.91 -38.6 10.76 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.008 HG11 HD13 ' A' ' 63' ' ' LEU . 17.0 t -60.23 -62.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 59' ' ' TYR . 17.3 t60 -58.34 -32.82 68.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.419 -0.801 . . . . 0.0 110.046 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -74.29 -39.33 62.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.046 -1.034 . . . . 0.0 109.548 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.551 ' HB2' ' CE ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -78.29 -44.59 24.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 109.295 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.883 ' HB2' HG12 ' A' ' 61' ' ' VAL . 5.4 m-85 -110.96 -174.43 2.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 54.5 tp60 -113.54 29.15 8.22 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.883 HG12 ' HB2' ' A' ' 59' ' ' TYR . 3.4 p -93.85 134.3 31.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.654 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -74.34 103.61 4.78 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.465 -0.772 . . . . 0.0 110.097 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.008 HD13 HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -116.81 95.79 47.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.118 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.518 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 37.4 Cg_endo -82.88 169.17 13.43 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.721 2.281 . . . . 0.0 110.157 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.72 HD21 ' HG2' ' A' ' 49' ' ' MET . 1.9 mt -66.52 -37.73 85.65 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.076 -1.015 . . . . 0.0 109.045 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -40.69 64.84 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.518 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 4.6 t -65.53 -43.6 94.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.073 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -58.06 -26.14 62.12 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.115 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.5 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 10.2 m-85 -86.29 -34.73 20.27 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.72 -25.39 64.73 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.915 0.864 . . . . 0.0 108.736 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.682 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -154.58 66.76 5.28 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -177.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.568 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.7 Cg_endo -75.1 53.99 3.55 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.767 2.311 . . . . 0.0 112.338 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 76' ' ' ALA . 14.6 t -153.23 170.03 21.58 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.591 -1.318 . . . . 0.0 111.238 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.684 HD11 ' CG ' ' A' ' 23' ' ' TRP . 9.4 mm -60.25 -71.69 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.869 -0.519 . . . . 0.0 111.776 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -50.22 -54.04 23.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.057 -1.027 . . . . 0.0 110.362 -178.049 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -53.45 -67.93 0.22 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.664 ' HB3' HD21 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -53.27 -59.32 4.72 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.479 -0.889 . . . . 0.0 109.323 -179.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.69 ' HB1' ' HG3' ' A' ' 16' ' ' GLU . . . -45.78 -44.68 14.17 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -61.71 -42.42 98.92 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.056 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.04 -33.82 65.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 108.856 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.869 HG13 HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -86.98 -60.98 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.481 1.134 . . . . 0.0 108.898 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.868 ' HB2' ' CB ' ' A' ' 15' ' ' VAL . . . -53.61 -41.24 66.46 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.688 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.478 ' HB ' ' OE1' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 120.927 -1.108 . . . . 0.0 109.598 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.593 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.963 0.411 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.134 HG21 ' HB2' ' A' ' 82' ' ' ALA . 57.5 t -51.62 -51.68 25.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.501 ' OE1' ' CD1' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -70.45 -27.92 64.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.593 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 49.5 m -53.4 -51.68 61.81 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.799 -1.161 . . . . 0.0 108.166 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.606 ' O ' HG23 ' A' ' 22' ' ' ILE . 5.7 tptm -66.53 -62.74 1.3 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.361 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.488 ' CA ' HG23 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -39.93 -49.72 2.46 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -51.23 -51.48 53.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' LYS . 4.0 mt-10 -58.64 -62.79 1.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.97 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -42.89 -46.36 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.068 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.644 ' CE2' HG12 ' A' ' 74' ' ' ILE . 4.1 m95 -54.93 -70.77 0.09 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 121.702 0.763 . . . . 0.0 110.194 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.615 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -57.83 -47.33 82.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 110.272 -178.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.449 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 14.2 ttm180 -62.41 -65.18 0.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.015 -1.053 . . . . 0.0 110.302 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' ' 50' ' ' ALA . 29.5 t -61.76 -36.13 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.372 -0.83 . . . . 0.0 111.007 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 42.2 mt -84.54 -35.78 22.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.974 -1.079 . . . . 0.0 110.01 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 92.59 56.55 1.53 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.208 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.53 172.49 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -1.203 . . . . 0.0 109.159 179.507 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.2 t -131.8 39.23 3.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.198 -0.939 . . . . 0.0 109.174 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -157.36 -89.0 0.07 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 24' ' ' GLU . 10.8 mt 59.07 141.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -1.158 . . . . 0.0 109.804 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.769 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -101.77 -147.26 19.71 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.501 ' CD1' ' OE1' ' A' ' 16' ' ' GLU . 20.2 tt -113.1 9.58 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.116 -1.226 . . . . 0.0 110.285 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.004 HD23 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -163.01 60.28 0.19 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.778 -1.202 . . . . 0.0 110.029 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 4.1 m-20 -92.76 148.86 21.69 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -83.4 52.27 2.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.687 -1.258 . . . . 0.0 109.272 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.635 ' CE2' ' HA ' ' A' ' 72' ' ' PRO . 22.6 m-85 . . . . . 0 N--CA 1.502 2.138 0 O-C-N 121.63 -0.669 . . . . 0.0 110.322 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -51.24 -54.75 22.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.761 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -55.44 -60.35 3.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 109.826 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.834 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -52.49 -44.57 65.72 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.797 -1.189 . . . . 0.0 108.73 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.947 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.38 -45.72 55.55 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.676 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -51.83 -56.04 16.36 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.97 ' CG1' HD11 ' A' ' 22' ' ' ILE . 34.2 t -43.82 -66.19 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.034 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.23 -44.27 32.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 108.721 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -58.96 -47.3 85.58 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.577 ' HG2' ' HB ' ' A' ' 22' ' ' ILE . 1.6 tp-100 -47.56 -33.24 6.24 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.593 HG21 ' HG ' ' A' ' 63' ' ' LEU . 15.0 t -67.53 -37.52 78.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 53' ' ' ALA . 36.5 t60 -77.48 -42.14 36.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.163 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -39.19 78.92 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.616 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 8.2 tp10 -74.53 -48.79 24.93 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.779 ' CD2' HG11 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -125.13 159.01 32.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 179.041 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -94.55 37.54 1.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.911 HG11 ' CG1' ' A' ' 81' ' ' VAL . 7.3 p -94.51 159.31 2.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.305 0.574 . . . . 0.0 109.834 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.458 ' N ' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -75.34 119.09 18.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 0.0 109.662 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -143.21 74.11 17.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.93 . . . . 0.0 108.8 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.2 Cg_endo -79.82 165.47 22.19 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.778 2.318 . . . . 0.0 110.267 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.947 HD21 ' SD ' ' A' ' 49' ' ' MET . 7.5 mt -65.18 -39.3 92.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.055 -1.028 . . . . 0.0 109.115 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -51.61 -45.34 63.19 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 2.7 t -61.59 -45.46 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.034 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -57.49 -28.9 63.83 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.441 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 49.4 m-85 -79.19 -42.91 24.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.013 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.45 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.64 -34.9 79.29 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.907 0.86 . . . . 0.0 109.153 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.45 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -144.02 71.46 16.66 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.635 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 33.7 Cg_endo -77.09 56.01 5.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.829 2.353 . . . . 0.0 111.959 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 1.004 HG21 HD23 ' A' ' 35' ' ' LEU . 4.8 t -152.26 178.82 9.1 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 117.664 -1.614 . . . . 0.0 113.094 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.769 HD12 ' O ' ' A' ' 33' ' ' GLY . 1.4 mt -69.97 -78.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.514 -178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.495 ' HB2' HG12 ' A' ' 34' ' ' ILE . 5.2 tttm -41.05 -54.86 2.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.503 -0.748 . . . . 0.0 109.388 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.722 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -52.65 -63.05 1.27 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.612 -0.835 . . . . 0.0 108.826 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.574 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -48.81 -63.64 1.03 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.448 -1.407 . . . . 0.0 108.245 178.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.688 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -43.18 -31.66 0.62 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.6 OUTLIER -79.18 -46.46 17.87 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -55.4 -33.14 63.25 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.911 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -89.02 -68.3 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 122.269 1.033 . . . . 0.0 109.014 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 1.134 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -55.94 -55.3 34.28 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.648 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' GLN . 76.1 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.41 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.63 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.959 HG21 ' HB2' ' A' ' 82' ' ' ALA . 48.4 t -44.72 -54.78 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.689 ' OE1' HD11 ' A' ' 34' ' ' ILE . 2.4 mt-10 -70.88 -30.1 66.38 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 69.8 m -55.94 -49.61 73.05 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.062 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.697 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -70.67 -56.28 6.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.4 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.721 ' HA ' HG23 ' A' ' 22' ' ' ILE . 3.4 mm? -50.14 -43.23 51.91 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -56.54 -49.05 75.93 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -60.67 -62.35 1.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.799 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -45.91 -52.26 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 1.169 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.9 m95 -40.53 -67.26 0.25 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.946 0.879 . . . . 0.0 110.417 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.628 ' HA ' HD11 ' A' ' 32' ' ' ILE . 14.6 pt-20 -63.02 -28.05 69.84 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.494 0.664 . . . . 0.0 109.903 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -73.05 -65.29 0.82 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.543 -0.723 . . . . 0.0 110.501 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.91 HG12 ' HB2' ' A' ' 47' ' ' LYS . 76.8 t -69.68 -30.98 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 110.356 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 21.9 mt -86.88 -20.66 27.12 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.118 -0.989 . . . . 0.0 110.019 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.04 62.4 2.35 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.126 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -138.39 -167.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.284 . . . . 0.0 108.906 179.038 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.01 70.09 1.26 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.186 -0.946 . . . . 0.0 109.301 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 132.0 -73.15 0.47 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.169 HG21 ' CE3' ' A' ' 23' ' ' TRP . 6.1 mt 61.49 133.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.24 -1.153 . . . . 0.0 109.29 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.992 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -52.35 -171.64 0.03 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.689 HD11 ' OE1' ' A' ' 16' ' ' GLU . 6.4 tt -106.2 8.49 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.102 -1.234 . . . . 0.0 109.188 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.823 HD12 ' CG2' ' A' ' 73' ' ' THR . 22.2 tp -157.52 48.98 0.42 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.081 -1.012 . . . . 0.0 109.872 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.642 ' O ' HG23 ' A' ' 73' ' ' THR . 5.9 m-20 -74.04 -166.38 0.39 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.117 -0.989 . . . . 0.0 110.29 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -132.48 33.35 3.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.453 -0.78 . . . . 0.0 109.122 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 72' ' ' PRO . 5.8 m-30 . . . . . 0 N--CA 1.5 2.053 0 O-C-N 121.875 -0.516 . . . . 0.0 111.245 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -43.09 -59.11 2.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.368 -0.833 . . . . 0.0 109.463 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.91 ' HB2' HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -54.56 -42.82 71.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.053 -1.029 . . . . 0.0 109.115 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.011 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -52.43 -52.88 51.7 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.868 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.95 -41.79 25.85 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.906 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -50.47 -48.52 56.63 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.799 HG13 ' CG1' ' A' ' 22' ' ' ILE . 10.0 t -54.51 -55.57 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.913 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -49.27 -47.92 46.29 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -53.63 -42.63 67.96 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 8.3 tp-100 -56.47 -30.38 62.86 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.945 HG21 HD22 ' A' ' 63' ' ' LEU . 21.2 t -70.63 -43.43 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -0.825 . . . . 0.0 109.208 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 59' ' ' TYR . 3.1 t60 -77.28 -32.74 55.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.019 . . . . 0.0 109.293 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.409 ' NE ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -80.5 -39.22 28.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 108.956 179.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -74.65 -44.78 48.72 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.771 ' HB2' HG12 ' A' ' 61' ' ' VAL . 1.1 m-85 -122.27 -176.8 3.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.918 . . . . 0.0 109.233 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -114.28 35.2 4.28 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.981 HG11 HG13 ' A' ' 81' ' ' VAL . 3.2 p -93.7 158.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.572 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' N ' HG22 ' A' ' 61' ' ' VAL . 1.7 tt0 -96.65 102.36 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.923 . . . . 0.0 110.453 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.945 HD22 HG21 ' A' ' 55' ' ' VAL . 3.2 tp -115.83 99.89 53.0 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.53 ' HG2' HG23 ' A' ' 67' ' ' VAL . 33.7 Cg_endo -77.15 152.82 31.51 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.378 2.052 . . . . 0.0 111.035 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.868 HD21 ' SD ' ' A' ' 49' ' ' MET . 1.9 mm? -52.74 -41.7 64.24 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' PHE . 1.5 ttmt -53.44 -57.1 11.84 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.53 HG23 ' HG2' ' A' ' 64' ' ' PRO . 4.0 t -50.08 -38.69 15.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.011 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -63.87 -31.11 72.18 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 66' ' ' LYS . 2.0 m-85 -84.25 -35.07 23.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.4 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.77 -38.59 89.46 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.781 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.2 69.14 27.69 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 31.9 Cg_endo -78.95 69.28 7.97 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.361 2.041 . . . . 0.0 108.001 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.823 ' CG2' HD12 ' A' ' 35' ' ' LEU . 98.5 m -151.83 167.2 29.04 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.013 -1.475 . . . . 0.0 111.633 -177.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.992 HD12 ' O ' ' A' ' 33' ' ' GLY . 5.5 mt -67.41 -77.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.352 -0.842 . . . . 0.0 110.99 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.8 ' HB3' HD13 ' A' ' 35' ' ' LEU . 16.7 ttpp -45.91 -46.6 16.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.333 -0.854 . . . . 0.0 109.517 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -58.73 -68.54 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.96 . . . . 0.0 109.75 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.781 HD23 ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -44.55 -59.21 2.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.772 -1.205 . . . . 0.0 108.522 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.753 ' HB1' HG12 ' A' ' 15' ' ' VAL . . . -47.26 -32.91 5.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -77.84 -44.17 28.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 0.0 109.042 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.401 ' CD2' ' NE2' ' A' ' 71' ' ' GLN . 3.3 t80 -64.83 -29.29 70.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.312 -0.868 . . . . 0.0 108.974 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.981 HG13 HG11 ' A' ' 61' ' ' VAL . 21.3 t -86.68 -59.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.332 1.063 . . . . 0.0 109.309 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.959 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -58.28 -26.67 63.26 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.458 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.056 -1.028 . . . . 0.0 109.661 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.624 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.71 0.29 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.074 HG12 ' HB1' ' A' ' 78' ' ' ALA . 40.2 t -65.29 -55.97 17.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 78' ' ' ALA . 42.1 mt-10 -77.59 -32.01 53.35 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.624 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -63.02 -42.89 99.92 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.837 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.621 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -66.32 -63.71 1.02 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 19' ' ' LEU . 5.5 mp -45.76 -45.07 14.36 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -47.54 -51.78 19.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.791 -1.193 . . . . 0.0 108.347 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.458 ' OE1' ' NH1' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -61.43 -62.08 2.08 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.974 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -43.46 -43.44 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-O 122.27 1.033 . . . . 0.0 108.331 178.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.795 ' CE3' HG21 ' A' ' 32' ' ' ILE . 3.7 m95 -53.19 -67.88 0.22 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.987 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.438 ' HA ' HG23 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -64.31 -35.14 79.89 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.378 -0.826 . . . . 0.0 110.288 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' NH1' ' OE1' ' A' ' 21' ' ' GLU . 27.1 ttm180 -68.83 -58.64 3.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.489 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.667 HG11 ' HB3' ' A' ' 50' ' ' ALA . 65.7 t -74.19 -37.24 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 0.0 110.823 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.46 ' CG ' ' O ' ' A' ' 23' ' ' TRP . 36.9 mt -77.22 -51.99 9.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.902 -1.124 . . . . 0.0 109.946 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.2 53.22 0.28 Allowed Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.184 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.653 ' CG2' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -137.42 -171.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -1.185 . . . . 0.0 108.716 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.81 39.87 0.96 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.3 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -161.06 -80.58 0.04 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.795 HG21 ' CE3' ' A' ' 23' ' ' TRP . 6.9 mt 40.83 94.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.52 -0.988 . . . . 0.0 109.932 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.864 ' C ' HD12 ' A' ' 34' ' ' ILE . . . -59.22 -88.49 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.864 HD12 ' C ' ' A' ' 33' ' ' GLY . 5.0 mp -151.1 -58.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.994 -1.298 . . . . 0.0 110.599 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -87.25 34.93 0.69 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.16 -1.588 . . . . 0.0 109.501 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -63.34 166.97 5.74 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.438 0.637 . . . . 0.0 109.634 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 38' ' ' PHE . 1.6 m120 -106.52 116.79 32.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.213 -0.93 . . . . 0.0 108.525 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.729 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 46.6 m-85 . . . . . 0 N--CA 1.501 2.105 0 O-C-N 121.284 -0.885 . . . . 0.0 109.793 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 46' ' ' LEU . 2.9 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.546 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -42.52 -51.07 5.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.653 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -51.99 -61.96 1.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 109.77 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.002 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.34 -51.26 35.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.082 -1.011 . . . . 0.0 109.414 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.914 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -46.45 -47.05 19.19 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.667 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -50.86 -54.57 22.7 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.974 ' CG1' HD11 ' A' ' 22' ' ' ILE . 38.2 t -44.65 -59.13 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.962 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -51.76 -46.62 64.17 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -53.44 -49.62 66.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.612 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.9 tp-100 -45.6 -39.9 8.21 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.836 HG11 HD12 ' A' ' 63' ' ' LEU . 2.6 t -66.36 -34.45 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.55 0.69 . . . . 0.0 109.471 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 53' ' ' ALA . 13.4 t-160 -82.13 -32.68 29.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.879 -1.138 . . . . 0.0 109.825 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -76.68 -37.01 56.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.982 -1.074 . . . . 0.0 108.566 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.501 ' HG3' ' HE2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -76.65 -51.23 11.92 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.32 -0.863 . . . . 0.0 108.859 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.613 ' HB2' HG12 ' A' ' 61' ' ' VAL . 2.0 m-85 -112.33 179.02 4.11 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.762 0.791 . . . . 0.0 109.439 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -109.85 40.51 1.89 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.028 HG11 HG13 ' A' ' 81' ' ' VAL . 4.3 p -92.9 127.06 45.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.763 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -71.19 97.09 1.47 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.722 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.836 HD12 HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -112.36 102.12 53.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.508 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.497 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 36.4 Cg_endo -79.64 160.47 25.05 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.428 2.085 . . . . 0.0 110.688 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.914 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.2 mm? -61.69 -45.45 93.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.274 -0.891 . . . . 0.0 108.943 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HE3' ' HB2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -52.02 -44.21 64.07 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.097 -1.002 . . . . 0.0 108.827 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.503 ' CG1' ' CD2' ' A' ' 63' ' ' LEU . 2.0 t -56.09 -42.99 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.002 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -60.29 -24.9 65.32 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.482 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 14.1 m-85 -87.31 -38.87 15.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.359 -0.838 . . . . 0.0 108.904 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.85 -31.74 72.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.516 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -144.59 70.34 15.42 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.576 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 33.2 Cg_endo -76.91 53.06 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.791 2.327 . . . . 0.0 111.887 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.642 ' HA ' ' CZ2' ' A' ' 23' ' ' TRP . 6.2 t -152.24 167.62 28.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.699 -1.251 . . . . 0.0 110.769 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.632 HD11 HG22 ' A' ' 32' ' ' ILE . 14.0 mt -68.68 -60.58 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.961 -1.087 . . . . 0.0 110.014 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.739 ' CB ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -42.13 -58.03 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.517 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -64.88 -66.81 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 110.245 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.792 HD11 HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -47.77 -64.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.017 . . . . 0.0 109.309 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 1.074 ' HB1' HG12 ' A' ' 15' ' ' VAL . . . -43.69 -45.28 6.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 3.4 tp60 -62.17 -39.67 93.44 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.487 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -57.56 -34.19 68.92 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.028 HG13 HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -84.47 -69.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.856 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -43.46 -36.04 1.84 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.256 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.47 ' HB ' ' NE2' ' A' ' 79' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.025 -1.047 . . . . 0.0 109.686 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.639 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.94 HG11 ' HB2' ' A' ' 82' ' ' ALA . 30.9 t -51.58 -54.02 14.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -70.85 -27.34 63.77 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.639 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 68.3 m -58.21 -50.39 73.71 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.916 -1.114 . . . . 0.0 108.514 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HE3' ' OE2' ' A' ' 58' ' ' GLU . 4.0 tptt -64.26 -51.36 63.96 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.647 -0.658 . . . . 0.0 109.654 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.871 ' HA ' HG22 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -60.89 -49.06 79.01 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.571 -1.252 . . . . 0.0 108.344 179.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -47.31 -42.41 21.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.339 -1.476 . . . . 0.0 107.498 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.48 -63.01 1.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.928 HG23 HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.94 -38.94 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.881 -1.137 . . . . 0.0 108.243 179.354 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.799 ' HB3' HD13 ' A' ' 32' ' ' ILE . 3.0 m95 -49.15 -66.96 0.31 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.884 0.849 . . . . 0.0 109.129 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.625 ' HA ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -53.86 -47.25 71.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.827 -0.545 . . . . 0.0 110.459 -178.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -60.06 -68.53 0.28 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.039 -1.038 . . . . 0.0 110.629 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.062 HG11 ' HB3' ' A' ' 50' ' ' ALA . 47.5 t -61.93 -34.67 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 110.979 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' CD1' ' CE3' ' A' ' 23' ' ' TRP . 64.7 mt -83.14 -43.67 15.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.802 -1.186 . . . . 0.0 109.991 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 106.45 49.63 0.91 Allowed Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.789 -1.196 . . . . 0.0 110.685 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.625 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.59 176.57 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.983 -1.304 . . . . 0.0 109.22 179.378 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 t -132.68 35.48 3.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 108.549 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -149.83 -98.39 0.19 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.002 HG22 HD11 ' A' ' 74' ' ' ILE . 1.3 mt 53.6 104.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.054 -1.262 . . . . 0.0 108.434 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.2 -88.12 1.95 Allowed Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.571 -1.3 . . . . 0.0 111.535 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.575 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 1.7 mt -142.36 111.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.053 -1.263 . . . . 0.0 109.531 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.818 ' C ' HG22 ' A' ' 73' ' ' THR . 0.3 OUTLIER 88.62 46.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.734 0.778 . . . . 0.0 109.737 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.684 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -83.97 -148.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -128.26 114.3 16.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.542 -1.349 . . . . 0.0 110.8 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.772 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 66.6 m-85 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 120.973 -1.079 . . . . 0.0 108.436 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.501 ' N ' HD22 ' A' ' 46' ' ' LEU . 3.2 mm? -52.39 -31.29 33.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.038 -1.038 . . . . 0.0 109.07 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.1 tptt -64.91 -71.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.025 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -46.99 -48.47 21.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.897 -1.127 . . . . 0.0 108.245 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.933 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.55 -45.23 37.36 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.425 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.062 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -49.67 -47.99 49.77 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.928 HG13 HG23 ' A' ' 22' ' ' ILE . 7.1 t -58.34 -55.81 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.865 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.65 -53.38 18.82 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.99 -43.72 50.59 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.588 ' CG ' HG13 ' A' ' 22' ' ' ILE . 8.0 tp-100 -52.51 -34.96 51.97 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.84 HG21 HD22 ' A' ' 63' ' ' LEU . 18.9 t -65.66 -49.27 78.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.567 -0.708 . . . . 0.0 109.759 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' TYR . 18.7 t60 -68.42 -33.61 74.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.969 -1.082 . . . . 0.0 109.589 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.12 -37.08 34.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.964 -1.085 . . . . 0.0 108.441 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.502 ' HG2' ' HG3' ' A' ' 54' ' ' GLN . 58.6 mm-40 -70.48 -44.38 67.81 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.889 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -136.04 175.93 9.15 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.46 40.95 1.18 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 59' ' ' TYR . 7.9 t -93.03 125.93 45.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 19.9 tt0 -68.89 92.04 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 0.0 109.292 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.84 HD22 HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -112.31 95.64 31.87 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 35.4 Cg_endo -78.57 169.73 19.38 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.354 2.036 . . . . 0.0 110.553 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.933 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.5 mm? -66.91 -37.17 83.86 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -56.13 -55.82 28.36 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.499 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 4.4 t -48.45 -46.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.025 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -58.49 -38.08 76.9 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.488 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 8.1 m-85 -74.84 -36.56 62.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 109.291 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.408 ' C ' ' HD3' ' A' ' 72' ' ' PRO . . . -66.88 -38.77 86.93 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.324 -0.86 . . . . 0.0 109.217 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -139.23 66.06 36.83 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -178.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.536 ' CA ' ' O ' ' A' ' 68' ' ' LEU . 33.3 Cg_endo -77.19 61.31 7.23 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.973 2.448 . . . . 0.0 112.462 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.818 HG22 ' C ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -152.13 150.09 29.51 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.881 -1.137 . . . . 0.0 110.657 178.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.002 HD11 HG22 ' A' ' 32' ' ' ILE . 9.4 mt -53.73 -54.04 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.854 -1.154 . . . . 0.0 109.669 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -51.26 -65.68 0.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.97 -1.081 . . . . 0.0 109.17 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.71 -63.45 1.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 0.0 109.661 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.732 HD21 HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -45.54 -67.04 0.32 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.541 -0.724 . . . . 0.0 109.128 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 74' ' ' ILE . . . -45.69 -49.84 14.16 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -56.7 -40.02 74.88 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -56.31 -37.75 70.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 108.573 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.705 HG11 ' CD1' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -86.73 -63.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.619 1.199 . . . . 0.0 108.981 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.94 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -49.7 -20.77 0.88 Allowed 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.209 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.47 ' CB ' ' OE1' ' A' ' 79' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.449 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.609 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.952 0.406 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.879 HG11 ' HB2' ' A' ' 82' ' ' ALA . 56.8 t -49.74 -52.48 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 178.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.653 ' OE1' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -72.72 -22.48 60.88 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.079 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.609 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 60.5 m -58.64 -48.21 81.78 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.746 ' O ' HG22 ' A' ' 22' ' ' ILE . 7.8 tptt -68.85 -51.89 35.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.304 -0.872 . . . . 0.0 108.723 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.754 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 3.4 mm? -54.99 -36.86 65.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.653 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . . . -56.79 -48.3 78.23 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 23.7 mt-10 -64.25 -63.09 1.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.174 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.754 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -47.86 -45.94 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.836 -1.165 . . . . 0.0 108.405 179.58 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.746 ' HB3' HD13 ' A' ' 32' ' ' ILE . 2.9 m95 -49.34 -68.44 0.18 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.449 0.642 . . . . 0.0 110.228 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.675 ' HA ' HD11 ' A' ' 32' ' ' ILE . 8.8 pt-20 -61.04 -31.5 71.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 110.218 -178.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -68.56 -68.32 0.4 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 110.333 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.91 HG11 ' HB3' ' A' ' 50' ' ' ALA . 77.6 t -67.99 -33.38 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 -178.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 37.2 mt -82.13 0.08 42.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.951 -1.093 . . . . 0.0 110.033 -179.182 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.79 56.9 22.61 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -136.84 -174.47 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -1.189 . . . . 0.0 109.161 179.518 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 t -153.02 60.35 0.78 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.272 -0.893 . . . . 0.0 109.322 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 165.43 -76.65 0.14 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.141 -1.983 . . . . 0.0 108.141 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.746 HD13 ' HB3' ' A' ' 23' ' ' TRP . 6.8 mt 58.37 151.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.426 -1.044 . . . . 0.0 109.952 178.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.97 -164.26 37.66 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.557 ' HA ' HG21 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -100.94 -2.02 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.381 -1.07 . . . . 0.0 110.326 -179.727 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.611 HD12 ' HB2' ' A' ' 75' ' ' LYS . 1.6 tp -156.19 53.28 0.56 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.826 -1.171 . . . . 0.0 109.94 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.573 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.5 OUTLIER -71.45 -154.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.776 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -138.14 35.06 2.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.03 -1.044 . . . . 0.0 108.601 178.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.706 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 12.5 m-85 . . . . . 0 N--CA 1.509 2.497 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.3 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 46' ' ' LEU . 81.0 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.447 ' HA ' HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -48.24 -36.7 14.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 109.387 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -60.5 -63.58 1.25 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.883 . . . . 0.0 109.515 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.077 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.82 -47.02 51.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.89 -1.131 . . . . 0.0 108.214 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.943 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.43 -42.28 42.33 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.323 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.91 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -51.04 -49.0 61.37 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.733 HG13 ' CG1' ' A' ' 22' ' ' ILE . 15.6 t -56.23 -54.33 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.824 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.17 -44.27 32.33 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -56.81 -44.84 82.36 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.609 HE21 HD13 ' A' ' 22' ' ' ILE . 9.0 tp-100 -47.71 -39.96 18.95 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.022 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.853 HG21 HD22 ' A' ' 63' ' ' LEU . 3.1 t -64.79 -32.2 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.328 0.585 . . . . 0.0 109.661 179.253 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 53' ' ' ALA . 7.6 t60 -82.16 -33.23 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.928 -1.108 . . . . 0.0 109.02 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -39.86 35.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.055 -1.028 . . . . 0.0 108.581 179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 1.1 mm-40 -75.92 -42.76 47.92 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.917 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -126.33 169.27 13.1 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.782 0.801 . . . . 0.0 109.771 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -103.23 33.21 3.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.698 -1.594 . . . . 0.0 106.698 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.918 HG11 HG13 ' A' ' 81' ' ' VAL . 6.2 p -93.35 121.5 44.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -68.82 99.26 1.01 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 110.297 -178.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.853 HD22 HG21 ' A' ' 55' ' ' VAL . 9.1 tp -100.9 110.17 60.17 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.563 ' HG2' ' CG2' ' A' ' 67' ' ' VAL . 35.1 Cg_endo -78.78 154.77 26.75 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.29 1.993 . . . . 0.0 110.719 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.943 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.4 mm? -63.67 -42.03 98.1 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -56.72 -32.56 65.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.288 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.563 ' CG2' ' HG2' ' A' ' 64' ' ' PRO . 2.2 t -71.42 -36.2 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.077 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -66.85 -25.23 66.32 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.271 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.458 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 m-85 -87.54 -35.9 17.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 108.989 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.41 ' C ' ' HD3' ' A' ' 72' ' ' PRO . . . -67.98 -37.36 81.41 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.07 0.938 . . . . 0.0 108.543 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.56 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -138.09 68.45 48.85 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -178.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 34.5 Cg_endo -78.24 52.93 4.29 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 123.306 2.671 . . . . 0.0 113.105 -177.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.573 ' HB ' ' O ' ' A' ' 36' ' ' ASP . 15.2 t -154.65 169.37 24.05 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 116.729 -1.988 . . . . 0.0 114.042 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.557 ' N ' ' CZ2' ' A' ' 23' ' ' TRP . 9.3 mm -51.14 -64.63 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.033 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.611 ' HB2' HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -55.08 -72.98 0.06 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.099 -1.001 . . . . 0.0 109.742 -178.451 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.56 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -48.16 -62.37 1.51 Allowed 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.268 -0.895 . . . . 0.0 110.648 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.569 ' CB ' ' O ' ' A' ' 73' ' ' THR . 0.5 OUTLIER -52.29 -64.8 0.7 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.963 -1.086 . . . . 0.0 109.553 -179.442 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.626 ' HB1' HG12 ' A' ' 15' ' ' VAL . . . -46.14 -43.11 14.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.064 -1.022 . . . . 0.0 109.16 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 25.2 mm-40 -65.99 -52.16 51.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.315 -0.865 . . . . 0.0 108.842 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.558 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 18.8 t80 -43.07 -41.83 3.71 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.918 HG13 HG11 ' A' ' 61' ' ' VAL . 18.4 t -74.59 -59.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.316 1.055 . . . . 0.0 108.991 179.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.879 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -58.77 -73.27 0.08 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.282 -179.058 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.468 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.623 ' HB2' ' HA2' ' A' ' 33' ' ' GLY . 53.2 t80 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.052 0.453 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.672 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 29.3 m -103.67 6.53 10.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.023 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 165.67 148.85 0.06 OUTLIER Pre-proline 0 C--N 1.292 -1.905 0 O-C-N 121.581 -0.699 . . . . 0.0 109.892 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 35.8 Cg_endo -81.23 -171.68 1.3 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.596 2.197 . . . . 0.0 109.117 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.457 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -115.45 -12.11 11.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.895 -1.128 . . . . 0.0 109.789 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 12' ' ' THR . 8.7 m120 -156.19 151.12 26.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.542 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -62.26 -15.19 45.65 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.353 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.063 HG21 ' HB2' ' A' ' 82' ' ' ALA . 2.1 t -65.76 -46.74 88.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HG2' ' HB3' ' A' ' 78' ' ' ALA . 7.5 mt-10 -70.98 -25.05 62.53 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.542 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 28.2 m -59.11 -48.93 79.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.689 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -68.37 -57.29 6.12 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.397 -0.814 . . . . 0.0 109.034 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.708 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -54.55 -19.26 5.56 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.276 -0.97 . . . . 0.0 108.956 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -74.79 -51.4 14.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.527 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 2.9 mt-10 -58.24 -63.96 1.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.826 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -43.55 -54.73 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.149 -0.969 . . . . 0.0 108.88 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.758 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.8 m95 -42.68 -57.54 2.68 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.58 -0.7 . . . . 0.0 110.924 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.724 ' HA ' HD11 ' A' ' 32' ' ' ILE . 6.8 pt-20 -65.83 -30.86 71.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.943 -1.098 . . . . 0.0 111.167 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.447 ' N ' ' HG3' ' A' ' 24' ' ' GLU . 17.8 ttm180 -75.15 -71.38 0.36 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.846 -1.159 . . . . 0.0 109.865 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.033 HG11 ' HB3' ' A' ' 50' ' ' ALA . 69.0 t -55.09 -34.5 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.536 -0.727 . . . . 0.0 110.555 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.512 ' HB2' HG23 ' A' ' 29' ' ' VAL . 39.2 mt -86.08 -17.63 34.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.894 -1.129 . . . . 0.0 109.883 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.94 27.61 60.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -102.96 -176.6 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -1.216 . . . . 0.0 108.886 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 t -142.3 83.24 1.82 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.131 -0.98 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 130.41 -74.87 0.43 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.868 ' CG2' HD11 ' A' ' 74' ' ' ILE . 3.8 mt 58.35 152.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -1.174 . . . . 0.0 109.781 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.933 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -96.61 -133.19 7.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.941 HG22 ' HB2' ' A' ' 75' ' ' LYS . 9.9 mt -120.42 -67.27 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.863 -1.375 . . . . 0.0 110.159 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.75 ' O ' HD23 ' A' ' 35' ' ' LEU . 2.4 tt -85.12 35.64 0.59 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.74 -1.225 . . . . 0.0 109.657 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.496 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -59.07 -166.47 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 109.588 178.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.534 ' CB ' ' HG2' ' A' ' 40' ' ' GLN . 1.1 m-20 -134.17 115.81 14.64 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.727 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 72.1 m-85 -41.54 -23.1 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.12 -0.988 . . . . 0.0 110.904 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.482 ' N ' ' O ' ' A' ' 37' ' ' ASN . 5.0 t80 -108.33 44.0 1.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.551 -1.343 . . . . 0.0 109.061 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.534 ' HG2' ' CB ' ' A' ' 37' ' ' ASN . 13.1 mm-40 -86.62 -14.29 43.16 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.5 tt 168.89 64.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.13 -120.08 1.83 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 44' ' ' HIS . . . 176.7 133.99 1.9 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 10.7 m170 61.56 -178.18 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -1.228 . . . . 0.0 109.026 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.99 -8.37 11.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.125 -0.985 . . . . 0.0 109.482 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.441 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -53.61 -23.92 12.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 109.498 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 26' ' ' VAL . 1.7 mptt -71.33 -68.32 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.038 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -46.9 -44.69 19.94 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.965 -1.085 . . . . 0.0 108.362 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.849 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.24 -53.88 31.09 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.033 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -43.65 -42.31 5.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.826 HG13 ' CG1' ' A' ' 22' ' ' ILE . 17.1 t -59.56 -48.31 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.961 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -58.08 -31.9 67.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.029 -1.045 . . . . 0.0 108.43 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.42 -33.04 70.89 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.562 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 6.8 tp-100 -63.07 -31.21 72.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.61 HG21 HD22 ' A' ' 63' ' ' LEU . 2.6 t -75.9 -28.8 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' TYR . 6.1 t60 -77.72 -33.63 52.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.204 -0.935 . . . . 0.0 110.047 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -80.92 -46.5 15.1 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.493 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -62.97 -36.33 83.15 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.677 ' CD2' HG11 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -141.71 156.6 45.61 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.586 0.708 . . . . 0.0 109.434 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -95.29 43.94 1.09 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.011 HG11 ' CG1' ' A' ' 81' ' ' VAL . 4.8 p -91.91 149.12 4.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.422 0.63 . . . . 0.0 110.014 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -80.73 97.32 7.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 110.384 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.78 HD21 ' CD1' ' A' ' 77' ' ' LEU . 1.1 tp -126.7 86.22 59.02 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 35.6 Cg_endo -77.47 175.67 11.0 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.696 2.264 . . . . 0.0 110.983 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.849 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.5 mm? -67.56 -41.87 83.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.435 -0.79 . . . . 0.0 109.299 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.44 -29.14 65.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.07 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.531 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 3.7 t -76.84 -34.05 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.038 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -69.88 -21.2 63.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -87.4 -34.63 18.7 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.488 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -72.85 -28.31 62.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.993 0.902 . . . . 0.0 108.735 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.595 ' CB ' ' HB1' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -146.13 65.66 10.87 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.572 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.7 Cg_endo -77.38 60.74 7.15 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.903 2.402 . . . . 0.0 112.674 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.666 HG23 ' H ' ' A' ' 76' ' ' ALA . 6.3 t -154.03 176.04 12.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.512 -1.368 . . . . 0.0 111.164 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.933 HD12 ' O ' ' A' ' 33' ' ' GLY . 9.6 mt -74.28 -42.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.268 -0.895 . . . . 0.0 111.606 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.941 ' HB2' HG22 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -70.39 -45.24 66.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.583 -1.323 . . . . 0.0 108.666 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.666 ' H ' HG23 ' A' ' 73' ' ' THR . . . -66.27 -35.01 79.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.647 -0.658 . . . . 0.0 109.945 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.78 ' CD1' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -73.04 -62.03 1.61 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.9 -1.125 . . . . 0.0 108.589 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.707 ' HB1' ' HB ' ' A' ' 15' ' ' VAL . . . -51.15 -28.04 10.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 2.0 tp60 -81.15 -34.47 32.42 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.8 -1.187 . . . . 0.0 108.564 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.689 ' CD2' HD12 ' A' ' 63' ' ' LEU . 11.5 t80 -61.89 -33.16 73.7 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.011 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -88.94 -73.65 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 122.44 1.114 . . . . 0.0 108.198 178.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 1.063 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -39.0 -27.05 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.156 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 81' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.059 -1.025 . . . . 0.0 109.523 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 76.6 t80 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.5 m -119.94 51.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.173 -0.954 . . . . 0.0 110.015 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -179.09 141.53 0.37 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.136 -0.978 . . . . 0.0 109.895 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 36.3 Cg_endo -82.92 -158.38 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.862 2.375 . . . . 0.0 110.345 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.88 -43.81 1.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.139 -0.976 . . . . 0.0 109.867 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -133.84 169.21 17.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.9 -1.125 . . . . 0.0 108.382 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.633 ' HA ' ' HB2' ' A' ' 17' ' ' SER . . . -73.21 -33.6 65.46 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 118.556 -1.258 . . . . 0.0 109.699 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.024 HG21 ' CB ' ' A' ' 82' ' ' ALA . 28.1 t -54.55 -49.62 65.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.662 ' OE2' HD12 ' A' ' 34' ' ' ILE . 3.9 tt0 -69.68 -26.84 64.57 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.633 ' HB2' ' HA ' ' A' ' 14' ' ' ALA . 32.7 t -53.66 -52.29 60.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.947 -1.096 . . . . 0.0 108.796 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.684 ' O ' HG22 ' A' ' 22' ' ' ILE . 1.3 tppm? -65.68 -53.07 46.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 109.251 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HA ' HG23 ' A' ' 22' ' ' ILE . 3.5 mp -57.67 -31.62 66.51 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.653 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 16' ' ' GLU . . . -59.84 -51.67 68.73 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -59.52 -64.74 0.84 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.811 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -44.49 -53.6 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.774 ' HE3' HG21 ' A' ' 32' ' ' ILE . 3.6 m95 -43.52 -61.93 1.23 Allowed 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.469 0.652 . . . . 0.0 110.523 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.772 ' CA ' HD11 ' A' ' 32' ' ' ILE . 3.5 pt-20 -64.01 -36.42 83.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.363 -0.836 . . . . 0.0 110.664 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -68.66 -63.34 1.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.314 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.029 HG11 ' HB3' ' A' ' 50' ' ' ALA . 61.3 t -68.52 -34.49 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 111.12 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.526 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 40.7 mt -83.84 4.75 27.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.867 -1.146 . . . . 0.0 109.939 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.21 51.77 48.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.645 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -129.09 171.76 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.227 -1.161 . . . . 0.0 109.249 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.1 t -139.51 70.63 1.37 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.103 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.6 68.94 0.31 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.774 HG21 ' HE3' ' A' ' 23' ' ' TRP . 2.9 mp -85.87 146.17 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -1.093 . . . . 0.0 109.615 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.822 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -66.88 -135.16 0.04 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.662 HD12 ' OE2' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -123.73 -54.48 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.013 -1.286 . . . . 0.0 109.973 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.913 HD23 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -96.6 44.46 1.06 Allowed 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.275 -1.516 . . . . 0.0 108.17 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.81 114.9 12.62 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -62.75 113.51 3.07 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.385 -1.447 . . . . 0.0 108.649 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.721 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 90.7 m-85 -38.94 -38.1 0.41 Allowed 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.119 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -90.23 33.97 0.88 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.44 -0.787 . . . . 0.0 109.833 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.555 ' O ' HD12 ' A' ' 41' ' ' ILE . 7.2 mt-30 -80.89 63.21 5.19 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.555 HD12 ' O ' ' A' ' 40' ' ' GLN . 2.2 mt 80.54 43.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.72 -131.59 1.08 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.87 -38.81 0.02 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -135.88 174.49 10.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.324 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.03 -34.61 7.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.11 -0.993 . . . . 0.0 109.444 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 46' ' ' LEU . 6.5 tp -52.08 -38.88 58.69 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.262 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.569 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.3 mttp -50.78 -62.79 1.39 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.113 -0.992 . . . . 0.0 108.615 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.992 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -50.29 -44.57 54.03 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.664 ' CG ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.89 -45.7 64.25 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.029 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -49.09 -42.97 40.66 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.811 HG13 ' CG1' ' A' ' 22' ' ' ILE . 4.6 t -64.07 -64.34 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.97 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -45.35 -40.33 7.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -63.32 -47.01 84.03 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.501 ' HG3' ' OE2' ' A' ' 58' ' ' GLU . 2.2 tp60 -50.32 -28.16 7.41 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.594 HG21 ' HG ' ' A' ' 63' ' ' LEU . 3.8 t -75.49 -62.43 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 59' ' ' TYR . 20.9 t-80 -54.05 -37.91 64.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.03 -1.044 . . . . 0.0 108.773 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 53' ' ' ALA . 4.0 mtt180 -69.37 -38.12 77.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.532 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -75.11 -56.99 4.18 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.341 -0.85 . . . . 0.0 108.903 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.798 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -119.05 176.88 5.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 108.825 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.66 43.68 1.17 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 59' ' ' TYR . 10.5 t -93.79 158.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.418 ' C ' ' HD3' ' A' ' 64' ' ' PRO . 3.0 tt0 -70.8 99.83 1.8 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.229 -0.919 . . . . 0.0 109.416 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.935 HD21 HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -134.45 68.44 72.76 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 0.0 109.276 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.635 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.9 Cg_endo -82.05 -168.02 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.959 2.439 . . . . 0.0 109.964 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.664 HD21 ' CG ' ' A' ' 49' ' ' MET . 0.4 OUTLIER -89.26 -37.14 15.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.136 -0.977 . . . . 0.0 109.311 179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.547 ' HG3' ' N ' ' A' ' 67' ' ' VAL . 5.7 pttt -56.66 -37.64 71.09 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.955 HG13 ' NE2' ' A' ' 71' ' ' GLN . 58.5 t -69.72 -47.24 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.992 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.82 -35.98 64.51 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.454 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 5.8 m-85 -74.45 -39.27 62.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 108.769 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.99 84.16 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.885 0.85 . . . . 0.0 108.863 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.955 ' NE2' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -135.09 70.87 69.41 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.58 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 30.4 Cg_endo -75.0 59.85 5.29 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.787 2.325 . . . . 0.0 112.224 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.913 HG21 HD23 ' A' ' 35' ' ' LEU . 1.9 t -153.18 167.53 28.99 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 117.337 -1.745 . . . . 0.0 112.453 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.822 HD12 ' O ' ' A' ' 33' ' ' GLY . 2.4 mt -63.07 -72.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.592 -0.693 . . . . 0.0 111.195 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.528 ' HB2' ' CG1' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -40.08 -57.86 1.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.554 -0.716 . . . . 0.0 109.468 -178.428 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.582 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -57.55 -52.33 65.83 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.379 -0.825 . . . . 0.0 109.527 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.935 HD13 HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -55.1 -65.37 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.706 -1.246 . . . . 0.0 108.708 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.667 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -44.78 -30.89 1.04 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.57 ' HG2' ' N ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -77.94 -43.9 28.49 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 108.633 179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.57 ' N ' ' HG2' ' A' ' 79' ' ' GLN . 2.3 t80 -58.8 -32.6 69.49 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.996 -1.065 . . . . 0.0 108.244 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -88.6 -67.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 122.46 1.124 . . . . 0.0 109.16 179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 1.024 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -54.13 -48.65 70.58 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.802 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 79' ' ' GLN . 5.6 t . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.871 -1.143 . . . . 0.0 109.765 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.0 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 34' ' ' ILE . 8.0 m -104.36 127.14 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.0 109.39 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.815 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -50.52 169.97 0.19 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.835 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.815 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 34.4 Cg_endo -76.86 159.07 34.78 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.843 2.362 . . . . 0.0 110.581 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.45 -0.89 10.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -0.912 . . . . 0.0 110.053 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -156.51 152.65 27.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.978 -1.076 . . . . 0.0 108.303 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -62.46 -32.01 72.82 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.847 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.985 HG21 ' CB ' ' A' ' 82' ' ' ALA . 2.4 t -49.12 -44.45 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.632 ' HG2' HG23 ' A' ' 34' ' ' ILE . 4.2 mt-10 -72.65 -35.59 67.8 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 53.9 p -55.56 -48.77 74.23 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.416 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.605 ' O ' HG22 ' A' ' 22' ' ' ILE . 8.6 tptm -68.69 -55.92 9.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.95 -1.094 . . . . 0.0 109.415 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.749 ' HA ' HG23 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -54.71 -31.06 57.54 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.062 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.06 -50.16 67.27 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 31.9 tt0 -59.79 -54.54 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.901 HD11 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -51.43 -54.24 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.872 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.7 m95 -41.19 -60.14 1.32 Allowed 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.463 0.649 . . . . 0.0 110.334 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.626 ' CA ' HD11 ' A' ' 32' ' ' ILE . 5.1 pt-20 -64.52 -30.86 71.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.95 . . . . 0.0 109.606 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 tpp85 -70.06 -66.19 0.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.507 -0.746 . . . . 0.0 110.039 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.842 HG11 ' HB3' ' A' ' 50' ' ' ALA . 53.6 t -68.41 -34.45 65.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.366 -0.834 . . . . 0.0 111.102 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 24.9 mt -84.18 -8.65 59.01 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.869 -1.144 . . . . 0.0 110.155 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.8 51.7 44.27 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.778 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -122.71 -166.21 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.016 -1.285 . . . . 0.0 108.965 178.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.411 ' H ' HG12 ' A' ' 29' ' ' VAL . 2.0 p -143.62 64.38 1.33 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.156 -1.018 . . . . 0.0 109.863 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 136.89 -72.86 0.45 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.286 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.872 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.8 mp 59.53 147.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.238 -1.154 . . . . 0.0 109.309 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 1.0 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -78.34 -153.41 6.66 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 34' ' ' ILE . 30.0 mm -113.56 15.67 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.035 -1.273 . . . . 0.0 109.626 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.857 ' O ' HD23 ' A' ' 35' ' ' LEU . 7.3 tt -167.65 66.67 0.08 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.598 ' N ' ' HG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -101.55 169.74 8.65 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.584 0.707 . . . . 0.0 110.103 -179.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.572 ' O ' ' N ' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -96.03 104.36 16.3 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.729 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 63.8 m-85 -26.83 -38.22 0.01 OUTLIER 'General case' 0 N--CA 1.519 3.002 0 O-C-N 121.78 -0.575 . . . . 0.0 112.293 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.571 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 52.6 t80 -88.18 28.57 1.05 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.303 -1.498 . . . . 0.0 110.128 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 37' ' ' ASN . 18.0 mm100 -84.13 78.62 9.73 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 108.504 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 40' ' ' GLN . 1.3 mt 71.62 54.46 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . 129.24 168.74 12.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 45' ' ' SER . . . 103.56 -49.57 0.93 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 26.2 m170 55.53 -86.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -1.137 . . . . 0.0 109.369 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 43' ' ' GLY . 1.4 p -166.55 -61.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.077 -1.014 . . . . 0.0 109.34 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 46' ' ' LEU . 14.2 tp -53.59 -44.39 69.34 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.107 -0.995 . . . . 0.0 108.835 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.648 ' HB3' HG12 ' A' ' 26' ' ' VAL . 6.8 mttm -48.25 -60.3 2.76 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.041 ' HB1' HD11 ' A' ' 68' ' ' LEU . . . -46.99 -48.9 21.57 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.927 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.86 -50.17 27.23 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.842 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -49.24 -43.41 42.75 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.901 HG22 HD11 ' A' ' 22' ' ' ILE . 12.0 t -58.93 -64.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.027 ' HB2' HD23 ' A' ' 68' ' ' LEU . . . -45.58 -39.99 8.27 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.709 ' HB2' ' CE ' ' A' ' 49' ' ' MET . . . -63.83 -45.34 90.0 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.538 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -48.28 -34.4 10.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.792 HG11 HD12 ' A' ' 63' ' ' LEU . 2.5 t -71.24 -31.68 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 53' ' ' ALA . 9.3 t60 -81.62 -35.04 30.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.415 -0.803 . . . . 0.0 109.12 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -75.73 -35.32 60.27 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 1.2 mp0 -78.87 -50.98 10.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.669 ' HB2' HG12 ' A' ' 61' ' ' VAL . 2.4 m-85 -113.83 -178.54 3.4 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.895 0.855 . . . . 0.0 109.71 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -112.51 38.4 2.76 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.998 HG11 HG13 ' A' ' 81' ' ' VAL . 5.0 p -93.17 149.28 4.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.378 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -90.15 97.11 11.0 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.194 -0.941 . . . . 0.0 110.549 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.966 ' CD2' HG11 ' A' ' 67' ' ' VAL . 4.9 mt -113.47 98.95 48.31 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.6 Cg_endo -78.99 164.13 25.21 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.866 2.378 . . . . 0.0 111.238 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.927 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.9 mm? -63.7 -34.85 78.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.535 ' N ' ' HD3' ' A' ' 66' ' ' LYS . 1.1 mmtt -56.08 -60.61 3.24 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.966 HG11 ' CD2' ' A' ' 63' ' ' LEU . 2.7 t -48.32 -52.81 7.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.041 HD11 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -47.1 -33.21 4.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 66' ' ' LYS . 1.7 m-85 -88.28 -36.34 16.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.524 -0.735 . . . . 0.0 109.969 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . -65.13 -32.32 73.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.775 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -140.53 71.85 31.19 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.1 Cg_endo -76.82 60.64 6.8 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.772 2.315 . . . . 0.0 112.052 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.689 HG22 ' HB3' ' A' ' 76' ' ' ALA . 13.5 t -154.66 170.86 20.54 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.569 -1.252 . . . . 0.0 110.816 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.0 HD12 ' O ' ' A' ' 33' ' ' GLY . 3.5 mt -65.71 -74.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.255 -0.903 . . . . 0.0 111.214 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB3' HD12 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -42.6 -58.86 2.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.286 -178.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.689 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -47.61 -61.92 1.69 Allowed 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.173 -0.955 . . . . 0.0 110.04 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.775 HD23 ' O ' ' A' ' 71' ' ' GLN . 0.2 OUTLIER -53.53 -66.94 0.3 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.127 -0.983 . . . . 0.0 109.496 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.553 ' CB ' ' HG3' ' A' ' 16' ' ' GLU . . . -47.01 -35.94 7.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.183 -0.948 . . . . 0.0 108.837 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 78.0 mm-40 -70.19 -40.15 74.8 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -55.28 -35.46 65.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.998 HG13 HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -87.69 -68.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.411 1.101 . . . . 0.0 108.301 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.985 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -43.93 -50.65 8.05 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.45 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 79' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.534 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.258 0.552 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.8 m -105.25 140.03 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 108.991 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -70.89 152.14 95.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.089 -1.007 . . . . 0.0 109.552 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 34.9 Cg_endo -78.12 -177.32 3.79 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.627 2.218 . . . . 0.0 110.763 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 12' ' ' THR . 0.4 OUTLIER -123.18 -3.25 8.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.866 . . . . 0.0 109.692 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -131.83 129.18 40.11 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.904 -1.123 . . . . 0.0 108.021 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.616 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -50.99 -31.7 18.83 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.54 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.034 ' CG1' ' HB2' ' A' ' 82' ' ' ALA . 40.5 t -46.4 -54.49 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.8 ' OE2' HG22 ' A' ' 34' ' ' ILE . 12.8 mt-10 -68.12 -37.74 81.44 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.616 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.7 m -48.95 -54.0 17.39 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.17 -1.012 . . . . 0.0 108.562 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.675 ' O ' HG23 ' A' ' 22' ' ' ILE . 1.2 tptt -60.05 -69.28 0.22 Allowed 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.335 -0.853 . . . . 0.0 108.837 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.474 ' HB3' HG23 ' A' ' 74' ' ' ILE . 8.3 mt -38.76 -48.25 1.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.604 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -51.52 -52.4 47.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.766 -1.209 . . . . 0.0 108.216 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.08 -60.31 4.03 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.086 ' CD1' HG13 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -44.27 -47.42 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.751 ' CB ' HG21 ' A' ' 32' ' ' ILE . 3.7 m95 -49.43 -63.05 1.22 Allowed 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.797 -0.564 . . . . 0.0 109.912 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.693 ' HB2' HD12 ' A' ' 32' ' ' ILE . 1.6 tt0 -61.49 -42.37 98.69 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.377 -0.827 . . . . 0.0 110.046 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -65.13 0.73 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 110.779 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.661 HG11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 t -69.82 -32.62 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.393 -0.817 . . . . 0.0 111.717 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 33.8 mt -87.36 -33.46 19.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.681 -1.262 . . . . 0.0 110.249 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.58 58.4 1.74 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.339 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.607 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -130.4 177.1 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.207 -1.173 . . . . 0.0 108.582 179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.81 38.22 3.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.027 -1.045 . . . . 0.0 109.764 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -150.24 -96.75 0.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.751 HG21 ' CB ' ' A' ' 23' ' ' TRP . 10.3 mt 52.7 103.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.923 -1.339 . . . . 0.0 109.877 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.687 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -107.86 -77.69 1.05 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.8 HG22 ' OE2' ' A' ' 16' ' ' GLU . 1.1 pp -166.03 101.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -1.195 . . . . 0.0 109.931 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.63 ' CB ' ' O ' ' A' ' 34' ' ' ILE . 22.4 tp 103.44 35.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.722 0.772 . . . . 0.0 109.237 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.459 ' O ' ' OG1' ' A' ' 73' ' ' THR . 0.7 OUTLIER -83.0 177.87 8.42 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.563 ' CB ' ' HG2' ' A' ' 40' ' ' GLN . 1.7 t30 -109.52 116.94 32.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.723 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 52.4 m-85 -41.54 -24.6 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.273 -0.892 . . . . 0.0 110.315 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 37' ' ' ASN . 19.0 t80 -98.25 27.15 4.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.489 -1.382 . . . . 0.0 109.778 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.754 ' C ' HD12 ' A' ' 41' ' ' ILE . 10.8 mm100 -82.62 76.88 9.45 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.754 HD12 ' C ' ' A' ' 40' ' ' GLN . 5.2 mp 64.12 65.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.137 -0.977 . . . . 0.0 108.518 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 38' ' ' PHE . . . 129.48 156.67 8.9 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.95 135.63 7.37 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.98 -76.76 0.21 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -1.096 . . . . 0.0 109.403 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.09 -71.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.202 -0.937 . . . . 0.0 109.402 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.545 ' HA ' HD13 ' A' ' 46' ' ' LEU . 4.1 mm? -53.35 -36.34 61.23 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.107 -0.995 . . . . 0.0 109.013 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.637 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -66.5 -60.5 2.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.24 -0.912 . . . . 0.0 109.042 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.064 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -52.37 -49.71 63.85 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.132 -0.98 . . . . 0.0 108.636 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.854 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.29 -45.61 45.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.82 ' O ' ' HB3' ' A' ' 53' ' ' ALA . . . -49.23 -44.59 43.64 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.086 HG13 ' CD1' ' A' ' 22' ' ' ILE . 18.3 t -60.14 -58.46 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.838 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.58 -26.96 2.48 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -73.24 -43.54 60.99 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.533 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -54.65 -28.49 47.5 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.623 HG11 ' HG ' ' A' ' 63' ' ' LEU . 2.6 t -73.77 -53.88 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 1.3 t-80 -56.3 -43.04 78.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.123 -0.986 . . . . 0.0 109.103 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -46.3 83.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 109.014 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.566 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -66.07 -50.15 65.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.889 . . . . 0.0 108.855 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.724 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -129.63 154.58 46.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.451 -0.781 . . . . 0.0 109.009 179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -94.53 40.04 1.09 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.11 HG11 HG13 ' A' ' 81' ' ' VAL . 7.0 p -93.09 162.75 2.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.272 0.558 . . . . 0.0 109.7 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.524 ' N ' HG22 ' A' ' 61' ' ' VAL . 5.1 tt0 -69.39 117.85 11.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.315 -0.865 . . . . 0.0 110.138 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.908 HD23 HG22 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -142.73 69.46 19.78 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.555 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.4 Cg_endo -80.23 154.66 22.01 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.866 2.378 . . . . 0.0 110.632 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.854 HD21 ' SD ' ' A' ' 49' ' ' MET . 4.4 mt -57.19 -40.68 77.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.217 -0.993 . . . . 0.0 108.782 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -49.91 -44.94 50.44 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.555 HG23 ' HG2' ' A' ' 64' ' ' PRO . 6.7 t -64.86 -41.98 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.064 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -62.58 -26.39 68.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.472 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 m-85 -87.86 -36.0 17.44 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.431 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -67.43 -32.0 72.57 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.959 0.885 . . . . 0.0 108.614 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.431 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -147.34 70.06 11.68 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.0 Cg_endo -75.11 60.26 5.47 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.812 2.342 . . . . 0.0 111.305 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.77 ' CG2' ' HB3' ' A' ' 76' ' ' ALA . 5.8 t -153.07 165.62 35.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 118.712 -1.195 . . . . 0.0 110.828 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.644 HG13 ' CZ2' ' A' ' 23' ' ' TRP . 2.9 mt -66.47 -64.87 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.602 -0.686 . . . . 0.0 110.501 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -49.75 -60.58 2.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.867 -1.145 . . . . 0.0 109.859 -179.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.77 ' HB3' ' CG2' ' A' ' 73' ' ' THR . . . -56.74 -67.84 0.27 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.958 -1.089 . . . . 0.0 110.372 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.712 HD11 HD12 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -49.42 -58.45 5.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.808 -1.182 . . . . 0.0 108.763 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' ILE . . . -44.94 -55.98 5.0 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 34.6 mm-40 -50.49 -49.83 54.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 108.844 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -48.3 -45.67 35.21 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.669 0.747 . . . . 0.0 109.302 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.11 HG13 HG11 ' A' ' 61' ' ' VAL . 3.5 t -81.73 -59.43 2.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 122.432 1.11 . . . . 0.0 109.313 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 1.034 ' HB2' ' CG1' ' A' ' 15' ' ' VAL . . . -53.73 -68.09 0.21 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.238 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.414 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.516 ' CD1' ' HA2' ' A' ' 33' ' ' GLY . 6.0 t80 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.3 0.571 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.7 HG23 HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -103.95 129.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.22 155.19 1.24 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.929 . . . . 0.0 109.639 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.01 150.77 34.36 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.65 2.234 . . . . 0.0 110.692 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.666 ' O ' HG22 ' A' ' 12' ' ' THR . 91.9 m -116.0 7.21 14.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 0.0 109.757 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 12' ' ' THR . 0.6 OUTLIER -148.47 133.47 18.16 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.556 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -54.65 -29.99 54.02 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.996 -1.065 . . . . 0.0 109.459 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.97 HG21 ' CB ' ' A' ' 82' ' ' ALA . 3.6 t -48.35 -43.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -72.08 -43.79 64.28 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 53.5 p -47.12 -50.1 20.83 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.391 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' H ' ' HG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -61.03 -70.35 0.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 108.706 179.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.844 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 4.3 mp -40.79 -35.12 0.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.371 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -61.89 -51.82 66.61 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.995 -1.066 . . . . 0.0 108.399 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -61.25 -56.06 24.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.393 -0.817 . . . . 0.0 109.298 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.844 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -52.67 -50.47 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.889 -1.132 . . . . 0.0 108.862 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.651 ' HB3' HD13 ' A' ' 32' ' ' ILE . 5.2 m95 -46.15 -59.82 2.66 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.413 0.625 . . . . 0.0 110.227 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.626 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -61.77 -37.06 82.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.227 -0.921 . . . . 0.0 110.021 -178.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -60.89 -49.42 77.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 110.289 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.07 HG11 ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -87.79 -48.9 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.241 -0.912 . . . . 0.0 110.778 -179.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 47' ' ' LYS . 45.7 mt -63.76 -9.97 17.32 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.363 -0.836 . . . . 0.0 109.87 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.07 58.63 11.89 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.581 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.32 167.48 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.166 -1.196 . . . . 0.0 109.45 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 t -126.78 81.43 2.01 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.249 -0.907 . . . . 0.0 109.185 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . 139.4 -73.55 0.4 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.693 ' CG2' HD11 ' A' ' 74' ' ' ILE . 14.7 mt 60.89 143.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -1.105 . . . . 0.0 109.628 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' HA2' ' CD1' ' A' ' 8' ' ' TYR . . . -86.46 -119.45 1.14 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.945 ' HA ' HD12 ' A' ' 74' ' ' ILE . 1.5 tt -149.28 -64.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.812 -1.405 . . . . 0.0 109.831 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.044 HD23 HG21 ' A' ' 73' ' ' THR . 0.6 OUTLIER -88.38 32.1 0.79 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.365 -1.46 . . . . 0.0 109.66 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.652 ' O ' HG23 ' A' ' 73' ' ' THR . 15.5 m-20 -59.73 167.12 2.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.343 -0.848 . . . . 0.0 110.753 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 39' ' ' PHE . 11.8 t-20 -110.53 40.37 2.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.681 ' CZ ' ' HA ' ' A' ' 72' ' ' PRO . 8.7 m-30 62.76 -56.3 0.15 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.769 -0.582 . . . . 0.0 111.008 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.499 ' N ' ' O ' ' A' ' 37' ' ' ASN . 2.8 t80 -86.47 22.14 1.94 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.443 -1.411 . . . . 0.0 110.238 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 9.9 mm-40 -81.4 -1.84 47.16 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 41' ' ' ILE . 9.9 tp 174.8 57.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.49 116.77 0.51 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 44' ' ' HIS . . . -150.12 -74.27 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.498 ' CB ' ' O ' ' A' ' 43' ' ' GLY . 0.5 OUTLIER 77.36 -156.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -1.089 . . . . 0.0 109.514 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -121.53 -51.62 2.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.925 . . . . 0.0 109.553 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 46' ' ' LEU . 1.1 mm? -57.84 -39.63 78.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.856 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.9 tptt -64.84 -64.14 0.94 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.099 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -47.9 -47.5 32.01 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.085 -1.009 . . . . 0.0 108.32 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.907 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.25 -49.93 31.5 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.07 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -46.81 -46.67 20.87 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.555 ' HA ' HG12 ' A' ' 22' ' ' ILE . 15.0 t -56.92 -54.16 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.882 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.42 -38.77 20.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -61.58 -44.05 97.73 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.528 ' CB ' HG12 ' A' ' 22' ' ' ILE . 3.0 tp-100 -48.7 -36.14 15.54 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG21 HD22 ' A' ' 63' ' ' LEU . 6.8 t -68.03 -45.71 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 59' ' ' TYR . 5.7 t-160 -69.94 -33.64 72.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.077 -1.015 . . . . 0.0 109.098 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -41.4 39.49 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 12.8 mm-40 -71.91 -46.06 59.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.946 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -124.87 168.85 12.7 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.608 0.718 . . . . 0.0 109.41 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -99.18 31.84 2.92 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.946 HG12 ' HB2' ' A' ' 59' ' ' TYR . 6.5 p -93.59 123.13 45.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 4.6 tt0 -69.21 97.76 0.96 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.449 -0.782 . . . . 0.0 110.856 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -103.05 106.65 51.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.133 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 35.8 Cg_endo -79.88 166.6 21.11 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.445 2.096 . . . . 0.0 111.292 -177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.907 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.4 mm? -69.02 -40.87 78.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -51.19 -51.7 51.29 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.424 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 3.0 t -55.93 -41.21 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.099 HD21 ' HB1' ' A' ' 48' ' ' ALA . 1.2 tp -62.43 -24.15 67.26 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.517 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.0 m-85 -87.62 -36.67 17.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.419 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.22 -32.55 74.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.52 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.08 71.74 18.42 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.681 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 30.5 Cg_endo -77.82 64.82 8.24 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.259 1.973 . . . . 0.0 108.209 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 1.044 HG21 HD23 ' A' ' 35' ' ' LEU . 81.4 m -152.68 165.11 36.29 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 117.961 -1.496 . . . . 0.0 111.939 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.945 HD12 ' HA ' ' A' ' 34' ' ' ILE . 7.3 mt -71.93 -72.88 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.14 -0.975 . . . . 0.0 109.286 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HB3' ' HG ' ' A' ' 35' ' ' LEU . 3.2 ttmm -45.21 -44.68 11.19 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.135 -0.978 . . . . 0.0 108.617 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -61.66 -55.02 35.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 108.955 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.006 HD11 HD12 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -59.11 -63.23 1.38 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.128 -0.983 . . . . 0.0 108.758 179.155 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.606 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . -44.87 -38.96 4.98 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.567 ' O ' HG22 ' A' ' 83' ' ' THR . 1.1 tp60 -68.89 -44.41 73.3 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.654 ' O ' HG22 ' A' ' 83' ' ' THR . 28.4 t80 -52.22 -35.56 49.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.14 -0.975 . . . . 0.0 108.386 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.607 HG11 ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.15 -70.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 122.375 1.084 . . . . 0.0 108.43 179.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.97 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -40.11 -27.77 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.06 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 80' ' ' TYR . 9.8 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.458 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.73 ' OH ' HG23 ' A' ' 34' ' ' ILE . 52.5 t80 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.583 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 15.3 m -121.34 54.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 109.966 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 171.02 146.3 0.13 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 110.131 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 36.3 Cg_endo -81.37 -154.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.937 2.425 . . . . 0.0 110.413 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.733 HG22 ' CG2' ' A' ' 34' ' ' ILE . 1.8 t -126.63 -57.26 1.36 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.911 -1.118 . . . . 0.0 110.1 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.633 ' H ' HG23 ' A' ' 12' ' ' THR . 45.8 p30 -131.56 175.93 8.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.831 -1.168 . . . . 0.0 108.209 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.728 ' HA ' ' HB3' ' A' ' 17' ' ' SER . . . -74.92 -36.53 62.16 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.626 -1.296 . . . . 0.0 110.068 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.951 HG21 ' CB ' ' A' ' 82' ' ' ALA . 20.6 t -53.42 -47.66 58.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 119.939 -1.726 . . . . 0.0 106.674 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.558 ' HG3' ' CG2' ' A' ' 74' ' ' ILE . 3.6 tm-20 -69.16 -29.19 67.15 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.728 ' HB3' ' HA ' ' A' ' 14' ' ' ALA . 35.2 p -54.13 -49.36 69.37 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.302 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.842 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.95 -51.38 69.53 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.774 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 6.7 mt -58.71 -40.7 84.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.174 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.82 -46.45 67.73 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.859 -1.15 . . . . 0.0 108.122 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 22' ' ' ILE . 23.0 mt-10 -65.21 -66.43 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.489 -0.757 . . . . 0.0 109.214 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -45.34 -46.51 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.966 . . . . 0.0 108.851 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.796 ' CE3' HG21 ' A' ' 32' ' ' ILE . 5.4 m95 -50.72 -64.49 0.79 Allowed 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.437 0.636 . . . . 0.0 110.867 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.761 ' HA ' HD11 ' A' ' 32' ' ' ILE . 2.6 pt-20 -59.53 -38.09 80.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.17 -61.59 2.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.829 . . . . 0.0 110.413 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.057 HG11 ' HB3' ' A' ' 50' ' ' ALA . 4.8 t -75.2 -33.23 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.135 -0.978 . . . . 0.0 111.337 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 41.9 mt -81.9 -8.07 59.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.706 -1.246 . . . . 0.0 109.829 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.19 53.29 45.91 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -137.38 -172.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.265 . . . . 0.0 109.03 179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 t -153.29 121.0 5.99 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.467 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 86.24 20.81 54.15 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.796 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.2 mt -42.08 150.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -1.199 . . . . 0.0 109.298 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.74 -170.43 21.03 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.733 ' CG2' HG22 ' A' ' 12' ' ' THR . 1.0 OUTLIER -106.33 12.3 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -1.047 . . . . 0.0 109.743 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.763 HD12 ' CG2' ' A' ' 73' ' ' THR . 10.4 tp -169.24 62.24 0.05 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.084 -1.01 . . . . 0.0 109.39 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.645 ' O ' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -89.59 -161.96 0.83 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.249 -0.907 . . . . 0.0 109.916 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -129.66 29.76 4.99 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.226 -0.921 . . . . 0.0 110.132 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.74 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 1.9 m-85 57.64 -65.01 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.961 -0.462 . . . . 0.0 111.144 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 37' ' ' ASN . 13.4 t80 -86.46 29.94 0.74 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.685 -1.259 . . . . 0.0 110.251 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.519 ' HG3' ' CB ' ' A' ' 37' ' ' ASN . 13.8 mt-30 -80.99 -4.55 55.5 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 0.3 OUTLIER 165.64 66.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.89 -130.48 2.45 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.48 -118.86 0.46 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -49.72 157.33 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -1.101 . . . . 0.0 109.618 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.8 p -94.0 -24.03 17.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 109.327 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 46' ' ' LEU . 9.9 tp -47.64 -41.11 21.41 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.167 -0.958 . . . . 0.0 108.982 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 8.0 mttt -50.29 -61.18 2.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.101 -1.0 . . . . 0.0 108.567 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.038 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -48.42 -46.32 37.32 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.928 ' SD ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.59 -52.39 30.58 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.057 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -46.87 -42.75 17.93 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.621 HG13 HG13 ' A' ' 22' ' ' ILE . 7.6 t -58.79 -61.2 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.933 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -45.9 -48.78 16.1 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -51.95 -47.4 64.78 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -46.29 -37.05 6.83 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.551 HG21 HD22 ' A' ' 63' ' ' LEU . 2.2 t -73.04 -32.96 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.687 -0.633 . . . . 0.0 109.565 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 59' ' ' TYR . 2.5 t-80 -78.1 -44.18 26.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.784 -1.198 . . . . 0.0 108.38 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -34.01 73.86 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -78.31 -48.35 15.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -128.87 170.09 13.81 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.253 -0.904 . . . . 0.0 109.433 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.45 51.59 0.74 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 177.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 59' ' ' TYR . 96.5 t -91.24 161.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-O 121.845 0.831 . . . . 0.0 110.798 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.615 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 12.6 pt-20 -75.26 49.05 0.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.797 -0.565 . . . . 0.0 110.16 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.59 HD21 HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -111.01 86.82 6.37 Favored Pre-proline 0 C--N 1.295 -1.796 0 O-C-N 121.108 -0.995 . . . . 0.0 110.986 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 37.3 Cg_endo -83.05 -152.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.745 2.297 . . . . 0.0 107.985 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.928 HD13 ' SD ' ' A' ' 49' ' ' MET . 7.9 tp -90.87 -41.55 11.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.457 -1.402 . . . . 0.0 109.611 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.562 ' HG3' ' N ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -50.29 -39.59 45.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.91 -1.119 . . . . 0.0 108.426 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.577 HG11 ' HG ' ' A' ' 63' ' ' LEU . 4.3 t -63.12 -34.37 66.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.038 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -65.6 -27.65 68.56 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.465 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 27.6 m-85 -86.92 -35.48 18.9 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.415 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.37 -35.34 80.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.415 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -142.72 71.93 19.91 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.641 ' C ' ' CE1' ' A' ' 38' ' ' PHE . 32.9 Cg_endo -77.59 64.65 8.1 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.52 2.147 . . . . 0.0 107.955 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.763 ' CG2' HD12 ' A' ' 35' ' ' LEU . 94.5 m -152.87 158.75 42.62 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 118.243 -1.383 . . . . 0.0 111.716 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.724 HG21 ' HA ' ' A' ' 34' ' ' ILE . 5.3 mm -64.1 -77.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.438 -0.789 . . . . 0.0 110.314 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.677 ' HB3' HD13 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -42.24 -49.4 4.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.65 -0.656 . . . . 0.0 110.002 -178.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -58.88 -69.15 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 109.13 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -47.57 -49.47 26.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.718 -1.239 . . . . 0.0 108.817 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -55.64 -27.57 50.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 1.5 pt20 -78.84 -32.56 46.17 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.545 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -67.79 -34.5 76.9 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -88.14 -63.12 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.317 1.056 . . . . 0.0 108.484 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.951 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -59.2 -31.24 68.85 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.425 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 13.4 m . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.517 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' A' ' 10' ' ' ALA . 37.0 t80 . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.608 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 9.9 m -114.93 40.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.886 . . . . 0.0 109.535 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 169.81 145.85 0.1 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.317 -0.865 . . . . 0.0 109.676 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.508 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 36.3 Cg_endo -80.62 -161.39 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.708 2.272 . . . . 0.0 110.45 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.55 -55.76 1.41 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.099 -1.001 . . . . 0.0 110.094 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.756 ' OD1' HG22 ' A' ' 15' ' ' VAL . 22.4 t-20 -119.36 169.84 9.65 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.643 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -73.26 -35.61 66.24 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.336 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.042 HG11 ' HB2' ' A' ' 82' ' ' ALA . 1.1 m -50.55 -56.56 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.761 ' HG3' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.68 -26.67 65.41 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.643 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 73.5 m -57.03 -51.11 70.57 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.555 ' HD3' ' CG ' ' A' ' 58' ' ' GLU . 1.3 tptm -61.43 -66.18 0.58 Allowed 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.792 ' HA ' HG23 ' A' ' 22' ' ' ILE . 4.3 mm? -41.04 -47.44 3.1 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.84 -48.27 64.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.864 -1.148 . . . . 0.0 108.502 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 4.3 mt-10 -64.82 -64.55 0.84 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.307 -0.871 . . . . 0.0 108.709 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.944 HD11 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -43.39 -47.08 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.71 ' CE3' HG21 ' A' ' 32' ' ' ILE . 3.7 m95 -50.25 -70.82 0.08 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.427 0.632 . . . . 0.0 110.741 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.629 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -55.27 -29.95 59.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.336 -0.852 . . . . 0.0 110.549 -178.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.423 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -76.23 -67.77 0.65 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.044 -1.035 . . . . 0.0 109.907 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.918 HG12 ' HG3' ' A' ' 47' ' ' LYS . 94.8 t -62.29 -31.55 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 110.11 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 19.4 mt -93.41 -4.68 50.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 110.121 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.52 56.27 25.41 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -136.97 -179.0 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 108.965 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.9 t -153.1 137.03 16.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.361 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 32' ' ' ILE . . . 83.64 6.46 87.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.026 HG22 HD11 ' A' ' 74' ' ' ILE . 3.4 mt -42.83 131.05 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -1.094 . . . . 0.0 109.301 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.87 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -71.29 -135.37 0.14 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.83 HD13 ' N ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -119.1 -55.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.961 -1.317 . . . . 0.0 110.185 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -92.09 39.97 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.184 -1.573 . . . . 0.0 108.878 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.599 ' OD2' HG23 ' A' ' 32' ' ' ILE . 1.3 m-20 -58.67 -172.06 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.612 0.72 . . . . 0.0 109.908 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 54.7 m-20 -126.29 115.39 19.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.705 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 25.4 m-85 -41.52 -24.9 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.11 -0.994 . . . . 0.0 110.342 -178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -99.65 37.42 1.6 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.501 -1.375 . . . . 0.0 109.585 179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.525 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 17.4 mm100 -81.33 -10.65 59.52 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 0.3 OUTLIER 165.71 60.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.68 74.78 0.31 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 45' ' ' SER . . . -124.45 -81.73 0.5 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 43' ' ' GLY . 46.5 t-80 63.26 -75.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -1.115 . . . . 0.0 109.457 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER 174.26 -61.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 109.515 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -50.27 -44.49 53.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.633 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.918 ' HG3' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -58.88 -71.37 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 109.23 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.075 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -46.98 -44.61 20.28 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.886 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.53 -51.03 29.5 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.812 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -47.36 -44.23 23.87 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.944 HG22 HD11 ' A' ' 22' ' ' ILE . 15.2 t -58.62 -58.03 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.055 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.46 -40.13 25.24 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -59.4 -46.41 88.77 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.53 ' HG2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -51.87 -31.17 26.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.41 HG21 HD22 ' A' ' 63' ' ' LEU . 3.3 t -74.21 -48.36 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.638 -0.664 . . . . 0.0 109.38 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 59' ' ' TYR . 4.6 t-80 -67.91 -34.59 76.92 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.155 -0.966 . . . . 0.0 109.189 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -76.02 -31.7 59.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 0.0 108.712 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.555 ' CG ' ' HD3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -82.67 -44.45 15.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.453 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.836 ' HB2' HG23 ' A' ' 61' ' ' VAL . 10.4 m-85 -120.51 -173.8 2.66 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.873 0.844 . . . . 0.0 109.639 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -117.95 39.96 3.25 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.836 HG23 ' HB2' ' A' ' 59' ' ' TYR . 1.3 t -93.09 137.91 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.33 0.586 . . . . 0.0 109.626 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 48.4 tt0 -69.37 95.46 0.8 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.327 -0.858 . . . . 0.0 109.292 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.777 HD23 ' HB1' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -116.4 91.57 33.78 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.484 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 35.6 Cg_endo -79.28 159.98 26.21 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.548 2.166 . . . . 0.0 110.215 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.886 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.3 mm? -57.83 -39.75 78.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.127 -0.983 . . . . 0.0 108.711 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -53.37 -52.22 59.97 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.484 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 2.6 t -51.07 -39.9 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.075 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -64.28 -26.83 68.67 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.495 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 4.3 m-30 -84.2 -36.38 22.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.44 -30.41 68.33 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.483 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -145.36 66.88 12.68 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.564 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.7 Cg_endo -76.46 53.15 3.85 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.86 2.374 . . . . 0.0 112.15 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 4.3 t -151.63 175.39 12.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.72 -1.237 . . . . 0.0 110.873 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.026 HD11 HG22 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -72.57 -67.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.687 -0.633 . . . . 0.0 110.794 -179.021 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.557 ' HE2' HD12 ' A' ' 35' ' ' LEU . 4.0 tttt -39.91 -56.87 1.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.575 -0.703 . . . . 0.0 109.303 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.489 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -59.44 -54.49 46.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 108.886 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.693 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -49.99 -64.49 0.79 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.731 -1.231 . . . . 0.0 108.585 179.032 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.716 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -46.15 -33.78 3.8 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.459 -0.776 . . . . 0.0 109.022 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -77.57 -40.26 42.98 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.947 -1.095 . . . . 0.0 109.142 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CE1' ' NE2' ' A' ' 71' ' ' GLN . 3.1 t80 -60.16 -34.27 73.34 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.933 -1.104 . . . . 0.0 108.127 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.699 HG12 HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -89.12 -66.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.386 1.088 . . . . 0.0 108.977 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 1.042 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -57.52 -28.17 63.24 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.81 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 79' ' ' GLN . 4.3 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 109.371 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.52 ' CE2' ' HA2' ' A' ' 33' ' ' GLY . 34.8 t80 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.6 OUTLIER -108.92 118.03 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.442 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.621 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -51.2 163.67 0.52 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.071 -1.018 . . . . 0.0 109.301 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.621 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 36.2 Cg_endo -78.85 157.12 27.47 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.576 2.184 . . . . 0.0 110.776 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.478 ' N ' ' OE2' ' A' ' 16' ' ' GLU . 1.2 m -130.67 1.11 4.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 110.709 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.555 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 2.3 p-10 -145.43 150.42 36.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.702 -1.248 . . . . 0.0 108.779 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.671 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -57.57 -25.42 59.95 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.019 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.854 HG21 ' CB ' ' A' ' 82' ' ' ALA . 2.2 t -47.07 -65.68 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.518 ' N ' HG12 ' A' ' 15' ' ' VAL . 4.0 pt-20 -70.76 -23.72 62.47 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.671 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 6.6 m -60.86 -44.85 96.47 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.394 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 22' ' ' ILE . 3.4 tptm -69.93 -61.57 1.73 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.964 -1.094 . . . . 0.0 108.351 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.898 HD21 HD12 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -48.34 -37.32 16.35 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.069 -1.052 . . . . 0.0 108.414 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' GLU . . . -58.19 -47.81 82.26 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.486 ' OE1' ' NH1' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -65.38 -51.99 56.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.378 -0.826 . . . . 0.0 108.785 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.951 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -54.37 -44.13 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.744 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.8 m95 -54.25 -68.57 0.17 Allowed 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.962 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.652 ' HA ' HD11 ' A' ' 32' ' ' ILE . 9.2 pt-20 -59.32 -33.21 70.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.486 ' NH1' ' OE1' ' A' ' 21' ' ' GLU . 24.1 ttm180 -71.17 -71.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 109.448 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.025 HG11 ' HB3' ' A' ' 50' ' ' ALA . 60.8 t -54.71 -33.78 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.556 -0.715 . . . . 0.0 110.232 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.466 ' CG ' ' O ' ' A' ' 23' ' ' TRP . 13.1 mt -91.43 -9.05 46.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.018 -1.051 . . . . 0.0 110.197 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.67 52.81 48.37 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.123 -0.986 . . . . 0.0 110.977 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -129.84 -173.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.249 . . . . 0.0 108.469 178.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.0 t -154.47 120.18 5.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.073 -1.017 . . . . 0.0 109.947 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.45 20.89 50.45 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.578 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 24' ' ' GLU . 2.8 mp -50.8 161.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.117 -1.225 . . . . 0.0 109.74 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.835 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -81.05 -153.01 9.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.719 ' O ' HG22 ' A' ' 34' ' ' ILE . 48.8 mm -121.37 19.85 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.78 -1.423 . . . . 0.0 109.762 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.816 HD12 ' HB3' ' A' ' 75' ' ' LYS . 1.7 tt -165.62 53.72 0.11 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.902 -1.124 . . . . 0.0 110.523 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.557 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 1.4 m-20 -84.76 160.08 20.34 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.653 ' O ' ' N ' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -88.42 45.91 1.33 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.833 -1.167 . . . . 0.0 108.787 179.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.744 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 13.4 m-85 51.01 -65.73 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.307 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.653 ' N ' ' O ' ' A' ' 37' ' ' ASN . 4.2 t80 -86.43 37.24 0.73 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.622 -1.299 . . . . 0.0 108.83 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.501 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 1.1 mm-40 -80.42 -7.76 59.26 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.2 tt 166.09 74.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.437 -0.789 . . . . 0.0 109.012 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.24 -118.95 0.95 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.972 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.545 ' CA ' ' HD3' ' A' ' 47' ' ' LYS . . . -58.11 162.33 9.91 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -116.27 -59.5 1.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -1.117 . . . . 0.0 109.224 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.57 -59.57 0.67 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.91 . . . . 0.0 109.444 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.469 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -52.59 -52.6 54.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.409 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.545 ' HD3' ' CA ' ' A' ' 43' ' ' GLY . 16.4 mttp -53.37 -51.45 62.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.066 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -53.62 -44.69 69.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.404 -1.435 . . . . 0.0 108.02 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.907 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.71 -48.98 49.53 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.025 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -48.88 -52.37 24.74 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.951 ' CG1' HD11 ' A' ' 22' ' ' ILE . 41.8 t -46.25 -59.5 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.92 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -52.52 -52.95 52.12 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 52' ' ' ALA . . . -47.34 -49.09 25.02 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.613 ' HB3' HD12 ' A' ' 22' ' ' ILE . 6.3 tp-100 -50.9 -37.66 45.23 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.872 HG11 HD23 ' A' ' 63' ' ' LEU . 21.0 t -63.52 -60.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -54.86 -46.85 74.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.209 -0.932 . . . . 0.0 110.504 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.529 ' HG3' ' N ' ' A' ' 58' ' ' GLU . 0.8 OUTLIER -61.43 -36.69 81.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.659 -1.276 . . . . 0.0 109.01 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -75.69 -53.67 8.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 108.934 179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.656 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -120.99 157.49 29.82 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.6 41.0 1.09 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.661 HG11 HG13 ' A' ' 81' ' ' VAL . 5.8 p -92.5 159.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.441 0.638 . . . . 0.0 109.672 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.471 ' N ' HG22 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -69.22 105.98 2.7 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.455 -0.778 . . . . 0.0 110.213 -179.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.872 HD23 HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -132.93 69.59 78.98 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.572 ' HG2' HG23 ' A' ' 67' ' ' VAL . 34.9 Cg_endo -77.92 156.96 30.95 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.683 2.255 . . . . 0.0 110.856 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.907 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.5 mm? -57.88 -39.67 78.38 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -55.37 -53.16 59.69 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.615 HG21 ' CE2' ' A' ' 80' ' ' TYR . 2.9 t -50.84 -48.45 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.066 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -55.03 -23.62 20.68 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 66' ' ' LYS . 6.2 m-85 -87.58 -39.67 14.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 0.0 109.05 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.17 -33.6 76.13 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.423 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -143.15 71.27 18.33 Favored Pre-proline 0 C--N 1.296 -1.749 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.62 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 32.3 Cg_endo -77.24 56.05 5.31 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.881 2.388 . . . . 0.0 112.236 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.734 HG22 ' HB3' ' A' ' 76' ' ' ALA . 15.3 t -154.11 174.91 14.08 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 117.34 -1.744 . . . . 0.0 112.725 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.835 HD12 ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -66.12 -72.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.207 -0.933 . . . . 0.0 111.516 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.816 ' HB3' HD12 ' A' ' 35' ' ' LEU . 32.2 ttmt -45.73 -49.33 14.88 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.133 -0.979 . . . . 0.0 109.766 -178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.734 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -66.38 -71.64 0.19 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.453 -0.78 . . . . 0.0 110.081 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.898 HD12 HD21 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -42.14 -55.85 3.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.309 -0.87 . . . . 0.0 108.952 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.757 ' HA ' HD13 ' A' ' 19' ' ' LEU . . . -50.28 -56.24 12.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 108.502 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 4.0 tp60 -50.35 -45.27 54.98 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.615 ' CE2' HG21 ' A' ' 67' ' ' VAL . 5.7 t80 -54.46 -35.82 63.42 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.166 -0.959 . . . . 0.0 108.613 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.749 HG21 HD11 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -79.78 -62.17 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 122.563 1.173 . . . . 0.0 108.976 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.854 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -53.01 -63.55 1.11 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.566 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.049 -1.032 . . . . 0.0 109.712 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.674 ' CE2' ' HA2' ' A' ' 33' ' ' GLY . 7.9 t80 . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.292 0.568 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.3 m -115.82 51.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.607 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.895 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -168.73 174.52 2.09 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 109.418 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.895 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 36.5 Cg_endo -81.45 174.13 10.86 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.597 2.198 . . . . 0.0 110.888 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.437 ' H ' ' CG ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -118.15 -52.52 2.4 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.71 176.83 4.88 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.606 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -79.81 -33.13 40.66 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.917 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.977 HG21 ' HB2' ' A' ' 82' ' ' ALA . 53.0 t -61.03 -48.66 88.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.957 ' OE1' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -71.84 -23.6 61.56 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.606 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 20.9 m -56.09 -50.08 72.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.687 ' O ' HG22 ' A' ' 22' ' ' ILE . 5.6 tptm -68.36 -52.44 33.12 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.745 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 2.3 mt -54.25 -37.35 64.56 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.696 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.957 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . . . -61.61 -45.83 92.42 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 22' ' ' ILE . 2.7 tt0 -61.82 -60.25 3.94 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.916 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -48.08 -57.57 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.906 ' HB3' HD13 ' A' ' 32' ' ' ILE . 1.9 m95 -38.24 -66.83 0.23 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.916 0.865 . . . . 0.0 110.308 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.661 ' HA ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -58.32 -43.43 88.19 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.443 0.64 . . . . 0.0 109.578 -178.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.429 ' HG3' ' N ' ' A' ' 26' ' ' VAL . 4.2 tpp180 -63.07 -71.93 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.517 -0.74 . . . . 0.0 110.511 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.673 HG11 ' HB3' ' A' ' 50' ' ' ALA . 91.1 t -63.17 -31.6 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 0.0 111.27 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 13.9 mt -93.05 -12.16 31.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.682 -1.261 . . . . 0.0 110.584 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 69.42 66.72 2.15 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.283 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.728 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -133.22 -168.56 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -1.09 . . . . 0.0 109.327 179.421 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.529 ' H ' HG12 ' A' ' 29' ' ' VAL . 3.3 m -153.42 69.26 0.81 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.428 -0.795 . . . . 0.0 109.04 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 142.16 -76.87 0.3 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.906 HD13 ' HB3' ' A' ' 23' ' ' TRP . 9.8 mt 60.07 128.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.397 -1.061 . . . . 0.0 110.768 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.674 ' HA2' ' CE2' ' A' ' 8' ' ' TYR . . . -75.19 -143.45 1.02 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -113.55 -62.93 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.122 -1.223 . . . . 0.0 109.763 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.559 ' C ' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -89.68 39.89 0.97 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.561 -1.337 . . . . 0.0 108.861 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.624 ' HB3' ' CH2' ' A' ' 23' ' ' TRP . 2.6 m-20 -60.05 -165.15 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.64 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -129.22 122.82 30.5 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CE1' ' N ' ' A' ' 73' ' ' THR . 7.9 m-30 -49.97 -21.37 1.19 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.098 -1.001 . . . . 0.0 109.07 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -97.71 39.86 1.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.025 -1.047 . . . . 0.0 108.323 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.546 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 4.4 mm-40 -80.73 83.03 6.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 40' ' ' GLN . 21.8 pt 46.2 62.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.655 0.74 . . . . 0.0 109.885 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.66 -103.23 1.8 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.33 -137.57 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -165.46 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.339 -1.095 . . . . 0.0 109.407 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.0 m -86.46 -10.57 53.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 109.66 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -48.44 69.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.704 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.9 mttt -56.81 -59.64 4.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.231 -0.918 . . . . 0.0 109.847 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.028 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -47.69 -51.87 20.33 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.975 -1.078 . . . . 0.0 109.141 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.886 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.72 -50.02 26.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.673 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -47.69 -41.86 23.55 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.916 HG13 ' CG1' ' A' ' 22' ' ' ILE . 17.9 t -61.12 -57.26 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.055 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -49.15 -46.16 44.79 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -57.58 -40.69 79.56 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.6 HE21 HD13 ' A' ' 22' ' ' ILE . 2.7 tp-100 -54.75 -33.76 61.66 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.986 HG11 HD12 ' A' ' 63' ' ' LEU . 3.5 t -68.95 -51.79 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' TYR . 4.3 t-160 -65.7 -37.46 86.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 109.252 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 53' ' ' ALA . 5.4 mtt180 -70.42 -32.33 69.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 108.727 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.504 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -81.47 -54.81 5.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.81 . . . . 0.0 108.864 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.835 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -118.38 -179.6 3.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.371 -0.831 . . . . 0.0 109.174 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.69 44.57 1.03 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.835 HG23 ' HB2' ' A' ' 59' ' ' TYR . 13.4 t -93.39 129.91 43.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.503 0.668 . . . . 0.0 109.734 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.76 104.05 2.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.729 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.986 HD12 HG11 ' A' ' 55' ' ' VAL . 6.5 mt -124.23 100.99 35.26 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 108.981 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.51 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.6 Cg_endo -80.18 157.4 23.15 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.548 2.166 . . . . 0.0 110.451 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.886 HD21 ' SD ' ' A' ' 49' ' ' MET . 1.9 mm? -57.03 -44.22 82.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.167 -0.958 . . . . 0.0 109.079 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HG3' ' HB2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -50.86 -51.24 53.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.0 -1.063 . . . . 0.0 108.337 179.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.931 HG11 ' CD2' ' A' ' 63' ' ' LEU . 2.7 t -50.76 -45.34 27.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.055 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -57.56 -25.02 59.33 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 66' ' ' LYS . 19.0 m-85 -86.72 -37.23 18.12 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.464 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.16 -30.68 68.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.453 -0.78 . . . . 0.0 109.305 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.657 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -144.82 66.11 12.86 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.596 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 34.3 Cg_endo -77.52 54.37 4.71 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.895 2.397 . . . . 0.0 110.588 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.622 ' N ' ' CE1' ' A' ' 38' ' ' PHE . 9.7 t -151.93 159.35 43.82 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.215 -0.928 . . . . 0.0 110.024 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.606 HG12 ' NE1' ' A' ' 23' ' ' TRP . 2.4 mt -64.49 -60.0 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.163 -0.961 . . . . 0.0 112.005 -178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 9.2 tttm -40.29 -53.85 2.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.318 -0.864 . . . . 0.0 108.912 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 77' ' ' LEU . . . -69.71 -60.93 2.0 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.666 -0.646 . . . . 0.0 110.051 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.3 OUTLIER -45.15 -59.17 2.76 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.707 -1.245 . . . . 0.0 108.623 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -50.22 -40.58 47.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -70.56 -34.91 72.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.05 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.719 ' CD1' HD21 ' A' ' 63' ' ' LEU . 7.7 t80 -63.14 -37.42 87.17 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.15 -0.969 . . . . 0.0 108.634 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.783 HG12 HG21 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -86.39 -62.19 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 122.367 1.08 . . . . 0.0 108.566 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.977 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -60.68 -54.24 47.63 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.031 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.334 179.855 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.466 ' CD2' ' O ' ' A' ' 8' ' ' TYR . 34.5 t80 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 11.4 m -121.71 39.43 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.16 -0.962 . . . . 0.0 109.781 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 169.35 145.36 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.291 -0.88 . . . . 0.0 109.949 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.547 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 36.8 Cg_endo -82.16 -167.69 0.51 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.743 2.295 . . . . 0.0 110.267 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.12 -45.69 2.11 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.094 -1.004 . . . . 0.0 109.769 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -122.89 153.63 39.39 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.606 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -67.81 -30.51 69.95 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.678 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.907 HG21 ' CB ' ' A' ' 82' ' ' ALA . 3.7 t -53.33 -51.84 36.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.547 ' OE1' ' HB3' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -68.79 -33.87 74.59 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.606 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.8 m -49.8 -52.2 33.9 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.407 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.866 ' O ' HG22 ' A' ' 22' ' ' ILE . 27.6 tptt -59.23 -49.46 77.75 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.293 -0.879 . . . . 0.0 108.728 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.779 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 9.9 mt -61.9 -41.76 98.28 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.512 ' O ' ' CG ' ' A' ' 24' ' ' GLU . . . -52.72 -45.38 66.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.792 -1.192 . . . . 0.0 108.036 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -64.56 -66.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 108.898 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.866 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -44.94 -48.12 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.785 ' HB3' HD12 ' A' ' 32' ' ' ILE . 3.3 m95 -46.69 -66.98 0.32 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.428 0.633 . . . . 0.0 110.504 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -63.73 -30.0 71.15 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.339 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.4 ttm180 -71.05 -64.18 0.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.037 -1.039 . . . . 0.0 110.223 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.06 HG11 ' HB3' ' A' ' 50' ' ' ALA . 99.3 t -71.37 -34.42 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 111.086 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.516 ' HB2' HG23 ' A' ' 29' ' ' VAL . 47.3 mt -79.33 4.78 14.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.669 -1.269 . . . . 0.0 110.052 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.34 49.12 61.47 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -134.1 -179.97 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.074 -1.251 . . . . 0.0 109.167 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.91 115.46 10.03 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.289 -0.882 . . . . 0.0 109.367 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 119.67 -69.64 0.36 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.785 HD12 ' HB3' ' A' ' 23' ' ' TRP . 10.2 mm 57.05 113.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -1.071 . . . . 0.0 109.656 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.45 -145.48 1.78 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.64 ' O ' ' N ' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -108.75 -50.81 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -1.22 . . . . 0.0 110.2 -179.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.592 ' HG ' HG21 ' A' ' 73' ' ' THR . 0.5 OUTLIER -109.81 45.21 1.11 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 119.775 -1.828 . . . . 0.0 109.174 179.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 73' ' ' THR . 2.5 m-20 -61.2 -164.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.337 0.589 . . . . 0.0 109.797 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.471 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 1.6 m-20 -135.27 118.8 16.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.8 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 70.5 m-85 -48.69 -22.3 0.76 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.924 -1.11 . . . . 0.0 109.31 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.444 ' O ' ' CD2' ' A' ' 39' ' ' PHE . 55.4 t80 -98.25 38.4 1.33 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.93 -1.106 . . . . 0.0 108.989 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.919 ' O ' HG22 ' A' ' 41' ' ' ILE . 10.9 mm-40 -81.07 77.03 8.01 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.919 HG22 ' O ' ' A' ' 40' ' ' GLN . 2.5 tt 60.75 39.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.549 0.69 . . . . 0.0 109.531 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.43 -113.18 1.37 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.36 -57.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.68 -169.06 2.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -1.137 . . . . 0.0 109.353 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.8 t -94.07 -5.59 47.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.307 -0.87 . . . . 0.0 109.42 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 49' ' ' MET . 16.6 tp -64.35 -55.79 18.8 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.091 -1.006 . . . . 0.0 109.568 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' A' ' 26' ' ' VAL . 1.9 mmtm -43.3 -58.35 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.046 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -51.62 -43.33 62.53 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.95 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.44 -50.63 51.66 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 178.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.06 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -47.37 -43.12 22.99 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.759 HG13 HG13 ' A' ' 22' ' ' ILE . 11.2 t -61.18 -60.76 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.995 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -47.74 -42.98 26.63 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 57' ' ' ARG . . . -58.23 -41.17 83.51 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.563 ' HG2' ' CG2' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -55.47 -29.99 59.74 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.641 HG11 HD23 ' A' ' 63' ' ' LEU . 6.6 t -75.19 -59.58 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.475 ' O ' ' O ' ' A' ' 59' ' ' TYR . 64.8 t-80 -57.33 -31.68 65.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 0.0 109.246 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -78.76 -38.58 38.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.122 -0.986 . . . . 0.0 108.737 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.478 ' OE2' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -71.94 -48.61 44.03 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.775 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -127.47 -178.82 4.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.481 -0.762 . . . . 0.0 109.17 178.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -110.72 44.97 1.19 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.775 HG23 ' HB2' ' A' ' 59' ' ' TYR . 13.9 t -93.14 153.9 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.799 -0.563 . . . . 0.0 109.723 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' C ' ' HD3' ' A' ' 64' ' ' PRO . 11.3 tt0 -70.78 94.85 1.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.641 HD23 HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -125.35 74.14 68.0 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.551 ' HG2' HG23 ' A' ' 67' ' ' VAL . 35.4 Cg_endo -77.2 -176.92 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.771 2.314 . . . . 0.0 110.885 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.95 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.9 mm? -81.27 -41.88 21.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.352 -0.843 . . . . 0.0 109.134 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.8 OUTLIER -59.88 -37.66 79.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.263 -0.898 . . . . 0.0 108.701 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.551 HG23 ' HG2' ' A' ' 64' ' ' PRO . 8.9 t -65.11 -47.08 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.046 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -52.74 -25.84 12.34 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.491 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.7 m-85 -79.17 -42.2 26.68 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.492 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -70.28 -26.18 63.68 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.841 0.829 . . . . 0.0 108.783 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.615 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -147.02 65.76 9.9 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.2 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.567 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 34.4 Cg_endo -78.81 55.73 5.67 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 123.074 2.516 . . . . 0.0 112.722 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.592 HG21 ' HG ' ' A' ' 35' ' ' LEU . 4.7 t -153.18 172.65 16.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.259 -1.526 . . . . 0.0 111.996 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.635 HG12 ' CE2' ' A' ' 23' ' ' TRP . 0.9 OUTLIER -64.36 -54.83 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.616 -0.677 . . . . 0.0 110.78 -179.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.64 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -55.49 -65.2 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.019 -1.051 . . . . 0.0 109.497 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -48.04 -53.93 14.73 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.585 -0.697 . . . . 0.0 110.206 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -57.64 -65.11 0.69 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.714 -1.241 . . . . 0.0 109.155 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.59 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -44.05 -34.92 1.91 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.478 ' HG3' ' N ' ' A' ' 80' ' ' TYR . 0.6 OUTLIER -71.71 -44.45 64.15 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.195 -0.941 . . . . 0.0 108.657 179.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.478 ' N ' ' HG3' ' A' ' 79' ' ' GLN . 2.3 t80 -57.58 -34.91 69.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.105 -0.997 . . . . 0.0 109.015 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.614 HG12 HG21 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -87.65 -63.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 122.289 1.042 . . . . 0.0 108.219 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.907 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -51.69 -59.57 4.14 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.024 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.405 ' HB ' ' OE1' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.514 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.32 0.581 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.475 ' HB ' ' CG1' ' A' ' 34' ' ' ILE . 1.6 t -103.11 106.71 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.344 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.15 156.56 1.8 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.447 -0.783 . . . . 0.0 110.147 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.66 ' HA ' HG21 ' A' ' 34' ' ' ILE . 36.4 Cg_endo -79.78 162.72 23.97 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.905 2.403 . . . . 0.0 110.52 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -124.26 -0.19 8.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.803 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.404 ' HB3' HG22 ' A' ' 15' ' ' VAL . 9.1 m120 -147.84 162.32 39.48 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.559 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -73.92 -29.98 62.33 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.534 -1.267 . . . . 0.0 109.328 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.09 ' CG1' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -54.08 -36.49 32.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.469 ' HG2' ' CB ' ' A' ' 78' ' ' ALA . 2.9 mt-10 -77.98 -36.16 49.33 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 67.8 m -56.3 -49.09 75.27 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.794 ' O ' HG22 ' A' ' 22' ' ' ILE . 10.0 tptt -67.64 -59.47 3.31 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.778 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -54.24 -27.37 34.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.895 . . . . 0.0 109.38 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.12 -52.23 37.17 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -55.28 36.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.769 -0.772 . . . . 0.0 108.925 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.794 HG22 ' O ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -53.52 -53.51 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 108.758 179.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.826 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.7 m95 -40.49 -57.74 1.74 Allowed 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.449 0.642 . . . . 0.0 109.72 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.595 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -61.49 -49.97 74.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.492 -0.755 . . . . 0.0 109.69 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -52.26 -47.69 65.65 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.48 -0.762 . . . . 0.0 110.683 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.928 HG11 ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -85.92 -50.38 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.093 -1.004 . . . . 0.0 110.371 -178.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.7 mt -68.86 -6.66 28.39 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.598 -0.689 . . . . 0.0 109.977 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.83 60.02 9.17 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -129.9 -178.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -1.162 . . . . 0.0 109.167 179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 30' ' ' SER . 1.3 p -148.91 40.0 0.87 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.59 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.37 59.86 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.826 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.2 mt -85.18 136.49 22.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.445 -1.032 . . . . 0.0 109.416 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.98 -120.92 0.04 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.66 HG21 ' HA ' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -138.59 -61.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.815 -1.403 . . . . 0.0 109.773 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.585 ' CD2' HG21 ' A' ' 73' ' ' THR . 0.3 OUTLIER -90.02 37.82 0.9 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.676 -1.265 . . . . 0.0 108.544 179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.476 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -58.99 -167.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.785 0.802 . . . . 0.0 109.484 178.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -131.72 110.96 11.25 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.737 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 53.6 m-85 -37.3 -28.87 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.562 -0.711 . . . . 0.0 110.197 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 37' ' ' ASN . 19.9 t80 -91.57 34.42 0.97 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.765 -1.209 . . . . 0.0 109.052 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 37' ' ' ASN . 6.7 mm-40 -81.78 -12.39 58.58 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 41' ' ' ILE . 10.0 tt 170.36 79.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.445 -0.784 . . . . 0.0 108.918 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.92 -127.62 1.18 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.614 -1.279 . . . . 0.0 109.95 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.34 -48.43 0.19 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -107.59 117.26 33.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.422 -1.046 . . . . 0.0 109.223 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 46' ' ' LEU . 0.3 OUTLIER -53.16 -19.6 3.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.855 . . . . 0.0 109.639 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -45.15 -47.2 12.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.151 -0.968 . . . . 0.0 109.294 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 7.0 tptt -47.83 -62.51 1.42 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.0 109.202 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.035 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.77 -48.79 50.21 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.045 -1.034 . . . . 0.0 108.594 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.86 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.4 -47.81 47.51 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.928 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -48.36 -42.12 30.69 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.701 HG22 HG21 ' A' ' 26' ' ' VAL . 14.8 t -62.67 -52.99 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.817 ' HB3' ' SD ' ' A' ' 49' ' ' MET . . . -48.4 -45.5 36.01 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.28 77.4 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.562 ' CG ' ' OE2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -51.91 -31.88 30.38 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.028 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.788 HG11 HD13 ' A' ' 63' ' ' LEU . 21.2 t -68.37 -42.03 83.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 59' ' ' TYR . 12.5 t-80 -71.16 -40.77 71.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.368 -0.832 . . . . 0.0 109.033 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -41.66 68.46 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.562 ' OE2' ' CG ' ' A' ' 54' ' ' GLN . 71.2 mt-10 -63.91 -49.4 72.81 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.865 ' CD1' HG11 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -139.96 172.63 12.49 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.74 45.87 0.94 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.835 HG23 ' HB2' ' A' ' 59' ' ' TYR . 21.2 t -92.97 145.66 7.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.437 0.637 . . . . 0.0 109.837 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.85 111.43 5.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 109.461 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.788 HD13 HG11 ' A' ' 55' ' ' VAL . 1.3 tt -147.01 85.37 6.99 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.299 -0.876 . . . . 0.0 109.436 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.1 Cg_endo -79.56 172.18 14.75 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.793 2.329 . . . . 0.0 109.589 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.86 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.1 mt -68.17 -43.23 78.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.716 -1.24 . . . . 0.0 109.116 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.416 ' CG ' ' N ' ' A' ' 67' ' ' VAL . 12.5 ptmm? -47.05 -37.9 10.19 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 80' ' ' TYR . 2.1 t -70.91 -42.21 77.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.035 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -61.28 -22.38 64.8 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.469 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 46.1 m-85 -83.55 -40.46 19.09 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.453 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -68.39 -29.61 68.34 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.994 0.902 . . . . 0.0 108.797 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.539 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -140.58 68.42 31.03 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -178.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.573 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 32.9 Cg_endo -76.9 55.23 4.86 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.989 2.459 . . . . 0.0 113.069 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.586 ' HA ' ' CZ2' ' A' ' 23' ' ' TRP . 10.2 t -153.39 174.44 14.35 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.736 -1.227 . . . . 0.0 110.887 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.815 HD11 ' CG2' ' A' ' 32' ' ' ILE . 21.0 mt -72.71 -65.07 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.311 -0.868 . . . . 0.0 109.883 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -39.76 -54.43 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.645 -0.659 . . . . 0.0 109.577 -179.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' H ' HG23 ' A' ' 73' ' ' THR . . . -62.76 -59.84 4.33 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.358 -0.839 . . . . 0.0 109.068 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.85 HD11 HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -44.54 -62.6 1.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.021 -1.049 . . . . 0.0 108.739 179.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.513 ' N ' HD13 ' A' ' 19' ' ' LEU . . . -48.7 -39.83 26.05 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.79 -40.82 79.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.913 . . . . 0.0 108.868 179.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.607 ' HD2' HD12 ' A' ' 63' ' ' LEU . 4.3 t80 -56.12 -35.12 66.73 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.865 HG11 ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -88.21 -69.26 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 122.334 1.064 . . . . 0.0 109.135 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 1.09 ' HB2' ' CG1' ' A' ' 15' ' ' VAL . . . -48.44 -25.99 1.9 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.341 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.06 . . . . 0.0 109.6 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.487 ' CE1' ' HA3' ' A' ' 33' ' ' GLY . 2.5 t80 . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.06 129.76 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -49.1 157.25 0.84 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.182 -0.949 . . . . 0.0 109.753 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.474 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 35.1 Cg_endo -76.2 -170.05 0.8 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.699 2.266 . . . . 0.0 110.717 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.05 -3.5 11.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 0.0 109.848 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.65 165.97 27.17 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.975 -1.078 . . . . 0.0 108.637 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.602 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -77.38 -22.36 51.81 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.02 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.892 HG21 ' CB ' ' A' ' 82' ' ' ALA . 2.2 t -52.0 -49.44 38.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.677 ' HG3' ' HB1' ' A' ' 78' ' ' ALA . 2.3 mt-10 -73.08 -38.25 66.47 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.602 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 16.6 m -53.27 -48.63 68.12 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.31 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.763 ' O ' HG22 ' A' ' 22' ' ' ILE . 6.9 tptt -63.28 -56.66 14.65 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -0.985 . . . . 0.0 108.861 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.792 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 1.3 tp -52.9 -37.54 60.78 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.432 -0.792 . . . . 0.0 109.15 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.68 84.13 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -61.89 -65.27 0.72 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.534 -0.729 . . . . 0.0 109.056 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.792 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -45.81 -45.91 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.951 -1.093 . . . . 0.0 108.895 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.738 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.5 m95 -47.37 -65.12 0.62 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.66 0.743 . . . . 0.0 109.938 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.613 ' CB ' HD11 ' A' ' 32' ' ' ILE . 8.0 pt-20 -60.22 -32.62 71.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 110.65 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -65.47 -61.66 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.128 -0.982 . . . . 0.0 110.664 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.108 HG11 ' HB3' ' A' ' 50' ' ' ALA . 22.0 t -77.44 -31.83 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.1 -1.0 . . . . 0.0 110.762 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 38.0 mt -78.83 -3.6 45.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.984 -1.073 . . . . 0.0 110.008 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.89 54.67 36.04 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.58 -172.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.186 -1.185 . . . . 0.0 109.374 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 t -143.29 38.22 1.4 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.386 -0.821 . . . . 0.0 109.073 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.612 ' O ' HD12 ' A' ' 32' ' ' ILE . . . -157.14 -94.84 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.659 HG22 ' CB ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER 19.76 86.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 117.746 0.773 . . . . 0.0 110.922 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.487 ' HA3' ' CE1' ' A' ' 8' ' ' TYR . . . -135.62 20.23 3.7 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 118.624 -1.751 . . . . 0.0 112.139 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.737 ' H ' HD12 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -174.69 114.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 120.222 -1.752 . . . . 0.0 110.979 178.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.563 ' HA ' ' OG1' ' A' ' 73' ' ' THR . 1.9 tp 37.81 42.47 0.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.348 0.594 . . . . 0.0 110.639 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.659 ' CB ' HG22 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -76.7 -178.42 4.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.827 . . . . 0.0 109.043 178.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.548 ' HB2' ' HG2' ' A' ' 40' ' ' GLN . 7.2 m120 -114.03 112.42 23.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.727 -1.233 . . . . 0.0 109.062 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.738 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 55.1 m-85 -42.31 -26.52 0.11 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.165 -0.959 . . . . 0.0 109.452 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' A' ' 37' ' ' ASN . 16.8 t80 -92.3 36.24 0.99 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.943 -1.098 . . . . 0.0 108.697 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.548 ' HG2' ' HB2' ' A' ' 37' ' ' ASN . 9.2 mm100 -80.66 -12.31 59.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.5 ' HB ' ' O ' ' A' ' 40' ' ' GLN . 2.3 tt 168.94 64.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.47 -170.58 12.11 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.5 -53.44 1.06 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -141.84 -118.51 0.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -1.182 . . . . 0.0 109.426 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.14 -5.47 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.791 -1.193 . . . . 0.0 109.795 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -50.95 -62.81 1.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.113 -0.992 . . . . 0.0 109.519 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 18.2 mttp -46.52 -54.86 8.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.082 -1.011 . . . . 0.0 108.782 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.07 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -48.92 -44.33 40.28 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.774 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.63 -46.14 58.04 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.301 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.108 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -48.64 -47.58 40.22 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.721 HG13 HG13 ' A' ' 22' ' ' ILE . 10.8 t -56.63 -56.41 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.76 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.89 -35.64 15.28 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -66.36 -39.93 89.45 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.526 ' CD ' ' HB ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -54.78 -29.53 54.48 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.811 HG21 ' CD2' ' A' ' 63' ' ' LEU . 5.0 t -73.97 -61.66 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 59' ' ' TYR . 71.3 t60 -52.4 -36.32 53.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.904 -1.123 . . . . 0.0 109.435 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.49 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -75.13 -44.8 44.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.044 . . . . 0.0 109.158 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.479 ' HG3' ' HG2' ' A' ' 18' ' ' LYS . 35.4 mm-40 -69.74 -33.47 72.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.408 -0.808 . . . . 0.0 109.217 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.575 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -143.91 162.34 36.38 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.539 -0.725 . . . . 0.0 109.436 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -96.57 39.94 1.15 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.025 HG11 HG13 ' A' ' 81' ' ' VAL . 7.1 p -92.96 153.83 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -82.78 111.27 18.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.034 HD21 HD13 ' A' ' 77' ' ' LEU . 4.9 tp -145.24 78.28 12.37 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.488 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 35.1 Cg_endo -79.0 -172.04 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.883 2.389 . . . . 0.0 110.284 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.774 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.4 mt -78.67 -37.63 41.34 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.033 -1.042 . . . . 0.0 109.278 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -53.08 -36.67 60.94 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.557 HG11 HD12 ' A' ' 63' ' ' LEU . 2.6 t -72.75 -45.2 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.07 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -62.26 -24.16 67.11 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.4 m-85 -87.52 -35.98 17.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.0 108.896 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.473 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -70.74 -30.31 66.79 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.545 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -143.94 66.82 15.13 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -178.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.3 Cg_endo -75.88 59.37 5.75 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.915 2.41 . . . . 0.0 112.235 -178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.563 ' OG1' ' HA ' ' A' ' 35' ' ' LEU . 4.1 t -153.8 174.37 14.65 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 117.559 -1.656 . . . . 0.0 112.584 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.737 HD12 ' H ' ' A' ' 34' ' ' ILE . 29.0 mt -67.72 -56.94 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.452 ' H ' ' H ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -61.85 -57.51 11.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.672 -1.268 . . . . 0.0 108.84 -178.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.404 ' HB3' HG23 ' A' ' 73' ' ' THR . . . -48.51 -55.09 11.96 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.572 -0.705 . . . . 0.0 109.144 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.034 HD13 HD21 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -55.17 -65.42 0.59 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.0 -1.062 . . . . 0.0 109.076 179.354 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.677 ' HB1' ' HG3' ' A' ' 16' ' ' GLU . . . -43.59 -46.13 7.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.492 ' O ' HG22 ' A' ' 83' ' ' THR . 47.5 mm-40 -61.78 -53.14 60.03 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.514 ' CD1' ' CD1' ' A' ' 63' ' ' LEU . 2.5 t80 -43.18 -39.2 2.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.327 -0.858 . . . . 0.0 109.252 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.025 HG13 HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -87.93 -67.31 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.433 1.111 . . . . 0.0 109.041 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.892 ' CB ' HG21 ' A' ' 15' ' ' VAL . . . -40.03 -25.94 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.868 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 79' ' ' GLN . 2.1 t . . . . . 0 N--CA 1.492 1.666 0 O-C-N 120.858 -1.151 . . . . 0.0 109.572 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.559 ' CD2' ' O ' ' A' ' 8' ' ' TYR . 33.0 t80 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 19.8 m -109.61 28.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 109.965 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 168.39 147.22 0.08 OUTLIER Pre-proline 0 C--N 1.296 -1.72 0 O-C-N 121.363 -0.836 . . . . 0.0 109.867 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 36.7 Cg_endo -81.24 -172.23 1.45 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.665 2.244 . . . . 0.0 110.357 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.46 HG22 ' OE2' ' A' ' 16' ' ' GLU . 5.6 t -115.78 -28.72 6.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.557 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.48 ' OD1' ' HB2' ' A' ' 16' ' ' GLU . 10.1 p30 -141.14 156.31 45.97 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.575 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -62.35 -34.76 77.29 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.838 -1.164 . . . . 0.0 109.758 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.992 HG11 ' HB2' ' A' ' 82' ' ' ALA . 43.5 t -49.92 -48.93 22.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HG2' ' CB ' ' A' ' 78' ' ' ALA . 31.6 mt-10 -71.17 -29.36 65.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.575 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 35.4 m -53.04 -51.12 62.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.038 -1.039 . . . . 0.0 108.679 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.599 ' O ' HG22 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -68.93 -54.61 14.45 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.02 -1.072 . . . . 0.0 108.818 179.6 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.059 HD21 HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -48.35 -38.43 19.2 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.78 -1.168 . . . . 0.0 108.063 179.128 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.03 -50.57 73.6 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -60.66 -62.94 1.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.023 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.922 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -45.78 -52.23 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.626 ' CE2' ' CE1' ' A' ' 38' ' ' PHE . 2.2 m95 -41.51 -62.41 0.88 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.425 0.631 . . . . 0.0 109.727 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.693 ' HA ' HD11 ' A' ' 32' ' ' ILE . 4.8 pt-20 -66.25 -33.41 75.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 110.437 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HG3' ' N ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -62.38 -63.9 1.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.349 -179.001 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.842 HG11 ' HB3' ' A' ' 50' ' ' ALA . 11.8 t -79.23 -35.01 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.918 . . . . 0.0 111.606 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 38.4 mt -75.64 -2.79 31.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.884 -1.135 . . . . 0.0 109.955 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.88 59.06 10.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.644 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -131.45 -174.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -1.154 . . . . 0.0 109.083 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t -150.79 49.94 0.86 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.256 -0.902 . . . . 0.0 109.208 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 168.18 -73.05 0.14 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.807 HG22 HD11 ' A' ' 74' ' ' ILE . 5.1 mt 59.43 143.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.433 -1.04 . . . . 0.0 109.776 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.665 ' O ' HD13 ' A' ' 74' ' ' ILE . . . -83.73 -143.53 5.54 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.508 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 5.3 tt -127.64 25.2 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.107 -1.231 . . . . 0.0 109.388 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.843 ' HA ' HG22 ' A' ' 73' ' ' THR . 6.2 tp -179.52 61.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.155 -0.965 . . . . 0.0 109.516 178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.904 ' O ' HG23 ' A' ' 73' ' ' THR . 0.6 OUTLIER -91.57 -160.48 0.73 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.488 -0.757 . . . . 0.0 109.32 179.618 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.621 ' O ' ' N ' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -126.84 29.85 5.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.878 -1.139 . . . . 0.0 109.953 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 63.0 m-85 58.24 -56.17 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 O-C-N 122.139 -0.351 . . . . 0.0 110.216 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.621 ' N ' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -84.91 26.17 0.87 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.631 -1.293 . . . . 0.0 109.809 179.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.519 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 7.7 mm100 -80.59 76.69 7.44 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 41' ' ' ILE . 9.2 mt 66.93 74.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.83 96.71 2.46 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 47' ' ' LYS . . . -167.93 -59.73 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.7 m170 53.25 -161.16 0.12 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.121 -1.223 . . . . 0.0 109.489 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -109.92 -50.01 3.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -57.09 -43.31 82.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.961 . . . . 0.0 109.335 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.717 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -61.13 -65.29 0.72 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -0.969 . . . . 0.0 109.625 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.934 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.68 -47.96 49.94 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.888 -1.132 . . . . 0.0 108.227 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.896 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.41 -37.93 18.28 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.012 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.842 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -57.22 -49.75 75.01 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.922 HG13 ' CG1' ' A' ' 22' ' ' ILE . 9.4 t -57.13 -57.83 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.97 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.67 -35.08 13.08 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -67.58 -45.19 76.27 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.598 ' O ' ' CB ' ' A' ' 58' ' ' GLU . 4.4 tp-100 -49.18 -31.8 9.13 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 177.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.874 HG11 HD23 ' A' ' 63' ' ' LEU . 3.4 t -68.75 -30.77 48.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.593 -0.692 . . . . 0.0 109.314 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 53' ' ' ALA . 2.8 t60 -81.57 -43.36 18.78 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.183 -0.948 . . . . 0.0 109.509 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -77.4 -34.05 54.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.956 -1.09 . . . . 0.0 108.611 179.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.598 ' CB ' ' O ' ' A' ' 54' ' ' GLN . 42.3 tp10 -77.1 -37.66 53.87 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.906 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -137.64 157.71 45.93 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 4.3 tt0 -93.78 32.02 1.5 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.964 HG11 ' CG1' ' A' ' 81' ' ' VAL . 6.7 p -93.64 144.33 9.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 3.1 pt-20 -69.75 136.24 50.7 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.05 -1.031 . . . . 0.0 109.456 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.874 HD23 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -143.22 92.24 6.79 Favored Pre-proline 0 C--N 1.297 -1.713 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.567 ' HG2' HG23 ' A' ' 67' ' ' VAL . 36.2 Cg_endo -78.79 162.19 26.99 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.554 2.169 . . . . 0.0 110.762 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.896 HD21 ' SD ' ' A' ' 49' ' ' MET . 4.1 mm? -70.3 -29.62 66.42 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -63.67 -55.07 26.33 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.671 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 3.9 t -49.97 -42.03 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.97 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -61.78 -32.14 72.39 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.499 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 23.4 m-85 -80.43 -37.7 31.53 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.4 -35.07 79.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.469 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -144.98 69.56 14.47 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -178.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.587 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 30.4 Cg_endo -77.67 66.84 8.02 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.712 2.275 . . . . 0.0 109.115 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 36' ' ' ASP . 22.2 m -153.31 161.98 41.78 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 117.088 -1.845 . . . . 0.0 113.108 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.807 HD11 HG22 ' A' ' 32' ' ' ILE . 87.2 mt -57.8 -70.14 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 110.007 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 21.8 ttpp -57.67 -49.39 76.66 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.259 -0.901 . . . . 0.0 109.305 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -58.65 -71.35 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.854 -1.154 . . . . 0.0 109.369 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.059 HD12 HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -42.76 -58.21 2.44 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.594 ' HA ' HD13 ' A' ' 19' ' ' LEU . . . -49.67 -60.65 2.68 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 12.5 mm100 -45.37 -42.09 9.74 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.227 -0.92 . . . . 0.0 108.865 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.671 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 7.8 t80 -54.39 -39.01 66.82 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.964 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -87.46 -66.78 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.386 1.089 . . . . 0.0 108.659 179.227 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.992 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -45.01 -40.96 6.97 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.089 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.397 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.409 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 21.6 t80 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.03 118.04 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.762 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.877 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -56.0 172.71 0.31 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.872 . . . . 0.0 109.536 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.877 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 36.3 Cg_endo -77.9 156.05 30.64 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.876 2.384 . . . . 0.0 110.96 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 12' ' ' THR . 26.3 m -109.98 3.66 20.65 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 109.608 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.577 ' HB3' HG22 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -169.53 173.11 6.61 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.577 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -73.48 -28.08 61.74 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.658 -1.217 . . . . 0.0 109.746 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.084 HG11 ' HB2' ' A' ' 82' ' ' ALA . 16.0 m -49.5 -37.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.518 ' HG2' HG23 ' A' ' 15' ' ' VAL . 1.1 mt-10 -82.99 -38.45 22.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.577 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 24.8 p -53.47 -38.99 64.14 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.691 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -71.49 -57.89 4.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.587 -0.695 . . . . 0.0 109.23 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.744 ' HB3' HG23 ' A' ' 74' ' ' ILE . 3.9 mm? -54.2 -42.4 69.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.941 -1.099 . . . . 0.0 108.422 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 24' ' ' GLU . . . -56.0 -46.75 78.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -60.48 -63.64 1.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.918 HG12 HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -46.98 -51.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.965 ' CE3' HG21 ' A' ' 32' ' ' ILE . 2.1 m95 -39.38 -66.73 0.27 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.607 0.718 . . . . 0.0 109.929 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.609 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -63.68 -25.63 68.3 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.972 -178.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.478 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . 4.5 tpp180 -74.06 -67.12 0.64 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.115 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.799 HG11 ' HB3' ' A' ' 50' ' ' ALA . 72.4 t -71.36 -31.63 44.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 111.0 -178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' TRP . 21.6 mt -85.58 -7.95 58.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.049 . . . . 0.0 109.992 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.58 56.44 9.78 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.484 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.9 179.3 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.886 -1.361 . . . . 0.0 108.724 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -140.98 74.09 1.45 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.157 -0.964 . . . . 0.0 108.984 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 146.32 -80.35 0.22 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.965 HG21 ' CE3' ' A' ' 23' ' ' TRP . 9.8 mt 59.58 150.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.223 -1.163 . . . . 0.0 109.64 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.53 -122.52 0.72 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.696 ' HA ' HD12 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -147.11 -52.51 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.717 -1.46 . . . . 0.0 111.079 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.82 HD23 HG21 ' A' ' 73' ' ' THR . 5.5 mt -95.5 31.14 2.07 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 120.049 -1.657 . . . . 0.0 110.976 -178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.729 ' O ' HG23 ' A' ' 73' ' ' THR . 2.9 m-20 -59.15 -166.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.113 -0.992 . . . . 0.0 109.616 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -133.98 30.62 3.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.086 -1.009 . . . . 0.0 109.245 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.599 ' CD1' ' CZ2' ' A' ' 23' ' ' TRP . 6.5 m-30 63.91 -61.88 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.362 -0.836 . . . . 0.0 109.64 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 37' ' ' ASN . 51.5 t80 -83.43 21.37 1.18 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.903 -1.123 . . . . 0.0 110.737 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.856 ' O ' HG23 ' A' ' 41' ' ' ILE . 8.1 mm-40 -79.13 0.75 26.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.772 -1.205 . . . . 0.0 108.342 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 40' ' ' GLN . 0.1 OUTLIER 170.66 59.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.35 -132.43 1.9 Allowed Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.116 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -170.55 124.55 1.14 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.78 -176.41 0.2 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.429 -1.042 . . . . 0.0 109.752 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 46' ' ' LEU . 4.2 t -124.25 -21.56 4.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.14 -0.975 . . . . 0.0 110.351 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 49' ' ' MET . 0.4 OUTLIER -43.97 -51.02 8.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.014 -1.054 . . . . 0.0 109.246 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -44.91 -47.44 11.24 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.018 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -57.2 -45.41 83.82 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.813 ' HG2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -46.68 -51.77 15.28 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.799 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -48.3 -50.0 31.76 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.918 HG13 HG12 ' A' ' 22' ' ' ILE . 21.2 t -51.22 -55.49 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.066 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -50.18 -46.2 54.09 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -52.05 -38.35 56.75 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.567 ' HG2' ' HB ' ' A' ' 22' ' ' ILE . 3.4 tp-100 -58.63 -41.04 85.03 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.9 HG21 HD22 ' A' ' 63' ' ' LEU . 14.7 t -61.5 -40.54 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.43 ' O ' ' O ' ' A' ' 59' ' ' TYR . 11.9 t60 -69.15 -53.27 20.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.056 -1.027 . . . . 0.0 109.149 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.37 -38.57 84.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.298 -0.876 . . . . 0.0 109.037 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.543 ' CG ' ' HE2' ' A' ' 18' ' ' LYS . 13.3 mm-40 -71.82 -56.64 5.37 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.305 -0.872 . . . . 0.0 108.651 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.843 ' CD1' HG11 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -127.03 165.04 20.22 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.767 0.794 . . . . 0.0 109.532 179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -95.78 46.18 1.09 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.6 t -91.44 138.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.514 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.63 103.16 1.65 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 109.765 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.9 HD22 HG21 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -138.94 82.58 19.81 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.38 -0.825 . . . . 0.0 109.055 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.564 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 34.5 Cg_endo -77.81 -178.84 4.91 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.78 2.32 . . . . 0.0 110.418 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.813 HD21 ' HG2' ' A' ' 49' ' ' MET . 2.5 mm? -65.22 -37.93 88.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 109.089 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -56.26 -60.99 2.71 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.587 HG12 HE22 ' A' ' 71' ' ' GLN . 15.2 t -47.04 -43.07 6.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.066 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -61.81 -48.68 79.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -65.51 -19.84 66.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 67' ' ' VAL . . . -76.31 -52.11 10.62 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.271 1.034 . . . . 0.0 108.838 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.587 HE22 HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -132.58 72.35 77.91 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.034 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.581 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 31.2 Cg_endo -76.4 67.43 7.06 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.397 2.064 . . . . 0.0 108.207 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.82 HG21 HD23 ' A' ' 35' ' ' LEU . 22.2 m -151.4 165.77 33.11 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.227 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.744 HG23 ' HB3' ' A' ' 19' ' ' LEU . 6.1 mt -76.79 -69.58 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.331 -0.856 . . . . 0.0 109.798 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -45.84 -47.54 15.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.182 -0.948 . . . . 0.0 108.867 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.457 ' HB3' ' HB ' ' A' ' 73' ' ' THR . . . -59.5 -55.48 34.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.387 -0.821 . . . . 0.0 109.147 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -56.23 -65.6 0.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.102 -0.999 . . . . 0.0 108.876 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.69 ' HB1' HG23 ' A' ' 15' ' ' VAL . . . -43.35 -37.42 2.26 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.46 -0.775 . . . . 0.0 109.054 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.447 ' O ' ' O ' ' A' ' 83' ' ' THR . 10.1 tp60 -69.95 -43.85 70.74 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.002 -1.061 . . . . 0.0 108.548 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.537 ' CD2' HD12 ' A' ' 63' ' ' LEU . 10.4 t80 -59.84 -33.4 71.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.33 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.843 HG11 ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -86.93 -60.74 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 122.48 1.133 . . . . 0.0 108.196 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 1.084 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -54.35 -65.32 0.6 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.418 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.585 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.485 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 2.1 t80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 121.36 0.6 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 9' ' ' VAL . 13.5 m -103.66 125.03 58.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.991 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -48.58 176.2 0.04 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.461 -0.774 . . . . 0.0 109.578 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.991 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 34.8 Cg_endo -76.63 136.52 17.28 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.612 2.208 . . . . 0.0 110.792 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.05 -9.01 13.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.35 -0.844 . . . . 0.0 109.323 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 15.6 m120 -141.36 153.88 45.34 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.622 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -64.98 -27.68 69.0 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.452 -1.299 . . . . 0.0 110.081 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.892 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 2.7 t -49.37 -49.62 17.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -78.18 -29.51 48.54 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.622 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 7.3 m -60.84 -42.31 97.53 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.664 -1.215 . . . . 0.0 108.684 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.475 ' HG2' ' HG3' ' A' ' 58' ' ' GLU . 0.7 OUTLIER -69.1 -51.31 39.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.712 ' HA ' HD11 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -61.11 -46.7 89.53 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.733 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.36 -45.43 55.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 22' ' ' ILE . 1.7 mm-40 -62.76 -69.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.537 -0.727 . . . . 0.0 109.541 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.973 HD12 ' CG1' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -47.06 -40.58 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.872 -1.143 . . . . 0.0 108.919 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.727 ' CZ2' ' CE1' ' A' ' 38' ' ' PHE . 2.6 m95 -49.25 -67.44 0.26 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.369 -0.832 . . . . 0.0 109.507 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.774 ' HA ' HD11 ' A' ' 32' ' ' ILE . 4.0 pt-20 -58.85 -39.29 80.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.348 -0.845 . . . . 0.0 110.439 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -69.51 -70.85 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.795 -1.191 . . . . 0.0 109.744 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 50' ' ' ALA . 55.3 t -55.92 -31.41 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 110.85 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.771 HD23 ' HG3' ' A' ' 47' ' ' LYS . 14.2 mt -96.53 15.0 22.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.115 -0.991 . . . . 0.0 110.8 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.42 44.77 45.65 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 121.208 -0.932 . . . . 0.0 110.978 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.771 ' HB ' HD11 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -117.82 -170.3 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.093 -1.239 . . . . 0.0 108.885 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 p -145.99 49.4 1.2 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.184 -0.948 . . . . 0.0 109.48 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 143.37 -66.8 0.46 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.774 HD11 ' HA ' ' A' ' 24' ' ' GLU . 1.7 mp 57.61 156.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -1.171 . . . . 0.0 109.776 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.817 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -80.31 -157.73 15.65 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -102.7 -49.08 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.272 . . . . 0.0 110.346 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.708 HD23 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -93.06 34.95 1.08 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.801 -1.187 . . . . 0.0 109.294 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -64.77 155.19 34.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.689 -0.632 . . . . 0.0 109.902 179.034 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.444 ' H ' ' CG ' ' A' ' 40' ' ' GLN . 1.8 m-20 -97.84 122.12 40.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.1 -1.0 . . . . 0.0 108.626 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.727 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 79.0 m-85 -44.5 -25.55 0.27 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.109 -0.995 . . . . 0.0 109.319 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 37' ' ' ASN . 11.9 t80 -102.05 41.26 1.23 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.903 -1.123 . . . . 0.0 108.846 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.516 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 16.5 mm-40 -79.88 -22.63 42.62 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 41' ' ' ILE . 8.4 tt 171.0 66.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.23 -104.94 2.04 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.18 49.15 0.05 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 173.38 -167.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -1.153 . . . . 0.0 109.377 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -141.01 -38.99 0.41 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 109.192 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 46' ' ' LEU . 2.0 mm? -53.92 -34.65 60.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.771 ' HG3' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -56.46 -51.98 66.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.114 -0.991 . . . . 0.0 108.39 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.704 ' HB1' ' CD2' ' A' ' 68' ' ' LEU . . . -58.73 -46.15 88.03 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.909 ' HG2' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -52.99 -32.91 48.99 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.257 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 47' ' ' LYS . . . -60.94 -44.57 97.06 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.973 ' CG1' HD12 ' A' ' 22' ' ' ILE . 4.3 t -62.13 -69.97 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.014 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -44.81 -50.14 10.39 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.264 -0.897 . . . . 0.0 108.679 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 49' ' ' MET . . . -55.89 -46.04 78.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.891 ' HG2' HG21 ' A' ' 22' ' ' ILE . 8.1 tp-100 -48.21 -33.54 8.73 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.536 HG13 HG11 ' A' ' 81' ' ' VAL . 3.5 t -67.26 -67.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 59' ' ' TYR . 3.0 t-160 -46.86 -36.25 7.27 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.792 -1.192 . . . . 0.0 109.593 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -72.1 -42.66 65.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.792 -1.193 . . . . 0.0 108.717 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 18' ' ' LYS . 52.8 mm-40 -71.58 -50.76 27.93 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.778 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -116.91 160.14 21.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -93.67 36.95 1.07 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.798 HG11 ' CG1' ' A' ' 81' ' ' VAL . 6.3 p -94.11 145.56 7.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -82.78 112.61 19.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.5 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.071 HD21 HD13 ' A' ' 77' ' ' LEU . 15.9 tp -133.14 94.7 19.79 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.8 Cg_endo -80.91 163.66 20.53 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.784 2.323 . . . . 0.0 110.771 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.909 HD11 ' HG2' ' A' ' 49' ' ' MET . 4.5 mt -65.15 -39.1 92.51 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.18 -1.008 . . . . 0.0 108.385 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -48.45 -53.33 18.28 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.902 HG11 ' CD1' ' A' ' 63' ' ' LEU . 1.2 t -56.01 -46.13 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.014 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -58.13 -22.32 50.5 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.477 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 3.3 m-85 -86.03 -37.66 18.68 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.45 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -69.7 -31.57 69.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.463 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.15 67.4 21.55 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.559 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 33.0 Cg_endo -77.13 61.58 7.28 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.912 2.408 . . . . 0.0 111.933 -178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.708 HG21 HD23 ' A' ' 35' ' ' LEU . 4.4 t -152.95 176.06 12.26 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.198 -1.401 . . . . 0.0 112.053 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.817 HD12 ' O ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -73.64 -69.22 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.904 -0.498 . . . . 0.0 110.411 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.557 ' CG ' HG12 ' A' ' 34' ' ' ILE . 11.6 tmtt? -39.91 -56.53 1.79 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HB3' HG23 ' A' ' 73' ' ' THR . . . -58.05 -64.33 0.95 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.514 -0.742 . . . . 0.0 109.884 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.071 HD13 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -46.27 -62.98 1.11 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.781 -1.2 . . . . 0.0 108.974 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 82' ' ' ALA . . . -44.78 -48.82 10.91 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 51.2 mm-40 -61.55 -44.5 96.93 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.429 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.464 ' CD2' HD13 ' A' ' 63' ' ' LEU . 1.1 t80 -53.29 -37.11 61.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.891 -1.13 . . . . 0.0 108.927 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.798 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -88.24 -65.43 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.431 1.11 . . . . 0.0 108.535 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.892 ' HB2' ' CB ' ' A' ' 15' ' ' VAL . . . -49.09 -20.7 0.6 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.355 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.531 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.541 ' CD1' ' O ' ' A' ' 32' ' ' ILE . 10.8 t80 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.433 0.635 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.41 130.47 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.596 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -48.94 160.63 0.47 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.118 -0.988 . . . . 0.0 110.02 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 33.3 Cg_endo -74.56 -159.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.855 2.37 . . . . 0.0 110.837 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.508 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 1.8 m -116.42 -7.3 11.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.25 -0.906 . . . . 0.0 110.192 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 12' ' ' THR . 13.5 m120 -140.66 149.45 42.27 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.878 -1.139 . . . . 0.0 108.267 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.615 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -61.61 -26.52 68.04 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.444 -1.302 . . . . 0.0 109.409 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.868 ' CB ' ' HB2' ' A' ' 82' ' ' ALA . 35.3 t -48.07 -58.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.69 ' HG3' ' HB1' ' A' ' 78' ' ' ALA . 1.2 mp0 -66.01 -36.67 83.9 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.615 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 70.7 m -48.55 -55.92 9.77 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.302 177.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.816 ' O ' HG23 ' A' ' 22' ' ' ILE . 20.1 tttm -52.44 -67.43 0.25 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.811 HD12 ' NZ ' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -43.0 -46.48 5.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.336 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -49.82 -57.98 6.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.78 -1.2 . . . . 0.0 109.08 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -51.08 71.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.212 -0.93 . . . . 0.0 109.4 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.972 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -54.69 -44.06 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.78 ' HB3' HD13 ' A' ' 32' ' ' ILE . 3.3 m95 -52.22 -66.2 0.42 Allowed 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.619 0.723 . . . . 0.0 109.721 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.651 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -58.9 -53.73 55.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.463 -0.773 . . . . 0.0 110.046 -178.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -54.15 -66.08 0.46 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 109.982 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.968 HG11 ' HB3' ' A' ' 50' ' ' ALA . 21.6 t -58.56 -43.73 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.797 . . . . 0.0 110.719 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 42.3 mt -78.69 -12.38 60.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.996 -1.065 . . . . 0.0 110.347 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 72.73 53.27 8.45 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.409 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.36 -178.33 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.125 -1.221 . . . . 0.0 109.127 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.08 39.71 1.34 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.209 -0.932 . . . . 0.0 109.472 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -156.17 -91.2 0.08 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.78 HD13 ' HB3' ' A' ' 23' ' ' TRP . 14.7 mt 58.63 149.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -1.164 . . . . 0.0 109.721 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.38 -154.96 19.41 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.618 ' HA ' HG21 ' A' ' 74' ' ' ILE . 9.1 pt -98.84 2.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.139 -1.212 . . . . 0.0 110.024 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 35' ' ' LEU . 1.3 tt -162.41 69.1 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.979 -1.076 . . . . 0.0 108.986 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.512 ' N ' ' HG1' ' A' ' 73' ' ' THR . 1.8 m-20 -98.49 160.68 14.12 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.679 -0.638 . . . . 0.0 109.562 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 40' ' ' GLN . 1.2 t-20 -89.49 106.83 18.71 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.726 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 43.4 m-85 -31.73 -34.02 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.595 0 O-C-N 121.789 -0.569 . . . . 0.0 111.111 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 37' ' ' ASN . 12.6 t80 -99.59 38.28 1.46 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.734 -1.229 . . . . 0.0 109.784 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.833 ' O ' HG23 ' A' ' 41' ' ' ILE . 5.3 mm-40 -81.27 -22.0 38.99 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.833 HG23 ' O ' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -172.67 52.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.427 -0.795 . . . . 0.0 109.082 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.04 -138.24 3.8 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.56 132.13 2.0 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 69.12 162.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -1.162 . . . . 0.0 109.263 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.81 -10.3 31.85 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 109.821 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -46.15 -58.86 3.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.08 -1.012 . . . . 0.0 109.51 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.467 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.0 tptt -47.0 -59.35 3.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 109.854 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.073 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -58.06 -45.26 87.38 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.032 -1.042 . . . . 0.0 109.137 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.72 ' HG2' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.77 -49.6 37.87 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.331 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.968 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -50.38 -55.63 14.86 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.972 ' CG1' HD11 ' A' ' 22' ' ' ILE . 21.6 t -43.13 -60.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.072 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -49.95 -54.89 16.96 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.527 ' HB2' ' CE ' ' A' ' 49' ' ' MET . . . -47.36 -50.63 21.75 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.73 ' HB3' HD12 ' A' ' 22' ' ' ILE . 7.3 tp-100 -46.91 -38.6 10.76 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.008 HG11 HD13 ' A' ' 63' ' ' LEU . 17.0 t -60.23 -62.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 59' ' ' TYR . 17.3 t60 -58.34 -32.82 68.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.419 -0.801 . . . . 0.0 110.046 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -74.29 -39.33 62.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.046 -1.034 . . . . 0.0 109.548 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.551 ' HB2' ' CE ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -78.29 -44.59 24.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 109.295 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.883 ' HB2' HG12 ' A' ' 61' ' ' VAL . 5.4 m-85 -110.96 -174.43 2.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 54.5 tp60 -113.54 29.15 8.22 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.883 HG12 ' HB2' ' A' ' 59' ' ' TYR . 3.4 p -93.85 134.3 31.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.654 -179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -74.34 103.61 4.78 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.465 -0.772 . . . . 0.0 110.097 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.008 HD13 HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -116.81 95.79 47.29 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.118 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.518 ' HD2' ' CG2' ' A' ' 67' ' ' VAL . 37.4 Cg_endo -82.88 169.17 13.43 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.721 2.281 . . . . 0.0 110.157 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.72 HD21 ' HG2' ' A' ' 49' ' ' MET . 1.9 mt -66.52 -37.73 85.65 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.076 -1.015 . . . . 0.0 109.045 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.27 -40.69 64.84 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.518 ' CG2' ' HD2' ' A' ' 64' ' ' PRO . 4.6 t -65.53 -43.6 94.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.073 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -58.06 -26.14 62.12 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.115 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.5 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 10.2 m-85 -86.29 -34.73 20.27 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.72 -25.39 64.73 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.915 0.864 . . . . 0.0 108.736 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.682 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -154.58 66.76 5.28 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -177.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.568 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 31.7 Cg_endo -75.1 53.99 3.55 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.767 2.311 . . . . 0.0 112.338 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 76' ' ' ALA . 14.6 t -153.23 170.03 21.58 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.591 -1.318 . . . . 0.0 111.238 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.684 HD11 ' CG ' ' A' ' 23' ' ' TRP . 9.4 mm -60.25 -71.69 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.869 -0.519 . . . . 0.0 111.776 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -50.22 -54.04 23.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.057 -1.027 . . . . 0.0 110.362 -178.049 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -53.45 -67.93 0.22 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.664 ' HB3' HD21 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -53.27 -59.32 4.72 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.479 -0.889 . . . . 0.0 109.323 -179.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.69 ' HB1' ' HG3' ' A' ' 16' ' ' GLU . . . -45.78 -44.68 14.17 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 0.6 OUTLIER -61.71 -42.42 98.92 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.056 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.04 -33.82 65.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 108.856 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.869 HG13 HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -86.98 -60.98 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.481 1.134 . . . . 0.0 108.898 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.868 ' HB2' ' CB ' ' A' ' 15' ' ' VAL . . . -53.61 -41.24 66.46 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.688 -178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.478 ' HB ' ' OE1' ' A' ' 79' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 120.927 -1.108 . . . . 0.0 109.598 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' A' ' 32' ' ' ILE . 47.8 t80 . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.693 ' O ' HG12 ' A' ' 9' ' ' VAL . 46.3 t -108.69 36.39 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.967 . . . . 0.0 110.38 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 169.27 142.73 0.07 OUTLIER Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.195 -0.941 . . . . 0.0 110.354 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 37.1 Cg_endo -84.64 -158.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.94 2.427 . . . . 0.0 110.442 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.457 ' OG1' ' OE1' ' A' ' 16' ' ' GLU . 0.6 OUTLIER -128.71 -41.93 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.429 -0.794 . . . . 0.0 109.105 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -131.8 171.73 13.17 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.593 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -73.1 -33.87 65.84 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.681 -1.262 . . . . 0.0 110.165 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.134 HG21 ' HB2' ' A' ' 82' ' ' ALA . 57.5 t -51.62 -51.68 25.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.501 ' OE1' ' CD1' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -70.45 -27.92 64.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.593 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 49.5 m -53.4 -51.68 61.81 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.799 -1.161 . . . . 0.0 108.166 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.606 ' O ' HG23 ' A' ' 22' ' ' ILE . 5.7 tptm -66.53 -62.74 1.3 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.361 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.488 ' CA ' HG23 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -39.93 -49.72 2.46 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -51.23 -51.48 53.52 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' LYS . 4.0 mt-10 -58.64 -62.79 1.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.97 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -42.89 -46.36 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.068 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.644 ' CE2' HG12 ' A' ' 74' ' ' ILE . 4.1 m95 -54.93 -70.77 0.09 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-O 121.702 0.763 . . . . 0.0 110.194 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.615 ' HA ' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -57.83 -47.33 82.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 110.272 -178.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.449 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 14.2 ttm180 -62.41 -65.18 0.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.015 -1.053 . . . . 0.0 110.302 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' ' 50' ' ' ALA . 29.5 t -61.76 -36.13 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.372 -0.83 . . . . 0.0 111.007 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 42.2 mt -84.54 -35.78 22.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.974 -1.079 . . . . 0.0 110.01 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 92.59 56.55 1.53 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.208 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.53 172.49 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -1.203 . . . . 0.0 109.159 179.507 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.2 t -131.8 39.23 3.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.198 -0.939 . . . . 0.0 109.174 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -157.36 -89.0 0.07 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 24' ' ' GLU . 10.8 mt 59.07 141.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -1.158 . . . . 0.0 109.804 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.769 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -101.77 -147.26 19.71 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.501 ' CD1' ' OE1' ' A' ' 16' ' ' GLU . 20.2 tt -113.1 9.58 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.116 -1.226 . . . . 0.0 110.285 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.004 HD23 HG21 ' A' ' 73' ' ' THR . 0.2 OUTLIER -163.01 60.28 0.19 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.778 -1.202 . . . . 0.0 110.029 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 4.1 m-20 -92.76 148.86 21.69 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -83.4 52.27 2.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.687 -1.258 . . . . 0.0 109.272 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.635 ' CE2' ' HA ' ' A' ' 72' ' ' PRO . 22.6 m-85 37.84 26.26 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.63 -0.669 . . . . 0.0 110.322 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 37' ' ' ASN . 17.3 t80 -162.52 27.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.864 -1.147 . . . . 0.0 110.57 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.486 ' HG3' ' OD1' ' A' ' 36' ' ' ASP . 62.2 mm-40 -80.53 -7.7 59.31 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER 178.04 56.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.8 134.76 4.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 44' ' ' HIS . . . -160.17 -98.89 0.14 Allowed Glycine 0 N--CA 1.489 2.21 0 O-C-N 120.949 -1.324 . . . . 0.0 109.891 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 43' ' ' GLY . 2.6 t-160 77.64 132.44 0.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -1.066 . . . . 0.0 109.146 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 t -58.53 -53.93 52.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.61 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -51.24 -54.75 22.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.761 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -55.44 -60.35 3.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 109.826 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.834 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -52.49 -44.57 65.72 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.797 -1.189 . . . . 0.0 108.73 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.947 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -50.38 -45.72 55.55 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.676 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -51.83 -56.04 16.36 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.97 ' CG1' HD11 ' A' ' 22' ' ' ILE . 34.2 t -43.82 -66.19 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.034 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.23 -44.27 32.96 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.336 -0.852 . . . . 0.0 108.721 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -58.96 -47.3 85.58 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.577 ' HG2' ' HB ' ' A' ' 22' ' ' ILE . 1.6 tp-100 -47.56 -33.24 6.24 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.593 HG21 ' HG ' ' A' ' 63' ' ' LEU . 15.0 t -67.53 -37.52 78.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 53' ' ' ALA . 36.5 t60 -77.48 -42.14 36.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.163 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -39.19 78.92 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.616 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 8.2 tp10 -74.53 -48.79 24.93 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.779 ' CD2' HG11 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -125.13 159.01 32.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.287 -0.883 . . . . 0.0 109.238 179.041 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -94.55 37.54 1.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.911 HG11 ' CG1' ' A' ' 81' ' ' VAL . 7.3 p -94.51 159.31 2.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-O 121.305 0.574 . . . . 0.0 109.834 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.458 ' N ' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -75.34 119.09 18.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 0.0 109.662 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -143.21 74.11 17.66 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.93 . . . . 0.0 108.8 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 36.2 Cg_endo -79.82 165.47 22.19 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.778 2.318 . . . . 0.0 110.267 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.947 HD21 ' SD ' ' A' ' 49' ' ' MET . 7.5 mt -65.18 -39.3 92.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.055 -1.028 . . . . 0.0 109.115 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -51.61 -45.34 63.19 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 2.7 t -61.59 -45.46 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.034 HD13 ' HB2' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -57.49 -28.9 63.83 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.441 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 49.4 m-85 -79.19 -42.91 24.98 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.739 . . . . 0.0 109.013 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.45 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.64 -34.9 79.29 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.907 0.86 . . . . 0.0 109.153 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.45 ' HG2' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -144.02 71.46 16.66 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.635 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 33.7 Cg_endo -77.09 56.01 5.25 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.829 2.353 . . . . 0.0 111.959 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 1.004 HG21 HD23 ' A' ' 35' ' ' LEU . 4.8 t -152.26 178.82 9.1 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 117.664 -1.614 . . . . 0.0 113.094 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.769 HD12 ' O ' ' A' ' 33' ' ' GLY . 1.4 mt -69.97 -78.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.514 -178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.495 ' HB2' HG12 ' A' ' 34' ' ' ILE . 5.2 tttm -41.05 -54.86 2.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.503 -0.748 . . . . 0.0 109.388 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.722 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -52.65 -63.05 1.27 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.612 -0.835 . . . . 0.0 108.826 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.574 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -48.81 -63.64 1.03 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.448 -1.407 . . . . 0.0 108.245 178.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.688 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -43.18 -31.66 0.62 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.6 OUTLIER -79.18 -46.46 17.87 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -55.4 -33.14 63.25 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.911 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -89.02 -68.3 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 122.269 1.033 . . . . 0.0 109.014 179.222 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 1.134 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -55.94 -55.3 34.28 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.648 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' GLN . 76.1 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.41 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.505 ' CD2' ' HA2' ' A' ' 33' ' ' GLY . 59.8 t80 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.305 0.574 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 t -104.12 123.74 58.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 108.719 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.824 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -49.22 170.15 0.15 Allowed Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.175 -0.953 . . . . 0.0 109.358 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.824 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 34.4 Cg_endo -77.27 139.09 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.654 2.236 . . . . 0.0 110.742 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.9 0.51 17.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.406 -0.809 . . . . 0.0 109.5 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' ALA . 1.1 m-80 -136.22 130.6 33.37 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.63 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -48.82 -34.87 13.26 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.552 -1.259 . . . . 0.0 109.711 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.959 HG21 ' HB2' ' A' ' 82' ' ' ALA . 48.4 t -44.72 -54.78 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.689 ' OE1' HD11 ' A' ' 34' ' ' ILE . 2.4 mt-10 -70.88 -30.1 66.38 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 69.8 m -55.94 -49.61 73.05 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.062 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.697 ' O ' HG22 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -70.67 -56.28 6.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.4 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.721 ' HA ' HG23 ' A' ' 22' ' ' ILE . 3.4 mm? -50.14 -43.23 51.91 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -56.54 -49.05 75.93 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -60.67 -62.35 1.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.021 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.799 ' CG1' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -45.91 -52.26 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 1.169 ' CE3' HG21 ' A' ' 32' ' ' ILE . 1.9 m95 -40.53 -67.26 0.25 Allowed 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.946 0.879 . . . . 0.0 110.417 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.628 ' HA ' HD11 ' A' ' 32' ' ' ILE . 14.6 pt-20 -63.02 -28.05 69.84 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.494 0.664 . . . . 0.0 109.903 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -73.05 -65.29 0.82 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.543 -0.723 . . . . 0.0 110.501 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.91 HG12 ' HB2' ' A' ' 47' ' ' LYS . 76.8 t -69.68 -30.98 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 110.356 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 21.9 mt -86.88 -20.66 27.12 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.118 -0.989 . . . . 0.0 110.019 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.04 62.4 2.35 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.126 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -138.39 -167.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.017 -1.284 . . . . 0.0 108.906 179.038 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.01 70.09 1.26 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.186 -0.946 . . . . 0.0 109.301 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 132.0 -73.15 0.47 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.169 HG21 ' CE3' ' A' ' 23' ' ' TRP . 6.1 mt 61.49 133.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.24 -1.153 . . . . 0.0 109.29 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.992 ' O ' HD12 ' A' ' 74' ' ' ILE . . . -52.35 -171.64 0.03 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.689 HD11 ' OE1' ' A' ' 16' ' ' GLU . 6.4 tt -106.2 8.49 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.102 -1.234 . . . . 0.0 109.188 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.823 HD12 ' CG2' ' A' ' 73' ' ' THR . 22.2 tp -157.52 48.98 0.42 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.081 -1.012 . . . . 0.0 109.872 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.642 ' O ' HG23 ' A' ' 73' ' ' THR . 5.9 m-20 -74.04 -166.38 0.39 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.117 -0.989 . . . . 0.0 110.29 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -132.48 33.35 3.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.453 -0.78 . . . . 0.0 109.122 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 72' ' ' PRO . 5.8 m-30 61.76 -52.07 0.13 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.875 -0.516 . . . . 0.0 111.245 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -81.27 25.64 0.48 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.684 -1.26 . . . . 0.0 110.925 -178.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.484 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 13.9 mm100 -80.74 -0.05 36.74 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 41' ' ' ILE . 0.8 OUTLIER 167.97 63.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.16 -137.63 2.69 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.71 -67.35 0.04 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.79 169.68 9.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -1.188 . . . . 0.0 109.465 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -98.19 -13.01 21.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.38 -0.825 . . . . 0.0 109.197 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -43.09 -59.11 2.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.368 -0.833 . . . . 0.0 109.463 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.91 ' HB2' HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -54.56 -42.82 71.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.053 -1.029 . . . . 0.0 109.115 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.011 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -52.43 -52.88 51.7 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.868 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.95 -41.79 25.85 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.906 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -50.47 -48.52 56.63 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.799 HG13 ' CG1' ' A' ' 22' ' ' ILE . 10.0 t -54.51 -55.57 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.913 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -49.27 -47.92 46.29 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -53.63 -42.63 67.96 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 8.3 tp-100 -56.47 -30.38 62.86 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.945 HG21 HD22 ' A' ' 63' ' ' LEU . 21.2 t -70.63 -43.43 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -0.825 . . . . 0.0 109.208 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 59' ' ' TYR . 3.1 t60 -77.28 -32.74 55.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.019 . . . . 0.0 109.293 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.409 ' NE ' ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -80.5 -39.22 28.33 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 108.956 179.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -74.65 -44.78 48.72 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.771 ' HB2' HG12 ' A' ' 61' ' ' VAL . 1.1 m-85 -122.27 -176.8 3.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.918 . . . . 0.0 109.233 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -114.28 35.2 4.28 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.981 HG11 HG13 ' A' ' 81' ' ' VAL . 3.2 p -93.7 158.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.572 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' N ' HG22 ' A' ' 61' ' ' VAL . 1.7 tt0 -96.65 102.36 14.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.923 . . . . 0.0 110.453 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.945 HD22 HG21 ' A' ' 55' ' ' VAL . 3.2 tp -115.83 99.89 53.0 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.53 ' HG2' HG23 ' A' ' 67' ' ' VAL . 33.7 Cg_endo -77.15 152.82 31.51 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.378 2.052 . . . . 0.0 111.035 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.868 HD21 ' SD ' ' A' ' 49' ' ' MET . 1.9 mm? -52.74 -41.7 64.24 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' PHE . 1.5 ttmt -53.44 -57.1 11.84 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.53 HG23 ' HG2' ' A' ' 64' ' ' PRO . 4.0 t -50.08 -38.69 15.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.011 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -63.87 -31.11 72.18 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 66' ' ' LYS . 2.0 m-85 -84.25 -35.07 23.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.4 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -65.77 -38.59 89.46 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.781 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.2 69.14 27.69 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 31.9 Cg_endo -78.95 69.28 7.97 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.361 2.041 . . . . 0.0 108.001 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.823 ' CG2' HD12 ' A' ' 35' ' ' LEU . 98.5 m -151.83 167.2 29.04 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.013 -1.475 . . . . 0.0 111.633 -177.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.992 HD12 ' O ' ' A' ' 33' ' ' GLY . 5.5 mt -67.41 -77.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.352 -0.842 . . . . 0.0 110.99 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.8 ' HB3' HD13 ' A' ' 35' ' ' LEU . 16.7 ttpp -45.91 -46.6 16.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.333 -0.854 . . . . 0.0 109.517 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -58.73 -68.54 0.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.96 . . . . 0.0 109.75 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.781 HD23 ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -44.55 -59.21 2.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.772 -1.205 . . . . 0.0 108.522 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.753 ' HB1' HG12 ' A' ' 15' ' ' VAL . . . -47.26 -32.91 5.01 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -77.84 -44.17 28.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 0.0 109.042 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.401 ' CD2' ' NE2' ' A' ' 71' ' ' GLN . 3.3 t80 -64.83 -29.29 70.24 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.312 -0.868 . . . . 0.0 108.974 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.981 HG13 HG11 ' A' ' 61' ' ' VAL . 21.3 t -86.68 -59.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.332 1.063 . . . . 0.0 109.309 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.959 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -58.28 -26.67 63.26 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.458 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.056 -1.028 . . . . 0.0 109.661 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.566 ' CE1' ' HA2' ' A' ' 33' ' ' GLY . 82.6 t80 . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.6 m -103.23 120.63 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 0.0 109.559 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.957 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -59.04 175.76 0.32 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.334 -0.854 . . . . 0.0 109.951 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.957 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 34.8 Cg_endo -77.63 -158.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.861 2.374 . . . . 0.0 110.896 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 p -126.62 -34.1 2.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.111 -0.993 . . . . 0.0 110.852 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 17' ' ' SER . 38.8 p-10 -122.29 169.04 11.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.841 -1.162 . . . . 0.0 109.131 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.624 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -74.65 -2.89 28.16 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.814 -1.154 . . . . 0.0 110.304 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.074 HG12 ' HB1' ' A' ' 78' ' ' ALA . 40.2 t -65.29 -55.97 17.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 78' ' ' ALA . 42.1 mt-10 -77.59 -32.01 53.35 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.624 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -63.02 -42.89 99.92 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.837 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.621 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -66.32 -63.71 1.02 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 19' ' ' LEU . 5.5 mp -45.76 -45.07 14.36 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -47.54 -51.78 19.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.791 -1.193 . . . . 0.0 108.347 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.458 ' OE1' ' NH1' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -61.43 -62.08 2.08 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.974 HD11 ' CG1' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -43.46 -43.44 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-O 122.27 1.033 . . . . 0.0 108.331 178.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.795 ' CE3' HG21 ' A' ' 32' ' ' ILE . 3.7 m95 -53.19 -67.88 0.22 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.987 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.438 ' HA ' HG23 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -64.31 -35.14 79.89 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.378 -0.826 . . . . 0.0 110.288 -179.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' NH1' ' OE1' ' A' ' 21' ' ' GLU . 27.1 ttm180 -68.83 -58.64 3.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.489 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.667 HG11 ' HB3' ' A' ' 50' ' ' ALA . 65.7 t -74.19 -37.24 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 0.0 110.823 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.46 ' CG ' ' O ' ' A' ' 23' ' ' TRP . 36.9 mt -77.22 -51.99 9.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.902 -1.124 . . . . 0.0 109.946 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.2 53.22 0.28 Allowed Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.184 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.653 ' CG2' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -137.42 -171.89 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.186 -1.185 . . . . 0.0 108.716 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.81 39.87 0.96 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.232 -0.917 . . . . 0.0 109.3 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -161.06 -80.58 0.04 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.795 HG21 ' CE3' ' A' ' 23' ' ' TRP . 6.9 mt 40.83 94.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.52 -0.988 . . . . 0.0 109.932 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.864 ' C ' HD12 ' A' ' 34' ' ' ILE . . . -59.22 -88.49 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.864 HD12 ' C ' ' A' ' 33' ' ' GLY . 5.0 mp -151.1 -58.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.994 -1.298 . . . . 0.0 110.599 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -87.25 34.93 0.69 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.16 -1.588 . . . . 0.0 109.501 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -63.34 166.97 5.74 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.438 0.637 . . . . 0.0 109.634 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 40' ' ' GLN . 1.6 m120 -106.52 116.79 32.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.213 -0.93 . . . . 0.0 108.525 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.729 ' CE1' ' CE2' ' A' ' 23' ' ' TRP . 46.6 m-85 -41.45 -27.27 0.08 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.284 -0.885 . . . . 0.0 109.793 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.454 ' N ' ' O ' ' A' ' 37' ' ' ASN . 6.5 t80 -93.02 35.96 1.05 Allowed 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.581 -1.248 . . . . 0.0 108.942 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.565 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 13.3 mm-40 -80.26 -12.96 59.57 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER 157.82 90.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.21 -137.83 2.79 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.18 -178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -139.01 -82.16 0.09 OUTLIER Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.152 -1.205 . . . . 0.0 110.215 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.75 -175.48 2.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.038 -1.272 . . . . 0.0 110.227 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 46' ' ' LEU . 2.9 p -75.18 -29.45 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -0.753 . . . . 0.0 109.601 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.546 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -42.52 -51.07 5.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.653 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -51.99 -61.96 1.93 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 109.77 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.002 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.34 -51.26 35.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.082 -1.011 . . . . 0.0 109.414 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.914 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -46.45 -47.05 19.19 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.667 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -50.86 -54.57 22.7 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.974 ' CG1' HD11 ' A' ' 22' ' ' ILE . 38.2 t -44.65 -59.13 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 177.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.962 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -51.76 -46.62 64.17 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 56' ' ' HIS . . . -53.44 -49.62 66.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.612 ' HB3' HD12 ' A' ' 22' ' ' ILE . 4.9 tp-100 -45.6 -39.9 8.21 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.836 HG11 HD12 ' A' ' 63' ' ' LEU . 2.6 t -66.36 -34.45 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.55 0.69 . . . . 0.0 109.471 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 53' ' ' ALA . 13.4 t-160 -82.13 -32.68 29.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.879 -1.138 . . . . 0.0 109.825 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -76.68 -37.01 56.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.982 -1.074 . . . . 0.0 108.566 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.501 ' HG3' ' HE2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -76.65 -51.23 11.92 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.32 -0.863 . . . . 0.0 108.859 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.613 ' HB2' HG12 ' A' ' 61' ' ' VAL . 2.0 m-85 -112.33 179.02 4.11 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.762 0.791 . . . . 0.0 109.439 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -109.85 40.51 1.89 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.028 HG11 HG13 ' A' ' 81' ' ' VAL . 4.3 p -92.9 127.06 45.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.763 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -71.19 97.09 1.47 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.722 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.836 HD12 HG11 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -112.36 102.12 53.54 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.508 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.497 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 36.4 Cg_endo -79.64 160.47 25.05 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.428 2.085 . . . . 0.0 110.688 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.914 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.2 mm? -61.69 -45.45 93.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.274 -0.891 . . . . 0.0 108.943 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.497 ' HE3' ' HB2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -52.02 -44.21 64.07 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.097 -1.002 . . . . 0.0 108.827 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.503 ' CG1' ' CD2' ' A' ' 63' ' ' LEU . 2.0 t -56.09 -42.99 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.002 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -60.29 -24.9 65.32 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.482 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 14.1 m-85 -87.31 -38.87 15.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.359 -0.838 . . . . 0.0 108.904 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' C ' ' HG2' ' A' ' 71' ' ' GLN . . . -66.85 -31.74 72.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.516 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -144.59 70.34 15.42 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.576 ' C ' ' CD2' ' A' ' 38' ' ' PHE . 33.2 Cg_endo -76.91 53.06 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.791 2.327 . . . . 0.0 111.887 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.642 ' HA ' ' CZ2' ' A' ' 23' ' ' TRP . 6.2 t -152.24 167.62 28.0 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.699 -1.251 . . . . 0.0 110.769 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.632 HD11 HG22 ' A' ' 32' ' ' ILE . 14.0 mt -68.68 -60.58 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.961 -1.087 . . . . 0.0 110.014 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.739 ' CB ' HG22 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -42.13 -58.03 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.517 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -64.88 -66.81 0.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 110.245 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.792 HD11 HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -47.77 -64.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.017 . . . . 0.0 109.309 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 1.074 ' HB1' HG12 ' A' ' 15' ' ' VAL . . . -43.69 -45.28 6.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 3.4 tp60 -62.17 -39.67 93.44 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.487 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -57.56 -34.19 68.92 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.028 HG13 HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -84.47 -69.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.856 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -43.46 -36.04 1.84 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.256 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.47 ' HB ' ' NE2' ' A' ' 79' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.025 -1.047 . . . . 0.0 109.686 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.589 ' CZ ' ' HA2' ' A' ' 33' ' ' GLY . 55.8 t80 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 15.3 m -126.22 41.43 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.134 -0.979 . . . . 0.0 109.945 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 169.71 144.06 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.919 . . . . 0.0 109.827 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 36.3 Cg_endo -82.55 -159.94 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.776 2.317 . . . . 0.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.45 ' N ' ' OE2' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -119.41 -44.69 2.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 109.403 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.465 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -126.59 168.35 14.43 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.133 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.639 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -76.47 -32.09 58.18 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.088 -1.445 . . . . 0.0 109.586 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.94 HG11 ' HB2' ' A' ' 82' ' ' ALA . 30.9 t -51.58 -54.02 14.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 13' ' ' ASN . 3.1 pt-20 -70.85 -27.34 63.77 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.639 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 68.3 m -58.21 -50.39 73.71 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.916 -1.114 . . . . 0.0 108.514 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HE3' ' OE2' ' A' ' 58' ' ' GLU . 4.0 tptt -64.26 -51.36 63.96 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.647 -0.658 . . . . 0.0 109.654 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.871 ' HA ' HG22 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -60.89 -49.06 79.01 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.571 -1.252 . . . . 0.0 108.344 179.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 23' ' ' TRP . . . -47.31 -42.41 21.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.339 -1.476 . . . . 0.0 107.498 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.48 -63.01 1.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.928 HG23 HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.94 -38.94 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.881 -1.137 . . . . 0.0 108.243 179.354 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.799 ' HB3' HD13 ' A' ' 32' ' ' ILE . 3.0 m95 -49.15 -66.96 0.31 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.884 0.849 . . . . 0.0 109.129 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.625 ' HA ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -53.86 -47.25 71.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.827 -0.545 . . . . 0.0 110.459 -178.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -60.06 -68.53 0.28 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.039 -1.038 . . . . 0.0 110.629 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.062 HG11 ' HB3' ' A' ' 50' ' ' ALA . 47.5 t -61.93 -34.67 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 110.979 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' CD1' ' CE3' ' A' ' 23' ' ' TRP . 64.7 mt -83.14 -43.67 15.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.802 -1.186 . . . . 0.0 109.991 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' GLU . . . 106.45 49.63 0.91 Allowed Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.789 -1.196 . . . . 0.0 110.685 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.625 HG23 ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -137.59 176.57 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.983 -1.304 . . . . 0.0 109.22 179.378 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 t -132.68 35.48 3.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 108.549 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . -149.83 -98.39 0.19 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.002 HG22 HD11 ' A' ' 74' ' ' ILE . 1.3 mt 53.6 104.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.054 -1.262 . . . . 0.0 108.434 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.589 ' HA2' ' CZ ' ' A' ' 8' ' ' TYR . . . -99.2 -88.12 1.95 Allowed Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.571 -1.3 . . . . 0.0 111.535 -178.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.575 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 1.7 mt -142.36 111.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.053 -1.263 . . . . 0.0 109.531 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.818 ' C ' HG22 ' A' ' 73' ' ' THR . 0.3 OUTLIER 88.62 46.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.734 0.778 . . . . 0.0 109.737 179.862 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.684 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -83.97 -148.83 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 40' ' ' GLN . 26.2 m-20 -128.26 114.3 16.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.542 -1.349 . . . . 0.0 110.8 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.772 ' HB3' ' HB2' ' A' ' 48' ' ' ALA . 66.6 m-85 -67.51 -67.56 0.45 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.973 -1.079 . . . . 0.0 108.436 178.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.552 ' CG ' ' O ' ' A' ' 39' ' ' PHE . 30.1 t80 -126.23 30.25 5.65 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.589 -0.694 . . . . 0.0 110.441 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 37' ' ' ASN . 16.9 mm-40 -79.91 -8.13 59.15 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -175.83 52.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.19 -101.45 1.76 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 44' ' ' HIS . . . 170.99 113.09 0.29 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 0.1 OUTLIER 70.03 120.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -1.11 . . . . 0.0 109.94 179.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.8 p -66.12 -15.74 63.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.925 . . . . 0.0 109.599 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.501 ' N ' HD22 ' A' ' 46' ' ' LEU . 3.2 mm? -52.39 -31.29 33.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.038 -1.038 . . . . 0.0 109.07 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.1 tptt -64.91 -71.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.184 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.025 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -46.99 -48.47 21.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.897 -1.127 . . . . 0.0 108.245 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.933 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.55 -45.23 37.36 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.425 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.062 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -49.67 -47.99 49.77 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.928 HG13 HG23 ' A' ' 22' ' ' ILE . 7.1 t -58.34 -55.81 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.865 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.65 -53.38 18.82 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.99 -43.72 50.59 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.588 ' CG ' HG13 ' A' ' 22' ' ' ILE . 8.0 tp-100 -52.51 -34.96 51.97 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.84 HG21 HD22 ' A' ' 63' ' ' LEU . 18.9 t -65.66 -49.27 78.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.567 -0.708 . . . . 0.0 109.759 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' TYR . 18.7 t60 -68.42 -33.61 74.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.969 -1.082 . . . . 0.0 109.589 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.12 -37.08 34.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.964 -1.085 . . . . 0.0 108.441 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.502 ' HG2' ' HG3' ' A' ' 54' ' ' GLN . 58.6 mm-40 -70.48 -44.38 67.81 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.889 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -136.04 175.93 9.15 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.46 40.95 1.18 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 59' ' ' TYR . 7.9 t -93.03 125.93 45.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 19.9 tt0 -68.89 92.04 0.49 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 0.0 109.292 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.84 HD22 HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -112.31 95.64 31.87 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 67' ' ' VAL . 35.4 Cg_endo -78.57 169.73 19.38 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.354 2.036 . . . . 0.0 110.553 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.933 HD21 ' SD ' ' A' ' 49' ' ' MET . 3.5 mm? -66.91 -37.17 83.86 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 0.5 OUTLIER -56.13 -55.82 28.36 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.499 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 4.4 t -48.45 -46.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.025 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -58.49 -38.08 76.9 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.488 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 8.1 m-85 -74.84 -36.56 62.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 109.291 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.408 ' C ' ' HD3' ' A' ' 72' ' ' PRO . . . -66.88 -38.77 86.93 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.324 -0.86 . . . . 0.0 109.217 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -139.23 66.06 36.83 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -178.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.536 ' CA ' ' O ' ' A' ' 68' ' ' LEU . 33.3 Cg_endo -77.19 61.31 7.23 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.973 2.448 . . . . 0.0 112.462 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.818 HG22 ' C ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -152.13 150.09 29.51 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.881 -1.137 . . . . 0.0 110.657 178.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.002 HD11 HG22 ' A' ' 32' ' ' ILE . 9.4 mt -53.73 -54.04 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.854 -1.154 . . . . 0.0 109.669 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -51.26 -65.68 0.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.97 -1.081 . . . . 0.0 109.17 -179.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.71 -63.45 1.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.51 -0.744 . . . . 0.0 109.661 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.732 HD21 HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -45.54 -67.04 0.32 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.541 -0.724 . . . . 0.0 109.128 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 74' ' ' ILE . . . -45.69 -49.84 14.16 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 1.0 OUTLIER -56.7 -40.02 74.88 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -56.31 -37.75 70.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 108.573 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.705 HG11 ' CD1' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -86.73 -63.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.619 1.199 . . . . 0.0 108.981 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.94 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -49.7 -20.77 0.88 Allowed 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.209 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.47 ' CB ' ' OE1' ' A' ' 79' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.449 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.514 ' HE2' HG23 ' A' ' 34' ' ' ILE . 41.0 t80 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 23.0 m -121.0 30.63 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.235 -0.916 . . . . 0.0 109.67 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 169.02 157.82 0.17 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.472 -0.767 . . . . 0.0 109.767 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.431 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 35.2 Cg_endo -78.74 -159.33 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.741 2.294 . . . . 0.0 110.516 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.1 m -124.55 -51.15 1.73 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.936 . . . . 0.0 109.63 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 5.7 t30 -137.37 177.29 7.98 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.609 ' HA ' ' CB ' ' A' ' 17' ' ' SER . . . -71.3 -37.54 71.82 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.654 -1.218 . . . . 0.0 109.937 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.879 HG11 ' HB2' ' A' ' 82' ' ' ALA . 56.8 t -49.74 -52.48 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 178.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.653 ' OE1' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -72.72 -22.48 60.88 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.079 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.609 ' CB ' ' HA ' ' A' ' 14' ' ' ALA . 60.5 m -58.64 -48.21 81.78 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.746 ' O ' HG22 ' A' ' 22' ' ' ILE . 7.8 tptt -68.85 -51.89 35.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.304 -0.872 . . . . 0.0 108.723 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.754 ' HA ' ' CG2' ' A' ' 22' ' ' ILE . 3.4 mm? -54.99 -36.86 65.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.653 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . . . -56.79 -48.3 78.23 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 23.7 mt-10 -64.25 -63.09 1.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.174 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.754 ' CG2' ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -47.86 -45.94 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.836 -1.165 . . . . 0.0 108.405 179.58 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.746 ' HB3' HD13 ' A' ' 32' ' ' ILE . 2.9 m95 -49.34 -68.44 0.18 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.449 0.642 . . . . 0.0 110.228 179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.675 ' HA ' HD11 ' A' ' 32' ' ' ILE . 8.8 pt-20 -61.04 -31.5 71.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 110.218 -178.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -68.56 -68.32 0.4 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 0.0 110.333 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.91 HG11 ' HB3' ' A' ' 50' ' ' ALA . 77.6 t -67.99 -33.38 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.573 -178.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 23' ' ' TRP . 37.2 mt -82.13 0.08 42.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.951 -1.093 . . . . 0.0 110.033 -179.182 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.79 56.9 22.61 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -136.84 -174.47 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -1.189 . . . . 0.0 109.161 179.518 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.3 t -153.02 60.35 0.78 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.272 -0.893 . . . . 0.0 109.322 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 32' ' ' ILE . . . 165.43 -76.65 0.14 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.141 -1.983 . . . . 0.0 108.141 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.746 HD13 ' HB3' ' A' ' 23' ' ' TRP . 6.8 mt 58.37 151.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.426 -1.044 . . . . 0.0 109.952 178.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.97 -164.26 37.66 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.557 ' HA ' HG21 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -100.94 -2.02 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.381 -1.07 . . . . 0.0 110.326 -179.727 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.611 HD12 ' HB2' ' A' ' 75' ' ' LYS . 1.6 tp -156.19 53.28 0.56 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.826 -1.171 . . . . 0.0 109.94 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.573 ' O ' ' HB ' ' A' ' 73' ' ' THR . 0.5 OUTLIER -71.45 -154.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.776 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 39' ' ' PHE . 95.2 m-20 -138.14 35.06 2.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.03 -1.044 . . . . 0.0 108.601 178.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.706 ' CE1' ' CZ2' ' A' ' 23' ' ' TRP . 12.5 m-85 56.37 -52.36 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.3 -179.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.625 ' N ' ' O ' ' A' ' 37' ' ' ASN . 72.1 t80 -83.88 29.19 0.55 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.284 -1.51 . . . . 0.0 109.945 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.565 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 5.3 mm-40 -80.4 87.82 5.62 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.565 ' CG1' ' O ' ' A' ' 40' ' ' GLN . 33.8 pt 44.52 70.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 43' ' ' GLY . . . 167.5 -128.0 1.66 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 39' ' ' PHE . . . -42.64 161.31 0.04 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -141.82 -41.93 0.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -1.116 . . . . 0.0 109.615 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 46' ' ' LEU . 81.0 p -155.24 -86.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -0.916 . . . . 0.0 109.466 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.447 ' HA ' HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -48.24 -36.7 14.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.385 -0.822 . . . . 0.0 109.387 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -60.5 -63.58 1.25 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.883 . . . . 0.0 109.515 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.077 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -49.82 -47.02 51.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.89 -1.131 . . . . 0.0 108.214 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.943 ' SD ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -49.43 -42.28 42.33 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.323 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.91 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -51.04 -49.0 61.37 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.733 HG13 ' CG1' ' A' ' 22' ' ' ILE . 15.6 t -56.23 -54.33 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.824 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -48.17 -44.27 32.33 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 50' ' ' ALA . . . -56.81 -44.84 82.36 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.609 HE21 HD13 ' A' ' 22' ' ' ILE . 9.0 tp-100 -47.71 -39.96 18.95 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.022 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.853 HG21 HD22 ' A' ' 63' ' ' LEU . 3.1 t -64.79 -32.2 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 121.328 0.585 . . . . 0.0 109.661 179.253 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 53' ' ' ALA . 7.6 t60 -82.16 -33.23 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.928 -1.108 . . . . 0.0 109.02 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -39.86 35.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.055 -1.028 . . . . 0.0 108.581 179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 1.1 mm-40 -75.92 -42.76 47.92 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.917 ' HB2' HG12 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -126.33 169.27 13.1 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.782 0.801 . . . . 0.0 109.771 179.893 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -103.23 33.21 3.39 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.698 -1.594 . . . . 0.0 106.698 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.918 HG11 HG13 ' A' ' 81' ' ' VAL . 6.2 p -93.35 121.5 44.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -68.82 99.26 1.01 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 110.297 -178.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.853 HD22 HG21 ' A' ' 55' ' ' VAL . 9.1 tp -100.9 110.17 60.17 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.563 ' HG2' ' CG2' ' A' ' 67' ' ' VAL . 35.1 Cg_endo -78.78 154.77 26.75 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.29 1.993 . . . . 0.0 110.719 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.943 HD21 ' SD ' ' A' ' 49' ' ' MET . 2.4 mm? -63.67 -42.03 98.1 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -56.72 -32.56 65.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 109.288 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.563 ' CG2' ' HG2' ' A' ' 64' ' ' PRO . 2.2 t -71.42 -36.2 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.077 HD21 ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -66.85 -25.23 66.32 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.271 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.458 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 m-85 -87.54 -35.9 17.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 108.989 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.41 ' C ' ' HD3' ' A' ' 72' ' ' PRO . . . -67.98 -37.36 81.41 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.07 0.938 . . . . 0.0 108.543 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.56 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -138.09 68.45 48.85 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -178.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . 34.5 Cg_endo -78.24 52.93 4.29 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 123.306 2.671 . . . . 0.0 113.105 -177.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.573 ' HB ' ' O ' ' A' ' 36' ' ' ASP . 15.2 t -154.65 169.37 24.05 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 116.729 -1.988 . . . . 0.0 114.042 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.557 ' N ' ' CZ2' ' A' ' 23' ' ' TRP . 9.3 mm -51.14 -64.63 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.033 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.611 ' HB2' HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -55.08 -72.98 0.06 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.099 -1.001 . . . . 0.0 109.742 -178.451 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.56 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -48.16 -62.37 1.51 Allowed 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.268 -0.895 . . . . 0.0 110.648 -179.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.569 ' CB ' ' O ' ' A' ' 73' ' ' THR . 0.5 OUTLIER -52.29 -64.8 0.7 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.963 -1.086 . . . . 0.0 109.553 -179.442 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.626 ' HB1' HG12 ' A' ' 15' ' ' VAL . . . -46.14 -43.11 14.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.064 -1.022 . . . . 0.0 109.16 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 25.2 mm-40 -65.99 -52.16 51.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.315 -0.865 . . . . 0.0 108.842 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.558 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 18.8 t80 -43.07 -41.83 3.71 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.918 HG13 HG11 ' A' ' 61' ' ' VAL . 18.4 t -74.59 -59.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 122.316 1.055 . . . . 0.0 108.991 179.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.879 ' HB2' HG11 ' A' ' 15' ' ' VAL . . . -58.77 -73.27 0.08 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.282 -179.058 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.468 -179.75 . . . . . . . . 1 1 . 1 stop_ save_